UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

(Mark One)  
(Mark One)þ 
þ
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
  For the fiscal year ended December 31, 20102011
OR
oOR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 For the transition period from                    to                     

Commission File Number 1-11239

HCA HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware 27-3865930
Delaware
27-3865930

(State or Other Jurisdiction of

Incorporation or Organization)

 (I.R.S. Employer Identification No.)
Incorporation or Organization)

One Park Plaza

Nashville, Tennessee

 
One Park Plaza
37203
Nashville, Tennessee(Zip Code)
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code:(615) 344-9551

Securities Registered Pursuant to Section 12(b) of the Act: None

Title of Each ClassName of Each Exchange on Which Registered
Common Stock, $0.01 Par ValueNew York Stock Exchange

Securities Registered Pursuant to Section 12(g) of the Act: Common Stock, $0.01 Par Value

None

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes   oþ     No   þ¨

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.     Yes   o¨     No   þ

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  þ    No  o¨

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 ofRegulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).    Yes  oþ    No  o¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 ofRegulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of thisForm 10-K or any amendment to thisForm 10-K.    ¨o

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” inRule 12b-2 of the Exchange Act.

Large accelerated filer oþ

 

Accelerated filer o¨

Non-accelerated filer ¨ Non-accelerated filer 

þSmaller reporting company ¨

(Do not check if a smaller reporting company) Smaller reporting company o

Indicate by check mark whether the Registrant is a shell company (as defined inRule 12b-2 of the Exchange Act).    Yes  o¨    No  þ

As of February 1, 2011,January 31, 2012, there were approximately 94,889,400437,618,000 outstanding shares of Registrant’s common stock outstanding. There is not a market for the Registrant’s common stock; therefore,stock. As of June 30, 2011, the aggregate market value of the Registrant’s common stock held by non-affiliates is not calculable.

nonaffiliates was approximately $5.186 billion. For purposes of the foregoing calculation only, Hercules Holding II, LLC and the Registrant’s directors and executive officers have been deemed to be affiliates.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Registrant’s definitive Information Statement in connection withproxy materials for its action on written consent2012 Annual Meeting of stockholders in lieu of an annual meetingStockholders are incorporated by reference into Part III hereof.


INDEX

INDEX
     Page
Reference
Reference
 
PART I
PART I

Item 1.

 Business   3  

Item 1A.

Risk Factors   39

Item 1B.

Risk FactorsUnresolved Staff Comments   3752  

Item 2.

Item 1B.Properties   53

Item 3.

Unresolved Staff CommentsLegal Proceedings   4853  

Item 4.

Item 2.Mine Safety Disclosures   Properties4955  
Item 3.Legal Proceedings49PART II 

Item 4.5.

 (Removed and Reserved)50
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   5155  

Item 6.

Selected Financial Data   Selected Financial Data5258  

Item 7.

 Management’s Discussion and Analysis of Financial Condition and Results of Operations   5460  

Item 7A.

 Quantitative and Qualitative Disclosures about Market Risk   7785  

Item 8.

 Financial Statements and Supplementary Data   7785  

Item 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure   7785  

Item 9A.

Controls and Procedures   85

Item 9B.

Controls and ProceduresOther Information   7788  
Item 9B.Other Information79PART III 
PART III

Item 10.

 Directors, Executive Officers and Corporate Governance   8088  

Item 11.

Executive Compensation   Executive Compensation8088  

Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   8088  

Item 13.

 Certain Relationships and Related Transactions, and Director Independence80
Item 14.Principal Accountant Fees and Services81
PART IV
Item 15.Exhibits and Financial Statement Schedules81
Signatures   89  

Item 14.

EX-10.26Principal Accountant Fees and Services89
EX-10.27PART IV

Item 15.

EX-10.29.(h)Exhibits and Financial Statement Schedules90
EX-10.29.(i)Signatures
EX-10.29.(j)
EX-10.29.(k)
EX-10.38101
EX-21
EX-23
EX-31.1
EX-31.2
EX-32


2


PART I

Item 1.

Item 1.Business
    Business

General

HCA Holdings, Inc. is one of the leading health care services companies in the United States. At December 31, 2010,2011, we operated 164163 hospitals, comprised of 158157 general, acute care hospitals; five psychiatric hospitals; and one rehabilitation hospital. The 164 hospital total includes eight hospitals (seven general, acute care hospitals and one rehabilitation hospital) owned by joint ventures in which an affiliate of HCA is a partner, and these joint ventures are accounted for using the equity method. In addition, we operated 106108 freestanding surgery centers, nine of which are owned by joint ventures in which an affiliate of HCA is a partner, and these joint ventures are accounted for using the equity method.centers. Our facilities are located in 20 states and England.

The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization (as defined below) and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The term “affiliates” means direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.

Our primary objective is to provide a comprehensive array of quality health care services in the most cost-effective manner possible. Our general, acute care hospitals typically provide a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by our general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Our psychiatric hospitals provide a full range of mental health care services through inpatient, partial hospitalization and outpatient settings.

On November 17, 2006, HCA Inc. was acquired by a private investor group, comprised ofincluding affiliates of or funds sponsored by Bain Capital Partners, LLC, (“Bain Capital”), Kohlberg Kravis Roberts & Co. (“KKR”) and Merrill Lynch Global Private Equity (“MLGPE”), now BAML Capital Partners (each a “Sponsor”), Citigroup Inc. and Bank of America Corporation (the “Sponsor Assignees”) and HCA founder, Dr. Thomas F. Frist, Jr. (the “Frist Entities”), a group we collectively refer to as(collectively, the “Investors,”“Investors”) and by members of management and certain other investors. We refer to the merger, the financing transactions related to the merger and other related transactions collectively as the “Recapitalization.” The mergertransaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities. As

During February 2011, our Board of Directors approved an increase in the number of our authorized shares to 1,800,000,000 shares of common stock and a result4.505-to-one split of our issued and outstanding common shares. All common share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements reflect the Recapitalization, our outstanding capital stock is owned by4.505-to-one split. During March 2011, we completed the Investors, certain membersinitial public offering of management and key employees. On April 29, 2008, we registered87,719,300 shares of our common stock pursuant to Section 12(g)at a price of $30.00 per share (before deducting underwriter discounts, commissions and other related offering expenses). Certain of our stockholders also sold 57,410,700 shares of our common stock in this offering. We did not receive any proceeds from the Securities Exchange Act of 1934, as amended (the “Exchange Act”), thus subjecting us toshares sold by the reporting requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended.selling stockholders. Our common stock is notnow traded on a national securities exchange.

the New York Stock Exchange (symbol “HCA”).

The Company was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. Our principal executive offices are located at One Park Plaza, Nashville, Tennessee 37203, and our telephone number is(615) 344-9551.

Corporate Reorganization

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). We are the new parent company, and HCA Inc. is now our wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of capital stock were automatically converted, on a share for share basis, into identical shares of our common stock. Our amended and restated certificate of incorporation, amended and restated by-laws, executive officers and board of directors are the same as HCA Inc.’s in effect immediately prior to the Corporate Reorganization, and the rights, privileges and interests of HCA Inc.’s stockholders remain the same with respect to us as the new holding company. Additionally, asAs a result of the


3


Corporate Reorganization, we are deemed the successor registrant to HCA Inc. under the Exchange Act, and shares of our common stock are deemed registered under Section 12(g) of the Exchange Act. As part of the Corporate Reorganization, we will becomebecame a guarantor but willdid not assume the debt of HCA Inc.’s outstanding secured notes.

We have assumed all of HCA Inc.’s obligations with respect to the outstanding shares previously registered onForm S-8 for distribution pursuant to HCA Inc.’s stock incentive plan and have also assumed HCA Inc.’s other equity incentive plans that provide for the right to acquire HCA Inc.’s common stock, whether or not exercisable. We have also assumed and agreed to perform HCA Inc.’s obligations under its other compensation plans and agreements pursuant to which HCA Inc. is to issue equity securities to its directors, officers, or employees.stock. The agreements and plans we assumed were each deemed to be automatically amended as necessary to provide that references therein to HCA Inc. now refer to HCA Holdings, Inc. Consequently, followingFollowing the Corporate Reorganization, the right to receive HCA Inc.’s common stock under its various compensation plans and agreements automatically converted into rights for the same number of shares of our common stock, with the same rights and conditions as the corresponding HCA Inc. rights prior to the Corporate Reorganization.

Available Information

We file certain reports with the Securities and Exchange Commission (“the SEC”(the “SEC”), including annual reports onForm 10-K, quarterly reports onForm 10-Q and current reports onForm 8-K. The public may read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at1-800-SEC-0330. We are an electronic filer, and the SEC maintains an Internet site athttp://www.sec.gov that contains the reports, proxy and information statements and other information we file electronically. Our website address is www.hcahealthcare.com. Please note that our website address is provided as an inactive textual reference only. We make available free of charge, through our website, our annual report onForm 10-K, quarterly reports onForm 10-Q, current reports onForm 8-K and all amendments to those reports filed or furnished pursuant to Section 13(a)13 or 15(d) of the Exchange Act, as soon as reasonably practicable after such material is electronically filed with or furnished to the SEC. The information provided on our website is not part of this report, and is therefore not incorporated by reference unless such information is specifically referenced elsewhere in this report.

Our Code of Conduct is available free of charge upon request to our Corporate Secretary, HCA Holdings, Inc., One Park Plaza, Nashville, Tennessee 37203.

Business Strategy

We are committed to providing the communities we serve with high quality, cost-effective health care while growing our business, increasing our profitability and creating long-term value for our stockholders. To achieve these objectives, we align our efforts around the following growth agenda:

grow our presence in existing markets;

achieve industry-leading performance in clinical and satisfaction measures;

• grow our presence in existing markets;
• achieve industry-leading performance in clinical and satisfaction measures;
• recruit and employ physicians to meet need for high quality health services;
• continue to leverage our scale and market positions to enhance profitability; and
• selectively pursue a disciplined development strategy.

recruit and employ physicians to meet the need for high quality health services;

continue to leverage our scale and market positions to enhance profitability; and

selectively pursue a disciplined development strategy.

Health Care Facilities

We currently own, manage or operate hospitals; freestanding surgery centers; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities.

At December 31, 2010,2011, we owned and operated 151157 general, acute care hospitals with 38,32140,988 licensed beds, and an additional seven general, acute care hospitals with 2,269 licensed beds are operated through joint ventures, which are accounted for using the equity method.beds. Most of our general, acute care hospitals provide medical and


4


surgical services, including inpatient care, intensive care, cardiac care, diagnostic services and emergency services. The general, acute care hospitals also provide outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. Each hospital has an organized medical staff and a local board of trustees or governing board, made up of members of the local community.

Our hospitals do not typically engage in extensive medical research and education programs. However, some of our hospitals are affiliated with medical schools and may participate in the clinical rotation of medical interns and residents and other education programs.

At December 31, 2010,2011, we operated five psychiatric hospitals with 506 licensed beds. Our psychiatric hospitals provide therapeutic programs including child, adolescent and adult psychiatric care, adult and adolescent alcohol and drug abuse treatment and counseling.

We also operate outpatient health care facilities which include freestanding ambulatory surgery centers (“ASCs”), freestanding emergency care facilities, diagnostic and imaging centers, comprehensive outpatient rehabilitation and physical therapy centers, outpatient radiation and oncology therapy centers and various other facilities. These outpatient services are an integral component of our strategy to develop comprehensive health care networks in select communities. Most of our ASCs are operated through partnerships or limited liability companies, with majority ownership of each partnership or limited liability company typically held by a general partner or subsidiary that is an affiliate of HCA.

Certain of our affiliates provide a variety of management services to our health care facilities, including patient safety programs; ethics and compliance programs; national supply contracts; equipment purchasing and leasing contracts; accounting, financial and clinical systems; governmental reimbursement assistance; construction planning and coordination; information technology systems and solutions; legal counsel; human resources services; and internal audit services.

Sources of Revenue

Hospital revenues depend upon inpatient occupancy levels, the medical and ancillary services ordered by physicians and provided to patients, the volume of outpatient procedures and the charges or payment rates for such services. Charges and reimbursement rates for inpatient services vary significantly depending on the type of payer, the type of service (e.g., medical/surgical, intensive care or psychiatric) and the geographic location of the hospital. Inpatient occupancy levels fluctuate for various reasons, many of which are beyond our control.

We receive paymentpayments for patient services from the federal government under the Medicare program, state governments under their respective Medicaid or similar programs, managed care plans, private insurers and directly from patients. The approximate percentages of ourOur revenues from such sources were as follows:

             
  Year Ended
 
  December 31, 
  2010  2009  2008 
 
Medicare  24%  23%  23%
Managed Medicare  7   7   6 
Medicaid  6   6   5 
Managed Medicaid  4   4   3 
Managed care and other insurers  53   52   53 
Uninsured  6   8   10 
             
Total  100%  100%  100%
             
third-party payers and the uninsured for the years ended December 31, 2011, 2010 and 2009 are summarized in the following table (dollars in millions):

   Years Ended December 31, 
   2011  Ratio  2010  Ratio  2009  Ratio 

Medicare

  $7,653    25.8 $7,203    25.7 $6,866    25.6

Managed Medicare

   2,442    8.2    2,162    7.7    2,006    7.5  

Medicaid

   1,845    6.2    1,962    7.0    1,691    6.3  

Managed Medicaid

   1,265    4.3    1,165    4.2    1,113    4.2  

Managed care and other insurers

   15,703    52.9    14,762    52.7    14,323    53.5  

International (managed care and other insurers)

   938    3.2    784    2.8    702    2.6  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   29,846    100.6    28,038    100.1    26,701    99.7  

Uninsured

   1,846    6.2    1,732    6.2    2,350    8.8  

Other

   814    2.7    913    3.3    1,001    3.7  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues before provision for doubtful accounts

   32,506    109.5    30,683    109.6    30,052    112.2  

Provision for doubtful accounts

   (2,824  (9.5  (2,648  (9.6  (3,276  (12.2
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

  $29,682    100.0 $28,035    100.0 $26,776    100.0
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Medicare is a federal program that provides certain hospital and medical insurance benefits to persons age 65 and over, some disabled persons, persons with end-stage renal disease and persons with Lou Gehrig’s Disease. Medicaid is a federal-state program, administered by the states, which provides hospital and medical benefits to qualifying individuals who are unable to afford health care. All of our general, acute care hospitals located in the United States are certified as health care services providers for persons covered under Medicare and Medicaid programs. Amounts received under Medicare and Medicaid programs are generally significantly less than established hospital gross charges for the services provided.


5


Our hospitals generally offer discounts from established charges to certain group purchasers of health care services, including private insurance companies, employers, HMOs, PPOshealth maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”) and other managed care plans. These discount programs generally limit our ability to increase revenues in response to increasing costs. See Item 1, “Business — Competition.” Patients are generally not responsible for the total difference between established hospital gross charges and amounts reimbursed for such services under Medicare, Medicaid, HMOs, or PPOs and other managed care plans, but are responsible to the extent of any exclusions, deductibles or coinsurance features of their coverage. The amount of such exclusions, deductibles and coinsurance continues to increase. Collection of amounts due from individuals is typically more difficult than from governmental or third-party payers. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care under our charity care policy. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, we attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care under our charity care policy. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.

Medicare

Medicare

Inpatient Acute Care

Under the Medicare program, we receive reimbursement under a prospective payment system (“PPS”) for general, acute care hospital inpatient services. Under the hospital inpatient PPS, fixed payment amounts per inpatient discharge are established based on the patient’s assigned Medicare severity diagnosis-related group

(“MS-DRG”). The Centers for Medicare & Medicaid Services (“CMS”) completed a two-year transition to full implementation of MS-DRGs to replace the previously used Medicare diagnosis related groups in an effort to better recognize severity of illness in Medicare payment rates. MS-DRGs classify treatments for illnesses according to the estimated intensity of hospital resources necessary to furnish care for each principal diagnosis. MS-DRG weights represent the average resources for a given MS-DRG relative to the average resources for all MS-DRGs. MS-DRG payments are adjusted for area wage differentials. Hospitals, other than those defined as “new,” receive PPS reimbursement for inpatient capital costs based on MS-DRG weights multiplied by a geographically adjusted federal rate. When the cost to treat certain patients falls well outside the normal distribution, providers typically receive additional “outlier” payments.

MS-DRG rates are updated and MS-DRG weights are recalibrated using cost relative weights each federal fiscal year (which begins October 1). The index used to update the MS-DRG rates (the “market basket”) gives consideration to the inflation experienced by hospitals and entities outside the health care industry in purchasing goods and services. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Health Reform Law”) provides for annual decreases to the market basket, including a 0.25% reduction in 2010 for discharges occurring on or after April 1, 2010. The Health Reform Law also provides for the following reductions to the market basket update for each of the following federal fiscal years: 0.25% in 2011, 0.1% in 2012 and 2013, 0.3% in 2014, 0.2% in 2015 and 2016 and 0.75% in 2017, 2018 and 2019. For federal fiscal year 2012 and each subsequent federal fiscal year, the Health Reform Law provides for the annual market basket update to be further reduced by a productivity adjustment. The amount of that reduction will be the projected, nationwide productivity gains over the preceding 10 years. To determine the projection, the Department of Health and Human Services (“HHS”) will use the Bureau of Labor Statistics (“BLS”)10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old). The Health Reform Law does not contain guidelines for use by HHS in projecting the productivity figure. Based upon the latest available data, federal fiscal year 2012 market basket reductions resulting from this productivity adjustment are likely to range from 1.0% to 1.4%. CMS estimates that the combined market basket and productivity adjustments will reduce Medicare payments under the inpatient PPS by $112.6 billion from 2010 to 2019. A decrease in paymentspayment rates or an increase in rates that is below the increase in our costs may adversely affect theour results of our operations.

For federal fiscal year 2010, CMS initially set the MS-DRG rate increase at the full market basket of 2.1%, but CMS reduced the increase to 1.85% for discharges occurring on or after April 1, 2010, as required by the Health Reform Law. For federal fiscal year 2011,

CMS increased the MS-DRG rate for federal fiscal year 2011 by 2.35%, representing the full market basket of 2.6% minus the 0.25% reduction required by the Health Reform Law. CMS also applied a documentation and coding adjustment of negative 2.9% in federal fiscal year 2011 to account for


6


increases in aggregate payments during implementation of the MS-DRG system.system, which resulted in an aggregate adjustment of negative 0.55% in federal fiscal year 2011. For federal fiscal year 2012, CMS issued a final rule that results in a net increase of 1.0%. This reduction represents half ofincrease reflects the 2.9% market basket increase, a prospective documentation and coding adjustment thatof negative 2.0%, a productivity adjustment of negative 1.0%, and a 1.1% increase in light of a January 2011 court decision. In addition, CMS intends to implement. CMS plans to recover the remaining 2.9% and interest in federal fiscal year 2012. The market basket update and themake an additional negative 1.9% documentation and coding adjustment together result in an aggregate market basketthe future, but has not specified when the adjustment for federal fiscal year 2011 of negative 0.55%. CMS has also announced that an additional prospective negative adjustment of 3.9% will be needed to avoid increased Medicare spending unrelated to patient severity of illness. CMS did not implement this additional 3.9% reduction in federal fiscal year 2011 but has stated that it will be required in the future.
made.

Further realignments in the MS-DRG system could also reduce the payments we receive for certain specialties, including cardiology and orthopedics. CMS has focused on payment levels for such specialties in recent years in part because of the proliferation of specialty hospitals. Changes in the payments received for specialty services could have an adverse effect on our results of operations.

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (“MMA”) provides for hospitals to receive a 2% reduction to their market basket updates if they fail to submit data for patient care quality indicators to the Secretary of HHS. As required by the Deficit Reduction Act of 2005 (“DRA 2005”), CMS has expanded, through a series of rulemakings, the number of quality measures that must be reported to avoid the market basket reduction. In federal fiscal year 2011,2012, CMS requires hospitals to report 55 quality measures in order to avoid the market basket reduction for inpatient PPS payments in federal fiscal year 2012.2013. All of our hospitals paid under the Medicare inpatient PPS are participating in the quality initiative by submitting the requested quality data. While we will endeavor to comply with all data submission requirements as additional requirements continue to be added, our submissions may not be deemed timely or sufficient to entitle us to the full market basket adjustment for all of our hospitals.

As part of CMS’ goal of transforming Medicare from a passive payer to an active purchaser of quality goods and services, for discharges occurring after October 1, 2008, Medicare no longer assignsdoes not allow an inpatient hospital discharge to be assigned to a higher paying MS-DRG

if a selected hospital acquired condition (“HAC”) was not present on admission. In this situation, the case is paid as though the secondary diagnosis was not present. Currently, there are ten categories of conditions on the list of HACs. In addition, CMS has established three National Coverage Determinations that prohibit Medicare reimbursement for erroneous surgical procedures performed on an inpatient or outpatient basis. The Health Reform Law provides for reduced payments based on a hospital’s HAC rates. Beginning in federal fiscal year 2015, the 25% of hospitals with the worst national risk-adjusted HAC rates in the previous year will receive a 1% reduction in their total inpatient operating Medicare payments. In addition, effective July 1, 2011, the Health Reform Law prohibits the use of federal funds under the Medicaid program to reimburse providers for medical services provided to treat HACs.

The Health Reform Law also provides for reduced payments to hospitals based on readmission rates. Beginning in federal fiscal year 2013, inpatient payments will be reduced if a hospital experiences “excessive” readmissions within athe 30-day time period specified by HHS from the date of discharge for heart attack, heart failure, pneumonia or other conditions that may be designated by HHS.CMS. Hospitals with what HHSCMS defines as excessive readmissions for these conditions will receive reduced payments for all inpatient discharges, not just discharges relating to the conditions subject to the excessive readmission standard. Each hospital’s performance will be publicly reported by HHS. HHS has the discretion to determine what “excessive” readmissions means and other terms and conditionsCMS. On August 1, 2011, CMS issued a final rule implementing portions of this program.

program but indicated that it will issue in future rulemakings additional policies with respect to excessive readmissions, including the specific payment adjustment methodology.

The Health Reform Law additionally establishes a value-based purchasing program to further link payments to quality and efficiency. In federal fiscal year 2013, HHS is directed to implement a value-based purchasing program for inpatient hospital services. Beginning in federal fiscal year 2013, CMS will reduce the inpatient PPS payment amount for all discharges by the following: 1% for 2013; 1.25% for 2014; 1.5% for 2015; 1.75% for 2016; and 2% for 2017 and subsequent years. For each federal fiscal year, the total amount collected from these reductions will be pooled and used to fund payments to reward hospitals that meet certain quality performance standards established by HHS. The Health Reform Law provides HHS will determine the quality performance measures, the standards hospitals must achieve in order to meet the quality performance measures and the methodology for calculating payments to hospitals that meet the required quality threshold. HHS will also determine the amount each hospital that meets or exceeds the quality performance standards will receive from the pool of dollars created by the reductions related towith considerable discretion over the value-based


7


purchasing program. On January 7,April 29, 2011, CMS issued a proposedfinal rule forestablishing the value-based purchasing program for hospital inpatient services. Under this final rule, CMS estimates it will distribute $850 million in federal fiscal year 2013 to hospitals based on their overall performance on a set of quality measures that would use 17have been linked to improved clinical processprocesses of care measures and eight dimensionspatient satisfaction. For payments in federal fiscal year 2013, hospitals will be scored based on a weighted average of a patient’spatient experience of carescores using the Hospital Consumer Assessment of Healthcare Providers and Systems (“HCAHPS”) survey to determine incentive payments for federal fiscal year 2013. As proposed, the incentive payments would be calculatedand 12 clinical process-of-care measures. CMS will score each hospital based on a combination of measures of hospitals’ achievement (relative to other hospitals) and improvement ranges (relative to the hospital’s own past performance) for each applicable measure. Because the Health Reform Law provides that the pool will be fully distributed, hospitals that meet or exceed the quality performance standards will receive greater reimbursement under the value-based purchasing program than they would have otherwise. Hospitals that do not achieve the necessary quality performance will receive reduced Medicare inpatient hospital payments. CMS will notify each hospital of the performance standards and their improvement in meeting the performance standards compared to prior periods. To determine payments in federalamount of its value-based incentive payment for fiscal year 2013 the baseline performance period (measurement standard) as proposed would be Julydischarges on November 1, 2009 through March 31, 2010. To determine whether hospitals meet performance standards, CMS would compare each hospital’s performance in the period July 1, 2011 through March 31, 2012 to its performance in the baseline performance period. CMS has not yet proposed specific threshold values for the performance standards. CMS also proposes to add three outcome measures for federal fiscal year 2014, for which the performance period would be July 1, 2011 through December 31, 2012 and the baseline performance period would be July 1, 2008 through December 31, 2009.
2012.

Historically, the Medicare program has set aside 5.10% of Medicare inpatient payments to pay for outlier cases. For federal fiscal year 2010,2011, CMS established an outlier threshold of $23,140,$23,075, and for federal fiscal year 2011,2012, CMS reduced the outlier threshold to $23,075.$22,385. We do not anticipate that the decrease to the outlier threshold for federal fiscal year 20112012 will have a material impact on our results of operations.

Outpatient

CMS reimburses hospital outpatient services (and certain Medicare Part B services furnished to hospital inpatients who have no Part A coverage) on a PPS basis. CMS uses fee schedules to pay for physical, occupational and speech therapies, durable medical equipment, clinical diagnostic laboratory services and nonimplantable orthotics and prosthetics, freestanding surgery centerscenter services and services provided by independent diagnostic testing facilities.

Hospital outpatient services paid under PPS are classified into groups called ambulatory payment classifications (“APCs”). Services for each APC are similar clinically and in terms of the resources they require. A payment rate is established for each APC. Depending on the services provided, a hospital may be paid for more than one APC for a patient visit. The APC payment rates wereare updated for each calendar years 2008 and 2009 by market baskets of 3.30% and 3.60%, respectively.year. For calendar year 2011, CMS updatedincreased APC payment rates for calendar year 2010 by the full2.35%, which represented a market basket update of 2.1%. However,2.6% and a 0.25% reduction required by the Health Reform Law includes a 0.25% reduction to the market basket for 2010.Law. The Health Reform Law also provides for the following reductions to the market basket update for each of the following calendar years: 0.25% in 2011, 0.1% in 2012 and 2013, 0.3% in 2014, 0.2% in 2015 and 2016 and 0.75% in 2017, 2018 and 2019. For calendar year 2011, CMS implemented a market basket update of 2.6%. With the 0.25% reduction required by the Health Reform Law, this update results in a market basket increase of 2.35%. For calendar year 2012 and each subsequent calendar year, the Health Reform Law provides for an annual market basket update to be further reduced by a productivity adjustment. The amount of that reduction will be the projected, nationwide productivity gains over the preceding 10 years. To determine the projection, HHS will use the BLS10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old). The Health Reform Law does not contain guidelines for use by HHS in projecting the productivity figure. However, CMS estimates that the combined market basket and productivity adjustments will reduce Medicare payments under the outpatient PPS by $26.3 billion from 2010 to 2019. CMS has issued a final rule that increases the APC payment rate for calendar year 2012 by 1.9%, which includes the full market basket update of 3.0%, a negative 1.0% productivity adjustment and the negative 0.1% adjustment required by the Health Reform Law. CMS continues to require hospitals to submit quality data relating to outpatient care to avoid receiving a 2% reduction to the market basket update under the outpatient PPS. CMS required hospitals to report data on 1115 quality measures in calendar year 20102011 for the payment determination in calendar year 20112012 and requires hospitals to report 1523 quality measures in calendar year 20112012 to avoid reduced payments in calendar year 2012.

2013.

Rehabilitation

CMS reimburses inpatient rehabilitation facilities (“IRFs”) on a PPS basis. Under the IRF PPS, patients are classified into case mix groups based upon impairment, age, comorbidities (additional diseases or disorders from which the patient suffers) and functional capability. IRFs are paid a predetermined amount per discharge that reflects the patient’s case mix group and is adjusted for area wage levels, low-income patients, rural areas and high-cost outliers. CMS provided for a market basket update of 2.5% forFor federal fiscal year 2010. However, the Health


8


Reform Law requires a 0.25% reduction to2011, CMS updated the market basket for 2010 for discharges occurring on or after April 1, 2010.by 2.25%, which represented the full market basket of 2.5% reduced by 0.25% as required by the Health Reform Law. The Health Reform Law also provides for the following reductions to the market basket update for each of the following federal fiscal years: 0.25% in 2011, 0.1% in 2012 and 2013, 0.3% in 2014, 0.2% in 2015 and 2016 and 0.75% in 2017, 2018 and 2019. For federal fiscal year 2011, CMS implemented a market basket update of 2.5%. With the 0.25% reduction required by the Health Reform Law, this update results in a market basket increase of 2.25% for federal fiscal year 2011. For federal fiscal year 2012 and each subsequent federal fiscal year, the Health Reform Law provides for the annual market basket update to be further reduced by a productivity adjustment. The amount of that reduction will be the projected, nationwide productivity gains over the preceding 10 years. To determine the projection, HHS will use the BLS10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old). The Health Reform Law does not contain guidelines for use by HHS in projecting the productivity figure. However, CMS estimates that the combined market basket and productivity adjustments will reduce Medicare payments under the IRF PPS by $5.7 billion from 2010 to 2019. For federal fiscal year 2012, CMS has issued a final rule updating inpatient rehabilitation payment rates by 2.2%, which reflects a 2.9% market basket increase, a negative 1.0% productivity adjustment, a 0.1% reduction required by the Health Reform Law, and a 0.4% increase resulting from an update to the outlier threshold amount. Beginning in federal fiscal year 2014, IRFs will be required to report quality measures to CMS or will receive a two percentage point reduction to the market basket update. As of December 31, 2010, we had one rehabilitation hospital, which is operated through a joint venture, and 43 hospital rehabilitation units.
On May 7, 2004, CMS published a final rule

In order to change the criteriaqualify for being classifiedclassification as an IRF. Pursuant to that final rule, 75%IRF, at least 60% of a facility’s inpatients over a given year had toduring the most recent 12-month CMS-defined review period must have been treated for at least one of 10 specified conditions, and a subsequent regulation expanded the number of specified conditions to 13. Since then, several statutory and regulatory adjustments have been made to the rule, including adjustments to the percentage of a facility’s patients that must be treatedrequired intensive rehabilitation services for one or more of the 13 specified conditions. Currently, the compliance threshold is set by statute at 60%. Implementation of this 60% threshold has reduced our IRF admissions and can be expected to continue to restrict the treatment of patients whose medical conditions do not meet any of the 13 approved conditions. In addition, effective January 1, 2010, IRFs must also meet additional coverage criteria, including patient selection and care requirements relating to pre-admission screenings, post-admission evaluations, ongoing coordination of care and involvement of rehabilitation physicians. A facility that fails to meet the 60% threshold or other criteria to be classified as an IRF will be paid under the acute care hospital inpatient or outpatient PPS, which generally provide for lower payment amounts.

As of December 31, 2011, we had one rehabilitation hospital and 42 hospital rehabilitation units.

Psychiatric

Inpatient hospital services furnished in psychiatric hospitals and psychiatric units of general, acute care hospitals and critical access hospitals are reimbursed under a prospective payment system (“IPF(the “IPF PPS”), a per diem payment, with adjustments to account for certain patient and facility characteristics. The IPF PPS contains an “outlier” policy for extraordinarily costly cases and an adjustment to a facility’s base payment if it maintains a full-service emergency department. CMS has established the IPF PPS payment rate in a manner intended to be budget neutral and historically has adoptedused a July 1 update cycle, with each twelve month period referred to as a “rate year.” However, CMS has issued a proposedfinal rule that includes changingwill transition the IPF PPS from the rateto a federal fiscal year update cycle to a fiscal year schedule. If implemented as proposed,cycle. Accordingly, the rates for 2012 wouldwill be effective from July 1, 2011 through September 30, 2012, with future updates coinciding with the federal fiscal year (from October 1 through September 30). The rehabilitation, psychiatric and long-term care (“RPL”) market basket update is used to update the IPF PPS. The annual RPL market basket update for rate year 2010 was 2.1%, and the annual RPL market basket update forFor rate year 2011, isCMS updated the market basket by 2.15%, representing the full market basket of 2.4%. However, reduced by 0.25% as required by the Health Reform Law includes a 0.25% reduction to the market basket for rate year 2010 and again in 2011.Law. The Health Reform Law also provides for the following reductions to the market basket update for ratepayment years that begin in the following calendar years: 0.1% in 2012 and 2013, 0.3% in 2014, 0.2% in 2015 and 2016 and 0.75% in 2017, 2018 and 2019. For rate year 2012 and each subsequent ratepayment year, the Health Reform Law provides for the annual market basket update to be further reduced by a productivity adjustment. The amount of that reduction will be the projected, nationwide productivity gains over the preceding 10 years. To determine the projection, HHS will use the BLS10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old). The Health Reform Law does not contain guidelines for use by HHS in projecting the productivity figure. However, CMS estimates that the combined market basket and productivity adjustments will reduce Medicare payments under the IPF PPS by $4.3 billion from 2010 to 2019. In a proposed rule,For rate year 2012, which will span 15 months from July 1, 2011 through September 30, 2012, CMS proposesincreased inpatient psychiatric payment rates by 2.95%, which includes a market basket updateincrease of 3.0% for rate year 2012. If implemented as proposed,3.2% and with thea 0.25% reduction


9


required by the Health Reform Law, this would result in a market basket update of 2.75%.Law. As of December 31, 2010,2011, we had five psychiatric hospitals and 3536 hospital psychiatric units.

Ambulatory Surgery Centers

CMS reimburses ASCs using a predetermined fee schedule. Reimbursements for ASC overhead costs are limited to no more than the overhead costs paid to hospital outpatient departments under the Medicare hospital outpatient PPS for the same procedure. Effective January 1, 2008, ASC payment groups increased from nine clinically disparate payment groups to an extensive list of covered surgical procedures among the APCs used under the outpatient PPS for these surgical services. Because the new payment system has a significant impact on payments for certain procedures, for services previously in the nine payment groups, CMS has established a four-year transition period for implementing the required payment rates. Moreover, ifIf CMS determines that a procedure is commonly performed in a physician’s office, the ASC reimbursement for that procedure is limited to the reimbursement allowable under the Medicare Part B Physician Fee Schedule, with limited exceptions. In addition, allAll surgical procedures, other than those that pose a significant safety risk or generally require an overnight stay, are payable as ASC procedures. As aFrom time to time, CMS considers expanding the services that may be performed in ASCs, which may result in more Medicare procedures nowthat historically have been performed in hospitals may bebeing moved to ASCs, reducing surgical volume in our hospitals. Also, more Medicare procedures nowthat historically have been performed in ASCs may be moved to physicians’ offices. Commercial third-party payers may adopt similar policies. The Health Reform Law requires HHS to issue a plan by January 1, 2011 for developing a value-based purchasing program for ASCs, but HHS has not yet publicly issued this plan. Such a program may further impact Medicare reimbursement of ASCs or increase our operating costs in order to satisfy the value-based standards. For federal fiscal year 2011 and each subsequent federal fiscal year, the Health Reform Law provides for the annual market basket update to be reduced by a productivity adjustment. The amount of that reduction will be the projected nationwide productivity gains over the preceding 10 years. To determine the projection, HHS will use the BLS10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old).

The Health Reform Law also required HHS to submit a report to Congress on plans for developing a value-based purchasing program for ASCs. In its report, HHS recommends a phased-in approach for implementing a value-based purchasing program but states additional statutory authority would be required to allow performance-based payments. CMS issued a final rule on November 1, 2011 that provides for a 1.6% annual update to ASC payments for calendar year 2012, which includes the market basket update of 2.7% and a negative 1.1% productivity adjustment. The final rule also establishes a quality reporting program for ASCs under which ASCs that fail to report on five quality measures beginning on October 1, 2012 will receive a 2% reduction in reimbursement for calendar year 2014.

Physician Services

Physician services are reimbursed under the physician fee schedule (“PFS”) system, under which CMS has assigned a national relative value unit (“RVU”) to most medical procedures and services that reflects the various resources required by a physician to provide the services relative to all other services. Each RVU is calculated based on a combination of work required in terms of time and intensity of effort for the service, practice expense (overhead) attributable to the service and malpractice insurance expense attributable to the service. These three elements are each modified by a geographic adjustment factor to account for local practice costs and are then aggregated. The aggregated amount is multiplied by a conversion factor that accounts for inflation and targeted growth in Medicare expenditures (as calculated by the sustainable growth rate (“SGR”)) to arrive at the payment amount for each service. While RVUs for various services may change in a given year, any alterations are required by statute to be virtually budget neutral, such that total payments made under the PFS may not differ by more than $20 million from what payments would have been if adjustments were not made.

The PFS rates are adjusted each year, and reductions in both current and future payments are anticipated. The SGR formula, if implemented as mandated by statute, would result in significant reductions to payments under the PFS. Since 2003, the U.S. Congress has passed multiple legislative acts delaying application of the SGR to the PFS. ForThe most recent legislative delay extends calendar year 2011 CMS issued a final rule that would have applied the SGR and resulted in an aggregate reduction of 24.9% to all physician payments under the PFS for federal fiscal year 2011. Onpayment rates through December 15, 2010, President Obama signed legislation delaying application of the SGR until January 1,31, 2012. We cannot predict whether the U.S. Congress will intervene to prevent this reduction to payments in the future.

Barring delay or repeal of the SGR by Congress, Medicare payments to physicians are scheduled to be cut by more than 30% effective January 1, 2013.

Other

Under PPS, the payment rates are adjusted for the area differences in wage levels by a factor (“wage index”) reflecting the relative wage level in the geographic area compared to the national average wage level. Beginning in federal fiscal year 2007, CMS adjusted 100% of the wage index factor for occupational mix. The redistributive impact of wage index changes, while slightly negative in the aggregate, is not anticipated to have a material


10


financial impact for 2011.2012. However, the Health Reform Law requires HHS to report toprovide Congress by December 31, 2011 with recommendations on how to comprehensively reform the Medicare wage index system.

Medicare reimburses hospitals for a portion of bad debts resulting from deductible and coinsurance amounts that are uncollectible from Medicare beneficiaries. The Middle Class Tax Relief and Jobs Creation Act of 2012 (the “Jobs Creation Act”) reduces the percentage of bad debt amounts that Medicare reimburses from 70% to 65% beginning in federal fiscal year 2013. These reductions are intended to offset, in part, the impact of the most recent legislative delay of the SGR reductions in physician compensation under the PFS. The U.S. Congress has not permanently addressed the SGR reductions, and any further delays or revisions to the SGR may be offset by additional reductions in Medicare payments to other types of providers.

As required by the MMA, CMS is implementing contractor reform whereby CMS has competitively bid the Medicare fiscal intermediary and Medicare carrier functions to 15 Medicare Administrative Contractors (“MACs”), which are geographically assigned and service both Part A and Part B providers within a given jurisdiction. Although CMS has awarded initial contracts to all 15 MAC jurisdictions, full transition to the MAC jurisdictions has been delayed due to CMS resoliciting some bids and implementing other corrective actions in response to filed protests. While chain providers had the option of having all hospitals use one home office MAC, HCA chose to use the MACs assigned to the geographic areas in which our hospitals are located. The individual MAC jurisdictions are in varying phases of transition. During the transition periods and for a potentially unforeseen period thereafter, all of these changes could impact claims processing functions and the resulting cash flow; however, we are unable to predict the impact at this time.

Under the Recovery Audit Contractor (“RAC”) program, CMS contracts with RACs on a contingency basis to conduct post-payment reviews to detect and correct improper payments in the fee-for-service Medicare program. The RAC program was originally limited to certain states, but in 2010, CMS has implemented the RAC program on a permanent, nationwide basis as required by statute.

The U.S. Congress has not permanently addressed the SGR reductions in physician compensation under the PFS. Any repeal of the SGR may be offset by reductions in Medicare payments to other types of providers.

Managed Medicare

Managed Medicare plans relate to situations where a private company contracts with CMS to provide members with Medicare Part A, Part B and Part D benefits. Managed Medicare plans can be structured as HMOs, PPOs or privatefee-for-service plans. The Medicare program allows beneficiaries to choose enrollment in certain managed Medicare plans. In 2003, MMA increased reimbursement to managed Medicare plans and expanded Medicare beneficiaries’ health care options. Since 2003, the number of beneficiaries choosing to receive their Medicare benefits through such plans has increased. However, the Medicare Improvements for Patients and Providers Act of 2008 imposed new restrictions and implemented focused cuts to certain managed Medicare plans. In addition, the Health Reform Law reduces, over a three year period starting in 2012, premium payments to managed Medicare plans such that CMS’ managed care per capita premium payments are, on average, equal to traditional Medicare. The Health Reform Law also implements fee payment adjustments based on service benchmarks and quality ratings. The Congressional Budget Office (“CBO”) has estimated that, as a result of these changes, payments to plans will be reduced by $138 billion between 2010 and 2019, while CMS has estimated the reduction to be $145 billion. In addition, the Health Reform Law expands the RAC program to include managed Medicare plans. In light of the current economic downturn and the Health Reform Law, managed Medicare plans may experience reduced premium payments, which may lead to decreased enrollment in such plans.

Medicaid

Medicaid programs are funded jointly by the federal government and the states and are administered by states under approved plans. Most state Medicaid program payments are made under a PPS or are based on negotiated payment levels with individual hospitals. Medicaid reimbursement is often less than a hospital’s cost of services. The Health Reform Law also requires states to expand Medicaid coverage to all individuals under age 65 with incomes up to 133% of the federal poverty level (“FPL”) by 2014. However, the Health Reform Law also requires states to apply a “5% income disregard” to the Medicaid eligibility standard, so that Medicaid eligibility will effectively be extended to those with incomes up to 138% of the FPL. In addition, effective July 1, 2011, the Health Reform Law will prohibitprohibits the use of federal funds under the Medicaid program to reimburse providers for medical assistance provided to treat HACs.

However, CMS has delayed enforcement of this prohibition until July 1, 2012. In a final rule issued June 1, 2011, CMS authorizes states to add additional provider-preventable conditions to the list of HACs for which Medicaid reimbursement will not be allowed.

Since most states must operate with balanced budgets and since the Medicaid program is often the state’s largest program, states can be expected to adopt or consider adopting legislation designed to reduce their Medicaid expenditures. The current economic downturn has increased the budgetary pressures on most states, and these budgetary pressures have resulted and likely will continue to result in decreased spending, or decreased spending growth, for Medicaid programs in many states. The American Recovery and Reinvestment Act of 2009 (“ARRA”) allocated approximately $87.0 billion to temporarily increase the share of program costs paid by the federal government to fund each state’s Medicaid program.


11


Although initially scheduled to expire at the end of 2010, Congress has allocated additional funds to extend this increased federal funding to states through June 2011. TheseAlthough these increased funds have helpedprovided a benefit to state Medicaid programs by temporarily helping to avoid more extensive program and reimbursement cuts, but the expiration of the increased federal funding could result in significant reductions to state Medicaid programs.
Further, as permitted by law, certain

Certain states in which we operate have adopted broad-based provider taxes to fund the non-federal share of Medicaid programs. Many states have also adopted, or are considering, legislation designed to reduce coverage, enroll Medicaid recipients in managed care programsand/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. Effective March 23, 2010, the Health Reform Law requires states to at least maintain Medicaid eligibility standards established prior to the enactment of the law for adults until January 1, 2014 and for children until October 1, 2019. However, states with budget deficits may seek a waiver from this requirement to address eligibility standards that apply to adults making more than 133% of the FPL.

Through DRA 2005, Congress has expanded the federal government’s involvement in fighting fraud, waste and abuse in the Medicaid program by creating the Medicaid Integrity Program. Among other things, DRA 2005 requires CMS to employ private contractors, referred to as Medicaid Integrity Contractors (“MICs”), to perform post-payment audits of Medicaid claims and identify overpayments. MICs are assigned to five geographic regions and have commenced audits in states assigned to those regions. The Health Reform Law increases federal funding for the MIC program for federal fiscal year 2011 and later years. In addition to MICs, several other contractors and state Medicaid agencies have increased their review activities. The Health Reform Law expands the RAC program’s scope to include Medicaid claims.

Managed Medicaid

Managed Medicaid programs enable states to contract with one or more entities for patient enrollment, care management and claims adjudication. The states usually do not relinquish program responsibilities for financing, eligibility criteria and core benefit plan design. We generally contract directly with one of the designated entities, usually a managed care organization. The provisions of these programs are state-specific.

Enrollment in managed Medicaid plans has increased in recent years, as state governments seek to control the cost of Medicaid programs. However, general economic conditions in the states in which we operate may require reductions in premium payments to these plans and may reduce enrollment in these plans.

Electronic Health Records
ARRA provides for Medicare and Medicaid incentive payments beginning in federal fiscal year 2011 for eligible hospitals and calendar year 2011 for eligible professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. A total of at least $20 billion in incentives is being made available through the Medicare and Medicaid EHR incentive programs to eligible hospitals and eligible professionals in the adoption of EHRs.
Under the Medicare incentive program, acute care hospitals that demonstrate meaningful use will receive incentive payments for up to four fiscal years. The Medicare incentive payment amount is the product of three factors: (1) an initial amount comprised of a base amount of $2,000,000 plus $200 for each acute care inpatient discharge during a payment year, beginning with a hospital’s 1,150th discharge of the year and ending with a hospital’s 23,000th discharge of the year; (2) the “Medicare share,” which is the sum of Medicare Part A and Part C acute care inpatient-bed-days divided by the product of the total inpatient-bed-days and a charity care factor; and (3) a transition factor applicable to the payment year. In order to maximize their incentive payments, acute care hospitals must participate in the incentive program by federal fiscal year 2013. Beginning in federal fiscal year 2015, acute care hospitals that fail to demonstrate meaningful use of certified EHR technology will receive reduced market basket updates under inpatient PPS.
Eligible professionals who demonstrate meaningful use are entitled to incentive payments for up to five payment years in an amount equal to 75% of their estimated Medicare allowed charges for covered professional services furnished during the relevant calendar year, subject to an annual limit. Eligible professionals must participate in the incentive payment program by calendar year 2012 in order to maximize their incentive payments and must participate by calendar year 2014 in order to receive any incentive payments. Beginning in calendar year


12


2015, eligible professionals who do not demonstrate meaningful use of certified EHR technology will face Medicare payment reductions.
The Medicaid EHR incentive program is voluntary for states to implement. For participating states, the Medicaid EHR incentive program will provide incentive payments for acute care hospitals and eligible professionals that meet certain volume percentages of Medicaid patients as well as children’s hospitals. Providers may only participate in a single state’s Medicaid EHR incentive program. Eligible professionals can only participate in either the Medicaid incentive program or the Medicare incentive program and can change this election only one time. Hospitals may participate in both the Medicare and Medicaid incentive programs.
To qualify for incentive payments under the Medicaid program, providers must adopt, implement, upgrade or demonstrate meaningful use of, certified EHR technology during their first participation year or successfully demonstrate meaningful use of certified EHR technology in subsequent participation years. Payments may be received for up to six participation years. For hospitals, the aggregate Medicaid EHR incentive amount is the product of two factors: (1) the overall EHR amount which is comprised of a base amount of $2,000,000 plus adischarge-related amount, multiplied by the Medicare share (which is set at one by statute) multiplied by a transition factor, and (2) the “Medicaid share,” which is the estimated Medicaid inpatient-bed days plus estimated Medicaid managed care inpatientbed-days, divided by the product of the estimated total inpatientbed-days and a charity care factor. Under the Medicaid incentive program, eligible professionals may receive payments based on their EHR costs, up to total amount of $63,750, or for pediatricians, $42,500. There is no penalty for hospitals or professionals under Medicaid for failing to meet EHR meaningful use requirements.
Accountable Care Organizations and Pilot ProjectsBundled Payment Initiatives

The Health Reform Law requires HHS to establish a Medicare Shared Savings Program (“MSSP”) that promotes accountability and coordination of care through the creation of Accountable Care Organizations (“ACOs”), beginning no later than January 1, 2012. The program will allow certain providers and suppliers (including hospitals),hospitals, physicians and other designated professionals and suppliersprofessionals) to voluntarily form ACOs and voluntarily work together along with other ACO participants to invest in infrastructure and redesign delivery processes to achieve high quality and efficient delivery of services. The program is intended to produce savings as a result of improved quality and operational efficiency. ACOs that achieve quality performance standards established by HHS will be eligible to share in a portion of the amounts saved by the Medicare program. HHS has significant discretion to determine key elements of the program, including what steps providers must takeprogram. In 2011, CMS, the HHS Office of Inspector General (the “OIG”) and certain other federal agencies released a series of rules and guidance further defining and implementing the ACO program. These rules and guidance provide for two different ACO tracks, the first of which allows ACOs to be considered an ACO, howshare only in the savings under the MSSP. The second track requires ACOs to decide if Medicare programshare in any savings have occurred,or losses under the MSSP but offers ACOs a greater share of any savings realized under the MSSP. As authorized by the Health Reform Law, the rules and what portion of such savings will be paid toguidance also provide for certain waivers from fraud and abuse laws for ACOs. In addition, HHS will determinebeginning January 1, 2012, CMS has authorized 32 organizations to what degree hospitals, physicians and other eligible participants will be ableparticipate in the “Pioneer” ACO program, which is similar to, form and operate an ACO without violating certain existing laws, includingbut separate from, the Civil Monetary Penalty Law,ACOs created under the Anti-kickback Statute and the Stark Law. MSSP regulations.

The Health Reform Law does not authorize HHS to waive other laws that may impactcreated the ability of hospitalsCenter for Medicare and Medicaid Innovation with responsibility for establishing demonstration projects and other eligible participantsinitiatives in order to participate in ACOs, such as antitrust laws.

Theidentify, develop, test and encourage the adoption of new methods of delivering and paying for healthcare that create savings under the Medicare and Medicaid programs while improving quality of care. For example, the Center for Medicare and Medicaid Innovation has announced a voluntary bundled payment initiative that will link payments to participating providers for services provided during an episode of care. In addition, the Health Reform Law requires HHS to establish a five-year, voluntary national bundled payment pilot program for Medicare services beginning no later than January 1, 2013. Under the program, providers would agree to receive one payment for services provided to Medicare patients for certain medical conditions or episodes of care. HHS will have the discretion to determine how the program will function. For example, HHS will determine what medical conditions will be included in the program and the amount of the payment for each condition. In addition, the Health Reform Law provides for a five-year bundled payment pilot program for Medicaid services to begin January 1, 2012.services. HHS willmay select up to eight states to participate, based on the potential to lower costs under the Medicaid program while improving care. Stateand these state programs may target particular categories of beneficiaries, selected diagnoses or geographic regions of the state. The selected state programs will provide one payment for both hospital and physician services provided to Medicaid patients for certain episodes of inpatient care. For both pilot programs, HHS will determine the relationship between the programs and restrictions in certain existing laws, including the Civil Monetary Penalty Law, the Anti-kickback Statute, the Stark Law and the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) privacy, security and transaction standard requirements. However, the Health Reform Law does not authorize HHS to waive other laws that may impact the ability of hospitals and other eligible participants to participate in the pilot programs, such as antitrust laws.


13


Disproportionate Share Hospital Payments

In addition to making payments for services provided directly to beneficiaries, Medicare makes additional payments to hospitals that treat a disproportionately large number of low-income patients (Medicaid and Medicare patients eligible to receive Supplemental Security Income). Disproportionate share hospital (“DSH”) payments are determined annually based on certain statistical information required by HHS and are calculated as a percentage addition to MS-DRG payments. The primary method used by a hospital to qualify for Medicare DSH payments is a complex statutory formula that results in a DSH percentage that is applied to payments on MS-DRGs.

Under the Health Reform Law, beginning in federal fiscal year 2014, Medicare DSH payments will be reduced to 25% of the amount they otherwise would have been absent the law. The remaining 75% of the amount that would otherwise be paid under Medicare DSH will be effectively pooled, and this pool will be reduced further each year by a formula that reflects reductions in the national level of uninsured who are under 65 years of age. Each DSH hospital will then be paid, out of the reduced DSH payment pool, an amount allocated based upon its level of uncompensated care. It is difficult to predict the full impact of the Medicare DSH reductions. The CBO estimates $22 billion in reductions to Medicare DSH payments between 2010 and 2019, while for the same time period, CMS estimates reimbursement reductions totaling $50 billion.

Hospitals that provide care to a disproportionately high number of low-income patients may receive Medicaid DSH payments. The federal government distributes federal Medicaid DSH funds to each state based on a statutory formula. The states then distribute the DSH funding among qualifying hospitals. States have broad discretion to define which hospitals qualify for Medicaid DSH payments and the amount of such payments. The Health Reform Law will reduce funding for the Medicaid DSH hospital program in federal fiscal years 2014 through 2020 by the following amounts: 2014 ($500 million); 2015 ($600 million); 2016 ($600 million); 2017 ($1.8 billion); 2018 ($5 billion); 2019 ($5.6 billion); and 2020 ($4 billion). In addition, the Jobs Creation Act provides for an additional Medicaid DSH reduction of $4.1 billion in federal fiscal year 2021. How such cuts are allocated among the states and how the states allocate these cuts among providers, have yet to be determined.

TRICARE

TRICARE is the Department of Defense’s health care program for members of the armed forces. For inpatient services, TRICARE reimburses hospitals based on a DRG system modeled on the Medicare inpatient PPS. The Department of Defense has also implemented a PPS for hospital outpatient services furnished to TRICARE beneficiaries similar to that utilized for services furnished to Medicare beneficiaries. Because the Medicare outpatient PPS APC rates have historically been below TRICARE rates, the adoption of this payment methodology for TRICARE beneficiaries has reduced our reimbursement; however, TRICARE outpatient services do not represent a significant portion of our patient volumes.

Annual Cost Reports

All hospitals participating in the Medicare, Medicaid and TRICARE programs, whether paid on a reasonable cost basis or under a PPS, are required to meet certain financial reporting requirements. Federal and, where applicable, state regulations require the submission of annual cost reports covering the revenues, costs and expenses associated with the services provided by each hospital to Medicare beneficiaries and Medicaid recipients.

Annual cost reports required under the Medicare and Medicaid programs are subject to routine audits, which may result in adjustments to the amounts ultimately determined to be due to us under these reimbursement programs. These audits often require several years to reach the final determination of amounts due to or from us under these programs. Providers also have rights of appeal, and it is common to contest issues raised in audits of cost reports.

Managed Care and Other Discounted Plans

Most of our hospitals offer discounts from established charges to certain large group purchasers of health care services, including managed care plans and private insurance companies. Admissions reimbursed by commercial managed care and other insurers were 31%, 32%, 34% and 35%34% of our total admissions for the years ended December 31, 2011, 2010 2009 and 2008,2009, respectively. Managed care contracts are typically negotiated for terms between one and three years. While we generally received contracted annual average yield increases ofthat were expected to yield 5% to 6% from managed care payers during 2010,2011, there can be no assurance that we will continue to receive increases in the future. It is not clear what impact, if


14


any, the increased obligations on managed care payers and other health plans imposed by the Health Reform Law will have on our ability to negotiate reimbursement increases.

Uninsured and Self-Pay Patients

A high percentage of our uninsured patients are initially admitted through our emergency rooms. For the year ended December 31, 2010,2011, approximately 82% of our admissions of uninsured patients occurred through our emergency rooms. The Emergency Medical Treatment and Active Labor Act (“EMTALA”) requires any hospital that participates in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize that condition or make an appropriate transfer of the individual to a facility that can handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. The Health Reform Law requires health plans to reimburse hospitals for emergency services provided to enrollees without prior authorization and without regard to whether a participating provider contract is in place. Further, as enacted, the Health Reform Law contains provisions that seek to decrease the number of uninsured individuals, including requirements and incentives, which do not become effective until 2014, for individuals to obtain, and large employers to provide, insurance coverage. These mandates may reduce the financial impact of screening for and stabilizing emergency medical conditions. However, many factors are unknown regarding the impact of the Health Reform Law, including how many previously uninsured individuals will obtain coverage as a result of the law or the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals and the payer mix. In addition, it is difficult to predict the full impact of the Health Reform Law due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual and potentially delayed implementation, pending court challenges and possible amendment or repeal.

We

Electronic Health Record Incentives

ARRA provides for Medicare and Medicaid incentive payments beginning in federal fiscal year 2011 for eligible hospitals and calendar year 2011 for eligible professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. A total of at least $20 billion in incentives is being made available through the Medicare and Medicaid EHR incentive programs to eligible hospitals and eligible professionals in the adoption of EHRs.

Under the Medicare incentive program, eligible hospitals that demonstrate meaningful use will receive incentive payments for up to four fiscal years. The Medicare incentive payment amount is the product of three factors: (1) an initial amount comprised of a base amount of $2,000,000, plus $200 for each acute care inpatient discharge, beginning with a hospital’s 1,150th discharge of the applicable year and ending with a hospital’s 23,000th discharge of the applicable year; (2) the “Medicare share,” which is the sum of Medicare Part A and Part C acute care inpatient-bed-days divided by the product of the total acute care inpatient-bed-days and a charity care factor; and (3) a transition factor applicable to the payment year. In order to maximize their incentive payments, acute care hospitals must participate in the incentive program by federal fiscal year 2013. Beginning in federal fiscal year 2015, acute care hospitals that fail to demonstrate meaningful use of certified EHR technology will receive reduced market basket updates under inpatient PPS.

Eligible professionals who demonstrate meaningful use are taking proactive measuresentitled to reduce our provisionincentive payments for doubtful accountsup to five payment years in an amount equal to 75% of their estimated Medicare allowed charges for covered professional services furnished during the relevant calendar year, subject to an annual limit. Eligible professionals must participate in the incentive payment program by among other things:

• screening all patients, including the uninsured, through our emergency screening protocol, to determine the appropriate care setting in light of their condition, while reducing the potential for bad debt; and
• increasing up-front collections from patients subject to co-pay and deductible requirements and uninsured patients.


15

calendar year 2012 in order to maximize their incentive payments and must participate by calendar year 2014 in order to receive any incentive payments. Beginning in calendar year 2015, eligible professionals who do not demonstrate meaningful use of certified EHR technology will face Medicare payment reductions.


The Medicaid EHR incentive program is voluntary for states to implement. For participating states, the Medicaid EHR incentive program will provide incentive payments for acute care hospitals and eligible professionals that meet certain volume percentages of Medicaid patients, as well as children’s hospitals. Providers may only participate in a single state’s Medicaid EHR incentive program. Eligible professionals can only participate in either the Medicaid incentive program or the Medicare incentive program and can change this election only one time. Eligible hospitals may participate in both the Medicare and Medicaid incentive programs.

To qualify for incentive payments under the Medicaid program, providers must either adopt, implement, upgrade or demonstrate meaningful use of, certified EHR technology during their first participation year or successfully demonstrate meaningful use of certified EHR technology in subsequent participation years. Payments may be received for up to six participation years. For hospitals, the aggregate Medicaid EHR incentive amount is the product of two factors: (1) the overall EHR amount which is comprised of a base amount of $2,000,000 plus a discharge-related amount, multiplied by the Medicare share (which is set at one by statute) multiplied by a transition factor, and (2) the “Medicaid share,” which is the estimated Medicaid inpatient-bed days plus estimated Medicaid managed care inpatient bed-days, divided by the product of the estimated total inpatient bed-days and a charity care factor. Under the Medicaid incentive program, eligible professionals may receive payments based on their EHR costs, up to total amount of $63,750, or for pediatricians, $42,500. There is no penalty for hospitals or professionals under Medicaid for failing to meet EHR meaningful use requirements.

Hospital Utilization

We believe the most important factors relating to the overall utilization of a hospital are the quality and market position of the hospital and the number and quality of physicians and other health care professionals providing patient care within the facility. Generally, we believe the ability of a hospital to be a market leader is determined by its breadth of services, level of technology, quality and condition of the facilities, emphasis on quality of care and convenience for patients and physicians. Other factors that impact utilization include the growth in local population, local economic conditions and market penetration of managed care programs.

The following table sets forth certain operating statistics for our health care facilities. Health care facility operations are subject to certain seasonal fluctuations, including decreases in patient utilization during holiday periods and increases in the cold weather months. The data set forth in this table includes only those facilities that are consolidated for financial reporting purposes.

                     
  Years Ended December 31, 
  2010  2009  2008  2007  2006 
 
Number of hospitals at end of period(a)  156   155   158   161   166 
Number of freestanding outpatient surgery centers at end of period(b)  97   97   97   99   98 
Number of licensed beds at end of period(c)  38,827   38,839   38,504   38,405   39,354 
Weighted average licensed beds(d)  38,655   38,825   38,422   39,065   40,653 
Admissions(e)  1,554,400   1,556,500   1,541,800   1,552,700   1,610,100 
Equivalent admissions(f)  2,468,400   2,439,000   2,363,600   2,352,400   2,416,700 
Average length of stay (days)(g)  4.8   4.8   4.9   4.9   4.9 
Average daily census(h)  20,523   20,650   20,795   21,049   21,688 
Occupancy rate(i)  53%  53%  54%  54%  53%
Emergency room visits(j)  5,706,200   5,593,500   5,246,400   5,116,100   5,213,500 
Outpatient surgeries(k)  783,600   794,600   797,400   804,900   820,900 
Inpatient surgeries(l)  487,100   494,500   493,100   516,500   533,100 

   Years Ended December 31, 
   2011  2010  2009  2008  2007 

Number of hospitals at end of period(a)

   163    156    155    158    161  

Number of freestanding outpatient surgery centers at end of period(b)

   108    97    97    97    99  

Number of licensed beds at end of period(c)

   41,594    38,827    38,839    38,504    38,405  

Weighted average licensed beds(d)

   39,735    38,655    38,825    38,422    39,065  

Admissions(e)

   1,620,400    1,554,400    1,556,500    1,541,800    1,552,700  

Equivalent admissions(f)

   2,595,900    2,468,400    2,439,000    2,363,600    2,352,400  

Average length of stay (days)(g)

   4.8    4.8    4.8    4.9    4.9  

Average daily census(h)

   21,123    20,523    20,650    20,795    21,049  

Occupancy rate(i)

   53  53  53  54  54

Emergency room visits(j)

   6,143,500    5,706,200    5,593,500    5,246,400    5,116,100  

Outpatient surgeries(k)

   799,200    783,600    794,600    797,400    804,900  

Inpatient surgeries(l)

   484,500    487,100    494,500    493,100    516,500  

(a)

Excludes eight facilities in 2010, 2009, 2008 and 2007 and seven facilities in 2006 that arewere not consolidated (accounted for using the equity method) for financial reporting purposes.

(b)

Excludes one facility in 2011, nine facilities in 2010 2007 and 20062007 and eight facilities in 2009 and 2008 that arewere not consolidated (accounted for using the equity method) for financial reporting purposes.

(c)

Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(d)

Represents the average number of licensed beds, weighted based on periods owned.

(e)

Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(f)

Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(g)

Represents the average number of days admitted patients stay in our hospitals.

(h)

Represents the average number of patients in our hospital beds each day.

(i)

Represents the percentage of hospital licensed beds occupied by patients. Both average daily census and occupancy rate provide measures of the utilization of inpatient rooms.

(j)

Represents the number of patients treated in our emergency rooms.

(k)

Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(l)

Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.


16


Competition

Generally, other hospitals in the local communities served by most of our hospitals provide services similar to those offered by our hospitals. Additionally, in recent years the number of freestanding ASCs and diagnostic centers (including facilities owned by physicians) in the geographic areas in which we operate has increased significantly. As a result, most of our hospitals operate in a highly competitive environment. In some cases, competing hospitals are more established than our hospitals. Some competing hospitals are owned by tax-supported government agencies and many others are owned bynot-for-profit entities that may be supported by endowments, charitable contributionsand/or tax revenues and are exempt from sales, property and income taxes. Such exemptions and support are not available to our hospitals.hospitals and may provide the tax supported or not-for-profit entities an advantage in funding capital expenditures. In certain localities there are large teaching hospitals that provide highly specialized facilities, equipment and services which may not be available at most of our hospitals. We also face increasing competition from specialty hospitals, some of which are physician-owned, and from both our own and unaffiliated freestanding ASCs for market share in certain high margin services.

Psychiatric hospitals frequently attract patients from areas outside their immediate locale and, therefore, our psychiatric hospitals compete with both local and regional hospitals, including the psychiatric units of general, acute care hospitals.

Our strategies are designed to ensure our hospitals are competitive. We believe our hospitals compete within local communities on the basis of many factors, including the quality of care, ability to attract and retain quality physicians, skilled clinical personnel and other health care professionals, location, breadth of services, technology offered, quality and condition of the facilities and prices charged. The Health Reform Law requires hospitals to publish annually a list of their standard charges for items and services. We have increased our focus on operating outpatient services with improved accessibility and more convenient service for patients, and increased predictability and efficiency for physicians.

Two of the most significant factors to the competitive position of a hospital are the number and quality of physicians affiliated with or employed by the hospital. Although physicians may at any time terminate their relationship with a hospital we operate, our hospitals seek to retain physicians with varied specialties on the hospitals’ medical staffs and to attract other qualified physicians. We believe physicians refer patients to a hospital on the basis of the quality and scope of services it renders to patients and physicians, the quality of physicians on the medical staff, the location of the hospital and the quality of the hospital’s facilities, equipment and employees. Accordingly, we strive to maintain and provide quality facilities, equipment, employees and services for physicians and patients.

Another major factor in the competitive position of a hospital is our ability to negotiate service contracts with purchasers of group health care services. Managed care plans attempt to direct and control the use of hospital services and obtain discounts from hospitals’ established gross charges. In addition, employers and traditional health insurers continue to attempt to contain costs through negotiations with hospitals for managed care programs and discounts from established gross charges. Generally, hospitals compete for service contracts with group health care services purchasers on the basis of price, market reputation, geographic location, quality and range of services, quality of the medical staff and convenience. Our future success will depend, in part, on our ability to retain and renew our managed care contracts and enter into new managed care contracts on favorable terms. Other health care providers may impact our ability to enter into managed care contracts or negotiate increases in our reimbursement and other favorable terms and conditions. For example, some of our competitors may negotiate exclusivity provisions with managed care plans or otherwise restrict the ability of managed care companies to contract with us. The trend toward consolidation among non-government payers tends to increase their bargaining power over fee structures. In addition, as various provisions of the Health Reform Law are implemented, including the establishment of American Health Benefit Exchanges (“Exchanges”) and limitations on rescissions of coverage and pre-existing condition exclusions, non-government payers may increasingly demand reduced fees or be unwilling to negotiate reimbursement increases. The

importance of obtaining contracts with managed care organizations varies from community to community, depending on the market strength of such organizations.

State certificate of need (“CON”) laws, which place limitations on a hospital’s ability to expand hospital services and facilities, make capital expenditures and otherwise make changes in operations, may also have the effect of restricting competition. We currently operate health care facilities in a number of states with CON laws. Before issuing a CON, these states consider the need for additional or expanded health care facilities or services. In


17


those states which have no CON laws or which set relatively high levels of expenditures before they become reviewable by state authorities, competition in the form of new services, facilities and capital spending is more prevalent. See Item 1, “Business — Regulation and Other Factors.”

We and the health care industry as a whole face the challenge of continuing to provide quality patient care while dealing with rising costs and strong competition for patients. Changes in medical technology, existing and future legislation, regulations and interpretations and managed care contracting for provider services by private and government payers remain ongoing challenges.

Admissions, average lengths of stay and reimbursement amounts continue to be negatively affected by payer-required pre-admission authorization, utilization review and payer pressure to maximize outpatient and alternative health care delivery services for less acutely ill patients. The Health Reform Law potentially expands the use of prepayment review by Medicare contractors by eliminating statutory restrictions on their use. Increased competition, admission constraints and payer pressures are expected to continue. To meet these challenges, we intend to expand and update our facilities or acquire or construct new facilities where appropriate, to enhance the provision of a comprehensive array of outpatient services, offer market competitive pricing to private payer groups, upgrade facilities and equipment and offer new or expanded programs and services.

Regulation and Other Factors

Licensure, Certification and Accreditation

Health care facility construction and operation are subject to numerous federal, state and local regulations relating to the adequacy of medical care, equipment, personnel, operating policies and procedures, maintenance of adequate records, fire prevention, rate-setting and compliance with building codes and environmental protection laws. Facilities are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensing and accreditation. We believe our health care facilities are properly licensed under applicable state laws. Each of our acute care hospitals areis certified for participation in the Medicare and Medicaid programs and areis accredited by The Joint Commission. If any facility were to lose its Medicare or Medicaid certification, the facility would be unable to receive reimbursement from federal health care programs. If any facility were to lose accreditation by The Joint Commission, the facility would be subject to state surveys, potentially be subject to increased scrutiny by CMS and likely lose payment from non-government payers. Management believes our facilities are in substantial compliance with current applicable federal, state, local and independent review body regulations and standards. The requirements for licensure, certification and accreditation are subject to change and, in order to remain qualified, it may become necessary for us to make changes in our facilities, equipment, personnel and services. The requirements for licensure, certification and accreditation also may include notification or approval in the event of the transfer or change of ownership.ownership or certain other changes. Failure to provide required notifications or obtain the necessary state approvalapprovals in these circumstances can result in the inability to complete an acquisition or change of ownership.

ownership, loss of licensure or other penalties.

Certificates of Need

In some states where we operate hospitals and other health care facilities, the construction or expansion of health care facilities, the acquisition of existing facilities, the transfer or change of ownership and the addition of

new beds or services may be subject to review by and prior approval of, or notifications to, state regulatory agencies under a CON program. Such laws generally require the reviewing state agency to determine the public need for additional or expanded health care facilities and services. Failure to provide required notifications or obtain necessary state approvalapprovals can result in the inability to expand facilities, complete an acquisition or change ownership.

ownership or other penalties.

State Rate Review

Some states have adopted legislation mandating rate or budget review for hospitals or have adopted taxes on hospital revenues, assessments or licensure fees to fund indigent health care within the state. In the aggregate, indigent tax provisions have not materially, adversely affected our results of operations. Although we do not currently operate facilities in states that mandate rate or budget reviews, we cannot predict whether we will operate in such states in the future, or whether the states in which we currently operate may adopt legislation mandating such reviews.


18


Federal Health Care Program Regulations

Participation in any federal health care program, including the Medicare and Medicaid programs, is heavily regulated by statute and regulation. If a hospital fails to substantially comply with the numerous conditions of participation in the Medicare and Medicaid programs or performs certain prohibited acts, the hospital’s participation in the federal health care programs may be terminated, or civiland/or criminal penalties may be imposed.

Anti-kickback Statute

A section of the Social Security Act known as the “Anti-kickback Statute” prohibits providers and others from directly or indirectly soliciting, receiving, offering or paying any remuneration with the intent of generating referrals or orders for services or items covered by a federal health care program. Courts have interpreted this statute broadly and held that there is a violation of the Anti-kickback Statute if just one purpose of the remuneration is to generate referrals, even if there are other lawful purposes. Furthermore, the Health Reform Law provides that knowledge of the law or the intent to violate the law is not required. Violations of the Anti-kickback Statute may be punished by a criminal fine of up to $25,000 for each violation or imprisonment, civil money penalties of up to $50,000 per violation and damages of up to three times the total amount of the remunerationand/or exclusion from participation in federal health care programs, including Medicare and Medicaid. The Health Reform Law provides that submission of a claim for services or items generated in violation of the Anti-kickback Statute constitutes a false or fraudulent claim and may be subject to additional penalties under the federal False Claims Act (“FCA”).

The Office of Inspector General at HHS (“OIG”),OIG, among other regulatory agencies, is responsible for identifying and eliminating fraud, abuse and waste. The OIG carries out this mission through a nationwide program of audits, investigations and inspections. As one means of providingThe OIG provides guidance to health care providers, the OIG issuesindustry through various methods including advisory opinions and “Special Fraud Alerts.” These alertsSpecial Fraud Alerts do not have the force of law, but identify features of arrangements or transactions that the government believes may cause the arrangements or transactions to violate the Anti-kickback Statute or other federal health care laws. The OIG has identified several incentive arrangements that constitute suspect practices, including: (a) payment of any incentive by a hospital each time a physician refers a patient to the hospital, (b) the use of free or significantly discounted office space or equipment in facilities usually located close to the hospital, (c) provision of free or significantly discounted billing, nursing or other staff services, (d) free training for a physician’s office staff in areas such as management techniques and laboratory techniques, (e) guarantees which provide, if the physician’s income fails to reach a predetermined level, the hospital will pay any portion of the remainder, (f) low-interest or interest-free loans, or loans which may be forgiven if a physician refers patients to the hospital, (g) payment of the costs of a physician’s travel and expenses for conferences, (h) coverage on the hospital’s group health insurance plans at an inappropriately low cost to the physician, (i) payment for services (which may include consultations at the hospital) which require few, if any, substantive duties by the physician, (j) purchasing goods or services from physicians at prices in

excess of their fair market value, and (k) rental of space in physician offices, at other than fair market value terms, by persons or entities to which physicians refer. The OIG has encouraged persons having information about hospitals who offer the above types of incentives to physicians to report such information to the OIG.

The OIG also issues Special Advisory Bulletins as a means of providing guidance to health care providers. These bulletins, along with the Special Fraud Alerts, have focused on certain arrangements that could be subject to heightened scrutiny by government enforcement authorities, including: (a) contractual joint venture arrangements and other joint venture arrangements between those in a position to refer business, such as physicians, and those providing items or services for which Medicare or Medicaid pays, and (b) certain “gainsharing” arrangements, i.e., the practice of giving physicians a share of any reduction in a hospital’s costs for patient care attributable in part to the physician’s efforts.

In addition to issuing Special Fraud Alerts and Special Advisory Bulletins, the OIG issues compliance program guidance for certain types of health care providers. The OIG guidance identifies a number of risk areas under federal fraud and abuse statutes and regulations. These areas of risk include compensation arrangements with physicians, recruitment arrangements with physicians and joint venture relationships with physicians.

As authorized by Congress, the OIG has published safe harbor regulations that outline categories of activities deemed protected from prosecution under the Anti-kickback Statute. Currently, there are statutory exceptions and


19


safe harbors for various activities, including the following: certain investment interests, space rental, equipment rental, practitioner recruitment, personnel services and management contracts, sale of practice, referral services, warranties, discounts, employees, group purchasing organizations, waiver of beneficiary coinsurance and deductible amounts, managed care arrangements, obstetrical malpractice insurance subsidies, investments in group practices, freestanding surgery centers, ambulance replenishing, and referral agreements for specialty services.

The fact that conduct or a business arrangement does not fall within a safe harbor, or it is identified in a Special Fraud Alert, orSpecial Advisory Bulletin or other guidance or as a risk area in the Supplemental Compliance Guidelines for Hospitals, does not necessarily render the conduct or business arrangement illegal under the Anti-kickback Statute. However, such conduct and business arrangements may lead to increased scrutiny by government enforcement authorities.

We have a variety of financial relationships with physicians and others who either refer or influence the referral of patients to our hospitals and other health care facilities, including employment contracts, leases, medical director agreements and professional service agreements. We also have similar relationships with physicians and facilities to which patients are referred from our facilities. In addition, we provide financial incentives, including minimum revenue guarantees, to recruit physicians into the communities served by our hospitals. While we endeavor to comply with the applicable safe harbors, certain of our current arrangements, including joint ventures and financial relationships with physicians and other referral sources and persons and entities to which we refer patients, do not qualify for safe harbor protection.

Although we believe our arrangements with physicians and other referral sources have been structured to comply with current law and available interpretations, there can be no assurance regulatory authorities enforcing these laws will determine these financial arrangements comply with the Anti-kickback Statute or other applicable laws. An adverse determination could subject us to liabilities under the Social Security Act and other laws, including criminal penalties, civil monetary penalties and exclusion from participation in Medicare, Medicaid or other federal health care programs.

Stark Law

The Social Security Act also includes a provision commonly known as the “Stark Law.” The Stark Law prohibits physicians from referring Medicare and Medicaid patients to entities with which they or any of their

immediate family members have a financial relationship, if these entities provide certain “designated health services” reimbursable by Medicare or Medicaid unless an exception applies. The Stark Law also prohibits entities that provide designated health services reimbursable by Medicare and Medicaid from billing the Medicare and Medicaid programs for any items or services that result from a prohibited referral and requires the entities to refund amounts received for items or services provided pursuant to the prohibited referral. “Designated health services” include inpatient and outpatient hospital services, clinical laboratory services and radiology services. Sanctions for violating the Stark Law include denial of payment, civil monetary penalties of up to $15,000 per claim submitted and exclusion from the federal health care programs. The statute also provides for a penalty of up to $100,000 for a circumvention scheme. There are exceptions to the self-referral prohibition for many of the customary financial arrangements between physicians and providers, including employment contracts, leases and recruitment agreements. Unlike safe harbors under the Anti-kickback Statute with which compliance is voluntary, an arrangement must comply with every requirement of a Stark Law exception or the arrangement is in violation of the Stark Law. Although there is an exception for a physician’s ownership interest in an entire hospital, the Health Reform Law prohibits newly created physician-owned hospitals from billing for Medicare patients referred by their physician owners. As a result, the law effectively prevents the formation of new physician-owned hospitals after December 31, 2010. While the Health Reform Law grandfathers existing physician-owned hospitals, it does not allow these hospitals to increase the percentage of physician ownership and significantly restricts their ability to expand services.

Through a series of rulemakings, CMS has issued final regulations implementing the Stark Law. Additional changes to these regulations, which became effective October 1, 2009, further restrict the types of arrangements facilities and physicians may enter, including additional restrictions on certain leases, percentage compensation arrangements, and agreements under which a hospital purchases services “under arrangements.” While these regulations were intended to clarify the requirements of the exceptions to the Stark Law, it is unclear how the government will interpret many of these exceptions for enforcement purposes. CMS has indicated it is considering


20


additional changes to the Stark Law regulations. WeFurther, we do not always have the benefit of significant regulatory or judicial interpretation of these lawsthe Stark Law and its implementing regulations. We attempt to structure our relationships to meet an exception to the Stark Law, but the regulations implementing the exceptions are detailed and complex, and we cannot assure that every relationship complies fully with the Stark Law.

Similar State Laws

Many states in which we operate also have laws similar to the Anti-kickback Statute that prohibit payments to physicians for patient referrals and laws similar to the Stark Law that prohibit certain self-referrals. The scope of these state laws is broad, since they can often apply regardless of the source of payment for care, and little precedent exists for their interpretation or enforcement. These statutes typically provide for criminal and civil penalties, as well as loss of facility licensure.

Other Fraud and Abuse Provisions

HIPAA broadened the scope of certain fraud and abuse laws by adding several criminal provisions for health care fraud offenses that apply to all health benefit programs. The Social Security Act also imposes criminal and civil penalties for making false claims and statements to Medicare and Medicaid. False claims include, but are not limited to, billing for services not rendered or for misrepresenting actual services rendered in order to obtain higher reimbursement, billing for unnecessary goods and services and cost report fraud. Federal enforcement officials have the ability to exclude from Medicare and Medicaid any investors, officers and managing employees associated with business entities that have committed health care fraud, even if the officer or managing employee had no knowledge of the fraud. Criminal and civil penalties may be imposed for a number of other prohibited activities, including failure to return known overpayments, certain gainsharing arrangements, billing Medicare amounts that are substantially in excess of a provider’s usual charges, offering remuneration to influence a Medicare or Medicaid beneficiary’s selection of a health care provider, contracting with an individual or entity known to be excluded from a federal health care program, making or accepting a payment to induce a physician to reduce or limit services, and soliciting or receiving any remuneration in return for referring an

individual for an item or service payable by a federal health care program. Like the Anti-kickback Statute, these provisions are very broad. Under the Health Reform Law, civil penalties may be imposed for the failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later. To avoid liability, providers must, among other things, carefully and accurately code claims for reimbursement, promptly return overpayments and accurately prepare cost reports.

Some of these provisions, including the federal Civil Monetary Penalty Law, require a lower burden of proof than other fraud and abuse laws, including the Anti-kickback Statute. Civil monetary penalties that may be imposed under the federal Civil Monetary Penalty Law range from $10,000 to $50,000 per act, and in some cases may result in penalties of up to three times the remuneration offered, paid, solicited or received. In addition, a violator may be subject to exclusion from federal and state health care programs. Federal and state governments increasingly use the federal Civil Monetary Penalty Law, especially where they believe they cannot meet the higher burden of proof requirements under the Anti-kickback Statute. Further, individuals can receive up to $1,000 for providing information on Medicare fraud and abuse that leads to the recovery of at least $100 of Medicare funds under the Medicare Integrity Program.

The Federal False Claims Act and Similar State Laws

Thequi tam, or whistleblower, provisions of the FCA allow private individuals to bring actions on behalf of the government alleging that the defendant has defrauded the federal government. Further, the government may use the FCA to prosecute Medicare and other government program fraud in areas such as coding errors, billing for services not provided and submitting false cost reports. When a private party brings aqui tamaction under the FCA, the defendant is not made aware of the lawsuit until the government commences its own investigation or makes a determination whether it will intervene. WhenIf a defendant is determined by a court of law to be liable under the FCA, the defendant may be required to pay three times the actual damages sustained by the government, plus mandatory civil penalties of between $5,500 and $11,000 for each separate false claim. There are many potential bases for liability under the FCA. Liability often arises when an entity knowingly submits a false claim for


21


reimbursement to the federal government. The FCA defines the term “knowingly” broadly. Though simple negligence will not give rise to liability under the FCA, submitting a claim with reckless disregard to its truth or falsity constitutes a “knowing” submission under the FCA and, therefore, will qualify formay create liability. The Fraud Enforcement and Recovery Act of 2009 expanded the scope of the FCA by, among other things, creating liability for knowingly and improperly avoiding repayment of an overpayment received from the government and broadening protections for whistleblowers. Under the Health Reform Law, the FCA is implicated by the knowing failure to report and return an overpayment within 60 days of identifying the overpayment or by the date a corresponding cost report is due, whichever is later. Further, the Health Reform Law expands the scope of the FCA to cover payments in connection with the Exchanges to be created by the Health Reform Law, if those payments include any federal funds.

In some cases, whistleblowers and the federal government have taken the position, and some courts have held, that providers who allegedly have violated other statutes, such as the Anti-kickback Statute and the Stark Law, have thereby submitted false claims under the FCA. The Health Reform Law clarifies this issue with respect to the Anti-kickback Statute by providing that submission of claims for services or items generated in violation of the Anti-kickback Statute constitutes a false or fraudulent claim under the FCA. Every entity that receives at least $5 million annually in Medicaid payments must have written policies for all employees, contractors or agents, providing detailed information about false claims, false statements and whistleblower protections under certain federal laws, including the FCA, and similar state laws. In addition, federal law provides an incentive to states to enact false claims laws comparable to the FCA. A number of states in which we operate have adopted their own false claims provisions as well as their own whistleblower provisions under which a private party may file a civil lawsuit in state court. We have adopted and distributed policies pertaining to the FCA and relevant state laws.

HIPAA Administrative Simplification and Privacy and Security Requirements

The Administrative Simplification Provisions of HIPAA require the use of uniform electronic data transmission standards for certain health care claims and payment transactions submitted or received electronically. These provisions are intended to encourage electronic commerce in the health care industry. HHS has issued regulations implementing the HIPAA Administrative Simplification Provisions and compliance with these regulations is mandatory for our facilities. In addition, HIPAA requires that each provider use a National Provider Identifier. In January 2009, CMS published a final rule making changes to the formats used for certain electronic transactions and requiring the use of updated standard code sets for certain diagnoses and procedures known as ICD-10 code sets. While use of the ICD-10 code sets is not mandatory until October 1, 2013, we will be modifying our payment systems and processes to prepare for the implementation. Implementing the ICD-10 code sets will require significant administrative changes, but we believe that the cost of compliance with these regulations has not had and is not expected to have a material, adverse effect on our business, financial position or results of operations. The Health Reform Law requires HHS to adopt standards for additional electronic transactions and to establish operating rules to promote uniformity in the implementation of each standardized electronic transaction.

In addition, HIPAA requires that each provider use a National Provider Identifier. CMS has also published a final rule requiring the use of updated standard code sets for certain diagnoses and procedures known as ICD-10 code sets. Implementing the ICD-10 code sets will require significant administrative changes. By regulation, use of the ICD-10 code sets is required beginning October 1, 2013, but CMS has announced that it intends to extend this deadline.

The privacy and security regulations promulgated pursuant to HIPAA extensively regulate the use and disclosure of individually identifiable health information and require covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the security of such information. ARRA broadened the scope of the HIPAA privacy and security regulations. In addition, ARRA extends the application of certain provisions of the security and privacy regulations to business associates (entities that handle identifiable health information on behalf of covered entities) and subjects business associates to civil and criminal penalties for violation of the regulations. On July 14, 2010, HHS issued a proposed rule that would implement many of these ARRA provisions. If finalized, these changes would likely require amendments to existing agreements with business associates and would subject business associates and their subcontractors to direct liability under the HIPAA privacy and security regulations. We currently enforce a HIPAA compliance plan, which we believe complies with HIPAA privacy and security requirements and under which a HIPAA compliance group monitors our compliance. The privacy regulations and security regulations have and will continue to impose significant costs on our facilities in order to comply with these standards.

As required by ARRA, HHS published an interim final rule on August 24, 2009, that requires covered entities to report breaches of unsecured protected health information to affected individuals without unreasonable delay but


22


not to exceed 60 days of discovery of the breach by a covered entity or its agents. Notification must also be made to HHS and, in certain situations involving large breaches, to the media. HHS is required to publish on its website a list of all covered entities that report a breach involving more than 500 individuals. Various state laws and regulations may also require us to notify affected individuals in the event of a data breach involving individually identifiable information.

Violations of the HIPAA privacy and security regulations may result in civil and criminal penalties, and ARRA has strengthened the enforcement provisions of HIPAA, which may result in increased enforcement activity. UnderAs required by ARRA, HHS is requiredhas announced a pilot program to conduct periodic complianceperform audits of up to 150 covered entities and their business associates.by the end of 2012. ARRA broadens the applicability of the criminal penalty provisions to employees of covered entities and requires HHS to impose penalties for violations resulting from willful neglect. ARRA also significantly increases the amount of the civil penalties, with penalties of up to $50,000 per violation for a maximum civil penalty of $1,500,000 in a calendar year for violations of the same requirement. In addition, ARRA authorizes state attorneys general to bring civil actions seeking either injunction or damages in response to violations of HIPAA privacy and security regulations that threaten the privacy of state residents.

There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. Our facilities also remain subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties.

There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. For example, the Federal Trade Commission (“FTC”) issued a final rule in October 2007 requiring financial institutions and creditors, which arguably included health providers and health plans, to implement written identity theft prevention programs to detect, prevent and mitigate identity theft in connection with certain accounts. The FTC delayed enforcement of this rule until December 31, 2010. In addition, on December 18, 2010, the Red Flag Program Clarification Act of 2010 became law, restricting the definition of a “creditor.” This law may exempt many hospitals from complying with the rule.

EMTALA

All of our hospitals in the United States are subject to EMTALA. This federal law requires any hospital participating in the Medicare program to conduct an appropriate medical screening examination of every individual who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize the condition or make an appropriate transfer of the individual to a facility able to handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. There are severe penalties under EMTALA if a hospital fails to screen or appropriately stabilize or transfer an individual or if the hospital delays appropriate treatment in order to first inquire about the individual’s ability to pay. Penalties for violations of EMTALA include civil monetary penalties and exclusion from participation in the Medicare program. In addition, an injured individual, the individual’s family or a medical facility that suffers a financial loss as a direct result of a hospital’s violation of the law can bring a civil suit against the hospital.

The government broadly interprets EMTALA to cover situations in which individuals do not actually present to a hospital’s emergency room, but present for emergency examination or treatment to the hospital’s campus, generally, or to a hospital-based clinic that treats emergency medical conditions or are transported in a hospital-owned ambulance, subject to certain exceptions. At least one court has interpreted the law also to apply to a hospital that has been notified of a patient’s pending arrival in a non-hospital owned ambulance. EMTALA does not generally apply to individuals admitted for inpatient services. The government has expressed its intent to investigate and enforce EMTALA violations actively in the future. We believe our hospitals operate in substantial compliance with EMTALA.

Corporate Practice of Medicine/Fee Splitting

Some of the states in which we operate have laws prohibiting corporations and other entities from employing physicians, practicing medicine for a profit and making certain direct and indirect payments or fee-splitting arrangements between health care providers designed to induce or encourage the referral of patients to, or the recommendation of, particular providers for medical products and services. Possible sanctions for violation of these


23


restrictions include loss of license and civil and criminal penalties. In addition, agreements between the corporation and the physician may be considered void and unenforceable. These statutes vary from state to state, are often vague and have seldom been interpreted by the courts or regulatory agencies.

Health Care Industry Investigations

Significant media and public attention has focused in recent years on the hospital industry. This media and public attention, changes in government personnel or other factors may lead to increased scrutiny of the health care industry. WhileExcept as may be disclosed in our SEC filings, we are currently not aware of any material investigations of the Company under federal or state health care laws or regulations, itregulations. It is possible that governmental entities could initiate investigations or litigation in the future at facilities we operate and that such matters could result in significant penalties, as well as adverse publicity. It is also possible that our executives and managers could be included in governmental investigations or litigation or named as defendants in private litigation.

Our substantial Medicare, Medicaid and other governmental billings result in heightened scrutiny of our operations. We continue to monitor all aspects of our business and have developed a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. Because the law in this area is complex and constantly evolving, governmental investigations or litigation may result in interpretations that are inconsistent with our or industry practices.

In public statements surrounding current investigations, governmental authorities have taken positions on a number of issues, including some for which little official interpretation previously has been available, that appear to be inconsistent with practices that have been common within the industry and that previously have not been challenged in this manner. In some instances, government investigations that have in the past been conducted under the civil provisions of federal law may now be conducted as criminal investigations.

Both federal and state government agencies have increased their focus on and coordination of civil and criminal enforcement efforts in the health care area. The OIG and the Department of Justice (“DOJ”) have, from time to time, established national enforcement initiatives, targeting all hospital providers that focus on specific billing practices or other suspected areas of abuse. The Health Reform Law includes additional federal funding of $350 million over the next 10 years to fight health care fraud, waste and abuse, including $105 million for federal fiscal year 2011 and $65 million in federal fiscal year 2012. In addition, governmental agencies and their agents, such as MACs, fiscal intermediaries and carriers, may conduct audits of our health care operations. Private payers may conduct similar post-payment audits, and we also perform internal audits and monitoring.

In addition to national enforcement initiatives, federal and state investigations have addressed a wide variety of routine health care operations such as: cost reporting and billing practices, including for Medicare outliers; financial arrangements with referral sources; physician recruitment activities; physician joint ventures; and hospital charges and collection practices for self-pay patients. We engage in many of these routine health care operations and other activities that could be the subject of governmental investigations or inquiries. For example, we have significant Medicare and Medicaid billings, numerous financial arrangements with physicians who are referral sources to our hospitals, and joint venture arrangements involving physician investors. Certain of our individual facilities have received, and other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Any additional investigations of the Company, our executives or managers could result in significant liabilities or penalties to us, as well as adverse publicity.

Commencing in 1997, we became aware we were the subject of governmental investigations and litigation relating to our business practices. As part of the investigations, the United States intervened in a number ofqui tamactions brought by private parties. The investigations related to, among other things, DRG coding, outpatient laboratory billing, home health issues, physician relations, cost report and wound care issues. The investigations were concluded through a series of agreements executed in 2000 and 2003 with the Criminal Division of the DOJ, the Civil Division of the DOJ, various U.S. Attorneys’ offices, CMS, a negotiating team representing states with claims against us, and others. In January 2001, we entered into an eight-year Corporate Integrity Act (“CIA”) with the Office of Inspector General of the Department of Health and Human Services, which expired January 24, 2009. We submitted our final report pursuant to the CIA on April 30, 2009, and in April 2010, we received notice from the OIG that our final report was accepted, relieving us of future obligations under the CIA. If the government were to


24


determine that we violated or breached the CIA or other federal or state laws relating to Medicare, Medicaid or similar programs, we could be subject to substantial monetary fines, civil and criminal penaltiesand/or exclusion from participation in the Medicare and Medicaid programs and other federal and state health care programs. Alleged violations may be pursued by the government or through privatequi tamactions. Sanctions imposed against us as a result of such actions could have a material, adverse effect on our results of operations and financial position.
Health Care Reform

As enacted, the Health Reform Law will change how health care services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending, reductions in Medicare and Medicaid DSH payments, and the establishment of programs where reimbursement is tied to quality and integration. In addition, the law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. More than 20 challenges toNumerous lawsuits have challenged the constitutionality of the Health Reform Law have been filed in federal courts.Law. Some federal district courts have upheld the constitutionality of the Health Reform Law or dismissed cases on procedural grounds. Others have held unconstitutional the requirement that individuals maintain health insurance or pay a penalty and have either found the Health Reform Law void in its entirety or left the remainder of the law intact. The U.S. Supreme Court is expected to decide the constitutionality of the Health Reform Law intact. These lawsuits are subject to appeal, and several are currentlyin 2012. Based on appeal, including those that hold the law unconstitutional. It is unclear how these lawsuits will be resolved. Further, Congress is considering bills that would repeal or reviseoutcome of the U.S. Supreme Court’s review, the Health Reform Law.

Law, or individual components of it, may be upheld, invalidated or modified. In addition, repeal of the Health Reform Law has become a theme in political campaigns during this election year.

Expanded Coverage

Based on CBO and CMS estimates made prior to enactment of the Health Reform Law, by 2019, the Health Reform Law will expand coverage to 32 to 34 million additional individuals (resulting in coverage of an estimated 94% of the legal U.S. population). This increased coverage will occur through a combination of public program expansion and private sector health insurance and other reforms.

Medicaid Expansion

The primary public program coverage expansion will occur through changes in Medicaid, and to a lesser extent, expansion of the Children’s Health Insurance Program (“CHIP”). The most significant changes will expand the categories of individuals eligible for Medicaid coverage and permit individuals with relatively higher incomes to qualify. The federal government reimburses the majority of a state’s Medicaid expenses, and it conditions its payment on the state meeting certain requirements. The federal government currently requires that states provide coverage for only limited categories of low-income adults under 65 years old (e.g., women who are pregnant, and the blind or disabled). In addition, the income level required for individuals and families to qualify for Medicaid varies widely from state to state.

The Health Reform Law materially changes the requirements for Medicaid eligibility. Commencing January 1, 2014, all state Medicaid programs are required to provide, and the federal government will subsidize, Medicaid coverage to virtually all adults under 65 years old with incomes at or under 133% of the federal poverty level (“FPL”). This expansion will create a minimum Medicaid eligibility threshold that is uniform across states. Further, the Health Reform Law also requires states to apply a “5% income disregard” to the Medicaid eligibility standard, so that Medicaid eligibility will effectively be extended to those with incomes up to 138% of the FPL. TheseAccording to the CBO’s March 2011 projection, the new eligibility requirements will expand Medicaid and CHIP coverage by an estimated 16 to 1817 million persons nationwide. A disproportionately large percentage of the new Medicaid coverage is likely to be in states that currently have relatively low income eligibility requirements.

As Medicaid is a joint federal and state program, the federal government provides states with “matching funds” in a defined percentage, known as the federal medical assistance percentage (“FMAP”). Beginning in 2014, states will receive an enhanced FMAP for the individuals enrolled in Medicaid pursuant to the Health Reform Law. The FMAP percentage is as follows: 100% for calendar years 2014 through 2016; 95% for 2017; 94% in 2018; 93% in 2019; and 90% in 2020 and thereafter.

The Health Reform Law also provides that the federal government will subsidize states that create non- Medicaidnon-Medicaid plans for residents whose incomes are greater than 133% of the FPL but do not exceed 200% of the FPL.


25


Approved state plans will be eligible to receive federal funding. The amount of that funding per individual will be equal to 95% of subsidies that would have been provided for that individual had he or she enrolled in a health plan offered through one of the Exchanges, as discussed below.

Historically, states often have attempted to reduce Medicaid spending by limiting benefits and tightening Medicaid eligibility requirements. Effective March 23, 2010,However, the Health Reform Law requires states to at least maintain Medicaid eligibility standards established prior to the enactment of the law for adults until January 1, 2014 and for children until October 1, 2019. States with budget deficits may however, seek a waiver from this requirement, but only to address eligibility standards that apply to adults making more than 133% of the FPL.

Private Sector Expansion

The expansion of health coverage through the private sector as a result of the Health Reform Law will occur through new requirements onapplicable to health insurers, employers and individuals. Health insurers must keep their annual nonmedical costs lower than 15% of premium revenue for the group market and lower than 20% in the small group and individual markets or rebate to enrollees the amount spent in excess of the percentage. In addition, health insurers are not permitted to deny coverage to children based upon a pre-existing condition and must allow dependent care coverage for children up to 26 years old. Commencing January 1, 2014, health insurance companiesinsurers will be prohibited from imposing annual coverage limits, dropping coverage, excluding persons based upon pre-existing conditions or denying coverage for any individual who is willing to pay the premiums for such coverage. Effective January 1, 2011, each health plan must keep its annual nonmedical costs lower than 15% of premium revenue for the group market and lower than 20% in the small group and individual markets or rebate its enrollees the amount spent in excess of the percentage. In addition, effective September 23, 2010, health insurers will not be permitted to deny coverage to children based upon a pre-existing condition and must allow dependent care coverage for children up to 26 years old.

Larger employers will be subject to new requirements and incentives to provide health insurance benefits to their full time employees. Effective January 1, 2014, employers with 50 or more employees that do not offer health insurance will be held subject to a penalty if an employee obtains government-subsidized coverage through an Exchange if the coverage is subsidized by the government.Exchange. The employer penalties will range from $2,000 to $3,000 per employee, subject to certain thresholds and conditions.

As enacted, the Health Reform Law uses various means to induce individuals who do not have health insurance to obtain coverage. By January 1, 2014, individuals will be required to maintain health insurance for a minimum defined set of benefits or pay a tax penalty. The penalty in most cases is $95 in 2014, $325 in 2015, $695 in 2016, and indexed to a cost of living adjustment in subsequent years. The Internal Revenue Service (“IRS”), in consultation with HHS, is responsible for enforcing the tax penalty, although the Health Reform Law

limits the availability of certain IRS enforcement mechanisms. In addition, for individuals and families below 400% of the FPL, the cost of obtaining health insurance through the Exchanges will be subsidized by the federal government. Those with lower incomes will be eligible to receive greater subsidies. It is anticipated that those at the lowest income levels will have the majority of their premiums subsidized by the federal government, in some cases in excess of 95% of the premium amount.

To facilitate the purchase of health insurance by individuals and small employers, each state must establish an Exchange by January 1, 2014. Based on CBO and CMS estimates between 29 and 31issued in March 2011, approximately 24 million individuals will obtain their health insurance coverage through an Exchange by 2019. Of that2021. This amount an estimated 16 million will beinclude individuals who were previously uninsured and 13 to 15 million will be individuals who have switched from their prior insurance coverage to a plan obtained through the Exchange. The Health Reform Law requires that the Exchanges be designed to make the process of evaluating, comparing and acquiring coverage simple for consumers. For example, each state’s Exchange must maintain an internet website through which consumers may access health plan ratings that are assigned by the state based on quality and price, view governmental health program eligibility requirements and calculate the actual cost of health coverage. Health insurers participating in an Exchange must offer a set of minimum benefits to be defined by HHS and may offer more benefits. Health insurers must offer at least two, and up to five, levels of plans that vary by the percentage of medical expenses that must be paid by the enrollee. These levels are referred to as platinum, gold, silver, bronze and catastrophic plans, with gold and silver being the two mandatory levels of plans. Each level of plan must require the enrollee to share the following percentages of medical expenses up to the deductible/co-paymentcopayment limit: platinum, 10%; gold, 20%; silver, 30%; bronze, 40%; and catastrophic, 100%. Health insurers may establish varying deductible/co-paymentcopayment levels, up to the statutory maximum (estimated to be between $6,000 and $7,000 for an individual). The health insurers must


26


cover 100% of the amount of medical expenses in excess of the deductible/co-paymentcopayment limit. For example, an individual making 100% to 200% of the FPL will have co-paymentscopayments and deductibles reduced to about one-third of the amount payable by those with the same plan with incomes at or above 400% of the FPL.

Public Program Spending

The Health Reform Law provides for Medicare, Medicaid and other federal health care program spending reductions between 2010 and 2019. TheIn March 2010, CMS estimated Medicare fee-for-service reductions from 2010 to 2019 would be $233 billion and the Medicare and Medicaid DSH reductions would be an additional $64 billion. In February 2011, the CBO estimatesestimated that these willfrom 2012 to 2021, the Health Reform Law reductions would include $156$379 billion in Medicarefee-for-service market basket and productivity reimbursement reductions, for all providers, the majority of which will come from hospitals; CMS sets this estimate at $233 billion.hospitals. The CBO estimates also includeestimate included an additional $36$57 billion in reductions ofin Medicare and Medicaid disproportionate share funding ($22 billion for Medicare and $14 billion for Medicaid). CMS estimates include an additional $64 billion in reductions of Medicare and Medicaid disproportionate share funding, with $50 billion of the reductions coming from Medicare.

DSH funding.

Payments for Hospitals and Ambulatory Surgery Centers

Inpatient Market Basket and Productivity Adjustment.    Under the Medicare program, hospitals receive reimbursement under a PPS for general, acute care hospital inpatient services. CMS establishes fixed PPS payment amounts per inpatient discharge based on the patient’s assigned MS-DRG. These MS-DRG rates are updated each federal fiscal year, which begins October 1, using a market basket index that takes into account inflation experienced by hospitals and other entities outside the health care industry in purchasing goods and services.

The Health Reform Law provides for three types of annual reductions in the market basket. The first is a general reduction of a specified percentage each federal fiscal year starting in 2010 and extending through 2019. These reductions are as follows: federal fiscal year 2010, 0.25% for discharges occurring on or after April 1, 2010; 2011 (0.25%); 2012 (0.1%); 2013 (0.1%); 2014 (0.3%); 2015 (0.2%); 2016 (0.2%); 2017 (0.75%); 2018 (0.75%); and 2019 (0.75%).

The second type of reduction to the market basket is a “productivity adjustment” that will bewas implemented by HHS beginning in federal fiscal year 2012. The amount of that reduction will beis the projected nationwide productivity

gains over the preceding 10 years. To determine the projection, HHS will useuses the BLS10-year moving average of changes in specified economy-wide productivity (the BLS data is typically a few years old). The Health Reform Law does not contain guidelines for HHS to use in projecting the productivity figure. Based upon the latest available data,For federal fiscal year 2012, CMS has announced a negative 1.0% productivity adjustment to the market basket. CMS estimates that the combined market basket reductions resultingand productivity adjustments will reduce Medicare payments under the inpatient PPS by $112.6 billion from this productivity adjustment are likely2010 to range from 1% to 1.4%.

2019.

The third type of reduction is in connection with the value-based purchasing program discussed in more detail below. Beginning in federal fiscal year 2013, CMS will reduce the inpatient PPS payment amount for all discharges by the following: 1% for 2013; 1.25% for 2014; 1.5% for 2015; 1.75% for 2016; and 2% for 2017 and subsequent years. For each federal fiscal year, the total amount collected from these reductions will be pooled and used to fund payments to hospitals that satisfy certain quality metrics. While some or all of these reductions may be recovered if a hospital satisfies these quality metrics, the recovery amounts may be delayed.

If the aggregate of the three market basket reductions described above is more than the annual market basket adjustments made to account for inflation, there will be a reduction in the MS-DRG rates paid to hospitals. For example, for the federal fiscal year 2011 hospital inpatient PPS, the market basket increase to account for inflation iswas 2.6% and the aggregate reduction due to the Health Reform Law and the documentation and coding adjustment iswas 3.15%. Thus, the rates paid to a hospital for inpatient services in federal fiscal year 2011 will bewere 0.55% less than rates paid for the same services in the prior year.

Quality-Based Payment Adjustments and Reductions for Inpatient Services.    The Health Reform Law establishes or expands three provisions to promote value-based purchasing and to link payments to quality and efficiency. First, in federal fiscal year 2013, HHS is directed to implement a value-based purchasing program for inpatient hospital services. This program will reward hospitals that meet certain quality performance standards established by HHS. The Health Reform Law provides HHS considerable discretion over the value-based purchasing program. For example, HHS will determine the quality performance measures, the standards hospitals


27


must achieve in order to meet the quality performance measures, and the methodology for calculating payments to hospitals that meet the required quality threshold. HHS will also determine how much money each hospital will receive from the pool of dollars created by the reductions related toOn April 29, 2011, CMS issued a final rule establishing the value-based purchasing program as described above.for hospital inpatient services. Under this final rule, CMS states that it estimates it will distribute $850 million in federal fiscal year 2013 to hospitals based on their overall performance on a set of quality measures that have been linked to improved clinical processes of care and patient satisfaction. For payments in federal fiscal year 2013, hospitals will be scored based on a weighted average of patient experience scores using the Hospital Consumer Assessment of Healthcare Providers and Systems survey and 12 clinical process-of-care measures. CMS will score each hospital based on achievement (relative to other hospitals) and improvement ranges (relative to the hospital’s own past performance) for each applicable measure. Because the Health Reform Law provides that the pool will be fully distributed, hospitals that meet or exceed the quality performance standards set by HHS will receive greater reimbursement under the value-based purchasing program than they would have otherwise. On the other hand, hospitalsHospitals that do not achieve the necessary quality performance will receive reduced Medicare inpatient hospital payments. On January 7, 2011, CMS issued a proposed rule for the value-based purchasing program that would use 17 clinical process of care measures and eight dimensions of a patient’s experience of care using the HCAHPS survey to determine incentive payments for federal fiscal year 2013. As proposed, the incentive payments would be calculated based on a combination of measures of hospitals’ achievementwill notify each hospital of the performance standards and their improvement in meeting the performance standards compared to prior periods. To determine payments in federalamount of its value-based incentive payment for fiscal year 2013 the baseline performance period (measurement standard) as proposed would be Julydischarges on November 1, 2009 through March 31, 2010. To determine whether hospitals meet performance standards, CMS would compare each hospital’s performance in the period July 1, 2011 through March 31, 2012 to its performance in the baseline performance period. CMS has not yet proposed specific threshold values for the performance standards. CMS also proposes to add three outcome measures for federal fiscal year 2014, for which the performance period would be July 1, 2011 through December 31, 2012 and the baseline performance period would be July 1, 2008 through December 31, 2009.
2012.

Second, beginning in federal fiscal year 2013, inpatient payments will be reduced if a hospital experiences “excessive readmissions” within a timethe 30-day period specified by HHS from the date of discharge for heart attack, heart failure, pneumonia or other conditions that may be designated by HHS.CMS. Hospitals with what HHSCMS defines as “excessive readmissions” for these conditions will receive reduced payments for all inpatient discharges, not just discharges relating to the conditions subject to the excessive readmission standard. Each hospital’s performance will be publicly reported by HHS. HHS has the discretion to determine what “excessive readmissions” means and other terms and conditionsCMS. On August 1, 2011, CMS issued a final rule implementing portions of this program.

program but indicated that it will issue in future rulemakings additional policies with respect to excessive readmissions, including the specific payment adjustment methodology.

Third, reimbursement will be reduced based on a facility’s HAC rates. An HAC is a condition that is acquired by a patient while admitted as an inpatient in a hospital, such as a surgical site infection. Beginning in federal fiscal year 2015, the 25% of hospitals with the worst national risk-adjusted HAC rates in the previous

year will receive a 1% reduction in their total inpatient operating Medicare payments. In addition, effective July 1, 2011, the Health Reform Law prohibits the use of federal funds under the Medicaid program to reimburse providers for medical services provided to treat HACs.

However, CMS has delayed enforcement of this prohibition until July 1, 2012. In a final rule issued June 1, 2011, CMS authorizes states to add additional provider-preventable conditions to the list of HACs for which Medicaid reimbursement will not be allowed.

Outpatient Market Basket and Productivity Adjustment.    Hospital outpatient services paid under PPS are classified into APCs. The APC payment rates are updated each calendar year based on the market basket. The first two market basket changes outlined above — the general reduction and the productivity adjustment — apply to outpatient services as well as inpatient services, although these are applied on a calendar year basis. The percentage changes specified in the Health Reform Law summarized above as the general reduction for inpatients — e.g., 0.2% in 2015 — are the same for outpatients.

Medicare and Medicaid DSH Payments.    The Medicare DSH program provides for additional payments to hospitals that treat a disproportionate share of low-income patients. Under the Health Reform Law, beginning in federal fiscal year 2014, Medicare DSH payments will be reduced to 25% of the amount they otherwise would have been absent the law. The remaining 75% of the amount that would otherwise be paid under Medicare DSH will be effectively pooled, and this pool will be reduced further each year by a formula that reflects reductions in the national level of uninsured who are under 65 years of age. In other words, the greater the level of coverage for the uninsured nationally, the more the Medicare DSH payment pool will be reduced. Each hospital will then be paid, out of the reduced DSH payment pool, an amount allocated based upon its level of uncompensated care.

It is difficult to predict the full impact of the Medicare DSH reductions, and CBO and CMS estimates differ by $38 billion. The Health Reform Law does not mandate what data source HHS must use to determine the reduction, if any, in the uninsured population nationally. In addition, the Health Reform Law does not contain a definition of “uncompensated care.” As a result, it is unclear how a hospital’s share of the Medicare DSH payment pool will be calculated. CMS could use the definition of “uncompensated care” used in connection with hospital cost reports.


28


However, in July 2009, CMS proposed material revisions to the definition of “uncompensated care” used for cost report purposes. Those revisions would exclude certain significant costs that had historically been covered, such as unreimbursed costs of Medicaid services. CMS has not issued a final rule, and the Health Reform Law does not require HHS to use this definition, even if finalized, for DSH purposes. How CMS ultimately defines “uncompensated care” for purposes of these DSH funding provisions could have a material effect on a hospital’s Medicare DSH reimbursements.

In addition to Medicare DSH funding, hospitals that provide care to a disproportionately high number of low-income patients may receive Medicaid DSH payments. The federal government distributes federal Medicaid DSH funds to each state based on a statutory formula. The states then distribute the DSH funding among qualifying hospitals. Although federal Medicaid law defines some level of hospitals that must receive Medicaid DSH funding, states have broad discretion to define additional hospitals that also may qualify for Medicaid DSH payments and the amount of such payments. The Health Reform Law will reduce funding for the Medicaid DSH hospital program in federal fiscal years 2014 through 2020 by the following amounts: 2014 ($500 million); 2015 ($600 million); 2016 ($600 million); 2017 ($1.8 billion); 2018 ($5 billion); 2019 ($5.6 billion); and 2020 ($4 billion). In addition, the Jobs Creation Act provides for an additional Medicaid DSH reduction of $4.1 billion in federal fiscal year 2021. How such cuts are allocated among the states, and how the states allocate these cuts among providers, have yet to be determined.

ACOs.    The Health Reform Law requires HHS to establish a Medicare Shared Savings Program thatthe MSSP, which promotes accountability and coordination of care through the creation of ACOs. Beginning no later than January 1, 2012, the program will allow certain providers and suppliers (including hospitals),hospitals, physicians and other designated professionals and suppliersprofessionals) to voluntarily form ACOs and voluntarily work together along with other ACO participants to invest in infrastructure and redesign delivery processes to achieve high quality and efficient delivery of services. The program is intended to produce savings as a result of improved quality and operational efficiency. ACOs that achieve quality performance standards established by HHS will be eligible to share in a portion of the amounts saved by the

Medicare program. HHS has significant discretion to determine key elements of the program, including what steps providers must takeprogram. In 2011, CMS, the OIG and certain other federal agencies released a series of rules and guidance further defining and implementing the ACO program. These rules and guidance provide for two different ACO tracks, the first of which allows ACOs to be considered an ACO, howshare only in the savings under the MSSP. The second track requires ACOs to decide if Medicare programshare in any savings have occurred, and what portionor losses under the MSSP but offers ACOs a greater share of suchany savings will be paid to ACOs. In addition, HHS will determine to what degree hospitals, physicians and other eligible participants will be able to form and operate an ACO without violating certain existing laws, includingrealized under the Civil Monetary Penalty Law, the Anti-kickback Statute and the Stark Law. However,MSSP. As authorized by the Health Reform Law, does not authorize HHS to waive otherthe rules and guidance also provide for certain waivers from fraud and abuse laws that may impact the ability of hospitals and other eligible participantsfor ACOs. In addition, beginning January 1, 2012, CMS has authorized 32 organizations to participate in the “Pioneer” ACO program, which is similar to, but separate from, the ACOs such as antitrust laws.

created under the MSSP regulations.

Bundled Payment Pilot Programs.    The Health Reform Law created the Center for Medicare and Medicaid Innovation with responsibility for establishing demonstration projects and other initiatives in order to identify, develop, test and encourage the adoption of new methods of delivering and paying for healthcare that create savings under the Medicare and Medicaid programs while improving quality of care. In addition, the Health Reform Law requires HHS to establish a five-year, voluntary national bundled payment pilot program for Medicare services beginning no later than January 1, 2013. Under the program, providers would agree to receive one payment for services provided to Medicare patients for certain medical conditions or episodes of care. HHS will have the discretion to determine how the program will function. For example, HHS will determine what medical conditions will be included in the program and the amount of the payment for each condition. In addition, the Health Reform Law provides for a five-year bundled payment pilot program for Medicaid services to begin January 1, 2012.services. HHS willmay select up to eight states to participate based on the potential to lower costs under the Medicaid program while improving care. State programs may target particular categories of beneficiaries, selected diagnoses or geographic regions of the state. The selected state programs will provide one payment for both hospital and physician services provided to Medicaid patients for certain episodes of inpatient care. For both pilot programs, HHS will determine the relationship between the programs and restrictions in certain existing laws, including the Civil Monetary Penalty Law, the Anti-kickback Statute, the Stark Law and the HIPAA privacy, security and transaction standard requirements. However, the Health Reform Law does not authorize HHS to waive other laws that may impact the ability of hospitals and other eligible participants to participate in the pilot programs, such as antitrust laws.

Ambulatory Surgery Centers.    The Health Reform Law reduces reimbursement for ASCs through a productivity adjustment to the market basket similar to the productivity adjustment for inpatient and outpatient hospital services, beginning in federal fiscal year 2011.

On November 1, 2011, CMS issued a final rule establishing a quality reporting program for ASCs by which ASCs that fail to report on five quality measures beginning on October 1, 2012, will receive a 2% reduction in reimbursement for calendar year 2014.

Medicare Managed Care (Medicare Advantage or “MA”).    Under the MA program, the federal government contracts with private health plans to provide inpatient and outpatient benefits to beneficiaries who enroll in such plans. Nationally,For 2012, approximately 22% of12.8 million Medicare beneficiaries have elected to enroll in MA plans. Effective in 2014, the Health Reform Law requires MA plans to keep annual administrative costs lower than 15% of annual


29


premium revenue. The Health Reform Law reduces, over a three year period starting in 2012, premium payments to the MA plans such that CMS’ managed care per capita premium payments are, on average, equal to traditional Medicare. In addition, the Health Reform Law implements fee payment adjustments based on service benchmarks and quality ratings. As a result of these changes, payments to MA plans are estimated to be reduced by $138 to $145 billion between 2010 and 2019. These reductions to MA plan premium payments may cause some plans to raise premiums or limit benefits, which in turn might cause some Medicare beneficiaries to terminate their MA coverage and enroll in traditional Medicare.

Specialty Hospital Limitations

Over the last decade, we have faced significant competition from hospitals that have physician ownership. The Health Reform Law prohibits newly created physician-owned hospitals from billing for Medicare patients referred by their physician owners. As a result, the law effectively prevents the formation of new physician-owned hospitals after December 31, 2010. While the law grandfathers existing physician-owned hospitals, it does not allow these hospitals to increase the percentage of physician ownership and significantly restricts their ability to expand services.

Program Integrity and Fraud and Abuse

The Health Reform Law makes several significant changes to health care fraud and abuse laws, provides additional enforcement tools to the government, increases cooperation between agencies by establishing mechanisms for the sharing of information and enhances criminal and administrative penalties for non-compliance. For example, the Health Reform Law: (1) provides $350 million in increased federal funding over the next 10 years to fight health care fraud, waste and abuse; (2) expands the scope of the RAC program to include MA plans and Medicaid; (3) authorizes HHS, in consultation with the OIG, to suspend Medicare and Medicaid payments to a provider of services or a supplier “pending an investigation of a credible allegation of fraud;” (4) provides Medicare contractors with additional flexibility to conduct random prepayment reviews; and (5) tightens up the rules for returning overpayments made by governmental health programs and expands FCA liability to include failure to timely repay identified overpayments.

Impact of Health Reform Law on the Company

The expansion of health insurance coverage under the Health Reform Law may result in a material increase in the number of patients using our facilities who have either private or public program coverage. In addition, a disproportionately large percentage of the new Medicaid coverage is likely to be in states that currently have relatively low income eligibility requirements. Two such states are Texas and Florida, where about one-half of the Company’s licensed beds are located. We also have a significant presence in other relatively low income eligibility states, including Georgia, Kansas, Louisiana, Missouri, Oklahoma and Virginia. Further, the Health Reform Law provides for a value-based purchasing program, the establishment of ACOs and bundled payment pilot programs, which will create possible sources of additional revenue.

However, it is difficult to predict the size of the potential revenue gains to the Company as a result of these elements of the Health Reform Law, because of uncertainty surrounding a number of material factors, including the following:

how many previously uninsured individuals will obtain coverage as a result of the Health Reform Law (while the CBO estimates 32 million by 2016 and 34 million by 2021, CMS estimates almost 34 million by 2019; both agencies made a number of assumptions to derive that figure, including how many individuals will ignore substantial subsidies and decide to pay the penalty rather than obtain health insurance and what percentage of people in the future will meet the new Medicaid income eligibility requirements);

what percentage of the newly insured patients will be covered under the Medicaid program and what percentage will be covered by private health insurers;

• how many previously uninsured individuals will obtain coverage as a result of the Health Reform Law (while the CBO estimates 32 million, CMS estimates almost 34 million; both agencies made a number of assumptions to derive that figure, including how many individuals will ignore substantial subsidies and decide to pay the penalty rather than obtain health insurance and what percentage of people in the future will meet the new Medicaid income eligibility requirements);
• what percentage of the newly insured patients will be covered under the Medicaid program and what percentage will be covered by private health insurers;
• the extent to which states will enroll new Medicaid participants in managed care programs;
• the pace at which insurance coverage expands, including the pace of different types of coverage expansion;


30

the extent to which states will enroll new Medicaid participants in managed care programs;

the pace at which insurance coverage expands, including the pace of different types of coverage expansion;

the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals;

the rate paid to hospitals by private payers for newly covered individuals, including those covered through the newly created Exchanges and those who might be covered under the Medicaid program under contracts with the state;

the rate paid by state governments under the Medicaid program for newly covered individuals;

the effect of the value-based purchasing program on our hospitals’ revenues and the effects of other quality programs;

the percentage of individuals in the Exchanges who select the high deductible plans, since health insurers offering those kinds of products have traditionally sought to pay lower rates to hospitals;


whether the net effect of the Health Reform Law, including the prohibition on excluding individuals based on pre-existing conditions, the requirement to keep medical costs at or above a specified minimum percentage of premium revenue, other health insurance reforms and the annual fee applied to all health insurers, will be to put pressure on the bottom line of health insurers, which in turn might cause them to seek to reduce payments to hospitals with respect to both newly insured individuals and their existing business; and

the possibility that implementation of the provisions expanding health insurance coverage or the entire Health Reform Law will be delayed due to court challenges or revised or eliminated as a result of court challenges and efforts to repeal or amend the law. Numerous lawsuits have challenged the constitutionality of the Health Reform Law. Some federal courts have upheld the constitutionality of the Health Reform Law or dismissed cases on procedural grounds. Others have held unconstitutional the requirement that individuals maintain health insurance or pay a penalty and have either found the Health Reform Law void in its entirety or left the remainder of the law intact. The U.S. Supreme Court is expected to decide the constitutionality of the Health Reform Law in 2012. In addition, repeal of the Health Reform Law has become a theme in political campaigns during this election year.

• the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals;
• the rate paid to hospitals by private payers for newly covered individuals, including those covered through the newly created Exchanges and those who might be covered under the Medicaid program under contracts with the state;
• the rate paid by state governments under the Medicaid program for newly covered individuals;
• how the value-based purchasing and other quality programs will be implemented;
• the percentage of individuals in the Exchanges who select the high deductible plans, since health insurers offering those kinds of products have traditionally sought to pay lower rates to hospitals;
• whether the net effect of the Health Reform Law, including the prohibition on excluding individuals based on pre-existing conditions, the requirement to keep medical costs at or above a specified minimum percentage of premium revenue, other health insurance reforms and the annual fee applied to all health insurers, will be to put pressure on the bottom line of health insurers, which in turn might cause them to seek to reduce payments to hospitals with respect to both newly insured individuals and their existing business; and
• the possibility that implementation of the provisions expanding health insurance coverage or the entire Health Reform Law will be delayed due to court challenges or revised or eliminated as a result of court challenges and efforts to repeal or amend the law. More than 20 challenges to the Health Reform Law have been filed in federal courts. Some federal district courts have upheld the constitutionality of the Health Reform Law or dismissed cases on procedural grounds. Others have held unconstitutional the requirement that individuals maintain health insurance or pay a penalty and have either found the entire Health Reform Law void in its entirety or left the remainder of the Health Reform Law intact. These lawsuits are subject to appeal, and several are currently on appeal, including those that hold the law unconstitutional.

On the other hand, the Health Reform Law provides for significant reductions in the growth of Medicare spending, reductions in Medicare and Medicaid DSH payments and the establishment of programs where reimbursement is tied to quality and integration. Since 40.7%44.5% of our revenues in 20102011 were from Medicare and Medicaid, reductions to these programs may significantly impact the Company and could offset any positive effects of the Health Reform Law. It is difficult to predict the size of the revenue reductions to Medicare and Medicaid spending, because of uncertainty regarding a number of material factors, including the following:

• 

the amount of overall revenues the Company will generate from Medicare and Medicaid business when the reductions are implemented;

• whether reductions required by the Health Reform Law will be changed by statute or by judicial decision prior to becoming effective;
• the size of the Health Reform Law’s annual productivity adjustment to the market basket beginning in 2012 payment years;
• the amount of the Medicare DSH reductions that will be made, commencing in federal fiscal year 2014;
• the allocation to our hospitals of the Medicaid DSH reductions, commencing in federal fiscal year 2014;
• what the losses in revenues will be, if any, from the Health Reform Law’s quality initiatives;
• how successful ACOs, in which we anticipate participating, will be at coordinating care and reducing costs or whether they will decrease reimbursement;
• the scope and nature of potential changes to Medicare reimbursement methods, such as an emphasis on bundling payments or coordination of care programs;


31


whether reductions required by the Health Reform Law will be changed by statute or by judicial decision prior to becoming effective;

the size of the Health Reform Law’s annual productivity adjustment to the market basket;

the amount of the Medicare DSH reductions that will be made, commencing in federal fiscal year 2014;

the allocation to our hospitals of the Medicaid DSH reductions, commencing in federal fiscal year 2014;

• whether the Company’s revenues from upper payment limit (“UPL”) programs will be adversely affected, because there may be fewer indigent, non-Medicaid patients for whom the Company provides services pursuant to UPL programs; and
• reductions to Medicare payments CMS may impose for “excessive readmissions.”

what the losses in revenues will be, if any, from the Health Reform Law’s quality initiatives;

how successful ACOs will be at coordinating care and reducing costs or whether they will decrease reimbursement;

the scope and nature of potential changes to Medicare reimbursement methods, such as an emphasis on bundling payments or coordination of care programs;

whether the Company’s revenues from upper payment limit (“UPL”) programs, or other Medicaid supplemental programs developed through a federally approved waiver program (“Waiver Program”), will be adversely affected because there may be reductions in available state and local government funding for the programs; and

reductions to Medicare payments CMS may impose for “excessive readmissions.”

Because of the many variables involved, we are unable to predict the net effect on the Company of the expected increases in insured individuals using our facilities, the reductions in Medicare spending, and reductions in Medicare and Medicaid DSH Funding,funding, and numerous other provisions in the Health Reform Law that may affect the Company. Further, it is unclear how efforts to repeal or revise the Health Reform Law and federal lawsuits challenging its constitutionality will be resolved or what the impact would be of any resulting changes to the law.

General Economic and Demographic Factors

The United States economy has weakened significantly in recent years. Depressed consumer spending and higher unemployment rates continue to pressure many industries. During economic downturns, governmental entities often experience budget deficits as a result of increased costs and lower than expected tax collections. These budget deficits have forced federal, state and local government entities to decrease spending for health and human service programs, including Medicare, Medicaid and similar programs, which represent significant payer sources for our hospitals. Other risks we face from general economic weakness include potential declines in the population covered under managed care agreements, increased patient decisions to postpone or cancel elective and nonemergency health care procedures, potential increases in the uninsured and underinsured populations, increased adoption of health plan structures that shift financial responsibility to patients and further difficulties in our collecting patient co-paymentcopayment and deductible receivables. The Health Reform Law seeks to decrease over time the number of uninsured individuals, by among other things requiring employers to offer, and individuals to carry, health insurance or be subject to penalties. However, it is difficult to predict the full impact of the Health Reform Law due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual and potentially delayed implementation, pending court challenges, and possible amendment or repeal.

The health care industry is impacted by the overall United States economy. The federal deficit, the growing magnitude of Medicare expenditures and the aging of the United States population will continue to place pressure on federal health care programs.

Compliance Program

We maintain a comprehensive ethics and compliance program that is designed to meet or exceed applicable federal guidelines and industry standards. The program is intended to monitor and raise awareness of various regulatory issues among employees and to emphasize the importance of complying with governmental laws and regulations. As part of the ethics and compliance program, we provide annual ethics and compliance training to our employees and encourage all employees to report any violations to their supervisor, an ethics and compliance officer or a toll-free telephone ethics line. The Health Reform Law requires providers to implement core elements of compliance program criteria to be established by HHS, on a timeline to be established by HHS, as a condition of enrollment in the Medicare or Medicaid programs, and we may have to modify our compliance programs to comply with these new criteria.

Antitrust Laws

The federal government and most states have enacted antitrust laws that prohibit certain types of conduct deemed to be anti-competitive. These laws prohibit price fixing, concerted refusal to deal, market monopolization, price discrimination, tying arrangements, acquisitions of competitors and other practices that have, or may have, an adverse effect on competition. Violations of federal or state antitrust laws can result in various sanctions, including criminal and civil penalties. Antitrust enforcement in the health care industry is currently a priority of the Federal Trade Commission. We believe we are in compliance with such federal and state laws, but courts or regulatory authorities may reach a determination in the future that could adversely affect our operations.


32


Environmental Matters

We are subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. We do not believe that we will be required to expend any material amounts in order to comply with these laws and regulations.

Insurance

As is typical in the health care industry, we are subject to claims and legal actions by patients in the ordinary course of business. Subject to a $5 million per occurrence self-insured retention, our facilities are insured by our wholly-owned insurance subsidiary for losses up to $50 million per occurrence. The insurance subsidiary has

obtained reinsurance for professional liability risks generally above a retention level of $15 million per occurrence. We also maintain professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by our insurance subsidiary.

We purchase, from unrelated insurance companies, coverage for directors and officers liability and property loss in amounts we believe are adequate. The directors and officers liability coverage includes a $25 million corporate deductible for the period prior to the Recapitalization andNovember 2006, a $1 million corporate deductible for the period subsequent to the Recapitalization.November 2006 until our initial public offering in March 2011 and a $5 million corporate deductible subsequent to our initial public offering in March 2011. In addition, we will continue to purchase coverage for our directors and officers on an ongoing basis. The property coverage includes varying deductibles depending on the cause of the property damage. These deductibles range from $500,000 per claim up to 5% of the affected property values for certain flood and wind and earthquake related incidents.

Employees and Medical Staffs

At December 31, 2010,2011, we had approximately 194,000199,000 employees, including approximately 48,00049,000 part-time employees. References herein to “employees” refer to employees of our affiliates. We are subject to various state and federal laws that regulate wages, hours, benefits and other terms and conditions relating to employment. At December 31, 2010,2011, employees at 3238 of our hospitals are represented by various labor unions. ItWhile no elections are expected in 2012, it is possible additional hospitals may unionize in the future. We consider our employee relations to be good and have not experienced work stoppages that have materially, adversely affected our business or results of operations. Our hospitals, like most hospitals, have experienced rising labor costs rising faster than the general inflation rate.costs. In some markets, nurse and medical support personnel availability has become a significant operating issue to health care providers. To address this challenge, we have implemented several initiatives to improve retention, recruiting, compensation programs and productivity.

Our hospitals are staffed by licensed physicians, including both employed physicians and physicians who generally are not employees of our hospitals. However, someSome physicians provide services in our hospitals under contracts, which generally describe a term of service, provide and establish the duties and obligations of such physicians, require the maintenance of certain performance criteria and fix compensation for such services. Any licensed physician may apply to be accepted to the medical staff of any of our hospitals, but the hospital’s medical staff and the appropriate governing board of the hospital, in accordance with established credentialing criteria, must approve acceptance to the staff. Members of the medical staffs of our hospitals often also serve on the medical staffs of other hospitals and may terminate their affiliation with one of our hospitals at any time.

We may be required to continue to enhance wages and benefits to recruit and retain nurses and other medical support personnel or to hire more expensive temporary or contract personnel. As a result, our labor costs could increase. We also depend on the available labor pool of semi-skilled and unskilled employees in each of the markets in which we operate. Certain proposed changes in federal labor laws includingand the Employee Free Choice Act,National Labor Relations Board’s (the “NLRB”) modification of its election procedures could increase the likelihood of employee unionization attempts. To the extent a significant portion of our employee base unionizes, our costs could increase materially. In addition, the states in which we operate could adopt mandatory nurse-staffing ratios or could reduce mandatory nurse-staffing ratios already in place. State-mandated nurse-staffing ratios could significantly affect labor costs, and have an adverse impact on revenues if we are required to limit patient admissions in order to meet the required ratios.


33


Executive Officers of the Registrant

As of February 11, 2011,17, 2012, our executive officers were as follows:

Name

Age   

Position(s)

Richard M. Bracken

   
Name
59
  
Age

Chairman of the Board and Chief Executive Officer

R. Milton Johnson

  
Position(s)
55

President, Chief Financial Officer and Director

David G. Anderson

64

Senior Vice President — Finance and Treasurer

Richard

Victor L. Campbell

65

Senior Vice President

Jana J. Davis

53

Senior Vice President — Communications

Jon M. BrackenFoster

50

President — Southwest Group

Charles J. Hall

   58    Chairman of the Board and Chief Executive Officer

President — National Group

R. Milton Johnson

Samuel N. Hazen

   5451    

President Chief Financial Officer and Director— Operations

David G. Anderson

A. Bruce Moore, Jr.

   6351    Senior Vice

President — FinanceService Line and TreasurerOperations Integration

Victor L. Campbell

Michael P. O’Boyle

   6455    Senior Vice

President and CEO — Parallon Business Solutionssm

Jana J. Davis52Senior Vice President — Communications
Jon M. Foster49Group President
Charles J. Hall57Group President
Samuel N. Hazen

Jonathan B. Perlin, M.D.

   50    President — Operations
A. Bruce Moore, Jr. 50Group President — Service Line and Operations Integration
Jonathan B. Perlin, M.D. 49

President — Clinical and Physician Services Group and Chief Medical Officer

W. Paul Rutledge

57

President — Central Group

Joseph A. Sowell, III

55

Senior Vice President and Chief Development Officer

Joseph N. Steakley

57

Senior Vice President — Internal Audit Services

John M. Steele

   56    Group President
Joseph A. Sowell, III54

Senior Vice President — DevelopmentHuman Resources

Joseph N. Steakley56Senior Vice President — Internal Audit Services
John M. Steele

Donald W. Stinnett

   55    Senior Vice President — Human Resources
Donald W. Stinnett54

Senior Vice President and Controller

Juan Vallarino

   5051    

Senior Vice President — Strategic Pricing and Analytics

Beverly B. Wallace

Robert A. Waterman

   6058    President — NewCo Business Solutions
Robert A. Waterman57

Senior Vice President, General Counsel and Chief Labor Relations Officer

Noel Brown Williams

   5556    

Senior Vice President and Chief Information Officer

Alan R. Yuspeh

   6162    

Senior Vice President and Chief Ethics and Compliance Officer

Richard M. Brackenhas served as Chief Executive Officer of the Company since January 2009 and was appointed as Chairman of the Board in December 2009. Mr. Bracken served as President and Chief Executive Officer from January 2009 to December 2009. Mr. Bracken was appointed Chief Operating Officer in July 2001 and served as President and Chief Operating Officer from January 2002 to January 2009. Mr. Bracken served as President — Western Group of the Company from August 1997 until July 2001. From January 1995 to August 1997, Mr. Bracken served as President of the Pacific Division of the Company. Prior to 1995, Mr. Bracken served in various hospital Chief Executive Officer and Administrator positions with HCA-Hospital Corporation of America.

R. Milton Johnsonhas served as President and Chief Financial Officer of the Company since February 2011 and was appointed as a director in December 2009. Mr. Johnson served as Executive Vice President and Chief Financial Officer from July 2004 to February 2011 and as Senior Vice President and Controller of the Company from July 1999 until July 2004. Mr. Johnson served as Vice President and Controller of the Company from November 1998 to July 1999. Prior to that time, Mr. Johnson served as Vice President — Tax of the Company from April 1995 to October 1998. Prior to that time, Mr. Johnson served as Director of Tax for Healthtrust, Inc. — The Hospital Company from September 1987 to April 1995.

David G. Andersonhas served as Senior Vice President — Finance and Treasurer of the Company since July 1999. Mr. Anderson served as Vice President — Finance of the Company from September 1993 to July 1999 and was appointed to the additional position of Treasurer in November 1996. From March 1993 until September 1993, Mr. Anderson served as Vice President — Finance and Treasurer of Galen Health Care, Inc. From July 1988 to March 1993, Mr. Anderson served as Vice President — Finance and Treasurer of Humana Inc.


34


Victor L. Campbellhas served as Senior Vice President of the Company since February 1994. Prior to that time, Mr. Campbell served as HCA-Hospital Corporation of America’s Vice President for Investor, Corporate

and Government Relations. Mr. Campbell joined HCA-Hospital Corporation of America in 1972. Mr. Campbell serves on the board of the Nashville Health Care Council, as a member of the American Hospital Association’s President’s Forum, and on the board and Executive Committee of the Federation of American Hospitals.

Jana J. Daviswas appointed Senior Vice President — Communications in February 2011. Prior to that time, she served as Vice President of Communications for the Company from November 1997 to February 2011. Ms. Davis joined HCA in 1997 from Burson-Marsteller, where she was a Managing Director and served as Corporate Practice Chair for Latin American operations. Ms. Davis also held a number of Public Affairs positions in the George H.W. Bush and Reagan Administrations. Ms. Davis is an attorney and serves as chairon the Board of the Public Relations CommitteeGovernors for the Federation of American Hospitals.

Jon M. Fosterwas appointed President Southwest Group President in February 2011. Prior to that, Mr. Foster served as Division President for the Central and West Texas Division from January 2006 to February 2011. Mr. Foster joined HCA in March 2001 as President and CEO of St. David’s HealthCare in Austin, Texas and served in that position until February 2011. Prior to joining the company,Company, Mr. Foster served in various executive capacities within the Baptist Health System, Knoxville, Tennessee and The Methodist Hospital System in Houston, Texas.

Charles J. Hallwas appointed President-National Group President in October 2006; his formal title priorFebruary 2011. Prior to February 2011 wasthat, Mr. Hall served as President — Eastern Group. PriorGroup from October 2006 to that time,February 2011. Mr. Hall had previously served the Company as President — North Florida Division sincefrom April 2003. Mr. Hall had previously served the Company2003 until October 2006, as President of the East Florida Division from January 1999 until April 2003, as a Market President in the East Florida Division from January 1998 until December 1998, as President of the South Florida Division from February 1996 until December 1997, and as President of the Southwest Florida Division from October 1994 until February 1996, and in various other capacities since 1987.

Samuel N. Hazenwas appointed President — Operations of the Company in February 2011. Mr. Hazen served as President — Western Group from July 2001 to February 2011 and as Chief Financial Officer — Western Group of the Company from August 1995 to July 2001. Mr. Hazen served as Chief Financial Officer — North Texas Division of the Company from February 1994 to July 1995. Prior to that time, Mr. Hazen served in various hospital and regional Chief Financial Officer positions with Humana Inc. and Galen Health Care, Inc.

A. Bruce Moore, Jr.,was appointed Group President — Service Line and Operations Integration in February 2011. Prior to that, Mr. Moore had served as President — Outpatient Services Group since January 2006. Mr. Moore served as Senior Vice President and as Chief Operating Officer — Outpatient Services Group from July 2004 to January 2006 and as Senior Vice President — Operations Administration from July 1999 until July 2004. Mr. Moore served as Vice President — Operations Administration of the Company from September 1997 to July 1999, as Vice President — Benefits from October 1996 to September 1997, and as Vice President — Compensation from March 1995 until October 1996.

Michael O’Boyle was appointed President and Chief Executive Officer of Parallon Business Solutions in January 2012. Prior to that, Mr. O’Boyle served as President of UnitedHealth Networks from 2008 to 2012. From 2005 to 2008, he served as the Chief Operating Officer of the Cleveland Clinic. He joined the Cleveland Clinic as Chief Financial Officer in 2001. From 1991 to 2001, he served as Chief Financial Officer for Medlantic Healthcare Group and MedStar Health, Inc. From 1987 to 1991, he held several financial leadership roles, including Chief Financial Officer, for three hospitals.

Dr. Jonathan B. Perlinwas appointed President — Clinical and Physician Services Group and Chief Medical Officer in February 2011. Dr. Perlin had served as President — Clinical Services Group and Chief Medical Officer from November 2007 to February 2011 and as Chief Medical Officer and Senior Vice President — Quality of the Company from August 2006 to November 2007. Prior to joining the Company, Dr. Perlin served as Under Secretary for Health in the U.S. Department of Veterans Affairs since April 2004. Dr. Perlin joined the Veterans Health Administration in November 1999 where he served in various capacities, including as Deputy Under Secretary for Health from July 2002 to April 2004, and as Chief Quality and Performance Officer from November 1999 to September 2002.

W. Paul Rutledgewas appointedhas served as Group President in October 2005; his formal title prior to February 2011 was President — Central Group.Group since October 2005. Mr. Rutledge had served as President of the MidAmerica Division sincefrom January 2001.2001 to October 2005. He served as President of TriStar Health System from June 1996 to January 2001 and served as President of Centennial Medical Center from May 1993 to June 1996. He has served in leadership capacities with HCA for more than 2829 years, working with hospitals in the United States and London, England.

Joseph A. Sowell, IIIwas appointed as Senior Vice President and Chief Development Officer of the Company in December 2009. From 1987 to 1996 and again from 1999 to 2009, Mr. Sowell was a partner at the law firm of


35


Waller Lansden Dortch & Davis where he specialized in the areas of health care law, mergers and acquisitions, joint ventures, private equity financing, tax law and general corporate law. He also co-managed the firm’s corporate and commercial transactions practice. From 1996 to 1999, Mr. Sowell served as the head of development, and later as the Chief Operating Officer of Arcon Healthcare.

Joseph N. Steakleyhas served as Senior Vice President — Internal Audit Services of the Company since July 1999. Mr. Steakley served as Vice President — Internal Audit Services from November 1997 to July 1999. From October 1989 until October 1997, Mr. Steakley was a partner with Ernst & Young LLP. Mr. Steakley is a member of the board of directors of J. Alexander’s Corporation, where he serves on the compensation committee and as chairman of the audit committee.

John M. Steelehas served as Senior Vice President — Human Resources of the Company since November 2003. Mr. Steele served as Vice President — Compensation and Recruitment of the Company from November 1997 to October 2003. From March 1995 to November 1997, Mr. Steele served as Assistant Vice President — Recruitment.

Donald W. Stinnetthas served as Senior Vice President and Controller since December 2008. Mr. Stinnett served as Chief Financial Officer — Eastern Group from October 2005 to December 2008 and Chief Financial Officer of the Far West Division from July 1999 to October 2005. Mr. Stinnett served as Chief Financial Officer and Vice President of Finance of Franciscan Health System of the Ohio Valley from 1995 until 1999, and served in various capacities with Franciscan Health System of Cincinnati and Providence Hospital in Cincinnati prior to that time.

Juan Vallarinowas appointed Senior Vice President — Strategic Pricing and Analytics in February 2011. Prior to that time, Mr. Vallarino had served as Vice President — Strategic Pricing and Analytics since October 2006. Prior to that, Mr. Vallarino served as Vice President of Managed Care for the Western Group of the Company from January 1998 to October 2006.

Beverly B. Wallacewas appointed President — NewCo Business Solutions in February 2011. From March 2006 until February 2011, Ms. Wallace served as President — Shared Services Group, and from January 2003 until March 2006, Ms. Wallace served as President — Financial Services Group. Ms. Wallace served as Senior Vice President — Revenue Cycle Operations Management of the Company from July 1999 to January 2003. Ms. Wallace served as Vice President — Managed Care of the Company from July 1998 to July 1999. From 1997 to 1998, Ms. Wallace served as President — Homecare Division of the Company. From 1996 to 1997, Ms. Wallace served as Chief Financial Officer — Nashville Division of the Company. From 1994 to 1996, Ms. Wallace served as Chief Financial Officer —

Mid-America Division of the Company.

Robert A. Watermanhas served as Senior Vice President and General Counsel of the Company since November 1997 and Chief Labor Relations Officer since March 2009. Mr. Waterman served as a partner in the law firm of Latham & Watkins from September 1993 to October 1997; he was Chair of the firm’s health care group during 1997.

Noel Brown Williamshas served as Senior Vice President and Chief Information Officer of the Company since October 1997. From October 1996 to September 1997, Ms. Williams served as Chief Information Officer for American Service Group/Prison Health Services, Inc. From September 1995 to September 1996, Ms. Williams worked as an independent consultant. From June 1993 to June 1995, Ms. Williams served as Vice President, Information Services for HCA Information Services. From February 1979 to June 1993, she held various positions with HCA-Hospital Corporation of America Information Services.

Alan R. Yuspehhas served as Senior Vice President and Chief Ethics and Compliance Officer of the Company since May 2007. From October 1997 to May 2007, Mr. Yuspeh served as Senior Vice President — Ethics, Compliance and Corporate Responsibility of the Company. From September 1991 until October 1997, Mr. Yuspeh was a partner with the law firm of Howrey & Simon. As a part of his law practice, Mr. Yuspeh served from 1987 to 1997 as Coordinator of the Defense Industry Initiative on Business Ethics and Conduct.


36


Item 1A.    Risk Factors

Item 1A.Risk Factors
If any of the events discussed in the following risk factors were to occur, our business, financial position, results of operations, cash flows or prospects could be materially, adversely affected. Additional risks and uncertainties not presently known, or currently deemed immaterial, may also constrain our business and operations.

Our substantial leverage could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk to the extent of our variable rate debt and prevent us from meeting our obligations.

We are highly leveraged. As of December 31, 2010,2011, our total indebtedness was $28.225$27.052 billion. As of December 31, 2010,2011, we had availability of $1.189$1.935 billion under our senior secured revolving credit facility and $125$202 million under our asset-based revolving credit facility, after giving effect to letters of credit and borrowing base limitations. Our high degree of leverage could have important consequences, including:

increasing our vulnerability to downturns or adverse changes in general economic, industry or competitive conditions and adverse changes in government regulations;

requiring a substantial portion of cash flow from operations to be dedicated to the payment of principal and interest on our indebtedness, therefore reducing our ability to use our cash flow to fund our operations, capital expenditures and future business opportunities;

• increasing our vulnerability to downturns or adverse changes in general economic, industry or competitive conditions and adverse changes in government regulations;
• requiring a substantial portion of cash flow from operations to be dedicated to the payment of principal and interest on our indebtedness, therefore reducing our ability to use our cash flow to fund our operations, capital expenditures and future business opportunities;
• exposing us to the risk of increased interest rates as certain of our unhedged borrowings are at variable rates of interest;
• limiting our ability to make strategic acquisitions or causing us to make nonstrategic divestitures;
• limiting our ability to obtain additional financing for working capital, capital expenditures, product or service line development, debt service requirements, acquisitions and general corporate or other purposes; and
• limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who are less highly leveraged.

exposing us to the risk of increased interest rates as certain of our unhedged borrowings are at variable rates of interest;

limiting our ability to make strategic acquisitions or causing us to make nonstrategic divestitures;

limiting our ability to obtain additional financing for working capital, capital expenditures, product or service line development, debt service requirements, acquisitions and general corporate or other purposes; and

limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who are less highly leveraged.

We and our subsidiaries have the ability to incur additional indebtedness in the future, subject to the restrictions contained in our senior secured credit facilities and the indentures governing our outstanding notes. If new indebtedness is added to our current debt levels, the related risks that we now face could intensify.

We may not be able to generate sufficient cash to service all of our indebtedness and may not be able to refinance our indebtedness on favorable terms. If we are unable to do so, we may be forced to take other actions to satisfy our obligations under our indebtedness, which may not be successful.

Our ability to make scheduled payments on or to refinance our debt obligations depends on our financial condition and operating performance, which isare subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond our control. We cannot assure you we will maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our indebtedness.

In addition, we conduct our operations through our subsidiaries. Accordingly, repayment of our indebtedness is dependent on the generation of cash flow by our subsidiaries and their ability to make such cash available to us by dividend, debt repayment or otherwise. Our subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to make payments in respect of our indebtedness. Each subsidiary is a distinct legal entity, and, under certain circumstances, legal and contractual restrictions may limit our ability to obtain cash from our subsidiaries.

We may find it necessary or prudent to refinance our outstanding indebtedness with longer-maturity debt at a higher interest rate. In February, April and August of 2009 and in March of 2010, for example, we issued $310 million in aggregate principal amount of 97/8% second lien notes due 2017, $1.500 billion in aggregate principal amount of 81/2% first lien notes due 2019, $1.250 billion in aggregate principal amount of 77/8% first lien notes due 2020 and $1.400 billion in aggregate principal amount of 71/4% first lien notes due 2020, respectively. The net proceeds of those offerings were used to prepay term loans under our cash flow credit facility, which currently bears interest at a lower floating rate. Our ability to refinance our indebtedness on favorable terms, or at all, is


37


directly affected by the current global economic and financial conditions. In addition, our ability to incur secured indebtedness (which would generally enable us to achieve better pricing than the incurrence of unsecured indebtedness) depends in part on the value of our assets, which depends, in turn, on the strength of our cash flows and results of operations, and on economic and market conditions and other factors.

If our cash flows and capital resources are insufficient to fund our debt service obligations or we are unable to refinance our indebtedness, we may be forced to reduce or delay investments and capital expenditures, or to sell assets, seek additional capital or restructure our indebtedness. These alternative measures may not be successful and may not permit us to meet our scheduled debt service obligations. If our operating results and available cash are insufficient to meet our debt service obligations, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt service and other obligations. We may not be able to consummate those dispositions, or the proceeds from the dispositions may not be adequate to meet any debt service obligations then due.

Our debt agreements contain restrictions that limit our flexibility in operating our business.

Our senior secured credit facilities and the indentures governing our outstanding notes contain various covenants that limit our ability to engage in specified types of transactions. These covenants limit our and certain of our subsidiaries’ ability to, among other things:

incur additional indebtedness or issue certain preferred shares;

pay dividends on, repurchase or make distributions in respect of our capital stock or make other restricted payments;

• incur additional indebtedness or issue certain preferred shares;
• pay dividends on, repurchase or make distributions in respect of our capital stock or make other restricted payments;
• make certain investments;
• sell or transfer assets;
• create liens;
• consolidate, merge, sell or otherwise dispose of all or substantially all of our assets; and
• enter into certain transactions with our affiliates.

make certain investments;

sell or transfer assets;

create liens;

consolidate, merge, sell or otherwise dispose of all or substantially all of our assets; and

enter into certain transactions with our affiliates.

Under our asset-based revolving credit facility, when (and for as long as) the combined availability under our asset-based revolving credit facility and our senior secured revolving credit facility is less than a specified amount for a certain period of time or, if a payment or bankruptcy event of default has occurred and is continuing, funds deposited into any of our depository accounts will be transferred on a daily basis into a blocked account with the administrative agent and applied to prepay loans under the asset-based revolving credit facility and to cash collateralize letters of credit issued thereunder.

Under our senior secured credit facilities, we are required to satisfy and maintain specified financial ratios. Our ability to meet those financial ratios can be affected by events beyond our control, and there can be no assurance we will continue to meet those ratios. A breach of any of these covenants could result in a default under both the cash flow credit facility and the asset-based revolving credit facility. Upon the occurrence of an event of default under the senior secured credit facilities, the lenders thereunder could elect to declare all amounts outstanding under the senior secured credit facilities to be immediately due and payable and terminate all commitments to extend further credit. If we were unable to repay those amounts, the lenders under the senior secured credit facilities could proceed against the collateral granted to them to secure such indebtedness. We have pledged a significant portion of our assets under our senior secured credit facilities and that collateral (other than certain European collateral securing our senior secured European term loan facility) is also pledged as collateral under our first lien notes. If any of the lenders under the senior secured credit facilities accelerate the repayment of borrowings, there can be no assurance there will be sufficient assets to repay the senior secured credit facilities, the first lien notes and our other indebtedness.

Our hospitals face competition for patients from other hospitals and health care providers.

The health care business is highly competitive, and competition among hospitals and other health care providers for patients has intensified in recent years. Generally, other hospitals in the local communities we serve provide services similar to those offered by our hospitals. In addition, CMS publicizes on its Hospital Compare website performance data related to quality measures and data on patient satisfaction surveys hospitals submit in connection with their Medicare reimbursement. Federal law provides for the future expansion of the number of


38


quality measures that must be reported. Additional quality measures and future trends toward clinical transparency may have an unanticipated impact on our competitive position and patient volumes. Further, the Health Reform Law requires all hospitals to annually establish, update and make public a list of the hospital’s standard charges for items and services. If any of our hospitals achieve poor results (or results that are lower than our competitors) on these quality measures or on patient satisfaction surveys or if our standard charges are higher than our competitors, our patient volumes could decline.

In addition, the number of freestanding specialty hospitals, surgery centers and diagnostic and imaging centers in the geographic areas in which we operate has increased significantly. As a result, most of our hospitals operate in a highly competitive environment. Some of the facilities that compete with our hospitals are owned by governmental agencies or not-for-profit corporations supported by endowments, charitable contributionsand/or tax revenues and can finance capital expenditures and operations on a tax-exempt basis. Our hospitals face increasing competition from specialty hospitals, some of which are physician-owned, and from both our own and unaffiliated freestanding surgery centers for market share in certain high margin services and for quality physicians and personnel. If ambulatory surgery centers are better able to compete in this environment than our hospitals, our hospitals may experience a decline in patient volume, and we may experience a decrease in margin, even if those patients use our ambulatory surgery centers. In states that do not require a CON for the purchase, construction or expansion of health care facilities or services, competition in the form of new services, facilities and capital spending is more prevalent. Further, if our competitors are better able to attract patients, make capital expenditures and maintain modern and technologically upgraded facilities and equipment, recruit physicians, expand services or obtain favorable managed care contracts at their facilities than our hospitals and ambulatory surgery centers, we may experience an overall decline in patient volume. See Item 1, “Business — Competition.”

The growth of uninsured and patient due accounts and a deterioration in the collectibility of these accounts could adversely affect our results of operations.

The primary collection risks of our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (deductibles(exclusions, deductibles and copayments) remain outstanding. The provision for doubtful accounts relates primarily to amounts due directly from patients.

Although Medicare reimburses hospitals for a portion of Medicare bad debts, the Jobs Creation Act will reduce the reimbursement level from 70% of eligible bad debts to 65% beginning in federal fiscal year 2013.

The amount of the provision for doubtful accounts is based upon management’s assessment of historical write-offs and expected net collections, business and economic conditions, trends in federal and state governmental and private employer health care coverage, the rate of growth in uninsured patient admissions and other collection indicators. At December 31, 2010,2011, our allowance for doubtful accounts represented approximately 93%92% of the $4.249$4.478 billion patient due accounts receivable balance. The sum of the provision for doubtful accounts, uninsured discounts and charity care increased from $7.009 billion for 2008 to $8.362 billion for 2009 and to $9.626 billion for 2010.

2010 and to $11.214 billion for 2011.

A continuation of the trends that have resulted in an increasing proportion of accounts receivable being comprised of uninsured accounts and a deterioration in the collectibility of these accounts will adversely affect our collection of accounts receivable, cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts as a result of increases in the adoption of plan structures, including

health savings accounts, that shift greater responsibility for care to individuals through greater exclusions and copayment and deductible amounts. Prior to the Health Reform Law being fully implemented, our facilities may experience growth in bad debts, uninsured discounts and charity care as a result of a number of factors, including the economic downturn and increase incontinued high unemployment. The Health Reform Law seeks to decrease, over time, the number of uninsured individuals. As enacted, the Health Reform Lawindividuals through reforms that mostly will become effective January 1, 2014, expand Medicaid and incentivize employersprovided the law is not found to offer, and require individuals to carry, health insurancebe unconstitutional or be subject to penalties. More than 20 challenges to the Health Reform Law have been filed in federal courts. Some federal courts have upheld the constitutionalityotherwise revised. Even after full implementation of the Health Reform Law, or dismissed cases on procedural grounds. Otherswe may continue to experience bad debts and have held unconstitutional the requirement that individuals maintainto provide uninsured discounts and charity care for undocumented aliens who are not permitted to enroll in a health insurance exchange or pay a penaltygovernment health care programs and certain others who may not have either foundinsurance coverage. Further, implementation of the Health Reform Law voidcould result in its entiretysome patients terminating their current insurance plans in favor of lower cost Medicaid plans or left the remainderother insurance coverage with lower reimbursement levels. Patient responsibility accounts may continue to increase even with expanded health plan coverage as a result of the law intact. These lawsuits are subject to appeal,increases in plan exclusions and several are currently on appeal, including those that hold the law unconstitutional. deductibles and copayment amounts.

It is difficult to predict the full impact of the Health Reform Law due to the law’s complexity, lack of implementing regulations or interpretive guidance, gradual and potentially delayed implementation, pending court challenges and possible amendment or repeal, as well as our inability to foresee how individuals and businesses will respond to the choices afforded them by the law. In addition, even after implementation of the Health Reform Law, we may continue to experience bad debts and have to provide uninsured discounts and charity care for


39


undocumented aliens who are not permitted to enroll in a health insurance exchange or government health care programs and certain others who may not have insurance coverage.
Changes in government health care programs may reduceadversely affect our revenues.

A significant portion of our patient volume is derived from government health care programs, principally Medicare and Medicaid. Specifically, we derived approximately 41%44.5% of our revenues from the Medicare and Medicaid programs in 2010.2011. Changes in government health care programs may reduce the reimbursement we receive and could adversely affect our business and results of operations.

In recent years, legislative and regulatory changes have resulted in limitations on and, in some cases, reductions in levels of payments to health care providers for certain services under the Medicare program. For example, CMS completed a two-year transitionThe Budget Control Act of 2011 (the “BCA”) provides for new spending on program integrity initiatives intended to full implementation ofreduce fraud and abuse under the MS-DRG system, which represents a refinementMedicare program. Further, pursuant to the existing diagnosis-related group system. Future realignmentsBCA, a bipartisan joint congressional committee was created to identify additional deficit reductions. Because the committee failed to propose a plan to cut the deficit by an additional $1.2 trillion by the November 23, 2011, deadline, the BCA requires automatic spending reductions of $1.2 trillion for federal fiscal years 2013 through 2021, minus any deficit reductions enacted by Congress and debt service costs. However, the percentage reduction for Medicare may not be more than 2% for a fiscal year, with a uniform percentage reduction across all Medicare programs. We are unable to predict how these spending reductions will be structured, what other deficit reduction initiatives may be proposed by Congress or whether Congress will attempt to suspend or restructure the automatic budget cuts.

These reductions will be in the MS-DRG system could impact the margins we receive for certain services. Further,addition to reductions mandated by the Health Reform Law, which provides for material reductions in the growth of Medicare program spending, including reductions in Medicare market basket updates and Medicare DSH funding. Medicare payments in federal fiscal year 2011 for inpatient hospital services are expectedFurther, from time to be slightly lower than payments fortime, CMS revises the same services in federal fiscal year 2010, because of reductions resulting from the Health Reform Law andreimbursement systems used to reimburse health care providers, including changes to the MS-DRG implementation.

system and other payment systems, which may result in reduced Medicare payments.

Since most states must operate with balanced budgets and since the Medicaid program is often a state’s largest program, some states can be expected to enacthave enacted or may consider enacting legislation designed to reduce their Medicaid expenditures. Further, many states have also adopted, or are considering, legislation designed to reduce coverage, enroll Medicaid recipients in managed care programs and/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. The current economic downturnenvironment has increased the budgetary pressures on many states, and these budgetary pressures have resulted, and likely will continue to result, in decreased spending, or decreased spending growth, for Medicaid programs and the CHIPChildren’s Health Insurance

Program in many states. For example, in May 2011, the Florida legislature passed a budget agreement for the fiscal year beginning July 1, 2011 that reduces Medicaid reimbursements to hospitals. As a result, we estimate that Florida Medicaid payments to our hospitals may be reduced by approximately $35 million during the first half of calendar year 2012. Additionally, the Texas legislature passed a budget agreement effective September 1, 2011 that reduces Medicaid reimbursements to hospitals. As a result, we estimate that Texas Medicaid payments to our hospitals may be reduced by approximately $60 million in 2012. Some states that provide Medicaid supplemental payments are reviewing these programs or have filed waiver requests with CMS to replace these programs, which could result in Medicaid supplemental payments being reduced or eliminated. CMS approved a Medicaid waiver in December 2011 that allows Texas to continue receiving supplemental Medicaid reimbursement while expanding its Medicaid managed care program. However, we cannot predict whether the Texas private supplemental Medicaid Waiver Program will continue or guarantee that revenues recognized from the program will not decrease.

The Health Reform Law has changed and will likely result in additional changes to the Medicaid program. For example, the Health Reform Law provides for material reductions to Medicaid DSH funding. Further, many states have also adopted, or are considering, legislation designed to reduce coverage, enroll Medicaid recipients in managed care programsand/or impose additional taxes on hospitals to help finance or expand the states’ Medicaid systems. Effective March 23, 2010, the Health Reform Law requires states to at least maintain Medicaid eligibility standards established prior to the enactment of the law for adults until January 1, 2014 and for children until October 1, 2019. However, states with budget deficits may seek a waiver from this requirement to address eligibility standards that apply to adults making more than 133% of the federal poverty level. The Health Reform Law also provides for significant expansions to the Medicaid program, but these changes are not required until 2014. In addition, the Health Reform Law will result in increased state legislative and regulatory changes in order for states to comply with new federal mandates, such as the requirement to establish Exchanges, and to participate in grants and other incentive opportunities.

In some cases, commercial third-party payers rely on all or portions of the MS-DRG systemMedicare payment systems to determine payment rates, which may result in decreased reimbursement from some commercial third-party payers. Other changesrates. Changes to government health care programs that reduce payments under these programs may negatively impact payments from commercial third-party payers.

Current or future health care reform and deficit reduction efforts, changes in laws or regulations regarding government health care programs, other changes in the administration of government health care programs and changes to commercial third-party payers in response to health care reform and other changes to government health care programs could have a material, adverse effect on our financial position and results of operations.

We are unable to predict the impact of the Health Reform Law, which represents a significant change to the health care industry.

As enacted, the Health Reform Law will change how health care services are covered, delivered, and reimbursed through expanded coverage of uninsured individuals, reduced growth in Medicare program spending, reductions in Medicare and Medicaid DSH payments and the establishment of programs where reimbursement is tied to quality and integration. In addition, the law reforms certain aspects of health insurance, expands existing efforts to tie Medicare and Medicaid payments to performance and quality, and contains provisions intended to strengthen fraud and abuse enforcement. The expansion of health insurance coverage under the Health Reform Law may result in a material increase in the number of patients using our facilities who have either private or public program coverage. In addition, a disproportionately large percentage of the new Medicaid coverage is likely to be in


40


states that currently have relatively low income eligibility requirements. Two such states are Texas and Florida, where about one-half of the Company’s licensed beds are located. The Company also has a significant presence in other relatively low income eligibility states, including Georgia, Kansas, Louisiana, Missouri, Oklahoma and Virginia. Further, the Health Reform Law provides for a value-based purchasing program, the establishment of ACOs and bundled payment pilot programs, which will create possible sources of additional revenue.

However, it is difficult to predict the size of the potential revenue gains to the Company as a result of these elements of the Health Reform Law, because of uncertainty surrounding a number of material factors, including the following:

how many previously uninsured individuals will obtain coverage as a result of the Health Reform Law (while the CBO estimates 32 million by 2016 and 34 million by 2021, CMS estimates almost 34 million by 2019; both agencies made a number of assumptions to derive that figure, including how many individuals will ignore substantial subsidies and decide to pay the penalty rather than obtain health insurance and what percentage of people in the future will meet the new Medicaid income eligibility requirements);

what percentage of the newly insured patients will be covered under the Medicaid program and what percentage will be covered by private health insurers;

• how many previously uninsured individuals will obtain coverage as a result of the Health Reform Law (while the CBO estimates 32 million, CMS estimates almost 34 million; both agencies made a number of assumptions to derive that figure, including how many individuals will ignore substantial subsidies and decide to pay the penalty rather than obtain health insurance and what percentage of people in the future will meet the new Medicaid income eligibility requirements);
• what percentage of the newly insured patients will be covered under the Medicaid program and what percentage will be covered by private health insurers;
• the extent to which states will enroll new Medicaid participants in managed care programs;
• the pace at which insurance coverage expands, including the pace of different types of coverage expansion;
• the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals;
• the rate paid to hospitals by private payers for newly covered individuals, including those covered through the newly created Exchanges and those who might be covered under the Medicaid program under contracts with the state;
• the rate paid by state governments under the Medicaid program for newly covered individuals;
• how the value-based purchasing and other quality programs will be implemented;
• the percentage of individuals in the Exchanges who select the high deductible plans, since health insurers offering those kinds of products have traditionally sought to pay lower rates to hospitals;
• whether the net effect of the Health Reform Law, including the prohibition on excluding individuals based on pre-existing conditions, the requirement to keep medical costs at or above a specified minimum percentage of premium revenue, other health insurance reforms and the annual fee applied to all health insurers, will be to put pressure on the bottom line of health insurers, which in turn might cause them to seek to reduce payments to hospitals with respect to both newly insured individuals and their existing business; and
• the possibility that implementation of the provisions expanding health insurance coverage or the entire Health Reform Law will be delayed due to court challenges or revised or eliminated as a result of court challenges and efforts to repeal or amend the law. More than 20 challenges to the Health Reform Law have been filed in federal courts. Some federal district courts have upheld the constitutionality of the Health Reform Law or dismissed cases on procedural grounds. Others have held unconstitutional the requirement that individuals maintain health insurance or pay a penalty and have either found the Health Reform Law void in its entirety or left the remainder of the law intact. These lawsuits are subject to appeal, and several are currently on appeal, including those that hold the law unconstitutional.

the extent to which states will enroll new Medicaid participants in managed care programs;

the pace at which insurance coverage expands, including the pace of different types of coverage expansion;

the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals;

the rate paid to hospitals by private payers for newly covered individuals, including those covered through the newly created Exchanges and those who might be covered under the Medicaid program under contracts with the state;

the rate paid by state governments under the Medicaid program for newly covered individuals;

the effect of the value-based purchasing program on our hospitals’ revenues and the effects of other quality programs;

the percentage of individuals in the Exchanges who select the high deductible plans, since health insurers offering those kinds of products have traditionally sought to pay lower rates to hospitals;

whether the net effect of the Health Reform Law, including the prohibition on excluding individuals based on pre-existing conditions, the requirement to keep medical costs at or above a specified minimum percentage of premium revenue, other health insurance reforms and the annual fee applied to all health insurers, will be to put pressure on the bottom line of health insurers, which in turn might cause them to seek to reduce payments to hospitals with respect to both newly insured individuals and their existing business; and

the possibility that implementation of the provisions expanding health insurance coverage or the entire Health Reform Law will be delayed, revised or eliminated as a result of court challenges and efforts to repeal or amend the law. Numerous lawsuits have challenged the constitutionality of the Health Reform Law. Some federal courts have upheld the constitutionality of the Health Reform Law or dismissed cases on procedural grounds. Others have held unconstitutional the requirement that individuals maintain health insurance or pay a penalty and have either found the Health Reform Law void in its entirety or left the remainder of the law intact. The U.S. Supreme Court is expected to decide the constitutionality of the Health Reform Law in 2012. In addition, repeal of the Health Reform Law has become a theme in political campaigns during this election year.

On the other hand, the Health Reform Law provides for significant reductions in the growth of Medicare spending, reductions in Medicare and Medicaid DSH payments and the establishment of programs where reimbursement is tied to quality and integration. Since 40.7%44.5% of our revenues in 20102011 were from Medicare and Medicaid, reductions to these programs may significantly impact the Company and could offset any positive effects of the Health Reform Law. It is difficult to predict the size of the revenue reductions to Medicare and Medicaid spending, because of uncertainty regarding a number of material factors, including the following:

• 

the amount of overall revenues the Company will generate from Medicare and Medicaid business when the reductions are implemented;


41


whether reductions required by the Health Reform Law will be changed by statute or by judicial decision prior to becoming effective;

the size of the Health Reform Law’s annual productivity adjustment to the market basket;

the amount of the Medicare DSH reductions that will be made, commencing in federal fiscal year 2014;

the allocation to our hospitals of the Medicaid DSH reductions, commencing in federal fiscal year 2014;

• whether reductions required by the Health Reform Law will be changed by statute or by judicial decision prior to becoming effective;
• the size of the Health Reform Law’s annual productivity adjustment to the market basket beginning in 2012 payment years;
• the amount of the Medicare DSH reductions that will be made, commencing in federal fiscal year 2014;
• the allocation to our hospitals of the Medicaid DSH reductions, commencing in federal fiscal year 2014;
• what the losses in revenues will be, if any, from the Health Reform Law’s quality initiatives;
• how successful ACOs, in which we anticipate participating, will be at coordinating care and reducing costs or whether they will decrease reimbursement;
• the scope and nature of potential changes to Medicare reimbursement methods, such as an emphasis on bundling payments or coordination of care programs;
• whether the Company’s revenues from UPL programs will be adversely affected, because there may be fewer indigent, non-Medicaid patients for whom the Company provides services pursuant to UPL programs; and
• reductions to Medicare payments CMS may impose for “excessive readmissions.”

what the losses in revenues will be, if any, from the Health Reform Law’s quality initiatives;

how successful ACOs will be at coordinating care and reducing costs or whether they will decrease reimbursement;

the scope and nature of potential changes to Medicare reimbursement methods, such as an emphasis on bundling payments or coordination of care programs;

whether the Company’s revenues from upper payment limit (“UPL”) programs, or other Medicaid supplemental programs developed through a federally approved waiver program (“Waiver Program”), will be adversely affected because there may be reductions in available state and local government funding for the programs; and

reductions to Medicare payments CMS may impose for “excessive readmissions.”

Because of the many variables involved, we are unable to predict the net effect on the Company of the expected increases in insured individuals using our facilities, the reductions in Medicare spending, reductions in Medicare and Medicaid DSH funding, and numerous other provisions in the Health Reform Law that may affect the Company. Further, it is unclear how efforts to repeal or revise the Health Reform Law and federal lawsuits challenging its constitutionality will be resolved or what the impact would be of any resulting changes to the law.

If we are unable to retain and negotiate favorable contracts with nongovernment payers, including managed care plans, our revenues may be reduced.

Our ability to obtain favorable contracts with nongovernment payers, including health maintenance organizations, preferred provider organizationsHMOs, PPOs and other managed care plans significantly affects the revenues and operating results of our facilities. Revenues derived from these entities and other insurers accounted for 53.7%52.9% and 53.4%52.7% of our revenues for 20102011 and 2009,2010, respectively. Nongovernment payers, including managed care payers, continue to demand discounted fee structures, and the trend toward consolidation among nongovernment payers tends to increase their bargaining power over fee structures. As various provisions of the Health Reform Law are implemented, including the establishment of the Exchanges, nongovernment payers increasingly may demand reduced fees. Our future success will depend, in part, on our ability to retain and renew our managed care contracts and enter into new managed care contracts on terms favorable to us. Other health care providers may impact our ability to enter into managed care contracts or negotiate increases in our reimbursement and other favorable terms and conditions. For example, some of our competitors may negotiate exclusivity provisions with managed care plans or otherwise restrict the ability of managed care companies to contract with us. It is not clear what impact, if any, the increased obligations on managed care payers and other payers imposed by the Health Reform Law will have on our ability to negotiate reimbursement increases. If we are unable to retain and negotiate favorable contracts with managed care plans or experience reductions in payment increases or amounts received from nongovernment payers, our revenues may be reduced.

Our performance depends on our ability to recruit and retain quality physicians.

The success of our hospitals depends in part on the number and quality of the physicians on the medical staffs of our hospitals, the admitting and utilization practices of those physicians, and maintaining good relations with those physicians and controlling costs related to the employment of physicians. Although we employ some physicians, physicians are often not employees of the hospitals at which they practice and, in many of the markets we serve, most physicians have admitting privileges at other hospitals in addition to our hospitals. Such physicians may terminate their affiliation with our hospitals at any time. If we are unable to provide adequate support personnel or technologically advanced equipment and hospital facilities that meet the needs of


42


those physicians and their patients, they may be discouraged from referring patients to our facilities, admissions may decrease and our operating performance may decline.

Our hospitals face competition for staffing, which may increase labor costs and reduce profitability.

Our operations are dependent on the efforts, abilities and experience of our management and medical support personnel, such as nurses, pharmacists and lab technicians, as well as our physicians. We compete with other health care providers in recruiting and retaining qualified management and support personnel responsible for the daily operations of each of our hospitals, including nurses and other nonphysician health care professionals. In some markets, the availability of nurses and other medical support personnel has been a significant operating issue to health care providers. We may be required to continue to enhance wages and benefits to recruit and retain nurses and other medical support personnel or to hire more expensive temporary or contract personnel. As a result, our labor costs could increase. We also depend on the available labor pool of semi-skilled and unskilled employees in each of the markets in which we operate. Certain proposed changes in federal labor laws includingand the Employee Free Choice Act,NLRB’s modification of its election procedures could increase the likelihood of employee unionization attempts. To the extent a significant portion of our employee base unionizes, it is possible our labor costs could increase materially. When negotiating collective bargaining agreements with unions, whether such agreements are renewals or first contracts, there is the possibility that strikes could occur during the negotiation process, and our continued operation during any strikes could increase our labor costs. In addition, the states in which we operate could adopt mandatory nurse-staffing ratios or could reduce mandatory nurse staffing ratios already in place. State-mandated nurse-staffing ratios could significantly affect labor costs and have an adverse impact on revenues if we are required to limit admissions in order to meet the required ratios. If our labor costs increase, we may not be able to raise rates to offset these increased costs. Because a significant percentage of our revenues consists of fixed, prospective payments, our ability to pass along increased labor costs is constrained. Our failure to recruit and retain qualified management, nurses and other medical support personnel, or to control labor costs, could have a material, adverse effect on our results of operations.

If we fail to comply with extensive laws and government regulations, we could suffer penalties or be required to make significant changes to our operations.

The health care industry is required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:

billing and coding for services and properly handling overpayments;

classification of level of care provided, including proper classification of inpatient admissions, observation services and outpatient care;

• billing and coding for services and properly handling overpayments;
• relationships with physicians and other referral sources;
• necessity and adequacy of medical care;
• quality of medical equipment and services;
• qualifications of medical and support personnel;
• 

relationships with physicians and other referral sources;

necessity and adequacy of medical care;

quality of medical equipment and services;

qualifications of medical and support personnel;

confidentiality, maintenance, data breach, identity theft and security issues associated with health-related and personal information and medical records;

• screening, stabilization and transfer of individuals who have emergency medical conditions;
• licensure and certification;
• hospital rate or budget review;
• preparing and filing of cost reports;
• operating policies and procedures;
• activities regarding competitors; and
• addition of facilities and services.


43


screening, stabilization and transfer of individuals who have emergency medical conditions;

licensure and certification;

hospital rate or budget review;

preparing and filing of cost reports;

operating policies and procedures;

activities regarding competitors; and

addition of facilities and services.

Among these laws are the federal Anti-kickback Statute, the federal physician self-referral law (commonly called the Stark Law),Law, the federal FCA and similar state laws. We have a variety of financial relationships with physicians and others who either refer or influence the referral of patients to our hospitals and other health care facilities, and these laws govern those relationships. The OIG has enacted safe harbor regulations that outline practices deemed protected from prosecution under the Anti-kickback Statute. While we endeavor to comply with the applicable safe harbors, certain of our current arrangements, including joint ventures and financial relationships with physicians and other referral sources and persons and entities to which we refer patients, do not qualify for safe harbor protection. Failure to qualify for a safe harbor does not mean the arrangement necessarily violates the Anti-kickback Statute but may subject the arrangement to greater scrutiny. However, we cannot offer assurance that practices outside of a safe harbor will not be found to violate the Anti-kickback Statute. Allegations of violations of the Anti-kickback Statute may be brought under the federal Civil Monetary Penalty Law, which requires a lower burden of proof than other fraud and abuse laws, including the Anti-kickback Statute.

Our financial relationships with referring physicians and their immediate family members must comply with the Stark Law by meeting an exception. We attempt to structure our relationships to meet an exception to the Stark Law, but the regulations implementing the exceptions are detailed and complex, and we cannot provide assurance that every relationship complies fully with the Stark Law. Unlike the Anti-kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is technical in nature.

Additionally, if we violate the Anti-kickback Statute or Stark Law, or if we improperly bill for our services, we may be found to violate the FCA, either under a suit brought by the government or by a private person under aqui tam, or “whistleblower,” suit. See Item 1, “Business — Regulation and Other Factors.”

If we fail to comply with the Anti-kickback Statute, the Stark Law, the FCA or other applicable laws and regulations, we could be subjected to liabilities, including civil penalties (including the loss of our licenses to operate one or more facilities), exclusion of one or more facilities from participation in the Medicare, Medicaid and other federal and state health care programs and, for violations of certain laws and regulations, criminal penalties.

We do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. In the future, different interpretations or enforcement of, or amendment to, these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses. A determination that we have violated these laws, or the public announcement that we are being investigated for possible violations of these laws, could have a material, adverse effect on our business, financial condition, results of operations or prospects, and our business reputation could suffer significantly. In addition, other legislation or regulations at the federal or state level may be adopted that adversely affect our business.

We have been and could become the subject of governmental investigations, claims and litigation.

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the FCA, private parties have the right to bringqui tam, or “whistleblower,” suits against companies that

submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

Governmental agencies and their agents, such as the Medicare Administrative Contractors, fiscal intermediaries and carriers, as well as the OIG, CMS and state Medicaid programs, conduct audits of our health care operations. Private payers may conduct similar post-payment audits, and we also perform internal audits and monitoring. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have a material, adverse effect on our financial position, results of operations and liquidity.


44


As required by statute, CMS has implemented the RAC program on a nationwide basis. Under the program, CMS contracts with RACs on a contingency fee basis to conduct post-payment reviews to detect and correct improper payments in the fee-for-service Medicare program. The Health Reform Law expands the RAC program’s scope to include managed Medicare plans and to include Medicaid claims. In addition, CMS employs MICs to perform post-payment audits of Medicaid claims and identify overpayments. The Health Reform Law increases federal funding for the MIC program for federal fiscal year 2011 and later years.program. In addition to RACs and MICs, the state Medicaid agencies and other contractors have increased their review activities.

Should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted.

ControlsPhysician utilization practices and treatment methodologies or governmental or managed care controls designed to reduce inpatient services or surgical procedures may reduce our revenues.

Controls imposed by Medicare, managed Medicare, Medicaid, managed Medicaid and commercial third-party payers designed to reduce admissions, intensity of services, surgical volumes and lengths of stay, commonlyin some instances referred to as “utilization review,” have affected and are expected to continue to affect our facilities. Utilization review entails the review of the admission and course of treatment of a patient by health plans. Inpatient utilization, average lengths of stay and occupancy rates continue to be negatively affected by payer-required preadmission authorization and utilization review and by payer pressure to maximize outpatient and alternative health care delivery services for less acutely ill patients. Efforts to impose more stringent cost controls are expected to continue. For example, the Health Reform Law potentially expands the use of prepayment review by Medicare contractors by eliminating statutory restrictions on their use. Although we are unable to predict the effect these changes will have on our operations, significant limits on the scope of services reimbursed and on reimbursement rates and fees could have a material, adverse effect on our business, financial position and results of operations.

Additionally, trends in physician treatment protocols and managed care health plan design, such as plans that shift increased costs and accountability for care to patients, could reduce our surgical volumes and admissions in favor of lower intensity and lower cost treatment methodologies.

Our overall business results may suffer from the economic downturn.

During periods of high unemployment, governmental entities often experience budget deficits as a result of increased costs and lower than expected tax collections. These budget deficits at federal, state and local government entities have decreased, and may continue to decrease, spending for health and human service programs, including Medicare, Medicaid and similar programs, which represent significant payer sources for our hospitals. Other risks we face during periods of high unemployment include potential declines in the population covered under managed care agreements, patient decisions to postpone or cancel elective and non-emergency health care procedures (including delaying surgical procedures), potential increases in the uninsured and underinsured populations and further difficulties in our collecting patient co-paymentcopayment and deductible receivables.

The industry trend towards value-based purchasing may negatively impact our revenues.

There is a trend in the health care industry towards value-based purchasing of health care services. These value-based purchasing programs include both public reporting of quality data and preventable adverse events tied to the quality and efficiency of care provided by facilities. Governmental programs including Medicare and Medicaid currently require hospitals to report certain quality data to receive full reimbursement updates. In addition, Medicare does not reimburse for care related to certain preventable adverse events (also called “never events”). Many large commercial payers currently require hospitals to report quality data, and several commercial payers do not reimburse hospitals for certain preventable adverse events. Further, we have implemented a policy pursuant to which we do not bill patients or third-party payers for fees or expenses incurred due to certain preventable adverse events.

Effective July 1, 2011, the Health Reform Law will prohibitalso prohibits the use of federal funds under the Medicaid program to reimburse providers for medical assistance provided to treat HACs. Beginning in federal fiscal year 2015, the 25% of hospitals with the worst national risk-adjusted HAC rates in the previous year will receive a 1% reduction in their total inpatient operating Medicare payments. HospitalsBeginning in fiscal year 2013, hospitals with excessive readmissions for


45


conditions designated by HHS will receive reduceda reduction of 1% in operating payments for all inpatient discharges, not just discharges relating to the conditions subject to the excessive readmission standard.
This rate will increase by 1% each year up to 3% in federal fiscal year 2015.

The Health Reform Law also requires HHS to implement a value-based purchasing program for inpatient hospital services. The Health Reform Law requires HHS to reduce inpatient hospital payments for all discharges by a percentage beginning at 1% in federal fiscal year 2013 and increasing by 0.25% each fiscal year up to 2% in federal fiscal year 2017 and subsequent years. HHS will pool the amount collected from these reductions to fund payments to reward hospitals that meet or exceed certain quality performance standards established by HHS. HHSAccording to the value-based purchasing program final rule, CMS estimates that it will determinedistribute $850 million to hospitals in federal fiscal year 2013 based on their achievement (relative to other hospitals) and improvement ranges (relative to the amount each hospitalhospital’s own past performance). Hospitals that meetsmeet or exceedsexceed the quality performance standards will receive from the pool of dollars created by these payment reductions. As proposed by CMS,greater reimbursement under the value-based purchasing program will initially calculate incentive payments based on hospitals’ achievement of 17 clinical process of care measures and eight dimensions of a patient’s experience of care using the HCAHPS survey and their improvement in meeting these standards compared to prior periods. For federal fiscal year 2013, CMS estimates the value-based purchasing program will redistribute $850 million among the nation’s hospitals.

than they would have otherwise.

We expect value-based purchasing programs, including programs that condition reimbursement on patient outcome measures, to become more common and to involve a higher percentage of reimbursement amounts. We are unable at this time to predict how this trend will affect our results of operations, but it could negatively impact our revenues.

Our operations could be impaired by a failure of our information systems.

Any system failure that causes an interruption in service or availability of our systems could adversely affect operations or delay the collection of revenues. Even though we have implemented network security measures, our servers are vulnerable to computer viruses, break-ins and similar disruptions from unauthorized tampering. The occurrence of any of these events could result in interruptions, delays, the loss or corruption of data, cessations in the availability of systems or liability under privacy and security laws, all of which could have a material adverse effect on our financial position and results of operations and harm our business reputation.

The performance of our information technology and systems is critical to our business operations. In addition to our shared services initiatives, our information systems are essential to a number of critical areas of our operations, including:

accounting and financial reporting;

billing and collecting accounts;

• accounting and financial reporting;
• billing and collecting accounts;
• coding and compliance;
• clinical systems;
• medical records and document storage;
• inventory management;
• negotiating, pricing and administering managed care contracts and supply contracts; and
• monitoring quality of care and collecting data on quality measures necessary for full Medicare payment updates.

coding and compliance;

clinical systems;

medical records and document storage;

inventory management;

negotiating, pricing and administering managed care contracts and supply contracts; and

monitoring quality of care and collecting data on quality measures necessary for full Medicare payment updates.

If we fail to effectively and timely implement electronic health record systems and transition to the ICD-10 coding system, our operations could be adversely affected.

As required by the ARRA, the Secretary of HHS is in the process of developinghas developed and implementingimplemented an incentive payment program for eligible hospitals and health care professionals that adopt and meaningfully use certified EHR technology. HHS intends to useuses the Provider Enrollment, Chain and Ownership System (“PECOS”) to verify Medicare enrollment prior to making EHR incentive program payments. During 2011, we anticipate receivingreceived Medicare and Medicaid incentive payments for being a meaningful user of certified EHR technology. We anticipate a majoritytechnology and recorded incentive income of 2011$210 million for the year. EHR incentive payments will be received and recognized as revenues during the fourth quarter of 2011. Medicare and Medicaid incentive paymentsincome for our eligible hospitals and professionals areis estimated to range from $275$325 million to $325$350 million for 2011.2012. Actual incentive payments could vary from theseour estimates due to certain


46


factors such as availability of federal funding for both Medicare and Medicaid incentive payments, timing of the approval of state Medicaid incentive payment plans by CMS and our ability to implement andcontinue to demonstrate meaningful use of certified EHR technology.

We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of expenses will not correlate with the receipt of the incentive payments and the recognition of revenues.incentive income. During 2011, we incurred $77 million of operating expenses to implement our certified EHR technology and to meet meaningful use. We estimate that operating expenses to implement our certified EHR technology and meet meaningful use will range from $125$140 million to $150$160 million for 2011.2012. Actual operating expenses could vary from these estimates. If our eligible hospitals and employed professionals are unable to meet the requirements for participation in the incentive payment program, including having an enrollment record in PECOS, we will not be eligible to receive incentive payments that could offset some of the costs of implementing EHR systems. Further, eligible providers that fail to demonstrate meaningful use of certified EHR technology will be subject to reduced payments from Medicare, beginning in federal fiscal year 2015 for eligible hospitals and calendar year 2015 for eligible professionals. Failure to implement certified EHR systems effectively and in a timely manner could have a material, adverse effect on our financial position and results of operations.

Health plans and providers, including our hospitals, are required to transition to the new ICD-10 coding system, which greatly expands the number and detail of billing codes used for inpatient claims. Under current regulations, use of the ICD-10 system is required beginning October 1, 2013, but CMS has announced its intent to extend this deadline. Transition to the new ICD-10 system requires significant investment in coding technology and software as well as the training of staff involved in the coding and billing process. In addition to these upfront costs of transition to ICD-10, it is possible that our hospitals could experience disruption or delays in payment due to technical or coding errors or other implementation issues involving our systems or the systems and implementation efforts of health plans and their business partners. Further, the transition to the more detailed ICD-10 coding system could result in decreased reimbursement if the use of ICD-10 codes results in conditions being reclassified to MS-DRGs or commercial payer payment groupings with lower levels of reimbursement than assigned under the previous system.

State efforts to regulate the construction or expansion of health care facilities could impair our ability to operate and expand our operations.

Some states, particularly in the eastern part of the country, require health care providers to obtain prior approval, known as a CON, for the purchase, construction or expansion of health care facilities, to make certain

capital expenditures or to make changes in services or bed capacity. In giving approval, these states consider the need for additional or expanded health care facilities or services. We currently operate health care facilities in a number of states with CON laws. The failure to obtain any requested CON could impair our ability to operate or expand operations. Any such failure could, in turn, adversely affect our ability to attract patients and physicians to our facilities and grow our revenues, which would have an adverse effect on our results of operations.

Our facilities are heavily concentrated in Florida and Texas, which makes us sensitive to regulatory, economic, environmental and competitive conditions and changes in those states.

We operated 164163 hospitals at December 31, 2010,2011, and 7475 of those hospitals are located in Florida and Texas. Our Florida and Texas facilities’ combined revenues represented approximately 52%50% of our consolidated revenues for the year ended December 31, 2010.2011. This concentration makes us particularly sensitive to regulatory, economic, environmental and competitive conditions and changes in those states. Any material change in the current payment programs or regulatory, economic, environmental or competitive conditions in those states could have a disproportionate effect on our overall business results.

In addition, our hospitals in Florida, Texas and other areas across the Gulf Coast are located in hurricane-prone areas. In the recent past, hurricanes have had a disruptive effect on the operations of our hospitals in Florida, Texas and other coastal states, and the patient populations in those states. Our business activities could be harmed by a particularly active hurricane season or even a single storm, and the property insurance we obtain may not be adequate to cover losses from future hurricanes or other natural disasters.

We may be subject to liabilities from claims by the Internal Revenue Service.

We are currently contesting before the IRS Appeals Division, certain claimed deficiencies and adjustments proposed by the IRS Examination Division in connection with its audit of HCA Inc.’s 2005 and 2006 federal income tax returns. The disputed items include the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts. In addition, eight taxable periods of HCA Inc. and its predecessors ended in 1997 through 2004, for which the primary remaining issue is the computation of the tax allowance for doubtful accounts, are currently pending before the IRS Examination Division. The IRS Examination Division began an audit of HCA Inc.’s 2007, 2008 and 2009 federal income tax returns in December 2010.

Management believes HCA Holdings, Inc., its predecessors, subsidiaries and affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and final resolution of these disputes will not have a material, adverse effect on our results of operations or financial position.


47


However, if payments due upon final resolution of these issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.

We may be subject to liabilities from claims brought against our facilities.

We are subject to litigation relating to our business practices, including claims and legal actions by patients and others in the ordinary course of business alleging malpractice, product liability or other legal theories. Many of these actions involve large claims and significant defense costs. We insure a portion of our professional liability risks through a wholly-owned subsidiary. Management believes our reserves for self-insured retentions and insurance coverage are sufficient to cover insured claims arising out of the operation of our facilities. Our wholly-owned insurance subsidiary has entered into certain reinsurance contracts, and the obligations covered by the reinsurance contracts are included in its reserves for professional liability risks, as the subsidiary remains liable to the extent that the reinsurers do not meet their obligations under the reinsurance contracts. If payments for claims exceed actuarially determined estimates, are not covered by insurance, or reinsurers, if any, fail to meet their obligations, our results of operations and financial position could be adversely affected.

We are exposed to market risks related to changes in the market values of securities and interest rate changes.

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiarysubsidiaries were $734$621 million and $8$7 million, respectively, at

December 31, 2010.2011. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At December 31, 2010,2011, we had a net unrealized gain of $10$11 million on the insurance subsidiary’ssubsidiaries’ investment securities.

We are exposed to market risk related to market illiquidity. Liquidity of the investmentsInvestments in debt and equity securities of our wholly-owned insurance subsidiarysubsidiaries could be impaired by the inability to access the capital markets. Should the wholly-owned insurance subsidiarysubsidiaries require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. At December 31, 2010, our wholly-owned insurance subsidiary had invested $250 million ($251 million par value) in tax-exempt student loan auction rate securities that continue to experience market illiquidity. It is uncertain if auction-related market liquidity will resume for these securities. We may be required to recognize other-than-temporary impairments on these long-term investments in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities.

Since the Recapitalization, theThe Investors control us and may have conflicts of interest with us in the future.

As of December 31, 2010,2011, the Investors indirectly owned approximately 96.8%62% of our capital stock due to the Recapitalization.stock. As a result, the Investors have control over our decisions to enter into any significant corporate transaction and have the ability to prevent any transaction that requires the approval of stockholders. For example, the Investors could cause us to make acquisitions that increase the amount of our indebtedness or sell assets.

Additionally, the SponsorsInvestors are in the business of making investments in companies and may acquire and hold interests in businesses that compete directly or indirectly with us. One or more of the SponsorsInvestors may also pursue acquisition opportunities that may be complementary to our business and, as a result, those acquisition opportunities may not be available to us. So long as investment funds associated with or designated by the SponsorsInvestors continue to indirectly own a significant amount of the outstanding shares of our common stock, even if such amount is less than 50%, the SponsorsInvestors will continue to be able to strongly influence or effectively control our decisions.


48


Item 1B.    Unresolved Staff Comments

None.

Item 1B.Unresolved Staff Comments
None.
Item 2.Properties

Item 2.    Properties

The following table lists, by state, the number of hospitals (general, acute care, psychiatric and rehabilitation) directly or indirectly owned and operated by us as of December 31, 2010:

         
State
 Hospitals  Beds 
 
Alaska  1   250 
California  5   1,637 
Colorado  7   2,259 
Florida  38   9,808 
Georgia  11   1,946 
Idaho  2   481 
Indiana  1   278 
Kansas  4   1,286 
Kentucky  2   384 
Louisiana  6   1,264 
Mississippi  1   130 
Missouri  6   1,055 
Nevada  3   1,074 
New Hampshire  2   295 
Oklahoma  2   793 
South Carolina  3   740 
Tennessee  12   2,345 
Texas  36   10,410 
Utah  6   968 
Virginia  10   3,089 
International
        
England  6   704 
         
   164   41,196 
         
2011:

State

  Hospitals   Beds 

Alaska

   1     250  

California

   5     1,617  

Colorado

   7     2,259  

Florida

   39     10,335  

Georgia

   9     1,588  

Idaho

   2     480  

Indiana

   1     278  

Kansas

   4     1,286  

Kentucky

   2     384  

Louisiana

   6     1,264  

Mississippi

   1     130  

Missouri

   6     1,055  

Nevada

   3     1,092  

New Hampshire

   2     295  

Oklahoma

   2     784  

South Carolina

   3     748  

Tennessee

   12     2,327  

Texas

   36     10,619  

Utah

   6     901  

Virginia

   10     3,074  

International

    

England

   6     828  
  

 

 

   

 

 

 
   163     41,594  
  

 

 

   

 

 

 

In addition to the hospitals listed in the above table, we directly or indirectly operate 106108 freestanding surgery centers. We also operate medical office buildings in conjunction with some of our hospitals. These office buildings are primarily occupied by physicians who practice at our hospitals. Fourteen of our general, acute care hospitals and three of our other properties have been mortgaged to support our obligations under our senior secured cash flow credit facility and the first lien secured notes we issued in 2009 and 2010.notes. These three other properties are also subject to second mortgages to support our obligations under theour second lien secured notes we issued in 2006 and 2009.

notes.

We maintain our headquarters in approximately 1,200,0001,300,000 square feet of space in the Nashville, Tennessee area. In addition to the headquarters in Nashville, we maintain regional service centers related to our shared services initiatives. These service centers are located in markets in which we operate hospitals.

We believe our headquarters, hospitals and other facilities are suitable for their respective uses and are, in general, adequate for our present needs. Our properties are subject to various federal, state and local statutes and ordinances regulating their operation. Management does not believe that compliance with such statutes and ordinances will materially affect our financial position or results of operations.


49


Item 3.    Legal Proceedings

Item 3.Legal Proceedings
We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could materially and adversely affect our results of operations and financial position in a given period.

Government Investigations, Claims and Litigation

Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal FCA, private parties have the right to bringqui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.

The Civil Division of the DOJ has contacted usthe Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. The review could potentially give rise to claims against usthe Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on us.

the Company.

New Hampshire Hospital Merger Litigation

In 2006, the Foundation for Seacoast Health (the “Foundation”) filed suit against HCA in state court in New Hampshire. The Foundation alleged that both the 2006 Recapitalizationrecapitalization transaction and a prior 1999 intra-corporate transaction violated a 1983 agreement that placed certain restrictions on transfers of the Portsmouth Regional Hospital. In May 2007, the trial court ruled against the Foundation on all its claims. On appeal, the New Hampshire Supreme Court affirmed the ruling on the Recapitalization,2006 recapitalization, but remanded to the trial court the claims based on the 1999 intra-corporate transaction. The trial court ruled in December 2009 that the 1999 intra-corporate transaction breached the transfer restriction provisions of the 1983 agreement. TheIn September of 2011, the trial court will now conduct additional proceedingsissued its remedies phase decision and held that the only remedy to determine whether any harm has flowed fromwhich the alleged breach, and if so, whatFoundation was entitled was rescission of the appropriate remedy should be. The court may consider whether to, among other things, award monetary damages, rescind or undo the 1999 intra-corporate transfer that breached the transfer restriction (the Company has complied with the Court’s order, and it is not expected that such compliance will have any material effect on our operations or givefinancial position). The Court awarded the Foundation, a right to purchase hospital assets at a price to be determined (whichunder the Foundation asserts should be below the fair market valueterms of the hospital).Asset Purchase Agreement, a “fraction” of its attorney fees. The Foundation appealed the remedy phase ruling, and the Company cross-appealed the liability determination. On October 31, 2011, the New Hampshire Supreme Court, on its own, raised the question whether the appeal needed to await the trial court’s further ruling on attorney fees. On November 21, 2011, after the parties briefed the issue, the New Hampshire Supreme Court dismissed the appeal as premature and remanded the case to the trial court. In February 2012, the trial court certified the case for a possible interlocutory appeal without addressing the attorney fees issue.

Securities Class Action Litigation

On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the remedies phase is currentlyMiddle District of Tennessee seeking monetary relief. The case seeks to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement and Prospectus issued in connection with the March 9, 2011 initial public offering. The lawsuit asserts a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleges deficiencies in the Company’s disclosures in the Registration Statement relating to: (1) accounting for its 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s revenue growth rate. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants in addition to Ernst & Young, LLP were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases have been consolidated, and the parties have agreed to initial scheduling matters.

In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for Maythe Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011.

 The federal derivative actions have been consolidated in the Middle District of Tennessee and the parties have agreed that those cases shall be stayed pending developments in the shareholder class actions. The state derivative action has been stayed pending developments in the shareholder class actions.

General Liability and Other Claims

We are a party to certain proceedings relatingsubject to claims for additional income taxes and related interest before the IRS Appeals Division.interest. For a description of those proceedings, see Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — IRS Disputes” and Note 5 to our consolidated financial statements.

We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or for wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants have asked for punitive damages against us, which may not be covered by insurance. In the opinion of management, the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

Item 4.(Removed and Reserved)


50


Item 4.    Mine Safety Disclosures

None.

PART II

Item 5.    

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Our outstanding common stock is privately held, and there is no established public trading market for our common stock. AsIssuer Purchases of February 1, 2011, there were 669 holders of our common stock. Equity Securities

See Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Liquidity and Capital Resources — Financing Activities” for a description of the restrictions on our ability to pay dividends. We did not paydeclare any dividends in 20082009 or 2009.

2011.

On January 27, 2010, our Board of Directors declared a distribution to the Company’s stockholders and holders of vested stock options. The distribution was $17.50$3.88 per share and vested stock option, or $1.751 billion in the aggregate. The distribution was paid on February 5, 2010 to holders of record on February 1, 2010. The distribution was funded using funds available under our existing senior secured credit facilities and approximately $100 million of cash on hand. Pursuant to the terms of our stock option plans, the holders of nonvested stock options received a $17.50$3.88 per share reduction to the exercise price of their share-based awards.

On May 5, 2010, our Board of Directors declared a distribution to the Company’s stockholders and holders of vested stock options. The distribution was $5.00$1.11 per share and vested stock option, or $500 million in the aggregate. The distribution was paid on May 14, 2010 to holders of record on May 6, 2010. The distribution was funded using funds available under our existing senior secured credit facilities. Pursuant to the terms of our stock option plans, the holders of nonvested stock options received a $5.00$1.11 per share reduction to the exercise price of their share-based awards.

On November 23, 2010, our Board of Directors declared a distribution to the Company’s stockholders and holders of stock options. The distribution was $20.00$4.44 per share and vested stock option, or approximately $2.1 billion in the aggregate. The distribution to stockholders and holders of vested options was paid on December 1, 2010 to holders of record on November 24, 2010. The distribution was funded using the proceeds from the November 2010 issuance of $1.525 billion aggregate principal amount of 73/4% senior notes due 2021, together with borrowings under our existing senior secured credit facilities. Pursuant to the terms of our stock option plans, the holders of nonvested options received $20.00$4.44 per share reductions (subject to certain tax imitations that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon the vesting of the applicable stock options) to the exercise price of the share-based awards.

During February 2011, our Board of Directors approved an increase in the quarter ended December 31, 2010, we issued and sold 80,750number of our authorized shares to 1,800,000,000 shares of common stock in connection with the cashless exerciseand a 4.505-to-one split of stock options for aggregate consideration of $1,029,563 resulting in 46,319 net settled shares. We alsoour issued and sold 186,533outstanding common shares. All common share and per common share amounts in this Form 10-K reflect the 4.505-to-one split. During March 2011, we completed the initial public offering of 87,719,300 shares of common stock in connection with the cash exercise of stock options for aggregate consideration of $2,378,296. The shares were issued without registration in reliance on the exemptions afforded by Section 4(2) of the Securities Act of 1933, as amended, and Rule 701 promulgated thereunder.

On April 29, 2008, we registered our common stock pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.
There were no repurchases of our common stock at a price of $30.00 per share (before deducting underwriter discounts, commissions and other related offering expenses). Certain of our stockholders also sold 57,410,700 shares of our common stock in this offering. We did not receive any proceeds from October 1, 2010the shares sold by the selling stockholders. Our common stock is now traded on the New York Stock Exchange (the “NYSE”) (symbol “HCA”). Our first day of trading was March 10, 2011.

On September 21, 2011, we repurchased 80,771,143 shares of our common stock beneficially owned by affiliates of Bank of America Corporation at a purchase price of $18.61 per share, the closing price of the Company’s common stock on the NYSE on September 14, 2011. The repurchase was financed using a combination of cash on hand and borrowings under available credit facilities. The shares repurchased represented approximately 15.6% of our total shares outstanding at the time of the repurchase.

The table below sets forth, for the calendar quarters indicated, the high and low sales prices per share reported on the NYSE for our common stock.

   Sales Price 
   High   Low 

2011

    

First Quarter

  $34.57    $30.36  

Second Quarter

   35.37     30.75  

Third Quarter

   34.92     17.03  

Fourth Quarter

   26.86     17.43  

At the close of business on January 12, 2012, there were approximately 1,030 holders of record of our common stock.

On February 3, 2012, our Board of Directors declared a cash distribution to the Company’s stockholders and holders of vested stock options. The distribution was $2.00 per share and vested stock option, or approximately $975 million in the aggregate (inclusive of the distributions to holders of stock options and restricted share units). The distribution will be paid on February 29, 2012 to the holders of record on February 16, 2012. The distribution will be funded through existing cash and borrowings under our existing senior secured credit facilities. Pursuant to the terms of our equity incentive plans, (1) the holders of any unvested options will receive $2.00 per share reductions (subject to certain tax limitations that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon vesting of the applicable stock options) to the exercise price of the stock option awards; (2) the holders of any unvested stock appreciation rights will receive $2.00 per share reductions to the base price of the stock appreciation right awards; and (3) the holders of any unvested restricted share units will receive $2.00 per unit, which will be paid upon vesting of the applicable restricted share units.

   3/10/2011   3/31/2011   6/30/2011   9/30/2011   12/30/2011 
          

HCA Holdings, Inc.

   100.00     109.19     106.38     64.99     71.02  

S&P 500

   100.00     100.04     100.14     86.25     96.44  

S&P Health Care

   100.00     101.90     109.91     98.90     108.76  

The graph shows the cumulative total return to our stockholders beginning as of March 10, 2011, the day our stock began trading on the NYSE, and through December 31, 2010.


5130, 2011, in comparison to the cumulative returns of the S&P 500 Index and the S&P Health Care Index. The graph assumes $100 invested on March 10, 2011 in our common stock and in each index with the subsequent reinvestment of dividends. The stock performance shown on the graph represents historical stock performance and is not necessarily indicative of future stock price performance.


Item 6.    Selected Financial Data

Item 6.Selected Financial Data
HCA HOLDINGS, INC.

SELECTED FINANCIAL DATA

AS OF AND FOR THE YEARS ENDED DECEMBER 31

(Dollars in millions, except per share amounts)

                     
  2010  2009  2008  2007  2006 
 
Summary of Operations:
                    
Revenues $30,683  $30,052  $28,374  $26,858  $25,477 
                     
Salaries and benefits  12,484   11,958   11,440   10,714   10,409 
Supplies  4,961   4,868   4,620   4,395   4,322 
Other operating expenses  5,004   4,724   4,554   4,233   4,056 
Provision for doubtful accounts  2,648   3,276   3,409   3,130   2,660 
Equity in earnings of affiliates  (282)  (246)  (223)  (206)  (197)
Gains on sales of investments              (243)
Depreciation and amortization  1,421   1,425   1,416   1,426   1,391 
Interest expense  2,097   1,987   2,021   2,215   955 
Losses (gains) on sales of facilities  (4)  15   (97)  (471)  (205)
Impairments of long-lived assets  123   43   64   24   24 
Transaction costs              442 
                     
   28,452   28,050   27,204   25,460   23,614 
                     
Income before income taxes  2,231   2,002   1,170   1,398   1,863 
Provision for income taxes  658   627   268   316   626 
                     
Net income  1,573   1,375   902   1,082   1,237 
Net income attributable to noncontrolling interests  366   321   229   208   201 
                     
Net income attributable to HCA Holdings, Inc.  $1,207  $1,054  $673  $874  $1,036 
                     
Per common share data:                    
Basic earnings per share $12.75  $11.16  $7.16  $9.31   (a) 
Diluted earnings per share  12.43   10.99   7.04   9.15   (a) 
Cash dividends declared per share  42.50            (a) 
Financial Position:
                    
Assets $23,852  $24,131  $24,280  $24,025  $23,675 
Working capital  2,650   2,264   2,391   2,356   2,502 
Long-term debt, including amounts due within one year  28,225   25,670   26,989   27,308   28,408 
Equity securities with contingent redemption rights  141   147   155   164   125 
Noncontrolling interests  1,132   1,008   995   938   907 
Stockholders’ deficit  (10,794)  (7,978)  (9,260)  (9,600)  (10,467)
Cash Flow Data:
                    
Cash provided by operating activities $3,085  $2,747  $1,990  $1,564  $1,988 
Cash used in investing activities  (1,039)  (1,035)  (1,467)  (479)  (1,307)
Capital expenditures  (1,325)  (1,317)  (1,600)  (1,444)  (1,865)
Cash used in financing activities  (1,947)  (1,865)  (451)  (1,326)  (383)


52


   2011  2010  2009  2008  2007 

Summary of Operations:

      

Revenues before provision for doubtful accounts

  $32,506   $30,683   $30,052   $28,374   $26,858  

Provision for doubtful accounts

   2,824    2,648    3,276    3,409    3,130  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

   29,682    28,035    26,776    24,965    23,728  

Salaries and benefits

   13,440    12,484    11,958    11,440    10,714  

Supplies

   5,179    4,961    4,868    4,620    4,395  

Other operating expenses

   5,470    5,004    4,724    4,554    4,233  

Electronic health record incentive income

   (210                

Equity in earnings of affiliates

   (258  (282  (246  (223  (206

Depreciation and amortization

   1,465    1,421    1,425    1,416    1,426  

Interest expense

   2,037    2,097    1,987    2,021    2,215  

Losses (gains) on sales of facilities

   (142  (4  15    (97  (471

Gain on acquisition of controlling interest in equity investment

   (1,522                

Impairments of long-lived assets

       123    43    64    24  

Losses on retirement of debt

   481                  

Termination of management agreement

   181                  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   26,121    25,804    24,774    23,795    22,330  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Income before income taxes

   3,561    2,231    2,002    1,170    1,398  

Provision for income taxes

   719    658    627    268    316  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income

   2,842    1,573    1,375    902    1,082  

Net income attributable to noncontrolling interests

   377    366    321    229    208  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income attributable to HCA Holdings, Inc.

  $2,465   $1,207   $1,054   $673   $874  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Per common share data:

      

Basic earnings per share

  $5.17   $2.83   $2.48   $1.59   $2.07  

Diluted earnings per share

  $4.97   $2.76   $2.44    1.56    2.03  

Cash dividends declared per share

      $9.43              

Financial Position:

      

Assets

  $26,898   $23,852   $24,131   $24,280   $24,025  

Working capital

   1,679    2,650    2,264    2,391    2,356  

Long-term debt, including amounts due within one year

   27,052    28,225    25,670    26,989    27,308  

Equity securities with contingent redemption rights

       141    147    155    164  

Noncontrolling interests

   1,244    1,132    1,008    995    938  

Stockholders’ deficit

   (7,014  (10,794  (7,978  (9,260  (9,600

Cash Flow Data:

      

Cash provided by operating activities

  $3,933   $3,085   $2,747   $1,990   $1,564  

Cash used in investing activities

   (2,995  (1,039  (1,035  (1,467  (479

Capital expenditures

   (1,679  (1,325  (1,317  (1,600  (1,444

Cash used in financing activities

   (976  (1,947  (1,865  (451  (1,326

   2011  2010  2009  2008  2007 

Operating Data:

      

Number of hospitals at end of period(a)

   163    156    155    158    161  

Number of freestanding outpatient surgical centers at end of period(b)

   108    97    97    97    99  

Number of licensed beds at end of period(c)

   41,594    38,827    38,839    38,504    38,405  

Weighted average licensed beds(d)

   39,735    38,655    38,825    38,422    39,065  

Admissions(e)

   1,620,400    1,554,400    1,556,500    1,541,800    1,552,700  

Equivalent admissions(f)

   2,595,900    2,468,400    2,439,000    2,363,600    2,352,400  

Average length of stay (days)(g)

   4.8    4.8    4.8    4.9    4.9  

Average daily census(h)

   21,123    20,523    20,650    20,795    21,049  

Occupancy(i)

   53  53  53  54  54

Emergency room visits(j)

   6,143,500    5,706,200    5,593,500    5,246,400    5,116,100  

Outpatient surgeries(k)

   799,200    783,600    794,600    797,400    804,900  

Inpatient surgeries(l)

   484,500    487,100    494,500    493,100    516,500  

Days revenues in accounts receivable(m)

   53    50    50    55    60  

Gross patient revenues(n)

  $141,516   $125,640   $115,682   $102,843   $92,429  

Outpatient revenues as a % of patient revenues(o)

   37  36  39  39  39

                     
  2010  2009  2008  2007  2006 
 
Operating Data:
                    
Number of hospitals at end of period(b)  156   155   158   161   166 
Number of freestanding outpatient surgical centers at end of period(c)  97   97   97   99   98 
Number of licensed beds at end of period(d)  38,827   38,839   38,504   38,405   39,354 
Weighted average licensed beds(e)  38,655   38,825   38,422   39,065   40,653 
Admissions(f)  1,554,400   1,556,500   1,541,800   1,552,700   1,610,100 
Equivalent admissions(g)  2,468,400   2,439,000   2,363,600   2,352,400   2,416,700 
Average length of stay (days)(h)  4.8   4.8   4.9   4.9   4.9 
Average daily census(i)  20,523   20,650   20,795   21,049   21,688 
Occupancy(j)  53%  53%  54%  54%  53%
Emergency room visits(k)  5,706,200   5,593,500   5,246,400   5,116,100   5,213,500 
Outpatient surgeries(l)  783,600   794,600   797,400   804,900   820,900 
Inpatient surgeries(m)  487,100   494,500   493,100   516,500   533,100 
Days revenues in accounts receivable(n)  46   45   49   53   53 
Gross patient revenues(o) $125,640  $115,682  $102,843  $92,429  $84,913 
Outpatient revenues as a % of patient revenues(p)  38%  38%  37%  37%  36%
(a)Due to our November 2006 Merger and Recapitalization, our capital structure and share-based compensation plans for periods before and after the Recapitalization are not comparable; therefore, we are presenting earnings and dividends declared per share information only for periods subsequent to the Recapitalization.
(b)

Excludes eight facilities in 2010, 2009, 2008 and 2007 and seven facilities in 2006 that arewere not consolidated (accounted for using the equity method) for financial reporting purposes.

(c)(b)

Excludes one facility in 2011, nine facilities in 2010 2007 and 20062007 and eight facilities in 2009 and 2008 that arewere not consolidated (accounted for using the equity method) for financial reporting purposes.

(d)(c)

Licensed beds are those beds for which a facility has been granted approval to operate from the applicable state licensing agency.

(e)(d)

Represents the average number of licensed beds, weighted based on periods owned.

(f)(e)

Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(g)(f)

Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(h)(g)

Represents the average number of days admitted patients stay in our hospitals.

(i)(h)

Represents the average number of patients in our hospital beds each day.

(j)(i)

Represents the percentage of hospital licensed beds occupied by patients. Both average daily census and occupancy rate provide measures of the utilization of inpatient rooms.

(k)(j)

Represents the number of patients treated in our emergency rooms.

(l)(k)

Represents the number of surgeries performed on patients who were not admitted to our hospitals. Pain management and endoscopy procedures are not included in outpatient surgeries.

(m)(l)

Represents the number of surgeries performed on patients who have been admitted to our hospitals. Pain management and endoscopy procedures are not included in inpatient surgeries.

(n)(m)

Revenues per day is calculated by dividing the revenues for the period by the days in the period. Days revenues in accounts receivable is then calculated as accounts receivable, net of the allowance for doubtful accounts, at the end of the period divided by revenues per day. With our adoption of ASU 2011-07, “revenues” used in this computation are net of the provision for doubtful accounts and the computations for all prior periods presented have been restated.

(o)(n)

Gross patient revenues are based upon our standard charge listing. Gross charges/revenues typically do not reflect what our hospital facilities are paid. Gross charges/revenues are reduced by the provision for doubtful accounts, contractual adjustments, discounts and charity care to determine reported revenues.

(p)(o)

Represents the percentage of patient revenues related to patients who are not admitted to our hospitals.


53


HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

Item 7.

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations
    Management’s Discussion and Analysis of Financial Condition and Results of Operations

The selected financial data and the accompanying consolidated financial statements present certain information with respect to the financial position, results of operations and cash flows of HCA Holdings, Inc. which should be read in conjunction with the following discussion and analysis. The terms “HCA,” “Company,” “we,” “our,” or “us,” as used herein, refer HCA Inc. and our affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and our affiliates after the Corporate Reorganization unless otherwise stated or indicated by context. The term “affiliates” means direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners.

Forward-Looking Statements

This annual report onForm 10-K includes certain disclosures which contain “forward-looking statements.” Forward-looking statements include all statements that do not relate solely to historical or current facts, and can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the ability to recognize the benefits of the Recapitalization, (2) the impact of our substantial indebtedness incurred to finance the Recapitalization and distributions to stockholders and the ability to refinance such indebtedness on acceptable terms, (3)(2) the effects related to the enactment and implementation of the Budget Control Act of 2011 (“BCA”) and the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law,Law”), the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (4)(3) increases in the amount and risk of collectibility of uninsured accounts and deductibles and copayment amounts for insured accounts, (5)(4) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6)(5) possible changes in the Medicare, Medicaid and other state programs, including Medicaid supplemental payments pursuant to upper payment limit (“UPL”) programs or Waiver Programs, that may impact reimbursements to health care providers and insurers, (7)(6) the highly competitive nature of the health care business, (8)(7) changes in service mix and revenue mix, including potential declines in the population covered under managed care agreements and the ability to enter into and renew managed care provider agreements on acceptable terms, (9)(8) the efforts of insurers, health care providers and others to contain health care costs, (10)(9) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11)(10) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12)(11) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13)(12) changes in accounting practices, (14)(13) changes in general economic conditions nationally and regionally in our markets, (15)(14) future divestitures which may result in charges and possible impairments of long-lived assets, (16)(15) changes in business strategy or development plans, (17)(16) delays in receiving payments for services provided, (18)(17) the outcome of pending and any future tax audits, appeals and litigation associated with our tax positions, (19)(18) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (19) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments, and (20) other risk factors described in this annual report onForm 10-K. As a consequence, current plans, anticipated actions and future financial position and results of operations may differ from those expressed in any forward-looking statements made by or on behalf of HCA. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this report.

2010HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

2011 Operations Summary

Net income attributable to HCA Holdings, Inc. totaled $2.465 billion, or $4.97 per diluted share, for 2011, compared to $1.207 billion, or $2.76 per diluted share, for 2010, compared to $1.0542010. The 2011 results include net gains on sales of facilities of $142 million (pretax), or $0.16 per diluted share, a gain on the acquisition of controlling interest in an equity investment of $1.522 billion for 2009.(pretax), or $2.87 per diluted share, losses on retirement of debt of $481 million (pretax), or $0.61 per diluted share, and termination of management agreement fees of $181 million (pretax), or $0.30 per diluted share. The 2010 results include net gains on sales of facilities of $4 million and impairments of long-lived assets of


54


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
2010 Operations Summary (Continued)
$123 million. The 2009 results include net losses on sales of facilities of $15 million(pretax), or $0.01 per diluted share, and impairments of long-lived assets of $43 million.
$123 million (pretax), or $0.18 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 495.943 million shares and 437.347 million shares for the years ended December 31, 2011 and 2010, respectively. During March 2011, we completed the initial public offering of 87.719 million shares of our common stock, and during September 2011, we repurchased 80.771 million shares of our common stock from affiliates of Bank of America Corporation.

Revenues increased to $30.683$29.682 billion for 20102011 from $30.052$28.035 billion for 2009.2010. Revenues increased 2.1%5.9% and 3.3%, respectively, on both a consolidated basis and on a same facility basis for 2010,2011, compared to 2009.2010. The consolidated revenues increase can be attributed to the combined impact of a 0.9%0.7% increase in revenue per equivalent admission and a 1.2%5.2% increase in equivalent admissions. The same facility revenues increase resulted from a 0.6%0.3% increase in same facility revenue per equivalent admission and a 1.4%3.0% increase in same facility equivalent admissions.

We experienced a shift in service mix from more complex surgical cases to less acute medical cases, resulting in lower than anticipated revenue per equivalent admission growth for 2011.

During 2010,2011, consolidated admissions declined 0.1%increased 4.2% and same facility admissions increased 0.1%2.3%, compared to 2009.2010. Inpatient surgical volumes declined 1.5%0.5% on a consolidated basis and declined 1.4%1.7% on a same facility basis during 2010,2011, compared to 2009.2010. Outpatient surgical volumes declined 1.4% on a consolidated basis and declined 1.2% on a same facility basis during 2010, compared to 2009. Emergency room visits increased 2.0% on a consolidated basis and increased 2.1%declined 0.6% on a same facility basis during 2010,2011, compared to 2009.

2010. Emergency room visits increased 7.7% on a consolidated basis and increased 6.2% on a same facility basis during 2011, compared to 2010.

For 2010,2011, the provision for doubtful accounts declined $628increased $176 million, compared to 8.6% of revenues from 10.9% of revenues for 2009.2010. The combined self-pay revenue deductions for charity care and uninsured discounts increased $1.892$346 million and $1.066 billion, respectively, for 2010,2011, compared to 2009.2010. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of net revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 27.4% for 2011, compared to 25.6% for 2010, compared to 23.8% for 2009.2010. Same facility uninsured admissions increased 5.4%7.4% and same facility uninsured emergency room visits increased 1.2%5.8% for 2010,2011, compared to 2009.

2010.

Interest expense totaled $2.037 billion for 2011, compared to $2.097 billion for 2010, compared to $1.987 billion for 2009.2010. The $110$60 million increasedecline in interest expense for 20102011 was due primarily to an increasea decline in the average effective interest rate.

Cash flows from operating activities increased $338$848 million, from $2.747 billion for 2009 to $3.085 billion for 2010.2010 to $3.933 billion for 2011. The increase in cash flows from operating activities was primarily due to improved cash flows of $885 million related primarily to the net impact of improvements from a $198 million increase in net income and a $547 million reduction in income tax payments, offsetting a $384 million net decline from changes in working capital items and the provision for doubtful accounts.

taxes.

Business Strategy

We are committed to providing the communities we serve with high quality, cost-effective health care while growing our business, increasing our profitability and creating long-term value for our stockholders. To achieve these objectives, we align our efforts around the following growth agenda:

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Business Strategy (Continued)

Grow Our Presence in Existing Markets.    We believe we are well positioned in a number of large and growing markets that will allow us the opportunity to generate long-term, attractive growth through the expansion of our presence in these markets. We plan to continue recruiting and strategically collaborating with the physician community and adding attractive service lines such as cardiology, emergency services, oncology and women’s services. Additional components of our growth strategy include expanding our footprint through developing various outpatient access points, including surgery centers, rural outreach, freestanding emergency departments and walk-in clinics. Since our Recapitalization, we have invested significant capital into these markets and expect to continue to see the benefit of this investment.

Achieve Industry-Leading Performance in Clinical and Satisfaction Measures.    Achieving high levels of patient safety, patient satisfaction and clinical quality are central goals of our business model. To achieve these goals, we have implemented a number of initiatives including infection reduction initiatives, hospitalist programs, advanced health information technology and evidence-based medicine programs. We routinely analyze operational practices from our best-performing hospitals to identify ways to implement organization-wide performance


55


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Business Strategy (Continued)
improvements and reduce clinical variation. We believe these initiatives will continue to improve patient care, help us achieve cost efficiencies, grow our revenues and favorably position us in an environment where our constituents are increasingly focused on quality, efficacy and efficiency.

Recruit and Employ Physicians to Meet Need for High Quality Health Services.    We depend on the quality and dedication of the health care providers and other team members who serve at our facilities. We believe a critical component of our growth strategy is our ability to successfully recruit and strategically collaborate with physicians and other professionals to provide high quality care. We attract and retain physicians by providing high quality, convenient facilities with advanced technology, by expanding our specialty services and by building our outpatient operations. We believe our continued investment in the employment, recruitment and retention of physicians will improve the quality of care at our facilities.

Continue to Leverage Our Scale and Market Positions to Enhance Profitability.    We believe there is significant opportunity to continue to grow the profitability of our company by fully leveraging the scale and scope of our franchise. We are currently pursuing next generation performance improvement initiatives such as contracting for services on a multistate basis and expanding our support infrastructure for additional clinical and support functions, such as physician credentialing, medical transcription and electronic medical recordkeeping. We believe our centrally managed business processes and ability to leverage cost-saving practices across our extensive network will enable us to continue to manage costs effectively. We are in the process of creatinghave created a subsidiary, that willParallon Business Solutions, to leverage key components of our support infrastructure, including revenue cycle management, healthcare group purchasing, supply chain management and staffing functions byand are offering these services to other hospital companies.

Selectively Pursue a Disciplined Development Strategy.    We continue to believe there are significant growth opportunities in our markets. We will continue to provide financial and operational resources to successfully execute on our in-market opportunities. To complement our in-market growth agenda, we intend to focus on selectively developing and acquiring new hospitals, outpatient facilities and other health care service providers. We believe the challenges faced by the hospital industry may spur consolidation and we believe our size, scale, national presence and access to capital will position us well to participate in any such consolidation. We have a strong record of successfully acquiring and integrating hospitals and entering into joint ventures and intend to continue leveraging this experience.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates

The preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities and the reported amounts of revenues and expenses. Our estimates are based on historical experience and various other assumptions we believe are reasonable under the circumstances. We evaluate our estimates on an ongoing basis and make changes to the estimates and related disclosures as experience develops or new information becomes known. Actual results may differ from these estimates.

We believe the following critical accounting policies affect our more significant judgments and estimates used in the preparation of our consolidated financial statements.

Revenues

Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from payers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. The estimated reimbursement amounts are made on a payer-specific basis and are recorded based on the best information available regarding management’s


56


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)

Revenues (Continued)
interpretation of the applicable laws, regulations and contract terms. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals. We have invested significant resources to refine and improve our computerized billing systems and the information system data used to make contractual allowance estimates. We have developed standardized calculation processes and related training programs to improve the utility of our patient accounting systems.

The Emergency Medical Treatment and Active Labor Act (“EMTALA”) requires any hospital participating in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition, to either stabilize the condition or make an appropriate transfer of the individual to a facility able to handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations, including but not limited to EMTALA, require, and our commitment to providing quality patient care encourages, the provision of services to patients who are financially unable to pay for the health care services they receive. The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (collectively, the “Health Reform Law”), requires health plans to reimburse hospitals for emergency services provided to enrollees without prior authorization and without regard to whether a participating provider contract is in place. Further, as enacted, the Health Reform Law contains provisions that seek to decrease the number of uninsured individuals, including requirements or incentives, which do not become effective until 2014, for individuals to obtain, and large employers to provide, insurance coverage. These mandates may reduce the financial impact of screening for and stabilizing emergency medical conditions. However, many factors are unknown regarding the impact of the Health Reform Law, including the outcome of court challenges to the constitutionality of the law and Congressional efforts to amend or repeal the law, how many previously uninsured individuals will obtain coverage as a result of the law or the change, if any, in the volume of inpatient and outpatient hospital services that are sought by and provided to previously uninsured individuals and the payer mix.

We do not pursue collection of amounts related to patients who meet our guidelines to qualify as charity care; therefore, they are not reported in revenues. Patients treated at our hospitals for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. We provide discounts from our

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates (Continued)

Revenues (Continued)

gross charges to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. After the discounts are applied, we are still unable to collect a significant portion of uninsured patients’ accounts, and we record significant provisions for doubtful accounts (based upon our historical collection experience) related to uninsured patients in the period the services are provided.

Due to the complexities involved in the classification and documentation of health care services authorized and provided, the estimation of revenues earned and the related reimbursement are often subject to interpretations that could result in payments that are different from our estimates. Adjustments to estimated Medicare and Medicaid reimbursement amounts and disproportionate-share funds, which resulted in net increases to revenues, related primarily to cost reports filed during the respective year were $40 million, $52 million and $40 million in 2011, 2010 and $32 million in 2010, 2009, and 2008, respectively. The adjustments to estimated reimbursement amounts, which resulted in net increases to revenues, related primarily to cost reports filed during previous years were $30 million, $50 million and $60 million in 2011, 2010 and $35 million in 2010, 2009, and 2008, respectively. We expect adjustments during the next 12 months related to Medicare and Medicaid cost report filings and settlements and disproportionate-share funds will result in increases to revenues within generally similar ranges.


57


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)
Provision for Doubtful Accounts and the Allowance for Doubtful Accounts

The collection of outstanding receivables from Medicare, managed care payers, other third-party payers and patients is our primary source of cash and is critical to our operating performance. The primary collection risks relate to uninsured patient accounts, including patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (deductibles and copayments) remain outstanding. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to amounts due directly from patients. An estimated allowance for doubtful accounts is recorded for all uninsured accounts, regardless of the aging of those accounts. Accounts are written off when all reasonable internal and external collection efforts have been performed. Our collection policies include a review of all accounts against certain standard collection criteria, upon completion of our internal collection efforts. Accounts determined to possess positive collectibility attributes are forwarded to a secondary external collection agency and the other accounts are written off. The accounts that are not collected by the secondary external collection agency are written off when they are returned to us by the collection agency (usually within 12 months). Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. We do not pursue collection of amounts related to patients that meet our guidelines to qualify as charity care.

During 2011, we adopted the provisions of Accounting Standards Update No. 2011-07,Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities (“ASU 2011-07”). ASU 2011-07 requires health care entities to change the presentation of the statement of operations by reclassifying the provision for doubtful accounts from an operating expense to a deduction from patient service revenues. All periods presented in this Form 10-K have been reclassified in accordance with ASU 2011-07. The amount of the provision for doubtful accounts is based upon management’s assessment of historical writeoffs and expected net collections, business and economic conditions, trends in federal, state, and private employer health care coverage and other collection indicators. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information in

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates (Continued)

Provision for Doubtful Accounts and the Allowance for Doubtful Accounts (Continued)

estimating the collectibility of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. We believe our quarterly updates to the estimated allowance for doubtful accounts at each of our hospital facilities provide reasonable valuations of our accounts receivable. These routine, quarterly changes in estimates have not resulted in material adjustments to our allowance for doubtful accounts, provision for doubtful accounts orperiod-to-period comparisons of our results of operations. At December 31, 20102011 and 2009,2010, the allowance for doubtful accounts represented approximately 93%92% and 94%93%, respectively, of the $4.249$4.478 billion and $5.176$4.249 billion, respectively, patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured portion of our accounts receivable. The estimated uninsured portion of Medicaid pending and uninsured discount pending accounts is included in our patient due accounts receivable balance.

The revenue deductions related to uninsured accounts (charity care and uninsured discounts) generally have the inverse effect on the provision for doubtful accounts. To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view these revenue deductions and provision for doubtful accounts in combination, rather than each separately. A summary of these amounts for the years ended December 31, follows (dollars in millions):

             
  2010  2009  2008 
 
Provision for doubtful accounts $2,648  $3,276  $3,409 
Uninsured discounts  4,641   2,935   1,853 
Charity care  2,337   2,151   1,747 
             
Totals $9,626  $8,362  $7,009 
             
The provision for doubtful accounts, as a percentage of revenues, declined from 12.0% for 2008

   2011   2010   2009 

Charity care

  $2,683    $2,337    $2,151  

Uninsured discounts

   5,707     4,641     2,935  

Provision for doubtful accounts

   2,824     2,648     3,276  
  

 

 

   

 

 

   

 

 

 

Totals

  $11,214    $9,626    $8,362  
  

 

 

   

 

 

   

 

 

 

Increases to 10.9% for 2009 and declined to 8.6% for 2010. Our decision to increaseour uninsured discounts during the second half of 2009 hashave directly contributed to the declinedeclining trend in the provision for doubtful accounts. However, the sum of the provision for


58


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)

Provision for Doubtful Accounts and the Allowance for Doubtful Accounts (Continued)
doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of net revenues, the provision for doubtful accounts, uninsured discounts and charity care increased from 21.9% for 2008 to 23.8% for 2009 and to 25.6% for 2010.
2010 and to 27.4% for 2011.

Days revenues in accounts receivable were 4653 days, 4550 days and 4950 days at December 31, 2011, 2010 2009 and 2008,2009, respectively. Management expects a continuation of the challenges related to the collection of the patient due accounts. Adverse changes in the percentage of our patients having adequate health care coverage, general economic conditions, patient accounting service center operations, payer mix, or trends in federal, state, and private employer health care coverage could affect the collection of accounts receivable, cash flows and results of operations.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates (Continued)

Provision for Doubtful Accounts and the Allowance for Doubtful Accounts (Continued)

The approximate breakdown of accounts receivable by payer classification as of December 31, 20102011 and 20092010 is set forth in the following table:

             
  % of Accounts Receivable
  Under 91 Days 91—180 Days Over 180 Days
 
Accounts receivable aging at December 31, 2010:            
Medicare and Medicaid  14%  1%  1%
Managed care and other insurers  21   4   4 
Uninsured  17   8   30 
             
Total  52%  13%  35%
             
Accounts receivable aging at December 31, 2009:            
Medicare and Medicaid  12%  1%  1%
Managed care and other insurers  18   4   4 
Uninsured  13   8   39 
             
Total  43%  13%  44%
             
Our decisions, to increase uninsured discounts and to reduce the length of time accounts are left with our secondary collection agency, have contributed to improvements in our accounts receivable aging trends, particularly for our uninsured accounts receivable.

   % of Accounts Receivable 
   Under 91 Days  91—180 Days  Over 180 Days 

Accounts receivable aging at December 31, 2011:

    

Medicare and Medicaid

   14  1  1

Managed care and other insurers

   22    5    5  

Uninsured

   15    8    29  
  

 

 

  

 

 

  

 

 

 

Total

   51  14  35
  

 

 

  

 

 

  

 

 

 

Accounts receivable aging at December 31, 2010:

    

Medicare and Medicaid

   14  1  1

Managed care and other insurers

   21    4    4  

Uninsured

   17    8    30  
  

 

 

  

 

 

  

 

 

 

Total

   52  13  35
  

 

 

  

 

 

  

 

 

 

Professional Liability Claims

We, along with virtually all health care providers, operate in an environment with professional liability risks. Our facilities are insured by our wholly-owned insurance subsidiary for losses up to $50 million per occurrence, subject to a $5 million per occurrence self-insured retention. We purchase excess insurance on a claims-made basis for losses in excess of $50 million per occurrence. Our professional liability reserves, net of receivables under reinsurance contracts, do not include amounts for any estimated losses covered by our excess insurance coverage. Provisions for losses related to professional liability risks were $244 million, $222 million $211 million and $175$211 million for the years ended December 31, 2011, 2010 and 2009, and 2008, respectively.

Reserves for professional liability risks represent the estimated ultimate cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The estimated ultimate cost includes estimates of direct expenses and fees paid to outside counsel and experts, but does not include the general overhead costs of our insurance subsidiary or corporate office. Individual case reserves are established based upon the particular circumstances of each reported claim and represent our estimates of the future costs that will be paid on


59


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)

Professional Liability Claims (Continued)
reported claims. Case reserves are reduced as claim payments are made and are adjusted upward or downward as our estimates regarding the amounts of future losses are revised. Once the case reserves for known claims are determined, information is stratified by loss layers and retentions, accident years, reported years, and geographic location of our hospitals. Several actuarial methods are employed to utilize this data to produce estimates of ultimate losses and reserves for incurred but not reported claims, including: paid and incurred extrapolation methods utilizing paid and incurred loss development to estimate ultimate losses; frequency and severity methods utilizing paid and incurred claims development to estimate ultimate average frequency (number of claims) and ultimate average severity (cost per claim); and Bornhuetter-Ferguson methods which add expected development to actual paid or incurred experience to estimate ultimate losses. These methods use our company-specific historical claims data and other information. Company-specific claim reporting and settlement data collected over an approximate20-year period is used in our reserve estimation process. This company-specific data includes information regarding our business, including historical paid losses and loss adjustment expenses,

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates (Continued)

Professional Liability Claims (Continued)

historical and current case loss reserves, actual and projected hospital statistical data, professional liability retentions for each policy year, geographic information and other data.

Reserves and provisions for professional liability risks are based upon actuarially determined estimates. The estimated reserve ranges, net of amounts receivable under reinsurance contracts, were $1.134 billion to $1.354 billion at December 31, 2011 and $1.067 billion to $1.276 billion at December 31, 2010 and $1.024 billion to $1.270 billion at December 31, 2009.2010. Our estimated reserves for professional liability claims may change significantly if future claims differ from expected trends. We perform sensitivity analyses which model the volatility of key actuarial assumptions and monitor our reserves for adequacy relative to all our assumptions in the aggregate. Based on our analysis, we believe the estimated professional liability reserve ranges represent the reasonably likely outcomes for ultimate losses. We consider the number and severity of claims to be the most significant assumptions in estimating reserves for professional liabilities. A 2% change in the expected frequency trend could be reasonably likely and would increase the reserve estimate by $16$18 million or reduce the reserve estimate by $15$17 million. A 2% change in the expected claim severity trend could be reasonably likely and would increase the reserve estimate by $71$78 million or reduce the reserve estimate by $65$71 million. We believe adequate reserves have been recorded for our professional liability claims; however, due to the complexity of the claims, the extended period of time to settle the claims and the wide range of potential outcomes, our ultimate liability for professional liability claims could change by more than the estimated sensitivity amounts and could change materially from our current estimates.

The reserves for professional liability risks cover approximately 2,700 and 2,600 individual claims at both December 31, 20102011 and 2009, respectively,2010 and estimates for unreported potential claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. The average time period between the occurrence and payment of final settlement for our professional liability claims is approximately five years, although the facts and circumstances of each individual claim can result in anoccurrence-to-settlement timeframe that varies from this average. The estimation of the timing of payments beyond a year can vary significantly.

Reserves for professional liability risks were $1.262$1.291 billion and $1.322$1.262 billion at December 31, 20102011 and 2009,2010, respectively. The current portion of these reserves, $268$298 million and $265$268 million at December 31, 20102011 and 2009,2010, respectively, is included in “other accrued expenses.” Obligations covered by reinsurance contracts are included in the reserves for professional liability risks, as the insurance subsidiary remains liable to the extent reinsurers do not meet their obligations. Reserves for professional liability risks (net of $14$39 million and $53$14 million receivable under reinsurance contracts at December 31, 20102011 and 2009,2010, respectively) were $1.248$1.252 billion and $1.269$1.248 billion at December 31, 20102011 and 2009,2010, respectively. The estimated total net reserves for professional liability risks at


60


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Critical Accounting Policies and Estimates (Continued)

Professional Liability Claims (Continued)
December 31, 20102011 and 20092010 are comprised of $758$817 million and $680$758 million, respectively, of case reserves for known claims and $490$435 million and $589$490 million, respectively, of reserves for incurred but not reported claims.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Critical Accounting Policies and Estimates (Continued)

Professional Liability Claims (Continued)

Changes in our professional liability reserves, net of reinsurance recoverable, for the years ended December 31, are summarized in the following table (dollars in millions):

             
  2010  2009  2008 
 
Net reserves for professional liability claims, January 1 $1,269  $1,330  $1,469 
Provision for current year claims  272   258   239 
Favorable development related to prior years’ claims  (50)  (47)  (64)
             
Total provision  222   211   175 
             
Payments for current year claims  7   4   7 
Payments for prior years’ claims  236   268   307 
             
Total claim payments  243   272   314 
             
Net reserves for professional liability claims, December 31 $1,248  $1,269  $1,330 
             

   2011  2010  2009 

Net reserves for professional liability claims, January 1

  $1,248   $1,269   $1,330  

Provision for current year claims

   298    272    258  

Favorable development related to prior years’ claims

   (54  (50  (47
  

 

 

  

 

 

  

 

 

 

Total provision

   244    222    211  
  

 

 

  

 

 

  

 

 

 

Payments for current year claims

   7    7    4  

Payments for prior years’ claims

   233    236    268  
  

 

 

  

 

 

  

 

 

 

Total claim payments

   240    243    272  
  

 

 

  

 

 

  

 

 

 

Net reserves for professional liability claims, December 31

  $1,252   $1,248   $1,269  
  

 

 

  

 

 

  

 

 

 

The favorable development related to prior years’ claims resulted from declining claim frequency and moderating claim severity trends. We believe these favorable trends are primarily attributable to tort reforms enacted in key states, particularly Texas, and our risk management and patient safety initiatives, particularly in the area of obstetrics.

Income Taxes

We calculate our provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized by identifying the temporary differences that arise from the recognition of items in different periods for tax and accounting purposes. Deferred tax assets generally represent the tax effects of amounts expensed in our income statement for which tax deductions will be claimed in future periods.

Although we believe we have properly reported taxable income and paid taxes in accordance with applicable laws, federal, state or international taxing authorities may challenge our tax positions upon audit. Significant judgment is required in determining and assessing the impact of uncertain tax positions. We report a liability for unrecognized tax benefits from uncertain tax positions taken or expected to be taken in our income tax return. During each reporting period, we assess the facts and circumstances related to uncertain tax positions. If the realization of unrecognized tax benefits is deemed probable based upon new facts and circumstances, the estimated liability and the provision for income taxes are reduced in the current period. Final audit results may vary from our estimates.

Results of Operations

Revenue/Volume Trends

Our revenues depend upon inpatient occupancy levels, the ancillary services and therapy programs ordered by physicians and provided to patients, the volume of outpatient procedures and the charge and negotiated payment rates for such services. Gross charges typically do not reflect what our facilities are actually paid. Our facilities have entered into agreements with third-party payers, including government programs and managed care health plans, under which the facilities are paid based upon the cost of providing services, predetermined rates per diagnosis,


61


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Revenue/Volume Trends (Continued)
fixed per diem rates or discounts from gross charges. We do not pursue collection of amounts related to patients who meet our guidelines to qualify for charity care; therefore, they are not reported in

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Revenue/Volume Trends (Continued)

revenues. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care that are similar to the discounts provided to many local managed care plans.

Revenues increased 2.1%5.9% to $30.683$29.682 billion for 2011 from $28.035 billion for 2010 and increased 4.7% for 2010 from $30.052$26.776 billion for 20092009. The increase in revenues in 2011 can be primarily attributed to the combined impact of a 0.7% increase in revenue per equivalent admission and increased 5.9% for 2009 from $28.374 billion for 2008.a 5.2% increase in equivalent admissions compared to the prior year. The increase in revenues in 2010 can be primarily attributed to the combined impact of a 0.9%3.5% increase in revenue per equivalent admission and a 1.2% increase in equivalent admissions compared to the prior year. The increase2009.

Consolidated admissions increased 4.2% in revenues in 2009 can be primarily attributed to the combined impact of a 2.6% increase in revenue per equivalent admission and a 3.2% increase in equivalent admissions2011 compared to 2008. The decline in the rate of revenue growth from 5.9% for 2009 compared to 2008 to 2.1% for 2010 compared to 2009 is primarily due to a decline in the rate of volume growth (equivalent admission growth declined from 3.2% for 2009 compared to 2008 to 1.2% for 2010 compared to 2009) and a decline in uninsured revenues (uninsured revenues were $1.732 billion, $2.350 billion and $2.695 billion for the years ended December 31, 2010, 2009 and 2008, respectively) resulting from our increased uninsured discounts (uninsured discounts were $4.641 billion, $2.935 billion and $1.853 billion for the years ended December 31, 2010, 2009 and 2008, respectively).

Consolidated admissions declined 0.1% in 2010 compared to 20092009. Consolidated inpatient surgeries declined 0.5% and consolidated outpatient surgeries increased 1.0% in 20092.0% during 2011 compared to 2008.2010. Consolidated inpatient surgeries declined 1.5% and consolidated outpatient surgeries declined 1.4% during 2010 compared to 2009. Consolidated inpatient surgeriesemergency room visits increased 0.3% and consolidated outpatient surgeries declined 0.4%7.7% during 20092011 compared to 2008. Consolidated emergency room visits2010 and increased 2.0% during 2010 compared to 2009 and increased 6.6% during 2009 compared to 2008.
2009.

Same facility revenues increased 2.1%3.3% for the year ended December 31, 2011 compared to the year ended December 31, 2010 and increased 4.6% for the year ended December 31, 2010 compared to the year ended December 31, 2009 and increased 6.1%2009. The 3.3% increase for the year ended December 31, 2009 compared2011 can be primarily attributed to the year ended December 31, 2008.combined impact of a 0.3% increase in same facility revenue per equivalent admission and a 3.0% increase in same facility equivalent admissions. The 2.1%4.6% increase for 2010 can be primarily attributed to the combined impact of a 0.6%3.2% increase in same facility revenue per equivalent admission and a 1.4% increase in same facility equivalent admissions. The 6.1% increase for 2009 can be primarily attributed to the combined impact of a 2.6% increase in same facility revenue per equivalent admission and a 3.4% increase in same facility equivalent admissions.

Same facility admissions increased 2.3% in 2011 compared to 2010 and increased 0.1% in 2010 compared to 20092009. Same facility inpatient surgeries declined 1.7% and increased 1.2% in 2009same facility outpatient surgeries declined 0.6% during 2011 compared to 2008.2010. Same facility inpatient surgeries declined 1.4% and same facility outpatient surgeries declined 1.2% during 2010 compared to 2009. Same facility inpatient surgeriesemergency room visits increased 0.5% and same facility outpatient surgeries declined 0.1%6.2% during 20092011 compared to 2008. Same facility emergency room visits2010 and increased 2.1% during 2010 compared to 20092009.

Same facility uninsured emergency room visits increased 5.8% and same facility uninsured admissions increased 7.0%7.4% during 20092011 compared to 2008.

2010. Same facility uninsured emergency room visits increased 1.2% and same facility uninsured admissions increased 5.4% during 2010 compared to 2009. Same facility uninsured emergency room visits increased 6.5% and same facility uninsured admissions increased 4.7% during 2009 compared to 2008.


62


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Revenue/Volume Trends (Continued)
The approximate percentages of our admissions related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care and other insurers and the uninsured for the years ended December 31, 2011, 2010 2009 and 20082009 are set forth below.
             
  Years Ended December 31,
  2010 2009 2008
 
Medicare  34%  34%  35%
Managed Medicare  10   10   9 
Medicaid  9   9   8 
Managed Medicaid  8   7   7 
Managed care and other insurers  32   34   35 
Uninsured  7   6   6 
             
   100%  100%  100%
             

   Years Ended December 31, 
   2011  2010  2009 

Medicare

   34  34  34

Managed Medicare

   11    10    10  

Medicaid

   9    9    9  

Managed Medicaid

   8    8    7  

Managed care and other insurers

   31    32    34  

Uninsured

   7    7    6  
  

 

 

  

 

 

  

 

 

 
   100  100  100
  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Revenue/Volume Trends (Continued)

The approximate percentages of our inpatient revenues, before provision for doubtful accounts, related to Medicare, managed Medicare, Medicaid, managed Medicaid, managed care plans and other insurers and the uninsured for the years ended December 31, 2011, 2010 2009 and 20082009 are set forth below.

             
  Years Ended December 31,
  2010 2009 2008
 
Medicare  31%  31%  31%
Managed Medicare  9   8   8 
Medicaid  9   8   7 
Managed Medicaid  4   4   4 
Managed care and other insurers  44   44   44 
Uninsured(a)  3   5   6 
             
   100%  100%  100%
             

   Years Ended December 31, 
   2011  2010  2009 

Medicare

   31  31  31

Managed Medicare

   9    9    8  

Medicaid

   8    9    8  

Managed Medicaid

   4    4    4  

Managed care and other insurers

   45    44    44  

Uninsured(a)

   3    3    5  
  

 

 

  

 

 

  

 

 

 
   100  100  100
  

 

 

  

 

 

  

 

 

 

(a)

Increases in discounts to uninsured revenues have resulted in declines in the percentage of our inpatient revenues related to the uninsured, as the percentage of uninsured admissions compared to total admissions has increased slightly.

At December 31, 2010,2011, we owned and operated 3839 hospitals and 3231 surgery centers in the state of Florida. Our Florida facilities’ revenues totaled $7.490$6.989 billion, $7.343$6.538 billion and $7.009$6.217 billion for the years ended December 31, 2011, 2010 2009 and 2008,2009, respectively. At December 31, 2010,2011, we owned and operated 36 hospitals and 2322 surgery centers in the state of Texas. Our Texas facilities’ revenues totaled $8.352$7.829 billion, $8.042$7.597 billion and $7.351$7.180 billion for the years ended December 31, 2011, 2010 2009 and 2008,2009, respectively. During each year 2011, 2010 and 2009, and 2008, 57%, 57% and 55% of our admissions and 52%, 51% and 51%, respectively,50% of our revenues were generated by our Florida and Texas facilities. Uninsured admissions in Florida and Texas represented 63%, 64%63% and 63%64% of our uninsured admissions during 2011, 2010 and 2009, and 2008, respectively.

We receive a significant portion of our revenues from government health programs, principally Medicare and Medicaid, which are highly regulated and subject to frequent and substantial changes. We have increased theprovide indigent care services we provide in several communities in the state of Texas, in affiliation with other hospitals. The state of Texas has been involved in the effortefforts to increase the indigent care provided by private hospitals. As a result of this additional indigent care being provided by private hospitals, public hospital districts or counties in Texas


63


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Revenue/Volume Trends (Continued)
have available funds that were previously devoted to indigent care. The public hospital districts or counties are under no contractual or legal obligation to provide such indigent care. The public hospital districts or counties have elected to transfer some portion of these available funds to the state’s Medicaid program. Such action is at the sole discretion of the public hospital districts or counties. It is anticipated that these contributions to the state will be matched with federal Medicaid funds. The state then may make supplemental payments to hospitals in the state for Medicaid services rendered. Hospitals receiving Medicaid supplemental payments may include those that are providing additional indigent care services. Such payments must be within the federal UPL established by federal regulation. Our Texas Medicaid revenues included $540 million, $657 million and $474 million during 2011, 2010 and $262 million during 2010, 2009, and 2008, respectively, of Medicaid supplemental payments. In addition, we receive supplemental payments in several other states. We are aware these supplemental payment programs are currently being reviewed by certain state agencies and some states have made waiver requests to the Centers for Medicare & Medicaid Services (“CMS”) to replace their existing supplemental payment programs. It is possible these reviews and waiver requests will result in the restructuring of such supplemental payment programs and

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Revenue/Volume Trends (Continued)

could result in the payment programs being reduced or eliminated. In December 2011, CMS approved a Medicaid waiver that allows Texas to continue receiving supplemental Medicaid reimbursement while expanding its Medicaid managed care program, thus Texas is operating pursuant to UPL programs.

a Waiver Program. However, we cannot predict whether the Texas private supplemental Medicaid reimbursement program will continue or guarantee that revenues recognized for the program will not decline. Because deliberations about these programs are ongoing, we are unable to estimate the financial impact the program structure modifications, if any, may have on our results of operations.

Electronic Health Record Incentive Payments

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments beginning in 2011 for eligible hospitals and professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. We estimaterecognize income related to Medicare and Medicaid incentive payments using a majority ofgain contingency model that is based upon when our eligible hospitals will attest to adopting, implementing, upgrading or demonstratinghave demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Medicaid EHR incentive calculations and related payment amounts are based upon prior period cost report information available at the time our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, and are not subject to revision for cost report data filed for a subsequent period. Thus, incentive income recognition occurs at the point our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, as the cost report information for the full cost report year that will determine the final calculation of the incentive payment is known at that time.

Medicare EHR incentive calculations and related initial payment amounts are based upon the most current filed cost report information available at the time our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period. However, unlike Medicaid, this initial payment amount will be adjusted based upon an updated calculation using the annual cost report information for the cost report period that began during the fourth quarterapplicable payment year. Thus, incentive income recognition occurs at the point our eligible hospitals demonstrate meaningful use of 2011,certified EHR technology for the applicable period and wethe cost report information for the full cost report year that will not recognize any revenuesdetermine the final calculation of the incentive payment is available.

We recognized $210 million of electronic health record incentive income related to theMedicaid ($87 million) and Medicare or Medicaid($123 million) incentive programs during 2011. At December 31, 2011, we have $134 million of deferred EHR incentive income, which represents initial incentive payments until we are able to complete these attestations. We currently estimate that, during 2011 (primarily during our fourth quarter), the amount of Medicare or Medicaidreceived for which EHR incentive payments realizable (and revenues recognized) will be in the range of $275 million to $325 million.income has not been recognized. Actual incentive payments could vary from these estimates due to certain factors such as availability of federal funding for both Medicare and Medicaid incentive payments, timing of the approval of state Medicaid incentive payment plans by CMS and our ability to implement andcontinue to demonstrate meaningful use of certified EHR technology. We have incurred and will continue to incur both capital costs and operating expenses in order to implement our certified EHR technology and meet meaningful use requirements. These expenses are ongoing and are projected to continue over all stages of implementation of meaningful use. The timing of recognizing the expenses willmay not correlate with the receipt of the incentive payments and the recognition of revenues. We estimate thatFor 2011, we incurred $77 million of operating expenses to implement our certified EHR technology and meet meaningful useuse.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Electronic Health Record Incentive Payments (Continued)

For 2012, we estimate EHR incentive income will be recognized in the range of $325 million to $350 million and that related EHR operating expenses will be in the range of $125$140 million to $150 million for 2011.$160 million. Actual EHR incentive income and EHR operating expenses could vary from these estimates. There can be no assurance that we will be able to continue to demonstrate meaningful use of certified EHR technology, and the failure to do so could have a material, adverse effect on our results of operations.


64


HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Operating Results Summary

The following are comparative summaries of operating results for the years ended December 31, 2011, 2010 2009 and 20082009 (dollars in millions):

                         
  2010  2009  2008 
  Amount  Ratio  Amount  Ratio  Amount  Ratio 
 
Revenues $30,683   100.0  $30,052   100.0  $28,374   100.0 
                         
Salaries and benefits  12,484   40.7   11,958   39.8   11,440   40.3 
Supplies  4,961   16.2   4,868   16.2   4,620   16.3 
Other operating expenses  5,004   16.3   4,724   15.7   4,554   16.1 
Provision for doubtful accounts  2,648   8.6   3,276   10.9   3,409   12.0 
Equity in earnings of affiliates  (282)  (0.9)  (246)  (0.8)  (223)  (0.8)
Depreciation and amortization  1,421   4.6   1,425   4.8   1,416   5.0 
Interest expense  2,097   6.8   1,987   6.6   2,021   7.1 
Losses (gains) on sales of facilities  (4)     15      (97)  (0.3)
Impairments of long-lived assets  123   0.4   43   0.1   64   0.2 
                         
   28,452   92.7   28,050   93.3   27,204   95.9 
                         
Income before income taxes  2,231   7.3   2,002   6.7   1,170   4.1 
Provision for income taxes  658   2.2   627   2.1   268   0.9 
                         
Net income  1,573   5.1   1,375   4.6   902   3.2 
Net income attributable to noncontrolling interests  366   1.2   321   1.1   229   0.8 
                         
Net income attributable to HCA Holdings, Inc.  $1,207   3.9  $1,054   3.5  $673   2.4 
                         
% changes from prior year:                        
Revenues  2.1%      5.9%      5.6%    
Income before income taxes  11.5       71.1       (16.3)    
Net income attributable to HCA Holdings, Inc.   14.5       56.7       (23.0)    
Admissions(a)  (0.1)      1.0       (0.7)    
Equivalent admissions(b)  1.2       3.2       0.5     
Revenue per equivalent admission  0.9       2.6       5.2     
Same facility % changes from prior year(c):                        
Revenues  2.1       6.1       7.0     
Admissions(a)  0.1       1.2       0.9     
Equivalent admissions(b)  1.4       3.4       1.9     
Revenue per equivalent admission  0.6       2.6       5.1     

   2011  2010  2009 
   Amount  Ratio  Amount  Ratio  Amount  Ratio 

Revenues before provision for doubtful accounts

  $32,506    $30,683    $30,052   

Provision for doubtful accounts

   2,824     2,648     3,276   
  

 

 

   

 

 

   

 

 

  

Revenues

   29,682    100.0    28,035    100.0    26,776    100.0  

Salaries and benefits

   13,440    45.3    12,484    44.5    11,958    44.7  

Supplies

   5,179    17.4    4,961    17.7    4,868    18.2  

Other operating expenses

   5,470    18.5    5,004    17.9    4,724    17.6  

Electronic health record incentive income

   (210  (0.7                

Equity in earnings of affiliates

   (258  (0.9  (282  (1.0  (246  (0.9

Depreciation and amortization

   1,465    4.9    1,421    5.0    1,425    5.2  

Interest expense

   2,037    6.9    2,097    7.5    1,987    7.4  

Losses (gains) on sales of facilities

   (142  (0.5  (4      15    0.1  

Gain on acquisition of controlling interest in equity investment

   (1,522  (5.1                

Impairments of long-lived assets

           123    0.4    43    0.2  

Losses on retirement of debt

   481    1.6                  

Termination of management agreement

   181    0.6                  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   26,121    88.0    25,804    92.0    24,774    92.5  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Income before income taxes

   3,561    12.0    2,231    8.0    2,002    7.5  

Provision for income taxes

   719    2.4    658    2.4    627    2.4  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income

   2,842    9.6    1,573    5.6    1,375    5.1  

Net income attributable to noncontrolling interests

   377    1.3    366    1.3    321    1.2  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income attributable to HCA Holdings, Inc.

  $2,465    8.3   $1,207    4.3   $1,054    3.9  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

% changes from prior year:

       

Revenues

   5.9   4.7   7.2 

Income before income taxes

   59.6     11.5     71.1   

Net income attributable to HCA Holdings, Inc.

   104.3     14.5     56.7   

Admissions(a)

   4.2     (0.1   1.0   

Equivalent admissions(b)

   5.2     1.2     3.2   

Revenue per equivalent admission

   0.7     3.5     3.9   

Same facility % changes from prior year(c):

       

Revenues

   3.3     4.6     7.5   

Admissions(a)

   2.3     0.1     1.2   

Equivalent admissions(b)

   3.0     1.4     3.4   

Revenue per equivalent admission

   0.3     3.2     4.0   

(a)

Represents the total number of patients admitted to our hospitals and is used by management and certain investors as a general measure of inpatient volume.

(b)

Equivalent admissions are used by management and certain investors as a general measure of combined inpatient and outpatient volume. Equivalent admissions are computed by multiplying admissions (inpatient volume) by the sum of gross inpatient revenue and gross outpatient revenue and then dividing the resulting amount by gross inpatient revenue. The equivalent admissions computation “equates” outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.

(c)

Same facility information excludes the operations of hospitals and their related facilities that were either acquired, divested or removed from service during the current and prior year.


65


HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)


Operating Results Summary (Continued)Years Ended December 31, 2011 and 2010

Supplemental Non-GAAP Disclosures
Operating Measures

Net income attributable to HCA Holdings, Inc. totaled $2.465 billion, or $4.97 per diluted share, for the year ended December 31, 2011 compared to $1.207 billion, or $2.76 per diluted share, for the year ended December 31, 2010. Financial results for 2011 include net gains on sales of facilities of $142 million (pretax), or $0.16 per diluted share, a Cash Revenues Basis
(Dollarsgain on the acquisition of controlling interest in millions)

Thean equity investment of $1.522 billion (pretax), or $2.87 per diluted share, losses on retirement of debt of $481 million (pretax), or $0.61 per diluted share, and termination of management agreement fees of $181 million (pretax), or $0.30 per diluted share. Financial results for 2010 include net gains on sales of operations presented on a cash revenues basisfacilities of $4 million (pretax), or $0.01 per diluted share, and asset impairment charges of $123 million (pretax), or $0.18 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 495.943 million shares and 437.347 million shares for the years ended December 31, 2011 and 2010, 2009respectively. During March 2011, we completed the initial public offering of 87.719 million shares of our common stock, and 2008 (dollarsduring September 2011, we repurchased 80.771 million shares of our common stock from affiliates of Bank of America Corporation.

During 2011, consolidated admissions increased 4.2% and same facility admissions increased 2.3% for 2011, compared to 2010. Consolidated inpatient surgical volumes declined 0.5%, and same facility inpatient surgeries declined 1.7% during 2011 compared to 2010. Consolidated outpatient surgical volumes increased 2.0%, and same facility outpatient surgeries declined 0.6% during 2011 compared to 2010. Emergency room visits increased 7.7% on a consolidated basis and increased 6.2% on a same facility basis during 2011 compared to 2010.

Revenues before provision for doubtful accounts increased 5.9% to $32.506 billion for 2011 from $30.683 billion for 2010. Provision for doubtful accounts increased $176 million from $2.648 billion in millions):

                                     
  2010  2009  2008 
     Non-
        Non-
        Non-
    
     GAAP %
  GAAP %
     GAAP %
  GAAP %
     GAAP %
  GAAP %
 
     of Cash
  of
     of Cash
  of
     of Cash
  of
 
     Revenues
  Revenues
     Revenues
  Revenues
     Revenues
  Revenues
 
  Amount  Ratios(b)  Ratios(b)  Amount  Ratios(b)  Ratios(b)  Amount  Ratios(b)  Ratios(b) 
 
Revenues $30,683       100.0% $30,052       100.0% $28,374       100.0%
Provision for doubtful accounts  2,648           3,276           3,409         
                                     
Cash revenues(a)  28,035   100.0%      26,776   100.0%      24,965   100.0%    
Salaries and benefits  12,484   44.5   40.7   11,958   44.7   39.8   11,440   45.8   40.3 
Supplies  4,961   17.7   16.2   4,868   18.2   16.2   4,620   18.5   16.3 
Other operating expenses  5,004   17.9   16.3   4,724   17.6   15.7   4,554   18.3   16.1 
% changes from prior year:                                    
Revenues  2.1%          5.9%          5.6%        
Cash revenues  4.7           7.2           5.2         
Revenue per equivalent admission  0.9           2.6           5.2         
Cash revenue per equivalent admission  3.5           3.9           4.7         
(a)Cash revenues is defined as reported revenues less the provision for doubtful accounts. We use cash revenues as an analytical indicator for purposes of assessing the effect of uninsured patient volumes, adjusted for the effect of both the revenue deductions related to uninsured accounts (charity care and uninsured discounts) and the provision for doubtful accounts (which relates primarily to uninsured accounts), on our revenues and certain operating expenses, as a percentage of cash revenues. Variations in the revenue deductions related to uninsured accounts generally have the inverse effect on the provision for doubtful accounts. During 2010, uninsured discounts increased $1.706 billion and the provision for doubtful accounts declined $628 million, compared to 2009. During 2009, uninsured discounts increased $1.082 billion and the provision for doubtful accounts declined $133 million, compared to 2008. Cash revenues is commonly used as an analytical indicator within the health care industry. Cash revenues should not be considered as a measure of financial performance under generally accepted accounting principles. Because cash revenues is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, cash revenues, as presented, may not be comparable to other similarly titled measures of other health care companies.
(b)Salaries and benefits, supplies and other operating expenses, as a percentage of cash revenues (a non-GAAP financial measure), present the impact on these ratios due to the adjustment of deducting the provision for doubtful accounts from reported revenues and results in these ratios being non-GAAP financial measures. We believe these non-GAAP financial measures are useful to investors to provide disclosures of our results of operations on the same basis as that used by management. Management uses this information to compare certain operating expense categories as a percentage of cash revenues. Management finds this information useful to evaluate certain expense category trends without the influence of whether adjustments related to revenues for uninsured accounts are recorded as revenue adjustments (charity care and uninsured discounts) or operating expenses (provision for doubtful accounts), and thus the expense category trends are generally analyzed as a percentage of cash revenues. These non-GAAP financial measures should not be considered alternatives to GAAP financial measures. We believe this supplemental information provides management and the users of our financial statements with useful information forperiod-to-period comparisons. Investors are encouraged to use GAAP measures when evaluating our overall financial performance.


66

2010 to $2.824 billion in 2011. With our adoption of ASU 2011-07, the provision for doubtful accounts has been reclassified from an operating expense to a deduction from patient service revenues. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The self-pay revenue deductions for charity care and uninsured discounts increased $346 million and $1.066 billion, respectively, during 2011 compared to 2010. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 27.4% for 2011 compared to 25.6% for 2010. At December 31, 2011, our allowance for doubtful accounts represented approximately 92% of the $4.478 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.


Revenues increased 5.9% to $29.682 billion for 2011 from $28.035 billion for 2010. The increase in revenues was due primarily to the combined impact of a 0.7% increase in revenue per equivalent admission and a 5.2% increase in equivalent admissions compared to 2010. Same facility revenues increased 3.3% due primarily to the combined impact of a 0.3% increase in same facility revenue per equivalent admission and a 3.0% increase in same facility equivalent admissions compared to 2010.

Salaries and benefits, as a percentage of revenues, were 45.3% in 2011 and 44.5% in 2010. Salaries and benefits per equivalent admission increased 2.4% in 2011 compared to 2010. Same facility labor rate increases averaged 2.3% for 2011 compared to 2010.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Years Ended December 31, 2011 and 2010 (Continued)

Supplies, as a percentage of revenues, were 17.4% in 2011 and 17.7% in 2010. Supply costs per equivalent admission declined 0.7% in 2011 compared to 2010. Supply costs per equivalent admission declined 3.0% for medical devices, 1.5% for pharmacy supplies and 1.7% for blood products, and increased 3.1% for general medical and surgical items in 2011 compared to 2010.

Other operating expenses, as a percentage of revenues, increased to 18.5% in 2011 from 17.9% in 2010. Other operating expenses are primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. Each of contract services and professional fees increased 20 basis points in 2011 compared to 2010. Other operating expenses include $317 million and $354 million of indigent care costs in certain Texas markets during 2011 and 2010, respectively. Provisions for losses related to professional liability risks were $244 million and $222 million for 2011 and 2010, respectively.

We recognized $210 million of electronic health record incentive income related to Medicaid ($87 million) and Medicare ($123 million) incentive programs during 2011. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Equity in earnings of affiliates declined from $282 million for 2010 to $258 million for 2011. Equity in earnings of affiliates relates primarily to our Denver, Colorado market joint venture, which effective November 1, 2011, we began consolidating due to our acquisition of the approximate 40% remaining ownership interest.

Depreciation and amortization declined, as a percentage of revenues, to 4.9% in 2011 from 5.0% in 2010. Depreciation expense was $1.461 billion for 2011 and $1.416 billion for 2010.

Interest expense declined to $2.037 billion for 2011 from $2.097 billion for 2010. The decline in interest expense was due primarily to a decline in the average interest rate. Our average debt balance was $26.588 billion for 2011 compared to $26.751 billion for 2010. The average interest rate for our long-term debt declined from 7.8% for 2010 to 7.7% for 2011.

Net gains on sales of facilities were $142 million for 2011 and primarily related to the sale of a hospital facility and other health care entity investments. Net gains on sales of facilities were $4 million for 2010 and were related to sales of real estate and other health care entity investments.

During October 2011, we completed our acquisition of the Colorado Health Foundation’s (“Foundation”) approximate 40% remaining ownership interest in the HCA-HealthONE LLC (“HealthONE”) joint venture for $1.450 billion. We recorded a gain on the acquisition of a controlling interest in an equity investment of $1.522 billion related to the remeasurement of our previous equity investment in HealthONE based upon our acquisition of the Foundation’s ownership interest and the resulting consolidation of the entire enterprise at estimated fair value.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Years Ended December 31, 2011 and 2010 (Continued)

Impairments of long-lived assets were $123 million for 2010 and included $74 million related to two hospital facilities and $49 million related to other health care entity investments, which includes $35 million for the writeoff of capitalized engineering and design costs related to certain building safety requirements (California earthquake standards) that have been revised. There were no impairments of long-lived assets in 2011.

During 2011, we recorded losses on retirement of debt of $481 million related to the redemptions of all $1.000 billion aggregate principal amount of our 9 1/8% Senior Secured Notes due 2014, at a redemption price of 104.563% of the principal amount; $108 million aggregate principal amount of our 9 7/8% Senior Secured Notes due 2017, at a redemption price of 109.875% of the principal amount; all of our outstanding $1.578 billion 9 5/8%/10  3/8% second lien toggle notes due 2016, at a redemption price of 106.783% of the principal amount and all of our outstanding $3.200 billion 9 1/4% second lien notes due 2016, at a redemption price of 106.513% of the principal amount. There were no losses on retirement of debt during the 2010.

Our Investors have provided management and advisory services to the Company, pursuant to a management agreement among HCA and the Investors executed in connection with the Investors’ acquisition of HCA in November 2006. In March 2011, the management agreement was terminated pursuant to its terms upon completion of the initial public offering of our common stock, and the Investors were paid a final fee of $181 million.

The effective tax rate was 22.6% and 35.3% for 2011 and 2010, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our income before income taxes for 2011 included $1.255 billion of nontaxable gain related to the reported gain on the acquisition of a controlling interest in an equity investment. Our provision for income taxes for 2010 was reduced by $44 million related to reductions in interest expense related to taxing authority examinations. Excluding the effect of these adjustments, the effective tax rate for 2011 and 2010 would have been 37.3% and 37.6%, respectively.

Net income attributable to noncontrolling interests increased from $366 million for 2010 to $377 million for 2011. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of certain surgery center joint ventures.

Years Ended December 31, 2010 and 2009

Net income attributable to HCA Holdings, Inc. totaled $1.207 billion, or $2.76 per diluted share, for the year ended December 31, 2010 compared to $1.054 billion, or $2.44 per diluted share, for the year ended December 31, 2009. Financial results for 2010 include net gains on sales of facilities of $4 million (pretax), or $0.01 per diluted share, and asset impairment charges of $123 million.million (pretax), or $0.18 per diluted share. Financial results for 2009 include net losses on sales of facilities of $15 million (pretax), or $0.02 per diluted share, and asset impairment charges of $43 million.

Revenues increased 2.1% to $30.683 billionmillion (pretax), or $0.08 per diluted share. All “per diluted share” disclosures are based upon amounts net of the applicable income taxes. Shares used for diluted earnings per share were 437.347 million shares and 432.227 million shares for the years ended December 31, 2010 from $30.052 billion for 2009. The increase in revenues was due primarily to the combined impact of a 0.9% increase in revenue per equivalent admission and a 1.2% increase in equivalent admissions compared to 2009. Same facility revenues increased 2.1% due primarily to the combined impact of a 0.6% increase in same facility revenue per equivalent admission and a 1.4% increase in same facility equivalent admissions compared to 2009. Cash revenues (reported revenues less the provision for doubtful accounts) increased 4.7% for 2010, compared to 2009.
2009, respectively.

During 2010, consolidated admissions declined 0.1% and same facility admissions increased 0.1% for 2010, compared to 2009. Consolidated inpatient surgical volumes declined 1.5%, and same facility inpatient surgeries

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Years Ended December 31, 2010 and 2009 (Continued)

declined 1.4% during 2010 compared to 2009. Consolidated outpatient surgical volumes declined 1.4%, and same facility outpatient surgeries declined 1.2% during 2010 compared to 2009. Emergency room visits increased 2.0% on a consolidated basis and increased 2.1% on a same facility basis during 2010 compared to 2009.

Revenues before provision for doubtful accounts increased 2.1% to $30.683 billion for 2010 from $30.052 billion for 2009. Provision for doubtful accounts declined $628 million from $3.276 billion in 2009 to $2.648 billion in 2010. With our adoption of ASU 2011-07, the provision for doubtful accounts has been reclassified from an operating expense to a deduction from patient service revenues. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients, including copayment and deductible amounts for patients who have health care coverage. The decline in the provision for doubtful accounts can be attributed to the $1.892 billion increase in the combined self-pay revenue deductions for charity care and uninsured discounts during 2010, compared to 2009. The self-pay revenue deductions for charity care and uninsured discounts increased $186 million and $1.706 billion, respectively, during 2010 compared to 2009. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of revenues, the provision for doubtful accounts, uninsured discounts and charity care, was 25.6% for 2010 compared to 23.8% for 2009. At December 31, 2010, our allowance for doubtful accounts represented approximately 93% of the $4.249 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.

Revenues increased 4.7% to $28.035 billion for 2010 from $26.776 billion for 2009. The increase in revenues was due primarily to the combined impact of a 3.5% increase in revenue per equivalent admission and a 1.2% increase in equivalent admissions compared to 2009. Same facility revenues increased 4.6% due primarily to the combined impact of a 3.2% increase in same facility revenue per equivalent admission and a 1.4% increase in same facility equivalent admissions compared to 2009.

Salaries and benefits, as a percentage of revenues, were 40.7% in 2010 and 39.8% in 2009. Salaries and benefits, as a percentage of cash revenues, were 44.5% in 2010 and 44.7% in 2009. Salaries and benefits per equivalent admission increased 3.2% in 2010 compared to 2009. Same facility labor rate increases averaged 2.7% for 2010 compared to 2009.

Supplies, as a percentage of revenues, were 16.2% in both 2010 and 2009. Supplies, as a percentage of cash revenues, were 17.7% in 2010 and 18.2% in 2009. Supply costs per equivalent admission increased 0.7% in 2010 compared to 2009. Supply costs per equivalent admission increased 2.4% for medical devices, 0.8% for blood products, and 2.9% for general medical and surgical items, and declined 0.7% for pharmacy supplies in 2010 compared to 2009.

Other operating expenses, as a percentage of revenues, increased to 16.3% in 2010 from 15.7% in 2009. Other operating expenses, as a percentage of cash revenues, increased to 17.9% in 2010 from 17.6% in 2009. Other operating expenses are primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. The major component of the increase in other operating expenses, as a percentage of revenues, was related to indigent care costs in certain Texas markets which increased to $354 million for 2010 from $248 million for 2009. Provisions for losses related to professional liability risks were $222 million and $211 million for 2010 and 2009, respectively.

Provision for doubtful accounts declined $628 million, from $3.276 billion in 2009 to $2.648 billion in 2010, and as a percentage of revenues, declined to 8.6% for 2010 from 10.9% in 2009. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients. The decline in the provision for doubtful accounts can be attributed to the $1.892 billion increase in the combined self-pay revenue deductions for charity care and uninsured discounts during 2010, compared to 2009. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of net revenues, uninsured discounts and charity care, was 25.6% for 2010, compared to 23.8% for 2009. At December 31, 2010, our allowance for doubtful accounts represented approximately 93% of the $4.249 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.


67


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Years Ended December 31, 2010 and 2009 (Continued)
Equity in earnings of affiliates increased from $246 million for 2009 to $282 million for 2010. Equity in earnings of affiliates relatesrelated primarily to our Denver, Colorado market joint venture.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Results of Operations (Continued)

Years Ended December 31, 2010 and 2009 (Continued)

Depreciation and amortization declined, as a percentage of revenues, to 4.6%5.0% in 2010 from 4.8%5.2% in 2009. Depreciation expense was $1.416 billion for 2010 and $1.419 billion for 2009.

Interest expense increased to $2.097 billion for 2010 from $1.987 billion for 2009. The increase in interest expense was due primarily to an increase in the average effective interest rate. Our average debt balance was $26.751 billion for 2010 compared to $26.267 billion for 2009. The average interest rate for our long-term debt increased from 7.6% for 2009 to 7.8% for 2010.

Net gains on sales of facilities were $4 million for 2010 and were related to sales of real estate and other health care entity investments. Net losses on sales of facilities were $15 million for 2009 and included $8 million of net losses on the sales of three hospital facilities and $7 million of net losses on sales of real estate and other health care entity investments.

Impairments of long-lived assets were $123 million for 2010 and included $74 million related to two hospital facilities and $49 million related to other health care entity investments, which includes $35 million for the writeoff of capitalized engineering and design costs related to certain building safety requirements (California earthquake standards) that have been revised. Impairments of long-lived assets were $43 million for 2009 and included $19 million related to goodwill and $24 million related to property and equipment.

The effective tax rate was 35.3% and 37.3% for 2010 and 2009, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Our provisions for income taxes for 2010 and 2009 were reduced by $44 million and $12 million, respectively, related to reductions in interest expense related to taxing authority examinations. Excluding the effect of these adjustments, the effective tax rate for 2010 and 2009 would have been 37.6% and 38.0%, respectively.

Net income attributable to noncontrolling interests increased from $321 million for 2009 to $366 million for 2010. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.

Years Ended December 31, 2009 and 2008
Net income attributable to HCA Holdings, Inc. totaled $1.054 billion for the year ended December 31, 2009 compared to $673 million for the year ended December 31, 2008. Financial results for 2009 include losses on sales of facilities of $15 million and asset impairment charges of $43 million. Financial results for 2008 include gains on sales of facilities of $97 million and asset impairment charges of $64 million.
Revenues increased 5.9% to $30.052 billion for 2009 from $28.374 billion for 2008. The increase in revenues was due primarily to the combined impact of a 2.6% increase in revenue per equivalent admission and a 3.2% increase in equivalent admissions compared to 2008. Same facility revenues increased 6.1% due primarily to the combined impact of a 2.6% increase in same facility revenue per equivalent admission and a 3.4% increase in same facility equivalent admissions compared to 2008. Cash revenues (reported revenues less the provision for doubtful accounts) increased 7.2% for 2009, compared to 2008.
During 2009, consolidated admissions increased 1.0% and same facility admissions increased 1.2% for 2009, compared to 2008. Consolidated inpatient surgical volumes increased 0.3%, and same facility inpatient surgeries increased 0.5% during 2009 compared to 2008. Consolidated outpatient surgical volumes declined 0.4%, and same


68


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Years Ended December 31, 2009 and 2008 (Continued)
facility outpatient surgeries declined 0.1% during 2009 compared to 2008. Emergency department visits increased 6.6% on a consolidated basis and increased 7.0% on a same facility basis during 2009 compared to 2008.
Salaries and benefits, as a percentage of revenues, were 39.8% in 2009 and 40.3% in 2008. Salaries and benefits, as a percentage of cash revenues, were 44.7% in 2009 and 45.8% in 2008. Salaries and benefits per equivalent admission increased 1.3% in 2009 compared to 2008. Same facility labor rate increases averaged 3.7% for 2009 compared to 2008.
Supplies, as a percentage of revenues, were 16.2% in 2009 and 16.3% in 2008. Supplies, as a percentage of cash revenues, were 18.2% in 2009 and 18.5% in 2008. Supply costs per equivalent admission increased 2.1% in 2009 compared to 2008. Same facility supply costs increased 5.9% for medical devices, 4.0% for pharmacy supplies, 7.1% for blood products and 7.0% for general medical and surgical items in 2009 compared to 2008.
Other operating expenses, as a percentage of revenues, declined to 15.7% in 2009 from 16.1% in 2008. Other operating expenses, as a percentage of cash revenues, declined to 17.6% in 2009 from 18.3% in 2008. Other operating expenses are primarily comprised of contract services, professional fees, repairs and maintenance, rents and leases, utilities, insurance (including professional liability insurance) and nonincome taxes. The overall decline in other operating expenses, as a percentage of revenues, is comprised of relatively small reductions in several areas, including utilities, employee recruitment and travel and entertainment. Other operating expenses include $248 million and $144 million of indigent care costs in certain Texas markets during 2009 and 2008, respectively. Provisions for losses related to professional liability risks were $211 million and $175 million for 2009 and 2008, respectively.
Provision for doubtful accounts declined $133 million, from $3.409 billion in 2008 to $3.276 billion in 2009, and as a percentage of revenues, declined to 10.9% for 2009 from 12.0% in 2008. The provision for doubtful accounts and the allowance for doubtful accounts relate primarily to uninsured amounts due directly from patients. The decline in the provision for doubtful accounts can be attributed to the $1.486 billion increase in the combined self-pay revenue deductions for charity care and uninsured discounts during 2009, compared to 2008. The sum of the provision for doubtful accounts, uninsured discounts and charity care, as a percentage of the sum of net revenues, uninsured discounts and charity care, was 23.8% for 2009, compared to 21.9% for 2008. At December 31, 2009, our allowance for doubtful accounts represented approximately 94% of the $5.176 billion total patient due accounts receivable balance, including accounts, net of estimated contractual discounts, related to patients for which eligibility for Medicaid coverage or uninsured discounts was being evaluated.
Equity in earnings of affiliates increased from $223 million for 2008 to $246 million for 2009. Equity in earnings of affiliates relates primarily to our Denver, Colorado market joint venture.
Depreciation and amortization decreased, as a percentage of revenues, to 4.8% in 2009 from 5.0% in 2008. Depreciation expense was $1.419 billion for 2009 and $1.412 billion for 2008.
Interest expense declined to $1.987 billion for 2009 from $2.021 billion for 2008. The decline in interest expense was due to reductions in the average debt balance. Our average debt balance was $26.267 billion for 2009 compared to $27.211 billion for 2008. The average interest rate for our long-term debt increased from 7.4% for 2008 to 7.6% for 2009.
Net losses on sales of facilities were $15 million for 2009 and included $8 million of net losses on the sales of three hospital facilities and $7 million of net losses on sales of real estate and other health care entity investments. Gains on sales of facilities were $97 million for 2008 and included $81 million of gains on the sales of two hospital facilities and $16 million of net gains on sales of real estate and other health care entity investments.


69


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Results of Operations (Continued)

Years Ended December 31, 2009 and 2008 (Continued)
Impairments of long-lived assets were $43 million for 2009 and included $19 million related to goodwill and $24 million related to property and equipment. Impairments of long-lived assets were $64 million for 2008 and included $48 million related to goodwill and $16 million related to property and equipment.
The effective tax rate was 37.3% and 28.5% for 2009 and 2008, respectively. The effective tax rate computations exclude net income attributable to noncontrolling interests as it relates to consolidated partnerships. Primarily as a result of reaching a settlement with the IRS Appeals Division and the revision of the amount of a proposed IRS adjustment related to prior taxable periods, we reduced our provision for income taxes by $69 million in 2008. Excluding the effect of these adjustments, the effective tax rate for 2008 would have been 35.8%.
Net income attributable to noncontrolling interests increased from $229 million for 2008 to $321 million for 2009. The increase in net income attributable to noncontrolling interests related primarily to growth in operating results of hospital joint ventures in two Texas markets.
Liquidity and Capital Resources

Our primary cash requirements are paying our operating expenses, servicing our debt, capital expenditures on our existing properties, acquisitions of hospitals and other health care entities, repurchases of our common stock, distributions to stockholders and distributions to noncontrolling interests. Our primary cash sources are cash flows from operating activities, issuances of debt and equity securities and dispositions of hospitals and other health care entities.

Cash provided by operating activities totaled $3.933 billion in 2011 compared to $3.085 billion in 2010 compared toand $2.747 billion in 2009 and $1.990 billion in 2008.2009. Working capital totaled $1.679 billion at December 31, 2011 and $2.650 billion at December 31, 2010. The decline in working capital is primarily related to an increase in our long-term debt due within one year. The $848 million increase in cash provided by operating activities for 2011, compared to 2010, and $2.264 billion at December 31, 2009.was primarily related to $885 million improvement from lower income tax payments. The $338 million increase in cash provided by operating activities for 2010, compared to 2009, was primarily comprised of the net impact of the $198 million increase in net income, a $547 million improvement from lower income tax payments and a $384

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Liquidity and Capital Resources (Continued)

$384 million decline from changes in operating assets and liabilities and the provision for doubtful accounts. The $757 million increase in cash provided by operating activities for 2009, compared to 2008, related primarily to the $473 million increase in net income and $143 million improvement from changes in operating assets and liabilities and the provision for doubtful accounts. Cash payments for interest and income taxes declined $780 million for 2011 compared to 2010 and declined $387 million for 2010 compared to 2009 and increased $203 million for 2009 compared to 2008.

2009.

Cash used in investing activities was $2.995 billion, $1.039 billion and $1.035 billion in 2011, 2010 and $1.467 billion in 2010, 2009, and 2008, respectively. Excluding acquisitions, capital expenditures were $1.679 billion in 2011, $1.325 billion in 2010 and $1.317 billion in 2009 and $1.600 billion in 2008.2009. We expended $1.682 billion, $233 million $61 million and $85$61 million for acquisitions of hospitals and health care entities during 2011, 2010 and 2009, and 2008, respectively. Expenditures for acquisitions in 2011 included eight hospital facilities, seven of which were related to the acquisition of the remaining interests in our joint venture in the Denver market. Expenditures for acquisitions in 2010 included two hospital facilities and in 2009 and 2008 were generally comprised of outpatient and ancillary services entities. Planned capital expenditures are expected to approximate $1.6$1.9 billion in 2011.2012. At December 31, 2010,2011, there were projects under construction which had an estimated additional cost to complete and equip over the next five years of $1.7approximately $1.5 billion. We expect to finance capital expenditures with internally generated and borrowed funds.

During 2011, we received cash of $281 million from sales of one hospital, other health care entities and real estate investments. We also received net cash proceeds of $80 million related to net changes in our investments. During 2010, we received cash proceeds of $37 million from sales of other health care entities and real estate investments. We also received net cash proceeds of $472 million related to net changes in our investments. During 2009, we received cash proceeds of $41 million from dispositions of three hospitals and sales of other health care entities and real estate investments. We also received net cash proceeds of $303 million related to net changes in our investments. During 2008, we received cash proceeds of $143 million from dispositions of two hospitals and $50 million from sales of other health care entities and real estate investments.


70


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Liquidity and Capital Resources (Continued)
Cash used in financing activities totaled $976 million in 2011, $1.947 billion in 2010 and $1.865 billion in 20092009. During 2011, we received cash of $2.506 billion related to the issuance of common stock in conjunction with our initial public offering; we used cash of $1.503 billion for repurchases of common stock; and $451 million in 2008.we used cash proceeds from issuance of common stock and available cash provided by operations to make net debt repayments of $1.589 billion. During 2010, we paid $4.257 billion in distributions to our stockholders and received net proceeds of $2.533 billion from our debt issuance and debt repayment activities. During 2009, and 2008, we used cash proceeds from sales of facilities and available cash provided by operations to make net debt repayments of $1.459 billion. During 2011 and 2010, we paid $31 million and $4.257 billion, and $260 million, respectively.respectively, in distributions to our stockholders. During 2010, we received contributions from noncontrolling interests of $57 million. During 2011, 2010 2009 and 2008,2009, we made distributions to noncontrolling interests of $378 million, $342 million $330 million and $178$330 million, respectively. We paid debt issuance costs of $92 million, $50 million and $70 million for 2011, 2010 and 2009, respectively. During 2011 and 2010, we received income tax benefits of $63 million and $114 million, respectively, for certain items (primarily the cash distributions to holders of our stock options and exercises of stock options) that were deductible expenses for tax purposes, but were recognized as adjustments to stockholders’ deficit for financial reporting purposes. We or our affiliates, including affiliates of the Sponsors, may in the future repurchase portions of our debt or equity securities, subject to certain limitations, from time to time in either the open market or through privately negotiated transactions, in accordance with applicable SEC and other legal requirements. The timing, prices, and sizes of purchases depend upon prevailing trading prices, general economic and market conditions, and other factors, including applicable securities laws. Funds for the repurchase of debt or equity securities have, and are expected to, come primarily from cash generated from operations and borrowed funds.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Liquidity and Capital Resources (Continued)

In addition to cash flows from operations, available sources of capital include amounts available under our senior secured credit facilities ($1.3142.137 billion as of December 31, 20102011 and $1.523$2.070 billion as of January 31, 2011)2012) and anticipated access to public and private debt and equity markets.

During 2010, our Board of Directors declared three distributions to our stockholders and holders of stock options. The distributions totaled $42.50$9.43 per share and vested stock option, or $4.332 billion in the aggregate. The distributions were funded using funds available under our existing senior secured credit facilities, proceeds from the November 2010 issuance of $1.525 billion aggregate principal amount of 73/4% senior unsecured notes due 2021 and cash on hand.

On May 5, 2010,February 3, 2012, our Board of Directors granted approval fordeclared a distribution to the Company to file withCompany’s existing stockholders and holders of vested stock awards. The distribution declared was $2.00 per share and vested stock award, or approximately $975 million in the Securities and Exchange Commission (“SEC”) a registration statement onForm S-1 relating to a proposed initial public offering of its common stock. We filed theForm S-1 on May 7, 2010. In connection with the Corporate Reorganization, on December 15, 2010, HCA Holdings, Inc.’s Board of Directors granted approval for the Company to file with the SEC a registration statement onForm S-1 relating to a proposed initial public offering of its common stock. TheForm S-1 was filed on December 22, 2010, with HCA Inc. at the same time filing a request to withdraw its registration statement onForm S-1. We intend to use the anticipated net proceeds to repay certain of our existing indebtedness, as will be determined prior to our offering, and for general corporate purposes. Upon completion of the offering and in connection with our termination of the management agreement we have with affiliates of the Investors, we will be required to pay a termination fee based upon the net present value of our future obligations under the management agreement.

aggregate.

Investments of our professional liability insurance subsidiary,subsidiaries, to maintain statutory equity and pay claims, totaled $742$628 million and $1.316 billion$742 million at December 31, 2011 and 2010, and 2009, respectively. Investments were reduced during 2010 as a result of the insurance subsidiary distributing $500 million of excess capital to the Company. The insurance subsidiary maintained net reserves for professional liability risks of $452$410 million and $590$452 million at December 31, 20102011 and 2009,2010, respectively. Our facilities are insured by our wholly-owned insurance subsidiary for losses up to $50 million per occurrence; however, since January 2007, this coverage is subject to a $5 million per occurrence self-insured retention. Net reserves for the self-insured professional liability risks retained were $796$842 million and $679$796 million at December 31, 20102011 and 2009,2010, respectively. Claims payments, net of reinsurance recoveries, during the next 12 months are expected to approximate $265$285 million. We estimate that approximately


71


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Liquidity and Capital Resources (Continued)
$165 $205 million of the expected net claim payments during the next 12 months will relate to claims subject to the self-insured retention.

Financing Activities

Due to the Recapitalization, we

We are a highly leveraged company with significant debt service requirements. Our debt totaled $28.225$27.052 billion and $25.670$28.225 billion at December 31, 20102011 and 2009,2010, respectively. Our interest expense was $2.037 billion for 2011 and $2.097 billion for 2010 and $1.987 billion for 2009.

2010.

During March 2010, we issued $1.400 billion aggregate principal amount of 71/4% senior secured first lien notes due 2020 at a price of 99.095% of their face value, resulting in $1.387 billion of gross proceeds. After the payment of related fees and expenses, we used the proceeds to repay outstanding indebtedness under our senior secured term loan facilities. During November 2010, we issued $1.525 billion aggregate principal amount of 73/4% senior unsecured notes due 2021 at a price of 100% of their face value. After the payment of related fees and expenses, we used the proceeds to make a distribution to our stockholders and optionholders.

During February 2009,June 2011, we issued $310redeemed all $1.000 billion aggregate principal amount of our 9 1/8% senior secured notes due 2014, at a redemption price of 104.563% of the principal amount, and $108 million aggregate principal amount of our 97/8% senior secured second lien notes due 2017, at a redemption price of 96.673%109.875% of their face value, resulting in $300 million of gross proceeds. the principal amount.

During April 2009,August 2011, we issued $1.500$5.000 billion aggregate principal amount of 81/2% senior secured first lien notes, due 2019 at a pricecomprised of 96.755% of their face value, resulting in $1.451$3.000 billion of gross proceeds. During August 2009, we issued $1.250 billion aggregate principal amount of 77/8%6.50% senior secured first lien notes due 2020 at a price of 98.254% of their face value, resulting in $1.228and $2.000 billion of gross proceeds.7.50% senior unsecured notes due 2022. After the payment of related fees and expenses, we used the net proceeds from these debt issuances to repayredeem all of our outstanding indebtedness$1.578 billion 9 5/8%/10 3/8% second lien toggle notes due 2016, at a redemption price of 106.783% of the principal amount, and all of our outstanding $3.200 billion 9 1/4% second lien notes due 2016, at a redemption price of 106.513% of the principal amount.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Liquidity and Capital Resources (Continued)

Financing Activities (Continued)

On September 21, 2011, we repurchased 80,771,143 shares of our common stock beneficially owned by affiliates of Bank of America Corporation at a purchase price of $18.61 per share, the closing price of the Company’s common stock on the New York Stock Exchange on September 14, 2011. The repurchase was financed using a combination of cash on hand and borrowings under available credit facilities. The shares repurchased represented approximately 15.6% of our total shares outstanding.

During October 2011, we issued $500 million aggregate principal amount of 8.00% senior secured term loan facilities.

unsecured notes due 2018. After the payment of related fees and expenses, we used the net proceeds for general corporate purposes, which included funding a portion of the acquisition of the Colorado Health Foundation’s approximate 40% remaining ownership interest in the HCA-HealthONE LLC joint venture, which was purchased during October 2011 for $1.450 billion.

Management believes that cash flows from operations, amounts available under our senior secured credit facilities and our anticipated access to public and private debt markets will be sufficient to meet expected liquidity needs during the next twelve months.


72


HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Contractual Obligations and Off-Balance Sheet Arrangements

As of December 31, 2010,2011, maturities of contractual obligations and other commercial commitments are presented in the table below (dollars in millions):

                     
  Payments Due by Period 
Contractual Obligations(a)
 Total  Current  2-3 Years  4-5 Years  After 5 Years 
 
Long-term debt including interest, excluding the senior secured credit facilities(b) $29,803  $1,845  $4,824  $5,053  $18,081 
Loans outstanding under the senior secured credit facilities, including interest(b)  12,013   848   7,828   1,147   2,190 
Operating leases(c)  1,876   269   466   293   848 
Purchase and other obligations(c)  225   37   44   36   108 
                     
Total contractual obligations $43,917  $2,999  $13,162  $6,529  $21,227 
                     
                     
Other Commercial Commitments Not Recorded on the
 Commitment Expiration by Period 
Consolidated Balance Sheet
 Total  Current  2-3 Years  4-5 Years  After 5 Years 
 
Surety bonds(d) $59  $52  $6  $1  $ 
Letters of credit(e)  82   9   41   32    
Physician commitments(f)  33   26   7       
Guarantees(g)  2            2 
                     
Total commercial commitments $176  $87  $54  $33  $2 
                     

   Payments Due by Period 

Contractual Obligations(a)

  Total   Current   2-3 Years   4-5 Years   After 5 Years 

Long-term debt including interest, excluding the senior secured credit facilities(b)

  $28,545    $2,248    $4,089    $4,063    $18,145  

Loans outstanding under the senior secured credit facilities, including interest(b)

   11,560     860     2,931     3,384     4,385  

Operating leases(c)

   1,934     280     482     302     870  

Purchase and other obligations(c)

   27     19     8            
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total contractual obligations

  $42,066    $3,407    $7,510    $7,749    $23,400  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

   Commitment Expiration by Period 

Other Commercial Commitments Not Recorded on the
Consolidated Balance Sheet

  Total   Current   2-3 Years   4-5 Years   After 5 Years 

Surety bonds(d)

  $52    $51    $1    $    $  

Letters of credit(e)

   65     7     15     43       

Physician commitments(f)

   24     17     7            

Guarantees(g)

   2                    2  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total commercial commitments

  $143    $75    $23    $43    $2  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(a)

We have not included obligations to pay net estimated professional liability claims ($1.2481.252 billion at December 31, 2010,2011, including net reserves of $452$410 million relating to the wholly-owned insurance subsidiary) in this table. The estimated professional liability claims, which occurred prior to 2007, are expected to be funded by the designated investment securities that are restricted for this purpose ($742628 million at December 31, 2010)2011). We also have not included obligations related to unrecognized tax benefits of $413$494 million at December 31, 2010,2011, as we cannot reasonably estimate the timing or amounts of cash payments, if any, at this time.

(b)

Estimates of interest payments assume that interest rates, borrowing spreads and foreign currency exchange rates at December 31, 2010,2011, remain constant during the period presented.

(c)

Amounts relate to future operating lease obligations, purchase obligations and other obligations and are not recorded in our consolidated balance sheet. Amounts also include physician commitments that are recorded in our consolidated balance sheet.

(d)

Amounts relate primarily to instances in which we have agreed to indemnify various commercial insurers who have provided surety bonds to cover self-insured workers’ compensation claims, utility deposits and damages for malpractice cases which were awarded to plaintiffs by the courts. These cases are currently under appeal and the bonds will not be released by the courts until the cases are closed.

(e)

Amounts relate primarily to various insurance programs and employee benefit plan obligations for which we have letters of credit outstanding.

(f)

In consideration for physicians relocating to the communities in which our hospitals are located and agreeing to engage in private practice for the benefit of the respective communities, we make advances to physicians, normally over a period of one year, to assist in establishing the physicians’ practices. The actual amount of these commitments to be advanced often depends upon the financial results of the physicians’ private practices


73


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Contractual Obligations and Off-Balance Sheet Arrangements (Continued)
practice during the recruitment agreement payment period. The physician commitments reflected were based on our maximum exposure on effective agreements at December 31, 2010.2011.

(g)

We have entered into guarantee agreements related to certain leases.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Market Risk

We are exposed to market risk related to changes in market values of securities. The investments in debt and equity securities of our wholly-owned insurance subsidiarysubsidiaries were $734$621 million and $8$7 million, respectively, at December 31, 2010.2011. These investments are carried at fair value, with changes in unrealized gains and losses being recorded as adjustments to other comprehensive income. At December 31, 2010,2011, we had a net unrealized gain of $10$11 million on the insurance subsidiary’ssubsidiaries’ investment securities.

We are exposed to market risk related to market illiquidity. Liquidity of the investmentsInvestments in debt and equity securities of our wholly-owned insurance subsidiarysubsidiaries could be impaired by the inability to access the capital markets. Should the wholly-owned insurance subsidiarysubsidiaries require significant amounts of cash in excess of normal cash requirements to pay claims and other expenses on short notice, we may have difficulty selling these investments in a timely manner or be forced to sell them at a price less than what we might otherwise have been able to in a normal market environment. At December 31, 2010,2011, our wholly-owned insurance subsidiarysubsidiaries had invested $250$131 million ($251139 million par value) in tax-exempt student loan auction rate securities that continue to experience market illiquidity. It is uncertain if auction-related market liquidity will resume for these securities. We may be required to recognizeother-than-temporary impairments on these long-term investments in future periods should issuers default on interest payments or should the fair market valuations of the securities deteriorate due to ratings downgrades or other issue specific factors.

We are also exposed to market risk related to changes in interest rates, and we periodically enter into interest rate swap agreements to manage our exposure to these fluctuations. Our interest rate swap agreements involve the exchange of fixed and variable rate interest payments between two parties, based on common notional principal amounts and maturity dates. The notional amounts of the swap agreements represent balances used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions. The interest payments under these agreements are settled on a net basis. These derivatives have been recognized in the financial statements at their respective fair values. Changes in the fair value of these derivatives, which are designated as cash flow hedges, are included in other comprehensive income, and changes in the fair value of derivatives which have not been designated as hedges are recorded in operations.

With respect to our interest-bearing liabilities, approximately $3.037$5.082 billion of long-term debt at December 31, 20102011 was subject to variable rates of interest, while the remaining balance in long-term debt of $25.188$21.970 billion at December 31, 20102011 was subject to fixed rates of interest. Both the general level of interest rates and, for the senior secured credit facilities, our leverage affect our variable interest rates. Our variable debt is comprised primarily of amounts outstanding under the senior secured credit facilities. Borrowings under the senior secured credit facilities bear interest at a rate equal to an applicable margin plus, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% and (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period. The applicable margin for borrowings under the senior secured credit facilities may fluctuate according to a leverage ratio. The average effective interest rate for our long-term debt increaseddeclined from 7.6% for 2009 to 7.8% for 2010.

On March 2, 2009, we amended our $13.550 billion and €1.000 billion senior secured cash flow credit facility, dated as of November 17, 2006, as amended February 16, 2007 (“the cash flow credit facility”),2010 to allow7.7% for one or more future issuances of additional secured notes, which may include notes that are secured on apari passubasis or


74

2011.


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Market Risk (Continued)
on a junior basis with the obligations under the cash flow credit facility, so long as (1) such notes do not require, subject to certain exceptions, scheduled repayments, payment of principal or redemption prior to the scheduled term loan B-1 maturity date, (2) the terms of such notes, taken as a whole, are not more restrictive than those in the cash flow credit facility and (3) no subsidiary of HCA Inc. that is not a U.S. guarantor is an obligor of such additional secured notes, and such notes are not secured by any European collateral securing the cash flow credit facility. The U.S. security documents related to the cash flow credit facility were also amended and restated in connection with the amendment in order to give effect to the security interests to be granted to holders of such additional secured notes.
On March 2, 2009, we amended our $2.000 billion senior secured asset-based revolving credit facility, dated as of November 17, 2006, as amended and restated as of June 20, 2007 (the “ABL credit facility”), to allow for one or more future issuances of additional secured notes or loans, which may include notes or loans that are secured on apari passubasis or on a junior basis with the obligations under the cash flow credit facility, so long as (1) such notes or loans do not require, subject to certain exceptions, scheduled repayments, payment of principal or redemption prior to the scheduled term loan B-1 maturity date, (2) the terms of such notes or loans, as applicable, taken as a whole, are not more restrictive than those in the cash flow credit facility and (3) no subsidiary of HCA Inc. that is not a U.S. guarantor is an obligor of such additional secured notes. The amendment to the ABL credit facility also altered the excess facility availability requirement to include a separate minimum facility availability requirement applicable to the ABL credit facility and increased the applicable LIBOR and ABR margins for all borrowings under the ABL credit facility by 0.25% each.
On June 18, 2009, the cash flow credit facility was amended to permit the unlimited incurrence of new term loans to refinance the term loans initially incurred as well as any previously incurred refinancing term loans and to permit the establishment of commitments under a replacement cash flow revolver under the cash flow credit facility to replace all or a portion of the revolving commitments initially established under the cash flow credit facility as well as any previously issued replacement revolvers. On April 6, 2010 the cash flow credit facility was further amended to (i) extend the maturity date for $2.0 billion of the tranche B term loans from November 17, 2013 to March 31, 2017 and (ii) increase the ABR margin and LIBOR margin with respect to such extended term loans to 2.25% and 3.25%, respectively.
On November 8, 2010, an amended and restated joinder agreement was entered into with respect to the cash flow credit facility to establish a new replacement revolving credit series, which will mature on November 17, 2015. The replacement

On May 4, 2011, we completed amendments to our senior secured credit agreement and senior secured asset-based revolving credit commitments will become effective upon the earlier of (i) our receipt of all or a portion of the proceeds (including by way of contribution) from an initial public offering of the common stock of HCA Inc. or its direct or indirect parent company (the “IPO Proceeds Condition”) and (ii) May 17, 2012, subject to the satisfactionagreement, as well as extensions of certain other conditions. If the IPO Proceeds Condition has not been satisfied, onof our term loans. The amendments extend $594 million of our term loan A facility with a final maturity of November 2012 to a final maturity of May 17,2016 and $2.373 billion of our term loan A and term loan B-1 facilities with final maturities of November 2012 or, if the IPO Proceeds Condition has been satisfied priorand November 2013, respectively, to a final maturity of May 17, 2012,2018.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Market Risk (Continued)

On September 30, 2011, we refinanced our $2.000 billion asset-based revolving credit facility maturing on November 17,16, 2012 to increase the applicable ABRtotal capacity to $2.500 billion and LIBOR margins with respectextend the maturity to the replacement revolving loans will be increased from the applicable ABR and LIBOR margins of the existing revolving loans based upon the achievement of a certain leverage ratio, which level will decrease from the levels of the existing revolving loans.

2016.

The estimated fair value of our total long-term debt was $28.738$27.199 billion at December 31, 2010.2011. The estimates of fair value are based upon the quoted market prices for the same or similar issues of long-term debt with the same maturities. Based on a hypothetical 1% increase in interest rates, the potential annualized reduction to future pretax earnings would be approximately $30$51 million. To mitigate the impact of fluctuations in interest rates, we generally target a portion of our debt portfolio to be maintained at fixed rates.

Our international operations and the European term loan expose us to market risks associated with foreign currencies. In order to mitigate the currency exposure related to debt service obligations through December 31,


75


HCA HOLDINGS, INC.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS — (Continued)
Market Risk (Continued)
2011 under the European term loan, we have entered into cross currency swap agreements. A cross currency swap is an agreement between two parties to exchange a stream of principal and interest payments in one currency for a stream of principal and interest payments in another currency over a specified period.

Financial Instruments

Derivative financial instruments are employed to manage risks, including foreign currency and interest rate exposures, and are not used for trading or speculative purposes. We recognize derivative instruments, such as interest rate swap agreements and foreign exchange contracts, in the consolidated balance sheets at fair value. Changes in the fair value of derivatives are recognized periodically either in earnings or in stockholders’ equity, as a component of other comprehensive income, depending on whether the derivative financial instrument qualifies for hedge accounting, and if so, whether it qualifies as a fair value hedge or a cash flow hedge. Gains and losses on derivatives designated as cash flow hedges, to the extent they are effective, are recorded in other comprehensive income, and subsequently reclassified to earnings to offset the impact of the hedged items when they occur. Changes in the fair value of derivatives not qualifying as hedges, and for any portion of a hedge that is ineffective, are reported in earnings.

The net interest paid or received on interest rate swaps is recognized as interest expense. Gains and losses resulting from the early termination of interest rate swap agreements are deferred and amortized as adjustments to expense over the remaining period of the debt originally covered by the terminated swap.

Effects of Inflation and Changing Prices

Various federal, state and local laws have been enacted that, in certain cases, limit our ability to increase prices. Revenues for general, acute care hospital services rendered to Medicare patients are established under the federal government’s prospective payment system. Totalfee-for-service Medicare revenues approximated 23.5% in 2010, 22.8% in 2009were 25.8%, 25.7% and 23.1% in 200825.6% of our revenues.

revenues for 2011, 2010 an 2009, respectively.

Management believes hospital industry operating margins have been, and may continue to be, under significant pressure because of changes in payer and service mix and growth in operating expenses in excess of the increase in prospective payments under the Medicare program. In addition, as a result of increasing regulatory and competitive pressures, our ability to maintain operating margins through price increases to non-Medicare patients is limited.

HCA HOLDINGS, INC.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS — (Continued)

Effects of Inflation and Changing Prices (Continued)

IRS Disputes

At December 31, 2010, we were

We are contesting, before the IRS Appeals Division, certain claimed deficiencies and adjustments proposed by the IRS Examination Division in connection with its audit of HCA Inc.’s 2005 and 2006 federal income tax returns. The disputed items include the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts. In addition, eight taxable periods of HCA Inc. and its predecessors ended in 1997 through 2004, for which the primary remaining issue is the computation of the tax allowance for doubtful accounts, were pending before the IRS Examination Division as of December 31, 2010. The IRS Examination Division began an audit of HCA Inc.’s 2007, 2008 and 2009 federal income tax returns in December 2010.

Management believes HCA Holdings, Inc., its predecessors and affiliates properly reported taxable income and paid taxes in accordance with applicable laws and agreements established with the IRS and final resolution of these disputes will not have a material, adverse effect on our results of operations or financial position. However, if payments due upon final resolution of these issues exceed our recorded estimates, such resolutions could have a material, adverse effect on our results of operations or financial position.


76


Item 7A.    Quantitative and Qualitative Disclosures about Market Risk

Item 7A.Quantitative and Qualitative Disclosures about Market Risk
Information with respect to this Item is provided under the caption “Market Risk” under Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Item 8.Financial Statements and Supplementary Data

Item 8.    Financial Statements and Supplementary Data

Information with respect to this Item is contained in our consolidated financial statements indicated in the Index to Consolidated Financial Statements onPage F-1 of this annual report onForm 10-K.

Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.Controls and Procedures
1.  Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Item 9A.    Controls and Procedures

1. Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined underRule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this annual report.

2.  Internal Control Over Financial Reporting

2. Internal Control Over Financial Reporting

(a) Management’s Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining effective internal control over financial reporting, as such term is defined in Exchange ActRule 13a-15(f). Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective, can provide only reasonable assurance with respect to financial statement preparation and presentation.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an assessment of the effectiveness of our internal control over financial reporting based on the framework in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment under the framework in Internal Control — Integrated Framework, our management concluded that our internal control over financial reporting was effective as of December 31, 2010.

2011.

Ernst & Young, LLP, the independent registered public accounting firm that audited our consolidated financial statements included in thisForm 10-K, has issued a report on our internal control over financial reporting, which is included herein.

(b) Attestation Report of the Independent Registered Public Accounting Firm


77


Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

HCA Holdings, Inc.

We have audited HCA Holdings, Inc.’s internal control over financial reporting as of December 31, 2010,2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). HCA Holdings, Inc.’s management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, HCA Holdings, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2010,2011, based on the COSO criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of HCA Holdings, Inc. as of December 31, 20102011 and 2009,2010, and the related consolidated statements of income, stockholders’ deficit, and cash flows for each of the three years in the period ended December 31, 20102011 and our report dated February 17, 201123, 2012 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP

Nashville, Tennessee

February 17, 2011


7823, 2012


(c)    Changes in Internal Control Over Financial Reporting

During the fourth quarter of 2010,2011, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Item 9B.

Other Information
Action on Written Consent of Controlling StockholderItem 9B. Other Information

On February 16, 2011, Hercules Holding II, LLC,22, 2012, the holder of 91,845,692 shares, or approximately 96.8%, of the issued and outstanding shares of capital stock of the Company, executed a written consent approving: (1) the removal and re-election of thirteen directors to serve as members of the Company’s Board of Directors, to hold office until their successors are duly elected and qualified or until the earlier of their death, resignation or removal, (2) the Company’s Amended and Restated Certificate of Incorporation, (3) an increase in the number of authorized shares of the Company’s common stock from One Hundred Twenty-Five Million (125,000,000) to One Billion Eight Hundred Million (1,800,000,000), as reflected in the Company’s Amended and Restated Certificate of Incorporation, (4) the amendment and restatement of the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (the “2006 Stock Incentive Plan”) and (5) HCA Inc.’s Amended and Restated Certificate of Incorporation. Pursuant to SEC rules, the foregoing consent will become effective on or about March 9, 2011. The written consent contemplates that the Amended and Restated Certificate of Incorporation and the 2006 Stock Incentive Plan will be effective immediately prior to and subject to the effectiveness of the registration statement relating to the anticipated initial public offering of the Company’s common stock. A notice of the foregoing stockholder action has been sent to the holders of record of the Company’s issued and outstanding capital stock as of the close of business on the record date, February 7, 2011.

Amendment to Employment Agreements
Effective as of February 9, 2011, the Company entered into amendments to employment agreements with Richard M. Bracken, R. Milton Johnson, Samuel N. Hazen and Beverly B. Wallace reflecting the new titles and responsibilities resulting from the Company’s internal reorganization. In addition, Mr. Johnson’s amendment reflects that he shall serve as a memberCompensation Committee of the Board of Directors approved a one-time cash payment of approximately $1.3 million to Beverly B. Wallace, formerly President–Parallon Business Solutions, to be paid upon her retirement from the Company, for so longeffective February 29, 2012. This payment will be in addition to any other payments made to Ms. Wallace in connection with her retirement as he is an officer of the Company.
The foregoing description does not purport to be completeset forth in her employment agreement and is qualified in its entirety by reference to the amendments to the employment agreements, copies of which are filed asExhibits 10.29(h)-(k) and are incorporated herein by reference.
Amendment to the Stock Option Agreements under the 2006 Plan
On February 16, 2011, the Company entered into an Omnibus Amendment to Stock Option Agreements Issued Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended and restated (the “Option Amendment”).
The Amendment modifies the definition of the term “Investor Return” as contained in each option agreement. Specifically, the Option Amendment would allow the consideration of the Fair Market Value of the HCA stock held directly or indirectly by the Investors to be deemed “cash proceeds” under the Investor Return Options with respect to1/3 upon each of the closing of the Company’s initial public offering, December 31, 2011, and December 31, 2012. In addition, the Amendment further clarifies how the term “Fair Market Value” will be determined for the purposes of the definition of “Investor Return,”other benefit plans in which for these purposes will refer to the average closing trading price over the thirty days preceding each relevant year end testing date.
The foregoing description does not purport to be complete and is qualified in its entirety by reference to the Option Amendment, a copy of which is filed as Exhibit 10.38 hereto and is incorporated herein by reference.


79

she participates.


PART III

Item 10.

Item 10.Directors, Executive Officers and Corporate Governance
    Directors, Executive Officers and Corporate Governance

The information required by this Item regarding the identity and business experience of our directors and executive officers is set forth under the heading “Action 1 — Election“Election of Directors” in the definitive information statementproxy materials of HCA to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meetingStockholders with respect to our directors and is set forth in Item 1 of Part I of this annual report onForm 10-K with respect to our executive officers. The information required by this Item contained in thesuch definitive information statementproxy materials is incorporated herein by reference.

Information on the beneficial ownership reporting for our directors and executive officers required by this Item is contained under the caption “Section 16(a) Beneficial Ownership Reporting Compliance” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meetingStockholders and is incorporated herein by reference.

Information on our Audit and Compliance Committee and Audit Committee Financial Experts required by this Item is contained under the caption “Corporate Governance” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meetingStockholders and is incorporated herein by reference.

We have a Code of Conduct which is applicable to all our directors, officers and employees (the “Code of Conduct”). The Code of Conduct is available on the Ethics and Compliance and Corporate Governance pages of our website at www.hcahealthcare.com. To the extent required pursuant to applicable SEC regulations, we intend to post amendments to or waivers from our Code of Conduct (to the extent applicable to our chief executive officer, principal financial officer or principal accounting officer) at this location on our website or report the same on a Current Report onForm 8-K. Our Code of Conduct is available free of charge upon request to our Corporate Secretary, HCA Holdings, Inc., One Park Plaza, Nashville, TN 37203.

Item 11.Executive Compensation

Item 11.    Executive Compensation

The information required by this Item is set forth under the headings “Executive Compensation” and “Compensation Committee Interlocks and Insider Participation” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meeting,Stockholders, which information is incorporated herein by reference.

Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information about security ownership of certain beneficial owners required by this Item is set forth under the heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meeting,Stockholders, which information is incorporated herein by reference.

Information about

This table provides certain information as of December 31, 2011 with respect to our equity compensation plans required by this Item is set forth under the heading “Action 4 — Approval of 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated” in the definitive information statement to be filed in connection with our written consent of stockholders in lieu of an annual meeting, which information is incorporated herein by reference.

plans:

EQUITY COMPENSATION PLAN INFORMATION

   (a)   (b)   (c) 
   Number of securities
to be issued
upon exercise of
outstanding options,
warrants and rights
   Weighted-average
exercise price of
outstanding
options,
warrants  and rights
   Number of securities  remaining
available for future issuance
under equity compensation
plans (excluding securities
reflected in column(a) )
 

Equity compensation plans approved by security holders

   46,311,800    $9.26     42,099,900  

Equity compensation plans not approved by security holders

               
  

 

 

   

 

 

   

 

 

 

Total

   46,311,800    $9.26     42,099,900  
  

 

 

   

 

 

   

 

 

 

*
Item 13.Certain Relationships and Related Transactions, and Director Independence

For additional information concerning our equity compensation plans, see the discussion in Note 2 — Share-Based Compensation in the notes to the consolidated financial statements.

Item 13.    Certain Relationships and Related Transactions, and Director Independence

The information required by this Item is set forth under the headings “Certain Relationships and Related Party Transactions” and “Corporate Governance” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meeting,Stockholders, which information is incorporated herein by reference.


80


Item 14.    Principal Accountant Fees and Services

Item 14.Principal Accountant Fees and Services
The information required by this Item is set forth under the heading “Principal Accountant Fees and Services” in the definitive information statementproxy materials to be filed in connection with our written consent2012 Annual Meeting of stockholders in lieu of an annual meeting,Stockholders, which information is incorporated herein by reference.

PART IV

Item 15.

 Exhibits and Financial Statement Schedules

Item 15.

Exhibits and Financial Statement Schedules
(a) Documents filed as part of the report:

1. Financial Statements.The accompanying Index to Consolidated Financial Statements onpage F-1 of this annual report onForm 10-K is provided in response to this item.

2. List of Financial Statement Schedules.All schedules are omitted because the required information is either not present, not present in material amounts or presented within the consolidated financial statements.

3. List of Exhibits

       
 2.1  Agreement and Plan of Merger, dated July 24, 2006, by and among HCA Inc., Hercules Holding II, LLC and Hercules Acquisition Corporation (filed as Exhibit 2.1 to the Company’s Current Report onForm 8-K filed July 25, 2006, and incorporated herein by reference).
 2.2  Merger Agreement, dated November 22, 2010, by and among HCA Inc., HCA Holdings, Inc., and HCA Merger Sub LLC (filed as Exhibit 2.1 to the Company’s Current Report onForm 8-K filed November 24, 2010, and incorporated herein by reference).
 3.1  Amended and Restated Certificate of Incorporation of the Company (filed as Exhibit 3.1 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).
 3.2  Amended and Restated Bylaws of the Company (filed as Exhibit 3.2 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).
 4.1  Specimen Certificate for shares of Common Stock, par value $0.01 per share, of the Company. (filed as Exhibit 3 to the Company’s Form 8-A/A Amendment No. 2, filed March 11, 2004 (file no. 001-11239), and incorporated herein by reference).
 4.2  Indenture, dated November 17, 2006, among HCA Inc., the guarantors party thereto and The Bank of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.3  Security Agreement, dated as of November 17, 2006, among HCA Inc., the subsidiary grantors party thereto and The Bank of New York, as collateral agent (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.4  Pledge Agreement, dated as of November 17, 2006, among HCA Inc., the subsidiary pledgors party thereto and The Bank of New York, as collateral agent (filed as Exhibit 4.3 to the Company’s Current Report ofForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.5(a)  Form of 91/8% Senior Secured Notes due 2014 (included in Exhibit 4.2).
 4.5(b)  Form of 91/4% Senior Secured Notes due 2016 (included in Exhibit 4.2).
 4.5(c)  Form of 95/8%/103/8% Senior Secured Toggle Notes due 2016 (included in Exhibit 4.2).
 4.6  Indenture, dated February 19, 2009, among HCA Inc, the guarantors party thereto, The Bank of New York Mellon, as collateral agent and The Bank of New York Mellon Trust Company, N.A., as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed February 25, 2009, and incorporated herein by reference).
 4.7  Form of 97/8% Senior Secured Notes due 2017 (included in Exhibit 4.6).


81


       
 4.8(a)  $13,550,000,000 — €1,000,000,000 Credit Agreement, dated as of November 17, 2006, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Banc of America Securities LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A. and Citicorp North America, Inc., as co-syndication agents and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.8 to the Company’s Current Report onForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.8(b)  Amendment No. 1 to the Credit Agreement, dated as of February 16, 2007, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.7(b) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).
 4.8(c)  Amendment No. 2 to the Credit Agreement, dated as of March 2, 2009, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as exhibit 4.8(c) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).
 4.8(d)  Amendment No. 3 to the Credit Agreement, dated as of June 18, 2009, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed June 22, 2009, and incorporated herein by reference).
 4.8(e)  Extension Amendment No. 1 to the Credit Agreement, dated as of April 6, 2010, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent and collateral agent (filed as Exhibit 10.1 to the Company’s Current Report onForm 8-K filed April 8, 2010, and incorporated herein by reference).
 4.8(f)  Amended and Restated Joinder Agreement No. 1, dated as of November 8, 2010, by and among each of the financial institutions listed as a “Replacement-1 Revolving Credit Lender” on Schedule A thereto, HCA Inc., Bank of America, N.A., as Administrative Agent and as Collateral Agent, and the other parties listed on the signature pages thereto (filed as Exhibit 4.1 to the Company’s Quarterly Report onForm 10-Q filed November 9, 2010, and incorporated herein by reference).
 4.9  U.S. Guarantee, dated November 17, 2006, among HCA Inc., the subsidiary guarantors party thereto and Bank of America, N.A., as administrative agent (filed as Exhibit 4.9 to the Company’s Current Report onForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.10  Indenture, dated as of April 22, 2009, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed April 28, 2009, and incorporated herein by reference).
 4.11  Security Agreement, dated as November 17, 2006, and amended and restated as of March 2, 2009, among the Company, the Subsidiary Grantors named therein and Bank of America, N.A., as Collateral Agent (filed as exhibit 4.10 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).

82


       
 4.12  Pledge Agreement, dated as of November 17, 2006, and amended and restated as of March 2, 2009, among the Company, the Subsidiary Pledgors named therein and Bank of America, N.A., as Collateral Agent (filed as exhibit 4.11 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).
 4.13  Form of 81/2% Senior Secured Notes due 2019 (included in Exhibit 4.10).
 4.14  Indenture, dated as of August 11, 2009, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed August 17, 2009, and incorporated herein by reference).
 4.15  Form of 77/8% Senior Secured Notes due 2020 (included in Exhibit 4.14).
 4.16  Indenture, dated as of March 10, 2010, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed March 12, 2010, and incorporated herein by reference).
 4.17  Form of 71/4% Senior Secured Notes due 2020 (included in Exhibit 4.16).
 4.18(a)  $2,000,000,000 Amended and Restated Credit Agreement, dated as of June 20, 2007, among HCA Inc., the subsidiary borrowers parties thereto, the lending institutions from time to time parties thereto, Banc of America Securities LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A. and Citicorp North America, Inc., as co-syndication agents, and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed June 26, 2007, and incorporated herein by reference).
 4.18(b)  Amendment No. 1 to the $2,000,000,000 Amended and Restated Credit Agreement, dated as of March 2, 2009, among HCA Inc., the subsidiary borrowers parties thereto, the lending institutions from time to time parties thereto, Banc of America Securities LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A. and Citicorp North America, Inc., as co-syndication agents, and Merrill Lynch Capital Corporation, as documentation agent (filed as exhibit 4.12(b) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).
 4.19  Security Agreement, dated as of November 17, 2006, among HCA Inc., the subsidiary borrowers party thereto and Bank of America, N.A., as collateral agent (filed as Exhibit 4.13 to the Company’s Current Report onForm 8-K filed November 24, 2006, and incorporated herein by reference).
 4.20(a)  General Intercreditor Agreement, dated as of November 17, 2006, between Bank of America, N.A., as First Lien Collateral Agent, and The Bank of New York, as Junior Lien Collateral Agent (filed as Exhibit 4.13(a) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.20(b)  Additional General Intercreditor Agreement, dated as of April 22, 2009, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as 2006 Second Lien Trustee and The Bank of New York Mellon Trust Company, N.A., in its capacity as 2009 Second Lien Trustee (filed as Exhibit 4.6 to the Company’s Current Report onForm 8-K filed April 28, 2009, and incorporated herein by reference).
 4.20(c)  Additional General Intercreditor Agreement, dated as of August 11, 2009, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as trustee for the Second Lien Notes issued on November 17, 2006, and The Bank of New York Mellon Trust Company, N.A., in its capacity as trustee for the Second Lien Notes issued on February 19, 2009 (filed as Exhibit 4.6 to the Company’s Current Report onForm 8-K filed August 17, 2009, and incorporated herein by reference).
 4.20(d)  Receivables Intercreditor Agreement, dated as of November 17, 2006, among Bank of America, N.A., as ABL Collateral Agent, Bank of America, N.A., as CF Collateral Agent and The Bank of New York, as Bonds Collateral Agent (filed as Exhibit 4.13(b) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).

83


       
 4.20(e)  Additional Receivables Intercreditor Agreement, dated as of April 22, 2009, by and between Bank of America, N.A. as ABL Collateral Agent, and Bank of America, N.A. as New First Lien Collateral Agent (filed as Exhibit 4.7 to the Company’s Current Report onForm 8-K filed April 28, 2009, and incorporated herein by reference).
 4.20(f)  Additional Receivables Intercreditor Agreement, dated as of August 11, 2009, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as New First Lien Collateral Agent (filed as Exhibit 4.7 to the Company’s Current Report onForm 8-K filed August 17, 2009, and incorporated herein by reference).
 4.20(g)  First Lien Intercreditor Agreement, dated as of April 22, 2009, among Bank of America, N.A. as Collateral Agent, Bank of America, N.A. as Authorized Representative under the Credit Agreement and Law Debenture Trust Company of New York as the Initial Additional Authorized Representative (filed as Exhibit 4.5 to the Company’s Current Report onForm 8-K filed April 28, 2009, and incorporated herein by reference).
 4.21  Registration Rights Agreement, dated as of November 22, 2010, among HCA Holdings, Inc., Hercules Holding II, LLC and certain other parties thereto (filed as Exhibit 4.4 to the Company’s Current Report onForm 8-K filed November 24, 2010, and incorporated herein by reference).
 4.22  Registration Rights Agreement, dated as of March 16, 1989, by and among HCA-Hospital Corporation of America and the persons listed on the signature pages thereto (filed as Exhibit 4.14 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.23  Assignment and Assumption Agreement, dated as of February 10, 1994, between HCA-Hospital Corporation of America and the Company relating to the Registration Rights Agreement, as amended (filed as Exhibit 4.15 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.24(a)  Indenture, dated as of December 16, 1993 between the Company and The First National Bank of Chicago, as Trustee (filed as Exhibit 4.16(a) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.24(b)  First Supplemental Indenture, dated as of May 25, 2000 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.16(b) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.24(c)  Second Supplemental Indenture, dated as of July 1, 2001 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.16(c) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.24(d)  Third Supplemental Indenture, dated as of December 5, 2001 between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.16(d) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.24(e)  Fourth Supplemental Indenture, dated as of November 14, 2006, between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed November 16, 2006, and incorporated herein by reference).
 4.25  Form of 7.5% Debentures due 2023 (filed as Exhibit 4.17 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.26  Form of 8.36% Debenture due 2024 (filed as Exhibit 4.18 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.27  Form of Fixed Rate Global Medium-Term Note (filed as Exhibit 4.19 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.28  Form of Floating Rate Global Medium-Term Note (filed as Exhibit 4.20 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.29  Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2004 (FileNo. 001-11239), and incorporated herein by reference).
 4.30  Form of 7.19% Debenture due 2015 (filed as Exhibit 4.22 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.31  Form of 7.50% Debenture due 2095 (filed as Exhibit 4.23 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).

84


       
 4.32  Form of 7.05% Debenture due 2027 (filed as Exhibit 4.24 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.33(a)  77/8% Note in the principal amount of $100,000,000 due 2011 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed January 31, 2001 (FileNo. 001-11239), and incorporated herein by reference).
 4.33(b)  77/8% Note in the principal amount of $400,000,000 due 2011 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K filed January 31, 2001 (FileNo. 001-11239), and incorporated herein by reference).
 4.34(a)  6.95% Note due 2012 in the principal amount of $400,000,000 (filed as Exhibit 4.29(a) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.34(b)  6.95% Note due 2012 in the principal amount of $100,000,000 (filed as Exhibit 4.29(b) to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054), and incorporated herein by reference).
 4.35(a)  6.30% Note due 2012 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K dated September 18, 2002 (FileNo. 001-11239), and incorporated herein by reference).
 4.35(b)  6.30% Note due 2012 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K dated September 18, 2002 (FileNo. 001-11239), and incorporated herein by reference).
 4.36(a)  6.25% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K dated February 5, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 4.36(b)  63/4% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K dated February 5, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 4.37(a)  63/4% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K dated July 23, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 4.37(b)  63/4% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K dated July 23, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 4.38  7.50% Note due 2033 in the principal amount of $250,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K dated November 6, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 4.39  5.75% Note due 2014 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K dated March 8, 2004 (FileNo. 001-11239), and incorporated herein by reference).
 4.40(a)  6.375% Note due 2015 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K dated November 16, 2004 (FileNo. 001-11239), and incorporated herein by reference).
 4.40(b)  6.375% Note due 2015 in the principal amount of $250,000,000 (filed as Exhibit 4.3 to the Company’s Current Report onForm 8-K dated November 16, 2004 (FileNo. 001-11239), and incorporated herein by reference).
 4.41(a)  6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed on February 8, 2006, and incorporated herein by reference).
 4.41(b)  6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report onForm 8-K filed on February 8, 2006, and incorporated herein by reference).
 4.42  Indenture, dated as of November 23, 2010, among HCA Holdings, Inc., Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report onForm 8-K filed November 24, 2010, and incorporated herein by reference).

85


       
 4.43  Form of 73/4% Senior Notes due 2021 (included in Exhibit 4.43).
 10.1(a)  Amended and Restated Columbia/HCA Healthcare Corporation 1992 Stock and Incentive Plan (filed as Exhibit 10.7(b) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 1998 (FileNo. 001-11239), and incorporated herein by reference).*
 10.1(b)  First Amendment to Amended and Restated Columbia/HCA Healthcare Corporation 1992 Stock and Incentive Plan (filed as Exhibit 10.2 to the Company’s Quarterly Report onForm 10-Q for the quarter ended September 30, 1999 (FileNo. 001-11239), and incorporated herein by reference).*
 10.2  HCA-Hospital Corporation of America Nonqualified Initial Option Plan (filed as Exhibit 4.6 to the Company’s Registration Statement onForm S-3 (FileNo. 33-52379), and incorporated herein by reference).*
 10.3  Form of Indemnity Agreement with certain officers and directors (filed as Exhibit 10.3 to the Company’s Registration Statement onForm S-4 (FileNo. 333-145054) and incorporated herein by reference).
 10.4  Form of Galen Health Care, Inc. 1993 Adjustment Plan (filed as Exhibit 4.15 to the Company’s Registration Statement onForm S-8 (FileNo. 33-50147) and incorporated herein by reference).
 10.5  Form of HCA-Hospital Corporation of America 1992 Stock Compensation Plan (filed as Exhibit 4.2 to the Company’s Registration Statement onForm S-8 (FileNo. 33-52253), and incorporated herein by reference).*
 10.6  Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan (filed as Exhibit A to the Company’s Proxy Statement for the Annual Meeting of Stockholders on May 25, 2000, and incorporated herein by reference).*
 10.7  Form of Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report onForm 8-K dated February 2, 2005 (FileNo. 001-11239), and incorporated herein by reference).*
 10.8 ��HCA 2005 Equity Incentive Plan (filed as Exhibit B to the Company’s Proxy Statement for the Annual Meeting of Shareholders on May 26, 2005, and incorporated herein by reference).*
 10.9  Form of 2005 Non-Qualified Stock Option Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report onForm 8-K dated October 6, 2005, and incorporated herein by reference).*
 10.10  Form of 2006 Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report onForm 8-K dated February 1, 2006, and incorporated herein by reference).*
 10.11  2006 Stock Incentive Plan for Key Employees of HCA Inc. and its Affiliates (filed as Exhibit 10.11 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.12  Management Stockholder’s Agreement dated November 17, 2006 (filed as Exhibit 10.12 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).
 10.13  Sale Participation Agreement dated November 17, 2006 (filed as Exhibit 10.13 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).
 10.14  Form of Option Rollover Agreement (filed as Exhibit 10.14 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.15  Form of Stock Option Agreement (2007) (filed as Exhibit 10.15 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.16  Form of Stock Option Agreement (2008) (filed as Exhibit 10.16 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*
 10.17  Form of Stock Option Agreement (2009) (filed as Exhibit 10.17 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*
 10.18  Form of Stock Option Agreement (2010) (filed as Exhibit 10.20 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2009, and incorporated herein by reference).*

86


       
 10.19  Form of 2x Time Stock Option Agreement (filed as Exhibit 10.2 to the Company’s Quarterly Report onForm 10-Q for the quarterly period ended September 30, 2009, and incorporated herein by reference).
 10.20  Exchange and Purchase Agreement (filed as Exhibit 10.16 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).
 10.21  Civil and Administrative Settlement Agreement, dated December 14, 2000 between the Company, the United States Department of Justice and others (filed as Exhibit 99.2 to the Company’s Current Report onForm 8-K dated December 20, 2000 (FileNo. 001-11239), and incorporated herein by reference).
 10.22  Plea Agreement, dated December 14, 2000 between the Company, Columbia Homecare Group, Inc., Columbia Management Companies, Inc. and the United States Department of Justice (filed as Exhibit 99.3 to the Company’s Current Report onForm 8-K dated December 20, 2000 (FileNo. 001-11239), and incorporated herein by reference).
 10.23  Corporate Integrity Agreement, dated December 14, 2000 between the Company and the Office of Inspector General of the United States Department of Health and Human Services (filed as Exhibit 99.4 to the Company’s Current Report onForm 8-K dated December 20, 2000 (FileNo. 001-11239), and incorporated herein by reference).
 10.24  Management Agreement, dated November 17, 2006, among HCA Inc., Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co. L.P., Dr. Thomas F. Frist, Jr., Patricia F. Elcan, William R. Frist and Thomas F. Frist III, and Merrill Lynch Global Partners, Inc. (filed as Exhibit 10.20 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).
 10.25  Retirement Agreement between the Company and Thomas F. Frist, Jr., M.D. dated as of January 1, 2002 (filed as Exhibit 10.30 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2001 (FileNo. 001-11239), and incorporated herein by reference).*
 10.26  Amended and Restated HCA Supplemental Executive Retirement Plan, effective December 22, 2010, except as provided therein.*
 10.27  Amended and Restated HCA Restoration Plan, effective December 22, 2010.*
 10.28(a)  HCA Inc.2008-2009 Senior Officer Performance Excellence Program (filed as Exhibit 10.27 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*
 10.28(b)  HCA Inc. Amendment No. 1 to the2008-2009 Senior Officer Performance Excellence Program (filed as Exhibit 10.28(b) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*
 10.29(a)  Employment Agreement dated November 16, 2006 (Richard M. Bracken) (filed as Exhibit 10.27(b) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.29(b)  Employment Agreement dated November 16, 2006 (R. Milton Johnson) (filed as Exhibit 10.27(c) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.29(c)  Employment Agreement dated November 16, 2006 (Samuel N. Hazen) (filed as Exhibit 10.27(d) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.29(d)  Employment Agreement dated November 16, 2006 (William P. Rutledge) (filed as Exhibit 10.27(e) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*
 10.29(e)  Employment Agreement dated November 16, 2006 (Beverly B. Wallace) (filed as Exhibit 10.28(e) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*
 10.29(f)  Amended and Restated Employment Agreement dated October 27, 2008 (Jack O. Bovender, Jr.) (filed as Exhibit 10.29(f) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*
 10.29(g)  Amendment to Employment Agreement effective January 1, 2009 (Richard M. Bracken) (filed as Exhibit 10.29(g) to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*

87


       
 10.29(h)  Amendment No. 2 to Employment Agreement effective February 9, 2011 (Richard M. Bracken).*
 10.29(i)  Amendment to Employment Agreement effective February 9, 2011 (R. Milton Johnson).*
 10.29(j)  Amendment to Employment Agreement effective February 9, 2011 (Samuel N. Hazen).*
 10.29(k)  Amendment to Employment Agreement effective February 9, 2011 (Beverly B. Wallace).*
 10.30  Administrative Settlement Agreement dated June 25, 2003 by and between the United States Department of Health and Human Services, acting through the Centers for Medicare and Medicaid Services, and the Company (filed as Exhibit 10.1 to the Company’s Quarterly Report onForm 10-Q for the quarter ended June 30, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 10.31  Civil Settlement Agreement by and among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services, the TRICARE Management Activity (filed as Exhibit 10.2 to the Company’s Quarterly Report ofForm 10-Q for the quarter ended June 30, 2003 (FileNo. 001-11239), and incorporated herein by reference).
 10.32  Form of Amended and Restated Limited Liability Company Agreement of Hercules Holding II, LLC dated as of November 17, 2006, among Hercules Holding II, LLC and certain other parties thereto (filed as Exhibit 10.3 to the Company’s Registration Statement onForm 8-A, filed April 29, 2008 (FileNo. 000-18406) and incorporated herein by reference).
 10.33  Indemnification Priority and Information Sharing Agreement, dated as of November 1, 2009, between HCA Inc. and certain other parties thereto (filed as Exhibit 10.35 to the Company’s Annual Report onForm 10-K for the fiscal year ended December 31, 2009 (FileNo. 001-11239), and incorporated herein by reference).
 10.34  HCA Inc. 2010 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report onForm 8-K dated April 6, 2010, and incorporated herein by reference).*
 10.35  Form of Restricted Share Unit Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report onForm 8-K dated April 6, 2010, and incorporated herein by reference).*
 10.36  Assignment and Assumption Agreement, dated November 22, 2010, by and among HCA Inc., HCA Holdings, Inc. and HCA Merger Sub LLC (filed as Exhibit 10.1 to the Company’s Current Report onForm 8-K filed November 24, 2010, and incorporated herein by reference).
 10.37  Omnibus Amendment to Various Stock and Option Plans and the Management Stockholders’ Agreement, dated November 22, 2010 (filed as Exhibit 10.2 to the Company’s Current Report onForm 8-K filed November 24, 2010, and incorporated herein by reference).*
 10.38  Omnibus Amendment to Stock Option Agreements Issued Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended, effective February 16, 2011.*
 21   List of Subsidiaries.
 23   Consent of Ernst & Young LLP.
 31.1  Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 31.2  Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 32   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

2.1

Agreement and Plan of Merger, dated July 24, 2006, by and among HCA Inc., Hercules Holding II, LLC and Hercules Acquisition Corporation (filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed July 25, 2006, and incorporated herein by reference).

*

2.2

Merger Agreement, dated November 22, 2010, by and among HCA Inc., HCA Holdings, Inc., and HCA Merger Sub LLC (filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).

2.3

Membership Interest Purchase Agreement by and between HealthONE, D/B/A The Colorado Health Foundation, and HealthONE of Denver, Inc., dated August 2, 2011 (Registrant agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request) (filed as Exhibit 2.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, and incorporated herein by reference).

3.1

Amended and Restated Certificate of Incorporation of the Company (filed as Exhibit 3.1 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).

3.2

Amended and Restated Bylaws of the Company (filed as Exhibit 3.2 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).

4.1

Specimen Certificate for shares of Common Stock, par value $0.01 per share, of the Company. (filed as Exhibit 4.1 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).

4.2

Security Agreement, dated as of November 17, 2006, among HCA Inc., the subsidiary grantors party thereto and The Bank of New York, as collateral agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed November 24, 2006, and incorporated herein by reference).

4.3

Pledge Agreement, dated as of November 17, 2006, among HCA Inc., the subsidiary pledgors party thereto and The Bank of New York, as collateral agent (filed as Exhibit 4.3 to the Company’s Current Report of Form 8-K filed November 24, 2006, and incorporated herein by reference).

4.4

Indenture, dated February 19, 2009, among HCA Inc, the guarantors party thereto, The Bank of New York Mellon, as collateral agent and The Bank of New York Mellon Trust Company, N.A., as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed February 25, 2009, and incorporated herein by reference).

4.5

Form of 9 7/8% Senior Secured Notes due 2017 (included in Exhibit 4.6).

4.6(a)

$13,550,000,000 — €1,000,000,000 Credit Agreement, dated as of November 17, 2006, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Banc of America Securities LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and joint bookrunners, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A. and Citicorp North America, Inc., as co-syndication agents and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.8 to the Company’s Current Report on Form 8-K filed November 24, 2006, and incorporated herein by reference).

4.6(b)

Amendment No. 1 to the Credit Agreement, dated as of February 16, 2007, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.7(b) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).

4.6(c)

Amendment No. 2 to the Credit Agreement, dated as of March 2, 2009, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as exhibit 4.8(c) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).

4.6(d)

Amendment No. 3 to the Credit Agreement, dated as of June 18, 2009, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent, JPMorgan Chase Bank, N.A., and Citicorp North America, Inc., as Co-Syndication Agents, Banc of America Securities, LLC, J.P. Morgan Securities Inc., Citigroup Global Markets Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as joint lead arrangers and bookrunners, Deutsche Bank Securities and Wachovia Capital Markets LLC, as joint bookrunners and Merrill Lynch Capital Corporation, as documentation agent (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed June 22, 2009, and incorporated herein by reference).

4.6(e)

Extension Amendment No. 1 to the Credit Agreement, dated as of April 6, 2010, among HCA Inc., HCA UK Capital Limited, the lending institutions from time to time parties thereto, Bank of America, N.A., as administrative agent and collateral agent (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 8, 2010, and incorporated herein by reference).

4.6(f)

Amended and Restated Joinder Agreement No. 1, dated as of November 8, 2010, by and among each of the financial institutions listed as a “Replacement-1 Revolving Credit Lender” on Schedule A thereto, HCA Inc., Bank of America, N.A., as Administrative Agent and as Collateral Agent, and the other parties listed on the signature pages thereto (filed as Exhibit 4.1 to the Company’s Quarterly Report on Form 10-Q filed November 9, 2010, and incorporated herein by reference).

4.6(g)

Restatement Agreement, dated as of May 4, 2011, by and among HCA Inc., HCA UK Capital Limited, the lenders party thereto and Bank of America, N.A., as administrative agent and collateral agent to the Credit Agreement, dated as of November 17, 2006, as amended on February 16, 2007, March 2, 2009, June 18, 2009, April 6, 2010 and November 8, 2010 (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed May 9, 2011, and incorporated herein by reference).

4.7

U.S. Guarantee, dated November 17, 2006, among HCA Inc., the subsidiary guarantors party thereto and Bank of America, N.A., as administrative agent (filed as Exhibit 4.9 to the Company’s Current Report on Form 8-K filed November 24, 2006, and incorporated herein by reference).

4.8

Indenture, dated as of April 22, 2009, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed April 28, 2009, and incorporated herein by reference).

4.9

Security Agreement, dated as November 17, 2006, and amended and restated as of March 2, 2009, among the Company, the Subsidiary Grantors named therein and Bank of America, N.A., as Collateral Agent (filed as exhibit 4.10 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).

4.10

Pledge Agreement, dated as of November 17, 2006, and amended and restated as of March 2, 2009, among the Company, the Subsidiary Pledgors named therein and Bank of America, N.A., as Collateral Agent (filed as exhibit 4.11 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).

4.11

Form of 8 1/2% Senior Secured Notes due 2019 (included in Exhibit 4.10).

4.12

Indenture, dated as of August 11, 2009, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed August 17, 2009, and incorporated herein by reference).

4.13

Form of 7 7/8% Senior Secured Notes due 2020 (included in Exhibit 4.14).

4.14

Indenture, dated as of March 10, 2010, among HCA Inc., the guarantors party thereto, Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed March 12, 2010, and incorporated herein by reference).

4.15

Form of 7 1/4% Senior Secured Notes due 2020 (included in Exhibit 4.16).

4.16

$2,500,000,000 Credit Agreement, dated as of September 30, 2011, by and among HCA Inc., the subsidiary borrowers party thereto, the lenders from time to time party thereto and Bank of America, N.A., as administrative agent (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed October 3, 2011, and incorporated herein by reference).

4.17

Security Agreement, dated as of September 30, 2011, by and among HCA Inc., the subsidiary borrowers party thereto and Bank of America, N.A., as collateral agent (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed October 3, 2011, and incorporated herein by reference).

4.18(a)

General Intercreditor Agreement, dated as of November 17, 2006, between Bank of America, N.A., as First Lien Collateral Agent, and The Bank of New York, as Junior Lien Collateral Agent (filed as Exhibit 4.13(a) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.18(b)

Additional General Intercreditor Agreement, dated as of April 22, 2009, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as 2006 Second Lien Trustee and The Bank of New York Mellon Trust Company, N.A., in its capacity as 2009 Second Lien Trustee (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K filed April 28, 2009, and incorporated herein by reference).

4.18(c)

Additional General Intercreditor Agreement, dated as of August 11, 2009, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as trustee for the Second Lien Notes issued on November 17, 2006, and The Bank of New York Mellon Trust Company, N.A., in its capacity as trustee for the Second Lien Notes issued on February 19, 2009 (filed as Exhibit 4.6 to the Company’s Current Report on Form 8-K filed August 17, 2009, and incorporated herein by reference).

4.18(d)

Receivables Intercreditor Agreement, dated as of November 17, 2006, among Bank of America, N.A., as ABL Collateral Agent, Bank of America, N.A., as CF Collateral Agent and The Bank of New York, as Bonds Collateral Agent (filed as Exhibit 4.13(b) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.18(e)

Additional Receivables Intercreditor Agreement, dated as of April 22, 2009, by and between Bank of America, N.A. as ABL Collateral Agent, and Bank of America, N.A. as New First Lien Collateral Agent (filed as Exhibit 4.7 to the Company’s Current Report on Form 8-K filed April 28, 2009, and incorporated herein by reference).

4.18(f)

Additional Receivables Intercreditor Agreement, dated as of August 11, 2009, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as New First Lien Collateral Agent (filed as Exhibit 4.7 to the Company’s Current Report on Form 8-K filed August 17, 2009, and incorporated herein by reference).

4.18(g)

First Lien Intercreditor Agreement, dated as of April 22, 2009, among Bank of America, N.A. as Collateral Agent, Bank of America, N.A. as Authorized Representative under the Credit Agreement and Law Debenture Trust Company of New York as the Initial Additional Authorized Representative (filed as Exhibit 4.5 to the Company’s Current Report on Form 8-K filed April 28, 2009, and incorporated herein by reference).

4.18(h)

Additional General Intercreditor Agreement, dated as of August 1, 2011, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as trustee for the Second Lien Notes issued on November 17, 2006, and The Bank of New York Mellon Trust Company, N.A., in its capacity as trustee for the Second Lien Notes issued on February 19, 2009 (filed as Exhibit 4.9 to the Company’s Current Report on Form 8-K filed August 1, 2011, and incorporated herein by reference).

4.18(i)

Additional Receivables Intercreditor Agreement, dated as of August 1, 2011 by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as New First Lien Collateral Agent (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed October 3, 2011, and incorporated herein by reference).

4.18(j)

Additional General Intercreditor Agreement, dated as of February 16, 2012, by and among Bank of America, N.A., in its capacity as First Lien Collateral Agent, The Bank of New York Mellon, in its capacity as Junior Lien Collateral Agent and in its capacity as trustee for the Second Lien Notes issued on November 17, 2006, and The Bank of New York Mellon Trust Company, N.A., in its capacity as trustee for the Second Lien Notes issued on February 19, 2009 (filed as Exhibit 4.9 to the Company’s Current Report on Form 8-K filed February 16, 2012, and incorporated herein by reference).

4.18(k)

Additional Receivables Intercreditor Agreement, dated as of February 16, 2012, by and between Bank of America, N.A., as ABL Collateral Agent, and Bank of America, N.A., as New First Lien Collateral Agent (filed as Exhibit 4.10 to the Company’s Current Report on Form 8-K filed February 16, 2012, and incorporated herein by reference).

4.19

Registration Rights Agreement, dated as of November 22, 2010, among HCA Holdings, Inc., Hercules Holding II, LLC and certain other parties thereto (filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).

4.20

Registration Rights Agreement, dated as of March 16, 1989, by and among HCA-Hospital Corporation of America and the persons listed on the signature pages thereto (filed as Exhibit 4.14 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.21

Assignment and Assumption Agreement, dated as of February 10, 1994, between HCA-Hospital Corporation of America and the Company relating to the Registration Rights Agreement, as amended (filed as Exhibit 4.15 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.22(a)

Indenture, dated as of December 16, 1993 between the Company and The First National Bank of Chicago, as Trustee (filed as Exhibit 4.16(a) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.22(b)

First Supplemental Indenture, dated as of May 25, 2000 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.16(b) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.22(c)

Second Supplemental Indenture, dated as of July 1, 2001 between the Company and Bank One Trust Company, N.A., as Trustee (filed as Exhibit 4.16(c) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.22(d)

Third Supplemental Indenture, dated as of December 5, 2001 between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.16(d) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.22(e)

Fourth Supplemental Indenture, dated as of November 14, 2006, between the Company and The Bank of New York, as Trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed November 16, 2006, and incorporated herein by reference).

4.23

Form of 7.5% Debentures due 2023 (filed as Exhibit 4.17 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.24

Form of 8.36% Debenture due 2024 (filed as Exhibit 4.18 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.25

Form of Fixed Rate Global Medium-Term Note (filed as Exhibit 4.19 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.26

Form of Floating Rate Global Medium-Term Note (filed as Exhibit 4.20 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.27

Form of 7.69% Note due 2025 (filed as Exhibit 4.10 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 (File No. 001-11239), and incorporated herein by reference).

4.28

Form of 7.19% Debenture due 2015 (filed as Exhibit 4.22 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.29

Form of 7.50% Debenture due 2095 (filed as Exhibit 4.23 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.30

Form of 7.05% Debenture due 2027 (filed as Exhibit 4.24 to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.31(a)

6.95% Note due 2012 in the principal amount of $400,000,000 (filed as Exhibit 4.29(a) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.31(b)

6.95% Note due 2012 in the principal amount of $100,000,000 (filed as Exhibit 4.29(b) to the Company’s Registration Statement on Form S-4 (File No. 333-145054), and incorporated herein by reference).

4.32(a)

6.30% Note due 2012 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated September 18, 2002 (File No. 001-11239), and incorporated herein by reference).

4.32(b)

6.30% Note due 2012 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated September 18, 2002 (File No. 001-11239), and incorporated herein by reference).

4.33(a)

6.25% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated February 5, 2003 (File No. 001-11239), and incorporated herein by reference).

4.33(b)

6 3/4% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated February 5, 2003 (File No. 001-11239), and incorporated herein by reference).

4.34(a)

6 3/4% Note due 2013 in the principal amount of $400,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated July 23, 2003 (File No. 001-11239), and incorporated herein by reference).

4.34(b)

6 3/4% Note due 2013 in the principal amount of $100,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated July 23, 2003 (File No. 001-11239), and incorporated herein by reference).

4.35

7.50% Note due 2033 in the principal amount of $250,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated November 6, 2003 (File No. 001-11239), and incorporated herein by reference).

4.36

5.75% Note due 2014 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K dated March 8, 2004 (File No. 001-11239), and incorporated herein by reference).

4.37(a)

6.375% Note due 2015 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K dated November 16, 2004 (File No. 001-11239), and incorporated herein by reference).

4.37(b)

6.375% Note due 2015 in the principal amount of $250,000,000 (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K dated November 16, 2004 (File No. 001-11239), and incorporated herein by reference).

4.38(a)

6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on February 8, 2006, and incorporated herein by reference).

4.38(b)

6.500% Note due 2016 in the principal amount of $500,000,000 (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on February 8, 2006, and incorporated herein by reference).

4.39

Indenture, dated as of November 23, 2010, among HCA Holdings, Inc., Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent, and Law Debenture Trust Company of New York, as trustee (filed as Exhibit 4.1 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).

4.40

Form of 7 3/4% Senior Notes due 2021 (included in Exhibit 4.39).

4.41

Form of Indenture of HCA Inc. (filed as Exhibit 4.2 to the Registrant’s Registration Statement on Form S-3 (File No. 333-175791), and incorporated herein by reference).

4.42

Supplemental Indenture No. 1, dated as of August 1, 2011, among HCA Inc., HCA Holdings, Inc., Law Debenture Trust Company of New York, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed August 1, 2011, and incorporated herein by reference).

4.43

Supplemental Indenture No. 2, dated as of August 1, 2011, among HCA Inc., HCA Holdings, Inc., the subsidiary guarantors named therein, Law Debenture Trust Company of New York, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.3 to the Company’s Current Report on Form 8-K filed August 1, 2011, and incorporated herein by reference).

4.44

Form of 7.50% Senior Notes Due 2022 (included in Exhibit 4.42).

4.45

Form of 6.50% Senior Secured Notes Due 2020 (included in Exhibit 4.43).

4.46

Supplemental Indenture No. 3, dated as of October 3, 2011, among HCA Inc., HCA Holdings, Inc., Law Debenture Trust Company of New York, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed October 3, 2011, and incorporated herein by reference).

4.47

Form of 8.00% Senior Notes Due 2018 (included in Exhibit 4.46).

4.48

Supplemental Indenture No. 4, dated as of February 16, 2012, among HCA Inc., HCA Holdings, Inc., the subsidiary guarantors named therein, Law Debenture Trust Company of New York, as trustee, and Deutsche Bank Trust Company Americas, as paying agent, registrar and transfer agent (filed as Exhibit 4.2 to the Company’s Current Report on Form 8-K filed February 16, 2012, and incorporated herein by reference).

4.49

Form of 5.875% Senior Secured Notes due 2022 (included in Exhibit 4.48).

10.1

HCA-Hospital Corporation of America Nonqualified Initial Option Plan (filed as Exhibit 4.6 to the Company’s Registration Statement on Form S-3 (File No. 33-52379), and incorporated herein by reference).*

10.2

Form of Indemnity Agreement with certain officers and directors (filed as Exhibit 10.3 to the Company’s Registration Statement on Form S-4 (File No. 333-145054) and incorporated herein by reference).

10.3

Columbia/HCA Healthcare Corporation 2000 Equity Incentive Plan (filed as Exhibit A to the Company’s Proxy Statement for the Annual Meeting of Stockholders on May 25, 2000, and incorporated herein by reference).*

10.4

Form of Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated February 2, 2005 (File No. 001-11239), and incorporated herein by reference).*

10.5

HCA 2005 Equity Incentive Plan (filed as Exhibit B to the Company’s Proxy Statement for the Annual Meeting of Shareholders on May 26, 2005, and incorporated herein by reference).*

10.6

Form of 2005 Non-Qualified Stock Option Agreement (Officers) (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated October 6, 2005, and incorporated herein by reference).*

10.7

Form of 2006 Non-Qualified Stock Option Award Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated February 1, 2006, and incorporated herein by reference).*

10.8(a)

2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated (filed as Exhibit 10.11(b) to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).*

10.8(b)

First Amendment to 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended and restated (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, and incorporated herein by reference).*

10.9(a)

Management Stockholder’s Agreement dated November 17, 2006 (filed as Exhibit 10.12 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).

10.9(b)

Form of Omnibus Amendment to HCA Holdings, Inc’s Management Stockholder’s Agreements (filed as Exhibit 10.39 to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).*

10.10

Form of Option Rollover Agreement (filed as Exhibit 10.14 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.11

Form of Stock Option Agreement (2007) (filed as Exhibit 10.15 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.12

Form of Stock Option Agreement (2008) (filed as Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*

10.13

Form of Stock Option Agreement (2009) (filed as Exhibit 10.17 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*

10.14

Form of Stock Option Agreement (2010) (filed as Exhibit 10.20 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and incorporated herein by reference).*

10.15

Form of 2x Time Stock Option Agreement (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2009, and incorporated herein by reference).

10.16

Form Stock Option Agreement (2011) (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2011, and incorporated herein by reference).*

10.17

Form of Stock Appreciation Right Award Agreement Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed February 14, 2012, and incorporated herein by reference).*

10.18

Form of Director Restricted Share Unit Agreement (Initial Award) Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed February 14, 2012, and incorporated herein by reference).*

10.19

Form of Director Restricted Share Unit Agreement (Annual Award) Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (filed as Exhibit 10.3 to the Company’s Current Report on Form 8-K filed February 14, 2012, and incorporated herein by reference).*

10.20

Exchange and Purchase Agreement (filed as Exhibit 10.16 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).

10.21

Civil and Administrative Settlement Agreement, dated December 14, 2000 between the Company, the United States Department of Justice and others (filed as Exhibit 99.2 to the Company’s Current Report on Form 8-K dated December 20, 2000 (File No. 001-11239), and incorporated herein by reference).

10.22

Plea Agreement, dated December 14, 2000 between the Company, Columbia Homecare Group, Inc., Columbia Management Companies, Inc. and the United States Department of Justice (filed as Exhibit 99.3 to the Company’s Current Report on Form 8-K dated December 20, 2000 (File No. 001-11239), and incorporated herein by reference).

10.23

Corporate Integrity Agreement, dated December 14, 2000 between the Company and the Office of Inspector General of the United States Department of Health and Human Services (filed as Exhibit 99.4 to the Company’s Current Report on Form 8-K dated December 20, 2000 (File No. 001-11239), and incorporated herein by reference).

10.24

Management Agreement, dated November 17, 2006, among HCA Inc., Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co. L.P., Dr. Thomas F. Frist, Jr., Patricia F. Elcan, William R. Frist and Thomas F. Frist III, and Merrill Lynch Global Partners, Inc. (filed as Exhibit 10.20 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).

10.25

Retirement Agreement between the Company and Thomas F. Frist, Jr., M.D. dated as of January 1, 2002 (filed as Exhibit 10.30 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2001 (File No. 001-11239), and incorporated herein by reference).*

10.26

Amended and Restated HCA Supplemental Executive Retirement Plan, effective December 22, 2010, except as provided therein (filed as Exhibit 10.26 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

10.27

Amended and Restated HCA Restoration Plan, effective December 22, 2010 (filed as Exhibit 10.27 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

10.28(a)

HCA Inc. 2008-2009 Senior Officer Performance Excellence Program (filed as Exhibit 10.27 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*

10.28(b)

HCA Inc. Amendment No. 1 to the 2008-2009 Senior Officer Performance Excellence Program (filed as Exhibit 10.28(b) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*

10.29(a)

Employment Agreement dated November 16, 2006 (Richard M. Bracken) (filed as Exhibit 10.27(b) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.29(b)

Employment Agreement dated November 16, 2006 (R. Milton Johnson) (filed as Exhibit 10.27(c) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.29(c)

Employment Agreement dated November 16, 2006 (Samuel N. Hazen) (filed as Exhibit 10.27(d) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.29(d)

Employment Agreement dated November 16, 2006 (William P. Rutledge) (filed as Exhibit 10.27(e) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2006, and incorporated herein by reference).*

10.29(e)

Employment Agreement dated November 16, 2006 (Beverly B. Wallace) (filed as Exhibit 10.28(e) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007, and incorporated herein by reference).*

10.29(f)

Amended and Restated Employment Agreement dated October 27, 2008 (Jack O. Bovender, Jr.) (filed as Exhibit 10.29(f) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*

  10.29(g)

Amendment to Employment Agreement effective January 1, 2009 (Richard M. Bracken) (filed as Exhibit 10.29(g) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008, and incorporated herein by reference).*

  10.29(h)

Amendment No. 2 to Employment Agreement effective February 9, 2011 (Richard M. Bracken) (filed as Exhibit 10.29(h) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

  10.29(i)

Amendment to Employment Agreement effective February 9, 2011 (R. Milton Johnson) (filed as Exhibit 10.29(i) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

  10.29(j)

Amendment to Employment Agreement effective February 9, 2011 (Samuel N. Hazen) (filed as Exhibit 10.29(j) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

  10.29(k)

Amendment to Employment Agreement effective February 9, 2011 (Beverly B. Wallace) (filed as Exhibit 10.29(k) to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

  10.30

Administrative Settlement Agreement dated June 25, 2003 by and between the United States Department of Health and Human Services, acting through the Centers for Medicare and Medicaid Services, and the Company (filed as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2003 (File No. 001-11239), and incorporated herein by reference).

  10.31

Civil Settlement Agreement by and among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General of the Department of Health and Human Services, the TRICARE Management Activity (filed as Exhibit 10.2 to the Company’s Quarterly Report of Form 10-Q for the quarter ended June 30, 2003 (File No. 001-11239), and incorporated herein by reference).

  10.32(a)

Form of Amended and Restated Limited Liability Company Agreement of Hercules Holding II, LLC dated as of November 17, 2006, among Hercules Holding II, LLC and certain other parties thereto (filed as Exhibit 10.3 to the Company’s Registration Statement on Form 8-A, filed April 29, 2008 (File No. 000-18406) and incorporated herein by reference).

  10.32(b)

Form of Amendment to the Amended and Restated Limited Liability Company Agreement of Hercules Holding II, LLC (filed as Exhibit 10.32(a) to the Company’s Registration Statement on Form S-1 (File No. 333-171369), and incorporated herein by reference).

  10.33

Indemnification Priority and Information Sharing Agreement, dated as of November 1, 2009, between HCA Inc. and certain other parties thereto (filed as Exhibit 10.35 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 (File No. 001-11239), and incorporated herein by reference).

  10.34

HCA Inc. 2010 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K dated April 6, 2010, and incorporated herein by reference).*

  10.35

Form of Restricted Share Unit Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K dated April 6, 2010, and incorporated herein by reference).*

  10.36

Assignment and Assumption Agreement, dated November 22, 2010, by and among HCA Inc., HCA Holdings, Inc. and HCA Merger Sub LLC (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).

  10.37

Omnibus Amendment to Various Stock and Option Plans and the Management Stockholders’ Agreement, dated November 22, 2010 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed November 24, 2010, and incorporated herein by reference).*

  10.38

Omnibus Amendment to Stock Option Agreements Issued Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as amended, effective February 16, 2011 (filed as Exhibit 10.38 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010, and incorporated herein by reference).*

  10.39

Stockholders’ Agreement, dated as of March 9, 2011, by and among the Company, Hercules Holding II, LLC and the other signatories thereto (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed March 16, 2011, and incorporated herein by reference).

  10.40

Amendment, dated as of September 21, 2011, to the Stockholders’ Agreement, dated as of March 9, 2011 (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed September 21, 2011, and incorporated herein by reference).

  10.41

HCA Holdings, Inc. 2011 Senior Officer Performance Excellence Program (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 5, 2011, and incorporated herein by reference).*

  10.42

Form of 2011 PEP Restricted Share Unit Agreement (Officers) (filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed April 5, 2011, and incorporated herein by reference).*

  10.43

Form of Director Restricted Share Unit Agreement Under the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates, as Amended and Restated (filed as Exhibit 10.5 to the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, and incorporated herein by reference).*

  10.44

Share Repurchase Agreement, dated September 15, 2011, between HCA Holdings, Inc. and ML Global Private Equity Fund, L.P. and ML HCA Co-Invest, L.P. (filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed September 21, 2011, and incorporated herein by reference).

  21

List of Subsidiaries.

  23

Consent of Ernst & Young LLP.

  31.1

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  31.2

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

  32

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101

The following financial information from our annual report on Form 10-K for the year ended December 31, 2011, filed with the SEC on February 23, 2012, formatted in Extensible Business Reporting Language (XBRL): (i) the consolidated balance sheets at December 31, 2011 and 2010, (ii) the consolidated income statements for the years ended December 31, 2011, 2010 and 2009, (iii) the consolidated comprehensive income statements for the years ended December 31, 2011, 2010 and 2009, (iv) the consolidated statements of stockholders’ deficit for the years ended December 31, 2011, 2010 and 2009, (v) the consolidated statements of cash flows for the years ended December 31, 2011, 2010 and 2009, and (vi) the notes to consolidated financial statements.(1)

(1)

The XBRL related information in Exhibit 101 to this annual report on Form 10-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

*

Management compensatory plan or arrangement.

88


SIGNATURES

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HCA HOLDINGS, INC.

HCA HOLDINGS, INC.

By:
/s/  S/    RICHARD M. BRACKEN
Richard M. Bracken

Chairman of the Board and

Chief Executive Officer

Richard M. Bracken
Chairman of the Board and
Chief Executive Officer

Dated: February 17, 2011

23, 2012

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

  

Title

 

Date

/S/    RICHARD M. BRACKEN        

Richard M. Bracken

  
Signature
Title
Date
/s/  Richard M. Bracken

Richard M. Bracken

Chairman of the Board and

Chief Executive Officer

(Principal Executive Officer)

 February 17, 201123, 2012

/S/    R. MILTON JOHNSON        

R. Milton Johnson

  
/s/  R. Milton Johnson

R. Milton Johnson

President, Chief Financial Officer and

Director (Principal Financial Officer and Principal Accounting Officer)

 February 17, 201123, 2012

/S/    JOHN P. CONNAUGHTON        

John P. Connaughton

  
/s/  Christopher J. Birosak

Christopher J. Birosak

Director

 February 17, 201123, 2012

/S/    KENNETH W. FREEMAN        

Kenneth W. Freeman

  
/s/  John P. Connaughton

John P. Connaughton

Director

 February 17, 201123, 2012

/S/    THOMAS F. FRIST III        

Thomas F. Frist III

  
/s/  James D. Forbes

James D. Forbes

Director

 February 17, 201123, 2012

/S/    WILLIAM R. FRIST        

William R. Frist

  
/s/  Kenneth W. Freeman

Kenneth W. Freeman

Director

 February 17, 201123, 2012

Signature

  

Title

 

Date

/s/  Thomas F. Frist, IIIS/    CHRISTOPHER R. GORDON        

Thomas F. Frist, III

Christopher R. Gordon

  

Director

 February 17, 201123, 2012

/S/    JAY O. LIGHT        

Jay O. Light

  
/s/  William R. Frist

William R. Frist

Director

 February 17, 201123, 2012

/S/    MICHAEL W. MICHELSON        

Michael W. Michelson

  
/s/  Christopher R. Gordon

Christopher R. Gordon

Director

 February 17, 201123, 2012

/S/    JAMES C. MOMTAZEE        

James C. Momtazee

  
/s/  Michael W. Michelson

Michael W. Michelson

Director

 February 17, 201123, 2012

/S/    GEOFFREY G. MEYERS        

Geoffrey G. Meyers

  
/s/  James C. Momtazee

James C. Momtazee

Director

 February 17, 201123, 2012

/S/    STEPHEN G. PAGLIUCA        

Stephen G. Pagliuca

  
/s/  Stephen G. Pagliuca

Stephen G. Pagliuca

Director

 February 17, 201123, 2012

/S/    WAYNE J. RILEY        

Wayne J. Riley

  
/s/  Nathan C. Thorne

Nathan C. Thorne

Director

 February 17, 201123, 2012


89



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders

HCA Holdings, Inc.

We have audited the accompanying consolidated balance sheets of HCA Holdings, Inc. as of December 31, 20102011 and 2009,2010, and the related consolidated statements of income, comprehensive income, stockholders’ deficit, and cash flows for each of the three years in the period ended December 31, 2010.2011. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of HCA Holdings, Inc. at December 31, 20102011 and 2009,2010, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2010,2011, in conformity with U.S. generally accepted accounting principles.

As discussed in Note 1 to the consolidated financial statements, the Company changed its presentation of revenues and provision for doubtful accounts as a result of the adoption of the amendments to the FASB Accounting Standards Codification resulting from Accounting Standards Update No. 2011-07,Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Healthcare Entities.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), HCA Holdings, Inc.’s internal control over financial reporting as of December 31, 2010,2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 17, 201123, 2012 expressed an unqualified opinion thereon.

/s/ Ernst & Young LLP
/s/  Ernst & Young LLP

Nashville, Tennessee

February 17, 2011


F-223, 2012


HCA HOLDINGS, INC.

CONSOLIDATED INCOME STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2011, 2010 2009 AND 2008
2009

(Dollars in millions, except per share amounts)

             
  2010  2009  2008 
 
Revenues $30,683  $30,052  $28,374 
             
Salaries and benefits  12,484   11,958   11,440 
Supplies  4,961   4,868   4,620 
Other operating expenses  5,004   4,724   4,554 
Provision for doubtful accounts  2,648   3,276   3,409 
Equity in earnings of affiliates  (282)  (246)  (223)
Depreciation and amortization  1,421   1,425   1,416 
Interest expense  2,097   1,987   2,021 
Losses (gains) on sales of facilities  (4)  15   (97)
Impairments of long-lived assets  123   43   64 
             
   28,452   28,050   27,204 
             
Income before income taxes  2,231   2,002   1,170 
Provision for income taxes  658   627   268 
             
Net income  1,573   1,375   902 
Net income attributable to noncontrolling interests  366   321   229 
             
Net income attributable to HCA Holdings, Inc.  $1,207  $1,054  $673 
             
Per share data:            
Basic earnings per share $12.75  $11.16  $7.16 
Diluted earnings per share $12.43  $10.99  $7.04 
Shares used in earnings per share calculations (in thousands):            
Basic  94,656   94,465   94,051 
Diluted  97,080   95,945   95,668 

   2011  2010  2009 

Revenues before the provision for doubtful accounts

  $32,506   $30,683   $30,052  

Provision for doubtful accounts

   2,824    2,648    3,276  
  

 

 

  

 

 

  

 

 

 

Revenues

   29,682    28,035    26,776  

Salaries and benefits

   13,440    12,484    11,958  

Supplies

   5,179    4,961    4,868  

Other operating expenses

   5,470    5,004    4,724  

Electronic health record incentive income

   (210        

Equity in earnings of affiliates

   (258  (282  (246

Depreciation and amortization

   1,465    1,421    1,425  

Interest expense

   2,037    2,097    1,987  

Losses (gains) on sales of facilities

   (142  (4  15  

Gain on acquisition of controlling interest in equity investment

   (1,522        

Impairments of long-lived assets

       123    43  

Losses on retirement of debt

   481          

Termination of management agreement

   181          
  

 

 

  

 

 

  

 

 

 
   26,121    25,804    24,774  
  

 

 

  

 

 

  

 

 

 

Income before income taxes

   3,561    2,231    2,002  

Provision for income taxes

   719    658    627  
  

 

 

  

 

 

  

 

 

 

Net income

   2,842    1,573    1,375  

Net income attributable to noncontrolling interests

   377    366    321  
  

 

 

  

 

 

  

 

 

 

Net income attributable to HCA Holdings, Inc.

  $2,465   $1,207   $1,054  
  

 

 

  

 

 

  

 

 

 

Per share data:

    

Basic earnings per share

  $5.17   $2.83   $2.48  

Diluted earnings per share

  $4.97   $2.76   $2.44  

Shares used in earnings per share calculations (in thousands):

    

Basic

   476,609    426,424    425,567  

Diluted

   495,943    437,347    432,227  

The accompanying notes are an integral part of the consolidated financial statements.


F-3


HCA HOLDINGS, INC.

CONSOLIDATED BALANCE SHEETS
COMPREHENSIVE INCOME STATEMENTS

FOR THE YEARS ENDED DECEMBER 31, 2011, 2010 AND 2009

(Dollars in millions)

         
  2010  2009 
 
ASSETS
Current assets:        
Cash and cash equivalents $411  $312 
Accounts receivable, less allowance for doubtful accounts of $3,939 and $4,860  3,832   3,692 
Inventories  897   802 
Deferred income taxes  931   1,192 
Other  848   579 
         
   6,919   6,577 
Property and equipment, at cost:        
Land  1,215   1,202 
Buildings  9,438   9,108 
Equipment  14,310   13,575 
Construction in progress  678   784 
         
   25,641   24,669 
Accumulated depreciation  (14,289)  (13,242)
         
   11,352   11,427 
         
Investments of insurance subsidiary  642   1,166 
Investments in and advances to affiliates  869   853 
Goodwill  2,693   2,577 
Deferred loan costs  374   418 
Other  1,003   1,113 
         
  $23,852  $24,131 
         
 
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:        
Accounts payable $1,537  $1,460 
Accrued salaries  895   849 
Other accrued expenses  1,245   1,158 
Long-term debt due within one year  592   846 
         
   4,269   4,313 
         
Long-term debt  27,633   24,824 
Professional liability risks  995   1,057 
Income taxes and other liabilities  1,608   1,768 
         
Equity securities with contingent redemption rights  141   147 
         
         
Stockholders’ deficit:        
Common stock $0.01 par; authorized 125,000,000 shares — 2010 and 2009; outstanding 94,885,500 shares — 2010 and 94,637,400 shares — 2009  1   1 
Capital in excess of par value  389   226 
Accumulated other comprehensive loss  (428)  (450)
Retained deficit  (11,888)  (8,763)
         
Stockholders’ deficit attributable to HCA Holdings, Inc.   (11,926)  (8,986)
Noncontrolling interests  1,132   1,008 
         
   (10,794)  (7,978)
         
  $23,852  $24,131 
         

   2011  2010  2009 

Net income

  $2,842   $1,573   $1,375  

Other comprehensive income (loss) before taxes:

    

Foreign currency translation

   (9  (25  39  

Unrealized gains on available-for-sale securities

   2    2    69  

Less: gains included in other operating expenses

       (13    
  

 

 

  

 

 

  

 

 

 
   2    (11  69  

Defined benefit plans

   (67  (76  (18

Less: pension costs included in salaries and benefits

   25    18    16  
  

 

 

  

 

 

  

 

 

 
   (42  (58  (2

Change in fair value of derivative financial instruments

   (311  (255  (209

Less: interest costs included in interest expense

   341    384    345  
  

 

 

  

 

 

  

 

 

 
   30    129    136  
  

 

 

  

 

 

  

 

 

 

Other comprehensive income (loss) before taxes

   (19  35    242  

Income taxes (benefits) related to other comprehensive income items

   (7  13    88  
  

 

 

  

 

 

  

 

 

 

Other comprehensive income (loss)

   (12  22    154  
  

 

 

  

 

 

  

 

 

 

Comprehensive income

   2,830    1,595    1,529  

Comprehensive income attributable to noncontrolling interests

   377    366    321  
  

 

 

  

 

 

  

 

 

 

Comprehensive income attributable to HCA Holdings, Inc.

  $2,453   $1,229   $1,208  
  

 

 

  

 

 

  

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.


F-4


HCA HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT
FOR THE YEARS ENDED BALANCE SHEETS

DECEMBER 31, 2010, 20092011 AND 2008
2010

(Dollars in millions)

                             
  Equity (Deficit) Attributable to HCA Holdings, Inc.       
           Accumulated
     Equity
    
  Common Stock  Capital in
  Other
     Attributable to
    
  Shares
  Par
  Excess of
  Comprehensive
  Retained
  Noncontrolling
    
  (000)  Value  Par Value  Loss  Deficit  Interests  Total 
 
Balances, December 31, 2007  94,182  $1  $112  $(172) $(10,479) $938  $(9,600)
Comprehensive income:                            
Net income                  673   229   902 
Other comprehensive income:                            
Change in fair value of investment securities              (44)          (44)
Foreign currency translation adjustments              (62)          (62)
Defined benefit plans              (62)          (62)
Change in fair value of derivative instruments              (264)          (264)
                             
Total comprehensive income              (432)  673   229   470 
Share-based benefit plans  185       40               40 
Distributions                      (178)  (178)
Other          13       (11)  6   8 
                             
Balances, December 31, 2008  94,367   1   165   (604)  (9,817)  995   (9,260)
Comprehensive income:                            
Net income                  1,054   321   1,375 
Other comprehensive income:                            
Change in fair value of investment securities              44           44 
Foreign currency translation adjustments              25           25 
Change in fair value of derivative instruments              85           85 
                             
Total comprehensive income              154   1,054   321   1,529 
Share-based benefit plans  270       47               47 
Distributions                      (330)  (330)
Other          14           22   36 
                             
Balances, December 31, 2009  94,637   1   226   (450)  (8,763)  1,008   (7,978)
Comprehensive income:                            
Net income                  1,207   366   1,573 
Other comprehensive income:                            
Change in fair value of investment securities              (8)          (8)
Foreign currency translation adjustments              (16)          (16)
Defined benefit plans              (37)          (37)
Change in fair value of derivative instruments              83           83 
                             
Total comprehensive income              22   1,207   366   1,595 
Share-based benefit plans  248       43               43 
Distributions                  (4,332)  (342)  (4,674)
Contributions                      57   57 
Other          120           43   163 
                             
Balances, December 31, 2010  94,885  $1  $389  $(428) $(11,888) $1,132  $(10,794)
                             

   2011  2010 

ASSETS

  

Current assets:

   

Cash and cash equivalents

  $373   $411  

Accounts receivable, less allowance for doubtful accounts of $4,106 and $3,939

   4,533    3,832  

Inventories

   1,054    897  

Deferred income taxes

   594    931  

Other

   679    848  
  

 

 

  

 

 

 
   7,233    6,919  

Property and equipment, at cost:

   

Land

   1,416    1,215  

Buildings

   10,231    9,438  

Equipment

   15,431    14,310  

Construction in progress

   997    678  
  

 

 

  

 

 

 
   28,075    25,641  

Accumulated depreciation

   (15,241)   (14,289
  

 

 

  

 

 

 
   12,834    11,352  

Investments of insurance subsidiaries

   548    642  

Investments in and advances to affiliates

   101    869  

Goodwill and other intangible assets

   5,251    2,693  

Deferred loan costs

   290    374  

Other

   641    1,003  
  

 

 

  

 

 

 
  $26,898   $23,852  
  

 

 

  

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

  

Current liabilities:

   

Accounts payable

  $1,597   $1,537  

Accrued salaries

   965    895  

Other accrued expenses

   1,585    1,245  

Long-term debt due within one year

   1,407    592  
  

 

 

  

 

 

 
   5,554    4,269  

Long-term debt

   25,645    27,633  

Professional liability risks

   993    995  

Income taxes and other liabilities

   1,720    1,608  

Equity securities with contingent redemption rights

       141  

Stockholders’ deficit:

   

Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 437,477,900 shares — 2011 and 427,458,800 shares — 2010

   4    4  

Capital in excess of par value

   1,601    386  

Accumulated other comprehensive loss

   (440  (428

Retained deficit

   (9,423  (11,888
  

 

 

  

 

 

 

Stockholders’ deficit attributable to HCA Holdings, Inc.

   (8,258  (11,926

Noncontrolling interests

   1,244    1,132  
  

 

 

  

 

 

 
   (7,014  (10,794
  

 

 

  

 

 

 
  $26,898   $23,852  
  

 

 

  

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.


F-5


HCA HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS
STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2011, 2010 2009 AND 2008
2009

(Dollars in millions)

             
  2010  2009  2008 
 
Cash flows from operating activities:            
Net income $1,573  $1,375  $902 
Adjustments to reconcile net income to net cash provided by operating activities:            
Increase (decrease) in cash from operating assets and liabilities:            
Accounts receivable  (2,789)  (3,180)  (3,328)
Inventories and other assets  (287)  (191)  159 
Accounts payable and accrued expenses  229   280   (198)
Provision for doubtful accounts  2,648   3,276   3,409 
Depreciation and amortization  1,421   1,425   1,416 
Income taxes  27   (520)  (448)
Losses (gains) on sales of facilities  (4)  15   (97)
Impairments of long-lived assets  123   43   64 
Amortization of deferred loan costs  81   80   79 
Share-based compensation  32   40   32 
Pay-in-kind interest
     58    
Other  31   46    
             
Net cash provided by operating activities  3,085   2,747   1,990 
             
Cash flows from investing activities:            
Purchase of property and equipment  (1,325)  (1,317)  (1,600)
Acquisition of hospitals and health care entities  (233)  (61)  (85)
Disposal of hospitals and health care entities  37   41   193 
Change in investments  472   303   21 
Other  10   (1)  4 
             
Net cash used in investing activities  (1,039)  (1,035)  (1,467)
             
Cash flows from financing activities:            
Issuances of long-term debt  2,912   2,979    
Net change in revolving bank credit facilities  1,889   (1,335)  700 
Repayment of long-term debt  (2,268)  (3,103)  (960)
Distributions to noncontrolling interests  (342)  (330)  (178)
Contributions from noncontrolling interests  57       
Payment of debt issuance costs  (50)  (70)   
Distributions to stockholders  (4,257)      
Income tax benefits  114       
Other  (2)  (6)  (13)
             
Net cash used in financing activities  (1,947)  (1,865)  (451)
             
Change in cash and cash equivalents  99   (153)  72 
Cash and cash equivalents at beginning of period  312   465   393 
             
Cash and cash equivalents at end of period $411  $312  $465 
             
Interest payments $1,994  $1,751  $1,979 
Income tax payments, net of refunds $517  $1,147  $716 

   Equity (Deficit) Attributable to HCA Holdings, Inc.       
   Common Stock  Capital in
Excess of
Par
Value
  Accumulated
Other
Comprehensive
Loss
  Retained
Deficit
  Equity
Attributable to
Noncontrolling
Interests
    
   

Shares

(000)

  

Par

Value

      Total 

Balances, December 31, 2008

   425,125   $4   $162   $(604 $(9,817 $995   $(9,260

Comprehensive income

      154    1,054    321    1,529  

Share-based benefit plans

   1,216     47       47  

Distributions

        (330  (330

Other

     14      22    36  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances, December 31, 2009

   426,341    4    223    (450  (8,763  1,008    (7,978

Comprehensive income

      22    1,207    366    1,595  

Share-based benefit plans

   1,118     43       43  

Distributions

       (4,332  (342  (4,674

Contributions

        57    57  

Other

     120      43    163  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances, December 31, 2010

   427,459    4    386    (428  (11,888  1,132    (10,794

Comprehensive income

      (12  2,465    377    2,830  

Issuance of common stock

   87,719    1    2,505       2,506  

Repurchase of common stock

   (80,771  (1  (1,502     (1,503

Share-based benefit plans

   3,071     35       35  

Distributions

        (378  (378

Consolidation of acquired controlling interest in equity investment

        93    93  

Reclassification of equity securities with contingent redemption rights

     141       141  

Other

     36      20    56  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances, December 31, 2011

   437,478   $4   $1,601   $(440 $(9,423 $1,244   $(7,014
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.


F-6


HCA HOLDINGS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED DECEMBER 31, 2011, 2010 AND 2009

(Dollars in millions)

   2011  2010  2009 

Cash flows from operating activities:

    

Net income

  $2,842   $1,573   $1,375  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Increase (decrease) in cash from operating assets and liabilities:

    

Accounts receivable

   (3,248  (2,789  (3,180

Inventories and other assets

   (18  (287  (191

Accounts payable and accrued expenses

   313    229    280  

Provision for doubtful accounts

   2,824    2,648    3,276  

Depreciation and amortization

   1,465    1,421    1,425  

Income taxes

   912    27    (520

Losses (gains) on sales of facilities

   (142  (4  15  

Gain on acquisition of controlling interest in equity investment

   (1,522        

Impairments of long-lived assets

       123    43  

Losses on retirement of debt

   481          

Amortization of deferred loan costs

   70    81    80  

Share-based compensation

   26    32    40  

Pay-in-kind interest

   (78      58  

Other

   8    31    46  
  

 

 

  

 

 

  

 

 

 

Net cash provided by operating activities

   3,933    3,085    2,747  
  

 

 

  

 

 

  

 

 

 

Cash flows from investing activities:

    

Purchase of property and equipment

   (1,679  (1,325  (1,317

Acquisition of hospitals and health care entities

   (1,682  (233  (61

Disposal of hospitals and health care entities

   281    37    41  

Change in investments

   80    472    303  

Other

   5    10    (1
  

 

 

  

 

 

  

 

 

 

Net cash used in investing activities

   (2,995  (1,039  (1,035
  

 

 

  

 

 

  

 

 

 

Cash flows from financing activities:

    

Issuances of long-term debt

   5,500    2,912    2,979  

Net change in revolving bank credit facilities

   (449  1,889    (1,335

Repayment of long-term debt

   (6,640  (2,268  (3,103

Distributions to noncontrolling interests

   (378  (342  (330

Contributions from noncontrolling interests

       57      

Payment of debt issuance costs

   (92  (50  (70

Issuance of common stock

   2,506          

Repurchase of common stock

   (1,503        

Distributions to stockholders

   (31  (4,257    

Income tax benefits

   63    114      

Other

   48    (2  (6
  

 

 

  

 

 

  

 

 

 

Net cash used in financing activities

   (976  (1,947  (1,865
  

 

 

  

 

 

  

 

 

 

Change in cash and cash equivalents

   (38  99    (153

Cash and cash equivalents at beginning of period

   411    312    465  
  

 

 

  

 

 

  

 

 

 

Cash and cash equivalents at end of period

  $373   $411   $312  
  

 

 

  

 

 

  

 

 

 

Interest payments

  $1,987   $1,994   $1,751  

Income tax (refunds) payments, net

  $(256 $517   $1,147  

The accompanying notes are an integral part of the consolidated financial statements.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 — ACCOUNTING POLICIES

NOTE 1 —

ACCOUNTING POLICIES
Reporting Entity and Corporate Reorganization

On November 17, 2006, HCA Inc. completed its merger (the “Merger”) with Hercules Acquisition Corporation, pursuant to which the Company was acquired by Hercules Holding II, LLC (“Hercules Holding”), a Delaware limited liability company owned by a private investor group, comprised ofincluding affiliates of or funds sponsored by Bain Capital Partners, LLC, Kohlberg Kravis Roberts & Co., BAML Capital Partners (formerly Merrill Lynch Global Private Equity) (each a “Sponsor”), affiliates of Citigroup Inc. and Bank of America Corporation (the “Sponsor Assignees”) and affiliates of HCA founder, Dr. Thomas F. Frist Jr., (the “Frist Entities,” and together with the Sponsors and the Sponsor Assignees, (collectively, the “Investors”), and by members of management and certain other investors. The Merger, the financing transactions related to the Merger and other related transactions are collectively referred to in this annual report as the “Recapitalization.” The Mergertransaction was accounted for as a recapitalization in our financial statements, with no adjustments to the historical basis of our assets and liabilities. As a result of the Recapitalization, our outstanding capital stock is owned by the Investors, certain members of management and key employees. On April 29, 2008, HCA Inc.’s common stock was registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended, thus subjecting us to the reporting requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Our common stock is not traded on a national securities exchange.

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure (the “Corporate Reorganization”). HCA Holdings, Inc. became the new parent company, and HCA Inc. is nowbecame HCA Holdings, Inc.’s wholly-owned direct subsidiary. As part of the Corporate Reorganization, HCA Inc.’s outstanding shares of common stock were automatically converted, on a share for share basis, into identical shares of HCA Holdings, Inc.’s common stock. HCA Holdings, Inc.’s amended and restated certificate of incorporation, amended and restated by-laws, executive officers and board of directors are the same as HCA Inc.’s in effect immediately prior to the Corporate Reorganization, and the rights, privileges and interests of HCA Inc.’s stockholders remain the same with respect to HCA Holdings, Inc., as the new holding company. Additionally, asAs a result of the Corporate Reorganization, HCA Holdings, Inc. was deemed the successor registrant to HCA Inc. under the Securities and Exchange ActAct.

During February 2011, our Board of 1934, as amended, andDirectors approved an increase in the number of our authorized shares to 1,800,000,000 shares of HCA Holdings, Inc.’s common stock are deemed registered under Section 12(g)and a 4.505-to-one split of our issued and outstanding common shares. All common share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements reflect the 4.505-to-one split. During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock at a price of $30.00 per share (before deducting underwriter discounts, commissions and other related offering expenses). Certain of our stockholders also sold 57,410,700 shares of our common stock in this offering. We did not receive any proceeds from the shares sold by the selling stockholders. Our common stock is now traded on the New York Stock Exchange Act.

(symbol “HCA”).

HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At December 31, 2010,2011, these affiliates owned and operated 156163 hospitals, 97108 freestanding surgery centers and provided extensive outpatient and ancillary services. Affiliates of HCA Holdings, Inc. are also partners in joint ventures that own and operate eight hospitals and nine freestanding surgery centers, which are accounted for using the equity method. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Inc. and its affiliates prior to the Corporate Reorganization and to HCA Holdings, Inc. and its affiliates after the Corporate Reorganization. The term “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees’’“employees” refers to employees of affiliates of HCA.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Basis of Presentation

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates.

The consolidated financial statements include all subsidiaries and entities controlled by HCA. We generally define “control” as ownership of a majority of the voting interest of an entity. The consolidated financial statements


F-7


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Basis of Presentation (Continued)
include entities in which we absorb a majority of the entity’s expected losses, receive a majority of the entity’s expected residual returns, or both, as a result of ownership, contractual or other financial interests in the entity. Significant intercompany transactions have been eliminated. Investments in entities we do not control, but in which we have a substantial ownership interest and can exercise significant influence, are accounted for using the equity method.

We have completed various acquisitions and joint venture transactions. The accounts of these entities have been included in our consolidated financial statements for periods subsequent to our acquisition of controlling interests. The majority of our expenses are “cost of revenue” items. Costs that could be classified as general and administrative include our corporate office costs, which were $178$228 million, $164$182 million and $174$164 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Revenues

In 2011, we adopted the provisions of Accounting Standards Update No. 2011-07,Presentation and 2008, respectively.

Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities (“ASU 2011-07”). ASU 2011-07 requires health care entities to change the presentation of the statement of operations by reclassifying the provision for doubtful accounts from an operating expense to a deduction from patient service revenues. All periods presented in these consolidated financial statements and notes to consolidated financial statements have been reclassified in accordance with ASU 2011-07.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Revenues (Continued)

Revenues consist primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per diagnosis, per diem rates or discountedfee-for-service rates. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts (based primarily on historical collection experience) related to these uninsured accounts to record the net self pay accounts receivable at the estimated amounts we expect to collect. Our revenues from our third party payers and the uninsured for the years ended December 31, are summarized in the following table (dollars in millions):

                         
  2010  Ratio  2009  Ratio  2008  Ratio 
 
Medicare $7,203   23.5% $6,866   22.8% $6,550   23.1%
Managed Medicare  2,162   7.0   2,006   6.7   1,696   6.0 
Medicaid  1,962   6.4   1,691   5.6   1,408   5.0 
Managed Medicaid  1,165   3.8   1,113   3.7   895   3.2 
Managed care and other insurers  15,675   51.1   15,324   51.1   14,355   50.5 
International (managed care and other insurers)  784   2.6   702   2.3   775   2.7 
                         
   28,951   94.4   27,702   92.2   25,679   90.5 
Uninsured  1,732   5.6   2,350   7.8   2,695   9.5 
                         
Revenues $30,683   100.0% $30,052   100.0% $28,374   100.0%
                         

   2011  Ratio  2010  Ratio  2009  Ratio 

Medicare

  $7,653    25.8 $7,203    25.7 $6,866    25.6

Managed Medicare

   2,442    8.2    2,162    7.7    2,006    7.5  

Medicaid

   1,845    6.2    1,962    7.0    1,691    6.3  

Managed Medicaid

   1,265    4.3    1,165    4.2    1,113    4.2  

Managed care and other insurers

   15,703    52.9    14,762    52.7    14,323    53.5  

International (managed care and other insurers)

   938    3.2    784    2.8    702    2.6  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   29,846    100.6    28,038    100.1    26,701    99.7  

Uninsured

   1,846    6.2    1,732    6.2    2,350    8.8  

Other

   814    2.7    913    3.3    1,001    3.7  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues before provision for doubtful accounts

   32,506    109.5    30,683    109.6    30,052    112.2  

Provision for doubtful accounts

   (2,824  (9.5  (2,648  (9.6  (3,276  (12.2
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

  $29,682    100.0 $28,035    100.0 $26,776    100.0
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. As a result, there is at least a reasonable possibility recorded estimates will change by a material amount. Estimated reimbursement amounts are adjusted in subsequent periods as cost reports are prepared and filed and as final settlements are determined (in relation to certain government programs, primarily Medicare, this is generally referred to as the “cost report” filing and settlement process). The adjustments to estimated Medicare and Medicaid reimbursement amounts and disproportionate-share funds, which resulted in net increases to revenues, related primarily to cost reports filed during the respective year were $40 million, $52 million and $40 million in 2011, 2010 and $32 million in 2010,


F-8


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Revenues (Continued)
2009, and 2008, respectively. The adjustments to estimated reimbursement amounts, which resulted in net increases to revenues, related primarily to cost reports filed during previous years were $30 million, $50 million and $60 million in 2011, 2010 and $35 million in 2010, 2009, and 2008, respectively.

The Emergency Medical Treatment and Active Labor Act (“EMTALA”) requires any hospital participating in the Medicare program to conduct an appropriate medical screening examination of every person who presents to the hospital’s emergency room for treatment and, if the individual is suffering from an emergency medical condition,

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Revenues (Continued)

to either stabilize the condition or make an appropriate transfer of the individual to a facility able to handle the condition. The obligation to screen and stabilize emergency medical conditions exists regardless of an individual’s ability to pay for treatment. Federal and state laws and regulations, including but not limited to EMTALA, require, and our commitment to providing quality patient care encourages, us to provide services to patients who are financially unable to pay for the health care services they receive. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in revenues. Patients treated at hospitals for nonelective care, who have income at or below 200% of the federal poverty level, are eligible for charity care. The federal poverty level is established by the federal government and is based on income and family size. We provide discounts to uninsured patients who do not qualify for Medicaid or charity care. These discounts are similar to those provided to many local managed care plans. In implementing the discount policy, we first attempt to qualify uninsured patients for Medicaid, other federal or state assistance or charity care. If an uninsured patient does not qualify for these programs, the uninsured discount is applied.

The revenue deductions related to uninsured accounts (charity care and uninsured discounts) generally have the inverse impact on the provision for doubtful accounts. To quantify the total impact of and trends related to uninsured accounts, we believe it is beneficial to view charity care, uninsured discounts and the provision for doubtful accounts in combination, rather than each separately. A summary of these amounts for the years ended December 31, follows (dollars in millions):

                         
  2010  Ratio  2009  Ratio  2008  Ratio 
 
Charity care $2,337   24% $2,151   26% $1,747   25%
Uninsured discounts  4,641   48   2,935   35   1,853   26 
Provision for doubtful accounts  2,648   28   3,276   39   3,409   49 
                         
Total uncompensated care $9,626   100% $8,362   100% $7,009   100%
                         

   2011   Ratio  2010   Ratio  2009   Ratio 

Charity care

  $2,683     24 $2,337     24 $2,151     26

Uninsured discounts

   5,707     51    4,641     48    2,935     35  

Provision for doubtful accounts

   2,824     25    2,648     28    3,276     39  
  

 

 

   

 

 

  

 

 

   

 

 

  

 

 

   

 

 

 

Total uncompensated care

  $11,214     100 $9,626     100 $8,362     100
  

 

 

   

 

 

  

 

 

   

 

 

  

 

 

   

 

 

 

A summary of the estimated cost of total uncompensated care for the years ended December 31, follows (dollars in millions):

             
  2010  2009  2008 
 
Gross patient charges $125,640  $115,682  $102,843 
Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)  23,870   22,975   22,030 
             
Cost-to-charges ratio
  19.0%  19.9%  21.4%
             
             
Total uncompensated care $9,626  $8,362  $7,009 
Multiplied by thecost-to-charges ratio
  19.0%  19.9%  21.4%
             
Estimated cost of total uncompensated care $1,829  $1,664  $1,500 
             


F-9


   2011  2010  2009 

Gross patient charges

  $141,516   $125,640   $115,682  

Patient care costs (salaries and benefits, supplies, other operating expenses and depreciation and amortization)

   25,554    23,870    22,975  
  

 

 

  

 

 

  

 

 

 

Cost-to-charges ratio

   18.1  19.0  19.9
  

 

 

  

 

 

  

 

 

 

Total uncompensated care

  $11,214   $9,626   $8,362  

Multiplied by the cost-to-charges ratio

   18.1  19.0  19.9
  

 

 

  

 

 

  

 

 

 

Estimated cost of total uncompensated care

  $2,030   $1,829   $1,664  
  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Revenues (Continued)
The sum of charity care, uninsured discounts and the provision for doubtful accounts, as a percentage of the sum of revenues, charity care, uninsured discounts and charity carethe provision for doubtful accounts increased from 21.9% for 2008, to 23.8% for 2009, and to 25.6% for 2010.
2010 and to 27.4% for 2011. The trend of the three components of uncompensated care indicateindicates that our decisionincreases to increase our uninsured discounts hashave resulted in the provision for doubtful accounts declining from 49%39% of total uncompensated care for 20082009 to 28%25% of total uncompensated care for 2010,2011, and uninsured discounts have increasedincreasing from 26%35% of total uncompensated care for 20082009 to 48%51% of total uncompensated care for 2010.
2011.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Cash and Cash Equivalents

Cash and cash equivalents include highly liquid investments with a maturity of three months or less when purchased. Our insurance subsidiary’ssubsidiaries’ cash equivalent investments in excess of the amounts required to pay estimated professional liability claims during the next twelve months are not included in cash and cash equivalents as these funds are not available for general corporate purposes. Carrying values of cash and cash equivalents approximate fair value due to the short-term nature of these instruments.

Our cash management system provides for daily investment of available balances and the funding of outstanding checks when presented for payment. Outstanding, but unpresented, checks totaling $384$382 million and $392$384 million at December 31, 20102011 and 2009,2010, respectively, have been included in “accounts payable” in the consolidated balance sheets. Upon presentation for payment, these checks are funded through available cash balances or our credit facility.

Accounts Receivable

We receive payments for services rendered from federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies, employers and patients. We recognize that revenues and receivables from government agencies are significant to our operations, but do not believe there are significant credit risks associated with these government agencies. We do not believe there are any other significant concentrations of revenues from any particular payer that would subject us to any significant credit risks in the collection of our accounts receivable.

Additions to the allowance for doubtful accounts are made by means of the provision for doubtful accounts. Accounts written off as uncollectible are deducted from the allowance for doubtful accounts and subsequent recoveries are added. The amount of the provision for doubtful accounts is based upon management’s assessment of historical and expected net collections, business and economic conditions, trends in federal, state and private employer health care coverage and other collection indicators. The provision for doubtful accounts and the allowance for doubtful accounts relate to “uninsured” amounts (including copayment and deductible amounts from patients who have health care coverage) due directly from patients. Accounts are written off when all reasonable internal and external collection efforts have been performed. We consider the return of an account from the secondary external collection agency to be the culmination of our reasonable collection efforts and the timing basis for writing off the account balance. Writeoffs are based upon specific identification and the writeoff process requires a writeoff adjustment entry to the patient accounting system. Management relies on the results of detailed reviews of historical writeoffs and recoveries at facilities that represent a majority of our revenues and accounts receivable (the “hindsight analysis”) as a primary source of information to utilize in estimating the collectibility of our accounts receivable. We perform the hindsight analysis quarterly, utilizing rolling twelve-months accounts receivable collection and writeoff data. At December 31, 20102011 and 2009,2010, the allowance for doubtful accounts represented approximately 93%92% and 94%93%, respectively, of the $4.249$4.478 billion and $5.176$4.249 billion, respectively, patient due accounts receivable balance. The patient due accounts receivable balance represents the estimated uninsured


F-10


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Accounts Receivable (Continued)
portion of our accounts receivable. The estimated uninsured portion of Medicaid pending and uninsured discount pending accounts is included in our patient due accounts receivable balance. Days revenues in accounts receivable were 4653 days, 4550 days and 4950 days at December 31, 2011, 2010 2009 and 2008,2009, respectively. Adverse changes in general economic conditions, patient accounting service center operations, payer mix or trends in federal or state governmental health care coverage could affect our collection of accounts receivable, cash flows and results of operations.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Inventories

Inventories are stated at the lower of cost(first-in, (first-in, first-out) or market.

Property and Equipment and Amortizable Intangibles

Depreciation expense, computed using the straight-line method, was $1.461 billion in 2011, $1.416 billion in 2010 and $1.419 billion in 2009 and $1.412 billion in 2008.2009. Buildings and improvements are depreciated over estimated useful lives ranging generally from 10 to 40 years. Estimated useful lives of equipment vary generally from four to 10 years.

Debt issuance costs are amortized based upon the terms of the respective debt obligations. The gross carrying amount of deferred loan costs at December 31, 2010 and 2009 was $712 million and $689 million, respectively, and accumulated amortization was $338 million and $271 million, respectively. Amortization of deferred loan costs is included in interest expense and was $81 million, $80 million and $79 million for 2010, 2009 and 2008, respectively.

When events, circumstances or operating results indicate the carrying values of certain long-lived assets and related identifiable intangible assets (excluding goodwill) expected to be held and used, might be impaired, we prepare projections of the undiscounted future cash flows expected to result from the use of the assets and their eventual disposition. If the projections indicate the recorded amounts are not expected to be recoverable, such amounts are reduced to estimated fair value. Fair value may be estimated based upon internal evaluations that include quantitative analyses of revenues and cash flows, reviews of recent sales of similar facilities and independent appraisals.

Long-lived assets to be disposed of are reported at the lower of their carrying amounts or fair value less costs to sell or close. The estimates of fair value are usually based upon recent sales of similar assets and market responses based upon discussions with and offers received from potential buyers.

Investments of Insurance SubsidiarySubsidiaries

At December 31, 20102011 and 2009,2010, the investments of our wholly-owned insurance subsidiarysubsidiaries were classified as“available-for-sale” “available-for-sale” as defined in Accounting Standards Codification (“ASC”) No. 320,Investments — Debt and Equity Securitiesand are recorded at fair value. The investment securities are held for the purpose of providing the funding source to pay professional liability claims covered by the insurance subsidiary.subsidiaries. We perform a quarterly assessment of individual investment securities to determine whether declines in market value are temporary orother-than-temporary. Our investment securities evaluation process involves multiple subjective judgments, often involves estimating the outcome of future events, and requires a significant level of professional judgment in determining whether an impairment has occurred. We evaluate, among other things, the financial position and near term prospects of the issuer, conditions in the issuer’s industry, liquidity of the investment, changes in the amount or timing of expected future cash flows from the investment, and recent downgrades of the issuer by a rating agency, to determine if, and when, a decline in the fair value of an investment below amortized cost is consideredother-than-temporary. The length of time and extent to which the fair value of the investment is less than amortized


F-11


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Investments of Insurance Subsidiary (Continued)
cost and our ability and intent to retain the investment, to allow for any anticipated recovery of the investment’s fair value, are important components of our investment securities evaluation process.

Goodwill and Other Intangible Assets

Goodwill is not amortized but is subject to annual impairment tests. In addition to the annual impairment review, impairment reviews are performed whenever circumstances indicate a possible impairment may exist. Impairment testing for goodwill is done at the reporting unit level. Reporting units are one level below the business segment level, and our impairment testing is performed at the operating division or market level. We compare the fair value of the reporting unit assets to the carrying amount, on at least an annual basis, to

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Goodwill and Other Intangible Assets (Continued)

determine if there is potential impairment. If the fair value of the reporting unit assets is less than their carrying value, we compare the fair value of the goodwill to its carrying value. If the fair value of the goodwill is less than its carrying value, an impairment loss is recognized. Fair value of goodwill is estimated based upon internal evaluations of the related long-lived assets for each reporting unit that include quantitative analyses of revenues and cash flows and reviews of recent sales of similar facilities. WeNo goodwill impairments were recognized during 2011, and we recognized goodwill impairments of $14 million $19 million and $48$19 million during 2010 and 2009, respectively.

During 2011, goodwill increased by $2.329 billion related to acquisitions, declined by $24 million related to facility sales, and 2008, respectively.

declined by $16 million related to foreign currency translation and other adjustments. During 2010, goodwill increased by $125 million related to acquisitions, declined by $14 million related to impairments and increased by $5 million related to foreign currency translation and other adjustments. During 2009, goodwill increased by $5 million related to acquisitions, decreased by $19 million related to impairments and increased by $11 million related to foreign currency translation and other adjustments.

Since January 1, 2000, we have recognized total goodwill impairments of $102 million in the aggregate. None of the goodwill impairments related to evaluations of goodwill at the reporting unit level, as all recognized goodwill impairments during this period related to goodwill allocated to asset disposal groups.

During 2011, other intangible assets increased by $269 million. Other intangible assets are not amortized but are subject to annual impairment tests.

Deferred Loan Costs

Debt issuance costs are amortized based upon the terms of the respective debt obligations. The gross carrying amount of deferred loan costs at December 31, 2011 and 2010 was $638 million and $712 million, respectively, and accumulated amortization was $348 million and $338 million, respectively. Amortization of deferred loan costs is included in interest expense and was $70 million, $81 million and $80 million for 2011, 2010 and 2009, respectively.

Physician Recruiting Agreements

In order to recruit physicians to meet the needs of our hospitals and the communities they serve, we enter into minimum revenue guarantee arrangements to assist the recruited physicians during the period they are relocating and establishing their practices. A guarantor is required to recognize, at the inception of a guarantee, a liability for the fair value of the stand-ready obligation undertaken in issuing the guarantee. We expense the total estimated guarantee liability amount at the time the physician recruiting agreement becomes effective as we are not able to justify recording a contract-based asset based upon our analysis of the related control, regulatory and legal considerations.

The physician recruiting liability amountsamount of $15 million and $24 million at both December 31, 2011 and 2010 and 2009, respectively, representrepresents the amount of expense recognized in excess of payments made through December 31, 20102011 and 2009, respectively.2010. At December 31, 20102011 the maximum amount we could have to pay under all effective minimum revenue guarantees was $48$39 million.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Professional Liability Claims

Reserves for professional liability risks were $1.262$1.291 billion and $1.322$1.262 billion at December 31, 20102011 and 2009,2010, respectively. The current portion of the reserves, $268$298 million and $265$268 million at December 31, 20102011 and 2009,2010, respectively, is included in “other accrued expenses” in the consolidated balance sheets. Provisions for losses related to professional liability risks were $244 million, $222 million and $211 million for 2011, 2010 and $175 million for 2010, 2009, and 2008, respectively, and are included in “other operating expenses” in our consolidated income statements. Provisions for losses related to professional liability risks are based upon actuarially determined estimates. Loss and loss expense


F-12


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 1 —ACCOUNTING POLICIES (Continued)

Professional Liability Claims (Continued)
reserves represent the estimated ultimate net cost of all reported and unreported losses incurred through the respective consolidated balance sheet dates. The reserves for unpaid losses and loss expenses are estimated using individual case-basis valuations and actuarial analyses. Those estimates are subject to the effects of trends in loss severity and frequency. The estimates are continually reviewed and adjustments are recorded as experience develops or new information becomes known. Adjustments to the estimated reserve amounts are included in current operating results. The reserves for professional liability risks cover approximately 2,700 and 2,600 individual claims at both December 31, 20102011 and 2009, respectively,2010 and estimates for unreported potential claims. The time period required to resolve these claims can vary depending upon the jurisdiction and whether the claim is settled or litigated. During 2011 and 2010, and 2009, $243$240 million and $272$243 million, respectively, of net payments were made for professional and general liability claims. The estimation of the timing of payments beyond a year can vary significantly. Although considerable variability is inherent in professional liability reserve estimates, we believe the reserves for losses and loss expenses are adequate; however, there can be no assurance the ultimate liability will not exceed our estimates.

A portion of our professional liability risks is insured through a wholly-owned insurance subsidiary. Subject to a $5 million per occurrence self-insured retention, our facilities are insured by our wholly-owned insurance subsidiary for losses up to $50 million per occurrence. The insurance subsidiary has obtained reinsurance for professional liability risks generally above a retention level of $15 million per occurrence. We also maintain professional liability insurance with unrelated commercial carriers for losses in excess of amounts insured by our insurance subsidiary.

The obligations covered by reinsurance contracts are included in the reserves for professional liability risks, as the insurance subsidiary remains liable to the extent the reinsurers do not meet their obligations under the reinsurance contracts. The amounts receivable under the reinsurance contracts include $11$25 million and $28$11 million at December 31, 20102011 and 2009,2010, respectively, recorded in “other assets” and $3$14 million and $25$3 million at December 31, 20102011 and 2009,2010, respectively, recorded in “other current assets”.

Financial Instruments

Derivative financial instruments are employed to manage risks, including interest rate and foreign currency exposures, and are not used for trading or speculative purposes. We recognize derivative instruments, such as interest rate swap agreements and foreign exchange contracts, in the consolidated balance sheets at fair value. Changes in the fair value of derivatives are recognized periodically either in earnings or in stockholders’ equity, as a component of other comprehensive income (loss), depending on whether the derivative financial instrument qualifies for hedge accounting, and if so, whether it qualifies as a fair value hedge or a cash flow hedge. Generally, changes in fair values of derivatives accounted for as fair value hedges are recorded in earnings, along with the changes in the fair value of the hedged items related to the hedged risk. Gains and losses on derivatives designated as cash flow hedges, to the extent they are effective, are recorded in other comprehensive income

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

Financial Instruments (Continued)

(loss), and subsequently reclassified to earnings to offset the impact of the forecasted transactions when they occur. In the event the forecasted transaction to which a cash flow hedge relates is no longer likely, the amount in other comprehensive income (loss) is recognized in earnings and generally the derivative is terminated. Changes in the fair value of derivatives not qualifying as hedges, and for any portion of a hedge that is ineffective, are reported in earnings.

The net interest paid or received on interest rate swaps is recognized as interest expense. Gains and losses resulting from the early termination of interest rate swap agreements are deferred and amortized as adjustments to interest expense over the remaining term of the debt originally covered byassociated with the terminated swap.


F-13


Electronic Health Record Incentive Payments

The American Recovery and Reinvestment Act of 2009 provides for Medicare and Medicaid incentive payments beginning in 2011 for eligible hospitals and professionals that adopt and meaningfully use certified electronic health record (“EHR”) technology. We recognize income related to Medicare and Medicaid incentive payments using a gain contingency model that is based upon when our eligible hospitals have demonstrated meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

Medicaid EHR incentive calculations and related payment amounts are based upon prior period cost report information available at the time our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, and are not subject to revision for cost report data filed for a subsequent period. Thus, incentive income recognition occurs at the point our eligible hospitals adopt, implement or demonstrate meaningful use of certified EHR technology for the applicable period, as the cost report information for the full cost report year that will determine the final calculation of the incentive payment is known at that time.

Medicare EHR incentive calculations and related initial payment amounts are based upon the most current filed cost report information available at the time our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period. However, unlike Medicaid, this initial payment amount will be adjusted based upon an updated calculation using the annual cost report information for the cost report period that began during the applicable payment year. Thus, incentive income recognition occurs at the point our eligible hospitals demonstrate meaningful use of certified EHR technology for the applicable period and the cost report information for the full cost report year that will determine the final calculation of the incentive payment is available.

We recognized $210 million of electronic health record incentive income related to Medicaid ($87 million) and Medicare ($123 million) incentive programs during the year ended December 31, 2011. At December 31, 2011, we have $134 million of deferred EHR incentive income, which represents initial incentive payments received for which EHR incentive income has not been recognized. We previously reported $39 million of Medicaid EHR incentives and $51 million ($34 million of Medicaid EHR incentives and $17 million of Medicare EHR incentives) for the quarters ended June 30, 2011 and September 30, 2011, respectively, in the line item “Revenues” in our consolidated income statements. These amounts have been reclassified and are now included in the line item “Electronic health record incentive income” in our consolidated income statement for the year ended December 31, 2011.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1 — ACCOUNTING POLICIES (Continued)

NOTE 1 —

ACCOUNTING POLICIES (Continued)
Noncontrolling Interests in Consolidated Entities

The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned entities that we control. Accordingly, we have recorded noncontrolling interests in the earnings and equity of such entities.

Related Party Transactions — Management Agreement

Affiliates of

The Investors have provided management and advisory services to the Investors entered intoCompany pursuant to a management agreement with us pursuant to which such affiliates will provide us with management services. Under the management agreement, the affiliates ofamong HCA Inc. and the Investors are entitled to receive an aggregate annual management fee of $15 million, which amount increases annually at a rate equal to the percentage increase in Adjusted EBITDA (as defined in the Management Agreement) in the applicable year compared to the preceding year, and reimbursement ofout-of-pocket expenses incurredexecuted in connection with the provisionInvestors’ acquisition of servicesHCA Inc. in November 2006. The management agreement was terminated pursuant to its terms upon completion of the agreement.initial public offering of our common stock during March 2011, and the Company paid the Investors a final fee of $181 million. The management agreement also provided that the Company pay a 1% fee in connection with certain financing, acquisition, divestiture and change of control transactions. The Company paid the Investors a fee of $26 million related to the initial public offering of our common stock, and this fee was recorded as a cost of the stock offering. The annual management fee was $18 million for 2010 and $15 million for both 2009 and 2008. The management agreement has an initial term expiring on December 31, 2016, provided that the term will be extended annually for one additional2009.

Reclassifications

Certain prior year unless we or the Investors provide noticeamounts have been reclassified to conform to the other of their desire not to automatically extend the term. In addition, the management agreement provides that the affiliates of the Investors are entitled to receive a fee equal to 1% of the gross transaction value in connection with certain financing, acquisition, disposition, and change of control transactions, as well as a termination fee based on the net present value of future payment obligations under the management agreement in the event of an initial public offering or under certain other circumstances. The agreement also contains customary exculpation and indemnification provisions in favor of the Investors and their affiliates.

2011 presentation.

NOTE 2 — SHARE-BASED COMPENSATION

NOTE 2 —

SHARE-BASED COMPENSATION
Certain management holders of outstanding HCA stock options retained certain of their stock options (the “Rollover Options”) in lieu of receiving the Merger consideration. The Rollover Options remain outstanding in accordance with the terms of the governing stock incentive plans and grant agreements pursuant to which the holder originally received the stock option grants, except the exercise price and number of shares subject to the rollover option agreement were adjusted so that the aggregate intrinsic value for each applicable option holder was maintained and the exercise price for substantially all the options was adjusted to $12.75 per option. Pursuant to the rollover option agreement, 10,967,500 prerecapitalization HCA stock options were converted into 2,285,200 Rollover Options, of which 1,021,900 are outstanding and exercisable at December 31, 2010.
2006 Stock Incentive Plan

The 2006 Stock Incentive Plan for Key Employees of HCA Holdings Inc. and its Affiliates, as Amended and Restated (the “2006“Stock Incentive Plan”) is designed to promote the long term financial interests and growth of the Company and its subsidiaries by attracting and retaining management and other personnel and key service providers and to motivate management personnel by means of incentives to achieve long range goals and further the alignment of interests of participants with those of our stockholders through opportunities for increased stock, or stock-based, ownership in the Company. During 2011, our Board of Directors approved certain amendments to the Stock Incentive Plan that became effective upon the initial public offering of our common stock. The amendments included an increase to the number of shares available for issuance under the plan by 40,000,000 shares. A portion of the options under the 2006Stock Incentive Plan vests solely based upon continued employment over a specific period of time, and a portion of the options vests based both upon continued employment over a specific period of time and upon the achievement of predetermined financial and Investor return targets over time. We granted 214,1001,288,000 and 1,785,900964,000 options under the 2006Stock Incentive Plan during 20102011 and 2009,2010, respectively. As of December 31, 2010, 4,495,4002011, 35,090,800 options granted under the 2006Stock Incentive Plan have vested, of which 4,269,80030,723,400 are outstanding and exercisable, and there were 329,70042,099,900 shares available for future grants under the 2006Stock Incentive Plan.


F-14


Rollover Options

Certain management holders of outstanding prerecapitalization HCA stock options retained certain of their stock options (the “Rollover Options”). The Rollover Options remain outstanding in accordance with the terms of the governing stock incentive plans and grant agreements pursuant to which the holder originally received the

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 2 — SHARE-BASED COMPENSATION (Continued)

NOTE 2 —

SHARE-BASED COMPENSATION (Continued)
Rollover Options (Continued)

stock option grants. Pursuant to the rollover option agreement, 49,408,100 prerecapitalization HCA stock options were converted into 10,294,500 Rollover Options, of which 2,825,100 are outstanding and exercisable at December 31, 2011.

Stock Option Activity

The fair value of each stock option award is estimated on the grant date, using option valuation models and the weighted average assumptions indicated in the following table. Awards under the 2006Stock Incentive Plan generally vest based on continued employment and based upon achievement of certain financial and Investor return targets. Each grant is valued as a single award with an expected term equal to the average expected term of the component vesting tranches. We use historical option exercise behavior data and other factors to estimate the expected term of the options. The expected term of the option is limited by the contractual term, and employee post-vesting termination behavior is incorporated in the historical option exercise behavior data. Compensation cost is recognized on the straight-line attribution method. The straight-line attribution method requires that total compensation expense recognized must at least equal the vested portion of the grant-date fair value. The expected volatility is derived using historical stock price information of certain peer group companies for a period of time equal to the expected option term. The risk-free interest rate is the approximate yield on United States Treasury Strips having a life equal to the expected option life on the date of grant. The expected life is an estimate of the number of years an option will be held before it is exercised.

             
  2010  2009  2008 
 
Risk-free interest rate  2.07%  1.45%  2.50%
Expected volatility  35%  35%  30%
Expected life, in years  5   5   4 
Expected dividend yield         

   2011  2010  2009 

Risk-free interest rate

   0.89  2.07  1.45

Expected volatility

   41  35  35

Expected life, in years

   5    5    5  

Expected dividend yield

             

Information regarding stock option activity during 2011, 2010 2009 and 20082009 is summarized below (share amounts in thousands):

                 
     Weighted
  Weighted
    
     Average
  Average
  Aggregate
 
  Stock
  Exercise
  Remaining
  Intrinsic Value
 
  Options  Price  Contractual Term  (dollars in millions) 
 
Options outstanding, December 31, 2007  11,172  $43.54         
Granted  357   58.21         
Exercised  (480)  15.01         
Cancelled  (412)  51.14         
                 
Options outstanding, December 31, 2008  10,637   45.02         
Granted  1,786   88.74         
Exercised  (506)  17.16         
Cancelled  (390)  52.08         
                 
Options outstanding, December 31, 2009  11,527   52.78         
Granted  214   70.87         
Exercised  (383)  18.30         
Cancelled  (140)  35.85         
                 
Options outstanding, December 31, 2010  11,218   38.64   6.3 years  $736 
                 
Options exercisable, December 31, 2010  5,292  $51.12   6.0 years  $281 

   Stock
Options
  Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual Term
   Aggregate
Intrinsic  Value
(dollars in millions)
 

Options outstanding, December 31, 2008

   47,906   $9.99      

Granted

   8,045    19.70      

Exercised

   (2,278  3.81      

Cancelled

   (1,756  11.56      
  

 

 

      

Options outstanding, December 31, 2009

   51,917    11.72      

Granted

   964    15.73      

Exercised

   (1,726  4.06      

Cancelled

   (629  7.96      
  

 

 

      

Options outstanding, December 31, 2010

   50,526    8.58      

Granted

   1,288    23.35      

Exercised

   (5,044  6.31      

Cancelled

   (458  5.88      
  

 

 

      

Options outstanding, December 31, 2011

   46,312    9.26     5.6 years    $595  
  

 

 

      

Options exercisable, December 31, 2011

   33,548   $9.74     5.4 years    $414  

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 2 — SHARE-BASED COMPENSATION (Continued)

Stock Option Activity (Continued)

During 2010, our Board of Directors declared three distributions to the Company’s stockholders and holders of stock options. The distributions totaled $42.50$9.43 per share and vested stock option. Pursuant to the terms of our stock option plans, the holders of nonvested stock options received $42.50$9.43 per share reductions (subject to certain tax


F-15


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 2 —SHARE-BASED COMPENSATION (Continued)

Stock Option Activity (Continued)
related limitations for certain stock options that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon the vesting of the applicable stock options) to the exercise price of the share-based awards.

The weighted average fair values of stock options granted during 2011, 2010 and 2009 were $8.53, $7.13 and 2008 were $32.13, $15.96 and $14.01$3.54 per share, respectively. The total intrinsic value of stock options exercised in the year ended December 31, 20102011 was $32$121 million. As of December 31, 2010,2011, the unrecognized compensation cost related to nonvested awards was $44$23 million.

NOTE 3 —ACQUISITIONS AND DISPOSITIONS

NOTE 3 — ACQUISITIONS AND DISPOSITIONS

HealthONE Acquisition

During October 2011, we completed the acquisition of the Colorado Health Foundation’s (“Foundation”) approximate 40% remaining ownership interest in the HCA-HealthONE LLC (“HealthONE”) joint venture for $1.450 billion. HealthONE’s assets include seven hospitals and 12 freestanding surgery centers in the Denver area. We accounted for our investment in HealthONE using the equity method through October 2011 with our share of their operations all recorded in the line item “Equity in earnings of affiliates” in our consolidated income statements, and we began consolidating HealthONE’s operations in our consolidated income statements beginning November 2011.

The total cost of the HealthONE acquisition has been allocated to the assets acquired and liabilities assumed based upon their respective fair values in accordance with ASC No. 805,Business Combinations. The purchase price represented a premium over the fair value of the net tangible and identifiable intangible assets acquired for reasons such as expected cash flows and HealthONE’s assembled workforce.

Based on our purchase price allocation as of December 31, 2011, we identified and analyzed the acquired fixed assets, contracts, contractual commitments and legal contingencies to record the fair value of all assets acquired and liabilities assumed, resulting in goodwill of $2.261 billion being recorded. The amount of goodwill expected to be tax deductible is approximately $894 million. We also recorded a gain of $1.522 billion related to this acquisition due to the remeasurement of our previous equity investment in HealthONE, based upon our acquisition of the Foundation’s ownership interest and the resulting consolidation of the entire enterprise at estimated fair value. Adjustments to the December 31, 2011 purchase price allocation are not expected to be material.

A summary of the purchase price allocation, including assumed liabilities, follows (in millions):

Current assets

  $400  

Property and equipment

   1,040  

Identifiable intangible asset (trade name)

   269  

Goodwill

   2,261  

Other assets

   7  

Liabilities

   152  

Noncontrolling interests

   93  

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 3 — ACQUISITIONS AND DISPOSITIONS (Continued)

HealthONE Acquisition (Continued)

The acquired HealthONE operating results have been included in the consolidated income statements since the acquisition date. The revenues and net income attributable to HCA Holdings, Inc. related to the acquired HealthONE operations for the period from November 1, 2011 through December 31, 2011 were $347 million and $15 million, respectively. The unaudited pro forma combined summary of our operations gives effect to including the acquired HealthONE operating results as if the acquisition had occurred as of January 1, 2010, follows (in millions):

   Years Ended
December 31,
 
   2011   2010 

Pro forma revenues

  $31,383    $29,925  

Pro forma net income attributable to HCA Holdings, Inc.

   2,507     1,257  

Pro forma adjustments to net income attributable to HCA Holdings, Inc. include adjustments to record HealthONE’s operating results on a consolidated basis and eliminate the equity method operating results, to record depreciation expense based on the estimated fair value assigned to the long-lived assets acquired, to record interest expense assuming the increase in long-term debt used to fund the acquisition had occurred as of January 1, 2010 and to record the related tax effects. These pro forma results are not necessarily indicative of the actual results of operations that would have occurred if the acquisition had occurred on January 1, 2010.

Other Acquisitions and Dispositions

During 2011, we paid $136 million to acquire a hospital and $96 million to acquire other nonhospital health care entities. During 2010, we paid $163 million to acquire two hospitals and $70 million to acquire other health care entities. During 2009, we paid $61 million to acquire nonhospital health care entities. During 2008, we paid $18 million to acquire one hospital and $67 million to acquire other health care entities. Purchase price amounts have been allocated to the related assets acquired and liabilities assumed based upon their respective fair values. The purchase price paid in excess of the fair value of identifiable net assets of these acquired entities aggregated $68 million, $125 million and $5 million in 2011, 2010 and $43 million in 2010, 2009, and 2008, respectively. The consolidated financial statements include the accounts and operations of the acquired entities subsequent to the respective acquisition dates. The pro forma effects of thethese acquired entities on our results of operations for periods prior to the respective acquisition dates were not significant.

During 2011, we received proceeds of $281 million and recognized a net pretax gain of $142 million ($80 million after tax) related to the sales of a hospital facility and our investment in a hospital joint venture. During 2010, we received proceeds of $37 million and recognized a net pretax gain of $4 million ($2 million after tax) from sales of nonhospital health care entities and real estate investments. During 2009, we received proceeds of $3 million and recognized a net pretax loss of $8 million ($5 million after tax) on the sales of three hospitals. We also received proceeds of $38 million and recognized a net pretax loss of $7 million ($4 million after tax) from sales of other health care entities and real estate investments. During 2008, we received proceeds

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 4 — IMPAIRMENTS OF LONG-LIVED ASSETS

There were no impairments of $143 million and recognized a net pretax gain of $81 million ($48 million after tax) from the sales of two hospitals. We also received proceeds of $50 million and recognized a net pretax gain of $16 million ($10 million after tax) from sales of other health care entities and real estate investments.

NOTE 4 —IMPAIRMENTS OF LONG-LIVED ASSETS
long-lived assets for 2011. During 2010, we recorded pretax charges of $123 million to reduce the carrying value of identified assets to estimated fair value. The $123 million asset impairment includes $57 million related to a hospital facility in our Central Group, $5 million related to other health care entity investments in our EasternNational Group, $17 million related to a hospital facility in our WesternSouthwest Group and $44 million related to Corporate and other, which includes $35 million for the writeoff of capitalized engineering and design costs related to certain building safety requirements (California earthquake standards) that have been revised. During 2009, we recorded pretax charges of $43 million to reduce the carrying value of identified assets to estimated fair value. The $43 million asset impairment includes $15 million related to certain hospital facilities and other health care entity investments in our Central Group, $14$16 million related to other health care entity investments in our EasternNational Group and $14$12 million related to certain hospital facilities in our WesternSouthwest Group. During 2008, we recorded pretax charges of $64 million to reduce the carrying value of identified assets to estimated fair value. The $64 million asset impairment includes $55 million related to other health care entity investments in our Eastern Group and $9 million related to certain hospital facilities in our Central Group.

The asset impairment charges did not have a significant impact on our operations or cash flows and are not expected to significantly impact cash flows for future periods. The impairment charges affected our property and equipment asset category by $109 million $24 million and $16$24 million in 2010 and 2009, and 2008, respectively.


F-16


NOTE 5 — INCOME TAXES

HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 5 —INCOME TAXES
The provision for income taxes consists of the following (dollars in millions):
             
  2010  2009  2008 
 
Current:            
Federal $401  $809  $699 
State  26   75   56 
Foreign  33   21   25 
Deferred:            
Federal  161   (274)  (505)
State  17   (37)  (29)
Foreign  20   33   22 
             
  $658  $627  $268 
             

   2011  2010   2009 

Current:

     

Federal

  $(119 $401    $809  

State

   (12  26     75  

Foreign

   44    33     21  

Deferred:

     

Federal

   714    161     (274

State

   71    17     (37

Foreign

   21    20     33  
  

 

 

  

 

 

   

 

 

 
  $719   $658    $627  
  

 

 

  

 

 

   

 

 

 

The provision for income taxes reflects $100 million, $69 million and $18 million and $20($63 million, ($44 million, $12$44 million and $12 million net of tax, respectively) reductions in interest related to taxing authority examinations for the years ended December 31, 2011, 2010 and 2009, and 2008, respectively.

A reconciliation of the federal statutory rate to the effective income tax rate follows:

             
  2010  2009  2008 
 
Federal statutory rate  35.0%  35.0%  35.0%
State income taxes, net of federal tax benefit  2.7   3.2   3.7 
Change in liability for uncertain tax positions  0.3   (0.2)  (7.4)
Nondeductible intangible assets     0.4   0.4 
Tax exempt interest income  (0.4)  (0.8)  (2.5)
Income attributable to noncontrolling interests from consolidated partnerships  (5.8)  (6.0)  (5.6)
Other items, net  (2.3)  (0.3)  (0.7)
             
Effective income tax rate  29.5%  31.3%  22.9%
             
As a result of a settlement reached with the Appeals Division of the Internal Revenue Service (the “IRS”) and the revision of a proposed IRS adjustment related to prior taxable years, we reduced our provision for income taxes by $69 million in 2008.

  2011  2010  2009 

Federal statutory rate

  35.0%   35.0  35.0

State income taxes, net of federal tax benefit

  2.0    2.7    3.2  

Change in liability for uncertain tax positions

  1.0    0.3    (0.2

Nontaxable gain on acquisition of controlling interest in equity investment

  (13.8)         

Tax exempt interest income

  (0.2)   (0.4  (0.8

Income attributable to noncontrolling interests from consolidated partnerships

  (2.4)   (5.8  (6.0

Other items, net

  (1.4)   (2.3  0.1  
 

 

 

  

 

 

  

 

 

 

Effective income tax rate

  20.2%   29.5  31.3
 

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 5 — INCOME TAXES (Continued)

A summary of the items comprising the deferred tax assets and liabilities at December 31 follows (dollars in millions):

                 
  2010  2009 
  Assets  Liabilities  Assets  Liabilities 
 
Depreciation and fixed asset basis differences $  $211  $  $258 
Allowances for professional liability and other risks  329      288    
Accounts receivable  1,011      1,453    
Compensation  202      190    
Other  776   400   740   336 
                 
  $2,318  $611  $2,671  $594 
                 


F-17


   2011   2010 
   Assets   Liabilities   Assets   Liabilities 

Depreciation and fixed asset basis differences

  $    $402    $    $211  

Allowances for professional liability and other risks

   337          329       

Accounts receivable

   706          1,011       

Compensation

   216          202       

Other

   698     511     776     400  
  

 

 

   

 

 

   

 

 

   

 

 

 
  $1,957    $913    $2,318    $611  
  

 

 

   

 

 

   

 

 

   

 

 

 

HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 5 —INCOME TAXES (Continued)
At December 31, 2010,2011, state net operating loss carryforwards (expiring in years 20112012 through 2030)2031) available to offset future taxable income approximated $65$34 million. Utilization of net operating loss carryforwards in any one year may be limited and, in certain cases, result in an adjustment to intangible assets. Net deferred tax assets related to such carryforwards are not significant.

At December 31, 2010,2011, we were contesting, before the IRS Appeals Division, certain claimed deficiencies and adjustments proposed by the IRS Examination Division in connection with its audit of HCA Inc.’s 2005 and 2006 federal income tax returns. The disputed items include the timing of recognition of certain patient service revenues, the deductibility of certain debt retirement costs and our method for calculating the tax allowance for doubtful accounts. In addition, eight taxable periods of HCA Inc. and its predecessors ended in 1997 through 2004, for which the primary remaining issue is the computation of the tax allowance for doubtful accounts, were pending before the IRS Examination Division as of December 31, 2010. The IRS Examination Division began an audit of HCA Inc.’s 2007, 2008 and 2009 federal income tax returns in December 2010.

The following table summarizes the activity related to our unrecognized tax benefits (dollars in millions):

         
  2010  2009 
 
Balance at January 1 $485  $482 
Additions (reductions) based on tax positions related to the current year  (18)  44 
Additions for tax positions of prior years  61   11 
Reductions for tax positions of prior years  (78)  (33)
Settlements  (134)  (8)
Lapse of applicable statutes of limitations  (3)  (11)
         
Balance at December 31 $313  $485 
         

   2011  2010 

Balance at January 1

  $313   $485  

Additions (reductions) based on tax positions related to the current year

   83    (18

Additions for tax positions of prior years

   73    61  

Reductions for tax positions of prior years

   (15  (78

Settlements

       (134

Lapse of applicable statutes of limitations

   (9  (3
  

 

 

  

 

 

 

Balance at December 31

  $445   $313  
  

 

 

  

 

 

 

During 2011, we finalized settlements with the IRS Examination Division resolving all outstanding issues for our 1997 through 2004 tax years. During 2010, we finalized settlements with the Appeals Division of the IRS resolving the deductibility of our 2003 government settlement payment, the timing of certain patient service revenues for 2003 and 2004 and the method for calculating the tax allowance for doubtful accounts for certain affiliated partnerships for 2003 and 2004.

Our liability for unrecognized tax benefits was $413$494 million, including accrued interest of $115$62 million and excluding $15$13 million that was recorded as reductions of the related deferred tax assets, as of December 31, 20102011 ($628413 million, $156$115 million and $13$15 million, respectively, as of December 31, 2009)2010). Unrecognized tax benefits of $190$173 million ($236190 million as of December 31, 2009)2010) would affect the effective rate, if recognized. The

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 5 — INCOME TAXES (Continued)

liability for unrecognized tax benefits does not reflect deferred tax assets of $63$45 million ($7763 million as of December 31, 2009)2010) related to deductible interest and state income taxes or a refundable deposit of $82$19 million ($10482 million as of December 31, 2009)2010), which is recorded in noncurrent assets.

Depending on the resolution of the IRS disputes, the completion of examinations by federal, state or international taxing authorities, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible that our liability for unrecognized tax benefits may significantly increase or decrease within the next 12 months. However, we are currently unable to estimate the range of any possible change.

NOTE 6 — EARNINGS PER SHARE

NOTE 6 — EARNINGS PER SHARE

We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding plus the dilutive effect of outstanding stock options, computed using the treasury stock method. The following table sets


F-18


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 6 — EARNINGS PER SHARE (Continued)
forth the computations of basic and diluted earnings per share for the years ended December 31, 2011, 2010 2009 and 20082009 (dollars in millions, except per share amounts, and shares in thousands):
             
  2010  2009  2008 
 
Net income attributable to HCA Holdings, Inc. $1,207  $1,054  $673 
             
Weighted average common shares outstanding  94,656   94,465   94,051 
Effect of dilutive stock options  2,424   1,480   1,617 
             
Shares used for diluted earnings per share  97,080   95,945   95,668 
             
Earnings per share:            
Basic earnings per share $12.75  $11.16  $7.16 
Diluted earnings per share $12.43  $10.99  $7.04 
NOTE 7 —INVESTMENTS OF INSURANCE SUBSIDIARY

   2011   2010   2009 

Net income attributable to HCA Holdings, Inc

  $2,465    $1,207    $1,054  

Weighted average common shares outstanding

   476,609     426,424     425,567  

Effect of dilutive stock options

   19,334     10,923     6,660  
  

 

 

   

 

 

   

 

 

 

Shares used for diluted earnings per share

   495,943     437,347     432,227  
  

 

 

   

 

 

   

 

 

 

Earnings per share:

      

Basic earnings per share

  $5.17    $2.83    $2.48  

Diluted earnings per share

  $4.97    $2.76    $2.44  

NOTE 7 — INVESTMENTS OF INSURANCE SUBSIDIARIES

A summary of the insurance subsidiary’ssubsidiaries’ investments at December 31 follows (dollars in millions):

                 
  2010 
     Unrealized
    
  Amortized
  Amounts  Fair
 
  Cost  Gains  Losses  Value 
 
Debt securities:                
States and municipalities $312  $12  $(1) $323 
Auction rate securities  251      (1)  250 
Asset-backed securities  26   1   (1)  26 
Money market funds  135         135 
                 
   724   13   (3)  734 
Equity securities  8   1   (1)  8 
                 
  $732  $14  $(4)  742 
                 
Amounts classified as current assets              (100)
                 
Investment carrying value             $642 
                 
                 
  2009 
     Unrealized
    
  Amortized
  Amounts  Fair
 
  Cost  Gains  Losses  Value 
 
Debt securities:                
States and municipalities $668  $30  $(3) $695 
Auction rate securities  401      (5)  396 
Asset-backed securities  43      (1)  42 
Money market funds  176         176 
                 
   1,288   30   (9)  1,309 
Equity securities  8   1   (2)  7 
                 
  $1,296  $31  $(11)  1,316 
                 
Amounts classified as current assets              (150)
                 
Investment carrying value             $1,166 
                 


F-19


   2011 
   Amortized
Cost
   Unrealized
Amounts
  Fair
Value
 
     Gains   Losses  

Debt securities:

       

States and municipalities

  $398    $19    $   $417  

Auction rate securities

   139          (8  131  

Asset-backed securities

   20              20  

Money market funds

   53              53  
  

 

 

   

 

 

   

 

 

  

 

 

 
   610     19     (8  621  

Equity securities

   7     1     (1  7  
  

 

 

   

 

 

   

 

 

  

 

 

 
  $617    $20    $(9  628  
  

 

 

   

 

 

   

 

 

  

Amounts classified as current assets

        (80
       

 

 

 

Investment carrying value

       $548  
       

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 7 —INVESTMENTS OF INSURANCE SUBSIDIARY (Continued)

NOTE 7 — INVESTMENTS OF INSURANCE SUBSIDIARIES (Continued)

   2010 
   Amortized
Cost
   Unrealized
Amounts
  Fair
Value
 
     Gains   Losses  

Debt securities:

       

States and municipalities

  $312    $12    $(1 $323  

Auction rate securities

   251          (1  250  

Asset-backed securities

   26     1     (1  26  

Money market funds

   135              135  
  

 

 

   

 

 

   

 

 

  

 

 

 
   724     13     (3  734  

Equity securities

   8     1     (1  8  
  

 

 

   

 

 

   

 

 

  

 

 

 
  $732    $14    $(4  742  
  

 

 

   

 

 

   

 

 

  

Amounts classified as current assets

        (100
       

 

 

 

Investment carrying value

       $642  
       

 

 

 

At December 31, 20102011 and 20092010 the investments of our insurance subsidiarysubsidiaries were classified as“available-for-sale. “available-for-sale. During 2010, investments in debt securities were reduced as a result of the insurance subsidiary distributing $500 million of excess capital to the Company. Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income (loss). At December 31, 2011 and 2010, and 2009, $92$19 million and $100$92 million, respectively, of our investments were subject to the restrictions included in insurance bond collateralization and assumed reinsurance contracts.

Scheduled maturities of investments in debt securities at December 31, 20102011 were as follows (dollars in millions):

         
  Amortized
  Fair
 
  Cost  Value 
 
Due in one year or less $148  $148 
Due after one year through five years  166   173 
Due after five years through ten years  117   120 
Due after ten years  16   17 
         
   447   458 
Auction rate securities  251   250 
Asset-backed securities  26   26 
         
  $724  $734 
         

   Amortized
Cost
   Fair
Value
 

Due in one year or less

  $101    $102  

Due after one year through five years

   112     119  

Due after five years through ten years

   143     151  

Due after ten years

   95     98  
  

 

 

   

 

 

 
   451     470  

Auction rate securities

   139     131  

Asset-backed securities

   20     20  
  

 

 

   

 

 

 
  $610    $621  
  

 

 

   

 

 

 

The average expected maturity of the investments in debt securities at December 31, 20102011 was 2.94.4 years, compared to the average scheduled maturity of 11.410.8 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to their scheduled maturity date. The average expected maturities for our auction rate and asset-backed securities were derived from valuation models of expected cash flows and involved management’s judgment. The average expected maturities for our auction rate and asset-backed securities at December 31, 20102011 were 4.14.9 years and 5.64.8 years, respectively, compared to average scheduled maturities of 24.124.9 years and 25.624.8 years, respectively.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 7 — INVESTMENTS OF INSURANCE SUBSIDIARIES (Continued)

The cost of securities sold is based on the specific identification method. Sales of securities for the years ended December 31 are summarized below (dollars in millions):

             
  2010  2009  2008 
 
Debt securities:            
Cash proceeds $329  $141  $23 
Gross realized gains  14       
Gross realized losses  1   1    
Equity securities:            
Cash proceeds $  $3  $4 
Gross realized gains     1   2 
Gross realized losses        2 

   2011   2010   2009 

Debt securities:

      

Cash proceeds

  $    $329    $141  

Gross realized gains

        14       

Gross realized losses

        1     1  

Equity securities:

      

Cash proceeds

  $    $    $3  

Gross realized gains

             1  

Gross realized losses

               

NOTE 8 — FINANCIAL INSTRUMENTS

NOTE 8 —

FINANCIAL INSTRUMENTS
Interest Rate Swap Agreements

We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based


F-20


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 8 —FINANCIAL INSTRUMENTS (Continued)

Interest Rate Swap Agreements (Continued)
on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. Pay-variable interest rate swaps effectively convert fixed interest rate obligations to LIBOR indexed variable rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities, for the interest rate swap agreements which have been designated as cash flow hedges. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at December 31, 20102011 (dollars in millions):

             
  Notional
     Fair
 
  Amount  Maturity Date  Value 
 
Pay-fixed interest rate swaps $7,100   November 2011  $(277)
Pay-fixed interest rate swaps (starting November 2011)  3,000   December 2016   (114)
Certain of our interest rate swaps are not designated as hedges, and changes in fair value are recognized in results of operations. The following table sets forth our interest rate swap agreements, which were not designated as hedges, at December 31, 2010 (dollars in millions):
             
  Notional
     Fair
 
  Amount  Maturity Date  Value 
 
Pay-fixed interest rate swap $500   March 2011  $(3)
Pay-variable interest rate swap  500   March 2011    
Pay-fixed interest rate swap  900   November 2011   (35)
Pay-variable interest rate swap  900   November 2011   3 

   Notional
Amount
   Maturity Date   Fair
Value
 

Pay-fixed interest rate swaps

  $500     December 2014    $(7

Pay-fixed interest rate swaps

   3,000     December 2016     (339

Pay-fixed interest rate swaps

   1,000     December 2017     (53

During the next 12 months, we estimate $330$110 million will be reclassified from other comprehensive income (“OCI”) to interest expense.

Cross Currency Swaps

The Company and certain subsidiaries have incurred obligations and entered into various intercompany transactions where such obligations are denominated in currencies, other than the functional currencies of the parties executing the trade. In order to mitigate the currency exposure risks and better match the cash flows of our obligations and intercompany transactions with cash flows from operations, we enter into various cross currency swaps. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.

Certain of our

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 8 — FINANCIAL INSTRUMENTS (Continued)

Cross Currency Swaps (Continued)

Our cross currency swaps areswap is not designated as hedges,a hedge, and changes in fair value are recognized in results of operations. The following table sets forth our cross currency swap agreement which was not designated as a hedge at December 31, 20102011 (amounts in millions):

             
  Notional
     Fair
 
  Amount  Maturity Date  Value 
 
Euro — United States Dollar Currency Swap  351 Euro   December 2011  $39 


F-21


   Notional
Amount
   Maturity Date   Fair
Value
 

Euro — United States Dollar Currency Swap

   291 Euro     November 2013    $(16

HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 8 —FINANCIAL INSTRUMENTS (Continued)
Derivatives — Results of Operations

The following tables present the effect of our interest rate and cross currency swaps on our results of operations for the year ended December 31, 20102011 (dollars in millions):

             
     Location of Loss
  Amount of Loss
 
  Amount of Loss (Gain)
  Reclassified from
  Reclassified from
 
  Recognized in OCI on
  Accumulated OCI
  Accumulated OCI
 
Derivatives in Cash Flow Hedging Relationships
 Derivatives, Net of Tax  into Operations  into Operations 
 
Interest rate swaps $170   Interest expense  $384 
Cross currency swaps  (9)  Interest expense    
             
  $161      $384 
             
         
  Location of Loss
  Amount of Loss
 
  Recognized in
  Recognized in
 
  Operations on
  Operations on
 
Derivatives Not Designated as Hedging Instruments
 Derivatives  Derivatives 
 
Interest rate swaps  Other operating expenses  $3 
Cross currency swap  Other operating expenses   40 

Derivatives in Cash Flow Hedging Relationships

  Amount of Loss
Recognized  in OCI on
Derivatives, Net of Tax
   Location of  Loss
Reclassified from
Accumulated  OCI
into Operations
   Amount of  Loss
Reclassified from
Accumulated  OCI
into Operations
 

Interest rate swaps

  $197     Interest expense    $341  

Derivatives Not Designated as Hedging Instruments

  Location of Loss
Recognized in
Operations on
Derivatives
   Amount of Loss
Recognized in
Operations on
Derivatives
 

Interest rate swaps

   Other operating expenses    $1  

Cross currency swap

   Other operating expenses     54  

Credit-risk-related Contingent Features

We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of December 31, 2010,2011, we have not been required to post any collateral related to these agreements. If we had breached these provisions at December 31, 2010,2011, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $404$452 million.

NOTE 9 —ASSETS AND LIABILITIES MEASURED AT FAIR VALUE
ASC

NOTE 9 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

Accounting Standards Codification 820,Fair Value Measurements and Disclosures(“ASC 820”) defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. ASC 820 applies to reported balances that are required or permitted to be measured at fair value under existing accounting pronouncements.

ASC 820 emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 9 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)

Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance


F-22


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 9 —ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)
of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

Cash Traded Investments

Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. Such instruments include auction rate securities (“ARS”) and limited partnership investments. The transaction price is initially used as the best estimate of fair value.

Our wholly-owned insurance subsidiarysubsidiaries had investments in tax-exempt ARS, which are backed by student loans substantially guaranteed by the federal government, of $250$131 million ($251139 million par value) at December 31, 2010.2011. We do not currently intend to attempt to sell the ARS as the liquidity needs of our insurance subsidiarysubsidiaries are expected to be met by other investments in itstheir investment portfolio. These securities continue to accrueportfolios. During 2011 and pay interest semi-annually based on the failed auction maximum rate formulas stated in their respective Official Statements. During 2010, and 2009, certain issuers and their broker/dealers redeemed or repurchased $150$112 million and $172$150 million, respectively, of our ARS at par value. The valuation of these securities involved management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived a fair market value compared to tax-equivalent yields of other student loan backed variable rate securities of similar credit worthiness and similar effective maturities.

Derivative Financial Instruments

We have entered into interest rate and cross currency swap agreements to manage our exposure to fluctuations in interest rates and foreign currency risks. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves, foreign exchange rates and implied volatilities. To comply with the provisions of ASC 820, we incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions and at December 31, 20102011 and 2009,2010, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.


F-23


HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 9 —ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)

NOTE 9 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)

The following table summarizes our assets and liabilities measured at fair value on a recurring basis as of December 31, 20102011 and 2009,2010, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):

                 
  December 31, 2010 
     Fair Value Measurements Using 
     Quoted Prices in
       
     Active Markets for
       
     Identical Assets
  Significant Other
  Significant
 
     and Liabilities
  Observable Inputs
  Unobservable Inputs
 
  Fair Value  (Level 1)  (Level 2)  (Level 3) 
 
Assets:                
Investments of insurance subsidiary:                
Debt securities:                
States and municipalities $323  $  $323  $ 
Auction rate securities  250         250 
Asset-backed securities  26      26    
Money market funds  135   135       
                 
   734   135   349   250 
Equity securities  8   2   5   1 
                 
Investments of insurance subsidiary  742   137   354   251 
Less amounts classified as current assets  (100)  (100)      
                 
  $642  $37  $354  $251 
                 
Cross currency swap (Other assets) $39  $  $39  $ 
                 
Liabilities:                
Interest rate swaps (Income taxes and other liabilities) $426  $  $426  $ 


F-24


   December 31, 2011 
      Fair Value Measurements Using 
   Fair Value  Quoted Prices in
Active  Markets for
Identical Assets
and Liabilities
(Level 1)
  Significant Other
Observable  Inputs
(Level 2)
  Significant
Unobservable  Inputs
(Level 3)
 

Assets:

     

Investments of insurance subsidiaries:

     

Debt securities:

     

States and municipalities

  $417   $   $417   $  

Auction rate securities

   131            131  

Asset-backed securities

   20        20      

Money market funds

   53    53          
  

 

 

  

 

 

  

 

 

  

 

 

 
   621    53    437    131  

Equity securities

   7    1    5    1  
  

 

 

  

 

 

  

 

 

  

 

 

 

Investments of insurance subsidiaries

   628    54    442    132  

Less amounts classified as current assets

   (80  (54  (26    
  

 

 

  

 

 

  

 

 

  

 

 

 
  $548   $   $416   $132  
  

 

 

  

 

 

  

 

 

  

 

 

 

Liabilities:

     

Cross currency swap (Income taxes and other liabilities)

  $16   $   $16   $  

Interest rate swaps (Income taxes and other liabilities)

   399        399      

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 9 —ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)
                 
  December 31, 2009 
     Fair Value Measurements Using 
     Quoted Prices in
       
     Active Markets for
       
     Identical Assets
  Significant Other
  Significant
 
     and Liabilities
  Observable Inputs
  Unobservable Inputs
 
  Fair Value  (Level 1)  (Level 2)  (Level 3) 
 
Assets:                
Investments of insurance subsidiary:                
Debt securities:                
States and municipalities $695  $  $695  $ 
Auction rate securities  396         396 
Asset-backed securities  42      42    
Money market funds  176   176       
                 
   1,309   176   737   396 
Equity securities  7   2   4   1 
                 
Investments of insurance subsidiary  1,316   178   741   397 
Less amounts classified as current assets  (150)  (150)      
                 
  $1,166  $28  $741  $397 
                 
Cross currency swap (Other assets) $79  $  $79  $ 
                 
Liabilities:                
Interest rate swaps (Income taxes and other liabilities) $528  $  $528  $ 
Cross currency swaps (Income taxes and other liabilities)  13      13    

NOTE 9 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Continued)

   December 31, 2010 
      Fair Value Measurements Using 
   Fair Value  Quoted Prices in
Active  Markets for
Identical Assets
and Liabilities
(Level 1)
  Significant Other
Observable  Inputs
(Level 2)
   Significant
Unobservable  Inputs
(Level 3)
 

Assets:

      

Investments of insurance subsidiaries:

      

Debt securities:

      

States and municipalities

  $323   $   $323    $  

Auction rate securities

   250             250  

Asset-backed securities

   26        26       

Money market funds

   135    135           
  

 

 

  

 

 

  

 

 

   

 

 

 
   734    135    349     250  

Equity securities

   8    2    5     1  
  

 

 

  

 

 

  

 

 

   

 

 

 

Investments of insurance subsidiaries

   742    137    354     251  

Less amounts classified as current assets

   (100  (100         
  

 

 

  

 

 

  

 

 

   

 

 

 
  $642   $37   $354    $251  
  

 

 

  

 

 

  

 

 

   

 

 

 

Cross currency swap (Other assets)

  $39   $   $39    $  

Liabilities:

      

Interest rate swaps (Income taxes and other liabilities)

  $426   $   $426    $  

The following table summarizes the activity related to the auction rate and equity securities investments of our insurance subsidiarysubsidiaries which have fair value measurements based on significant unobservable inputs (Level 3) during the year ended December 31, 20102011 (dollars in millions):

     
Asset balances at December 31, 2009 $397 
Unrealized gains included in other comprehensive income  4 
Settlements  (150)
     
Asset balances at December 31, 2010 $251 
     

Asset balances at December 31, 2010

  $251  

Unrealized losses included in other comprehensive income

   (7

Settlements

   (112
  

 

 

 

Asset balances at December 31, 2011

  $132  
  

 

 

 

The estimated fair value of our long-term debt was $28.738$27.199 billion and $25.659$28.738 billion at December 31, 20102011 and 2009,2010, respectively, compared to carrying amounts aggregating $28.225$27.052 billion and $25.670$28.225 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

F-25


HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 10 —LONG-TERM DEBT

NOTE 10 — LONG-TERM DEBT

A summary of long-term debt at December 31, including related interest rates at December 31, 2010,2011, follows (dollars in millions):

         
  2010  2009 
 
Senior secured asset-based revolving credit facility (effective interest rate of 1.5%) $1,875  $715 
Senior secured revolving credit facility (effective interest rate of 1.8%)  729    
Senior secured term loan facilities (effective interest rate of 6.9%)  7,530   8,987 
Senior secured first lien notes (effective interest rate of 8.4%)  4,075   2,682 
Other senior secured debt (effective interest rate of 7.1%)  322   362 
         
First lien debt  14,531   12,746 
         
Senior secured cash-pay notes (effective interest rate of 9.7%)  4,501   4,500 
Senior secured toggle notes (effective interest rate of 10.0%)  1,578   1,578 
         
Second lien debt  6,079   6,078 
         
Senior unsecured notes (effective interest rate of 7.1%)  7,615   6,846 
         
Total debt (average life of 6.1 years, rates averaging 7.3%)  28,225   25,670 
Less amounts due within one year  592   846 
         
  $27,633  $24,824 
         

   2011   2010 

Senior secured asset-based revolving credit facility (effective interest rate of 1.8%)

  $2,155    $1,875  

Senior secured revolving credit facility

        729  

Senior secured term loan facilities (effective interest rate of 4.8%)

   7,425     7,530  

Senior secured first lien notes (effective interest rate of 7.7%)

   7,081     4,075  

Other senior secured debt (effective interest rate of 6.8%)

   350     322  
  

 

 

   

 

 

 

First lien debt

   17,011     14,531  
  

 

 

   

 

 

 

Senior secured second lien notes (effective interest rate of 11.0%)

   197     4,501  

Senior secured toggle notes

        1,578  
  

 

 

   

 

 

 

Second lien debt

   197     6,079  
  

 

 

   

 

 

 

Senior unsecured notes (effective interest rate of 7.3%)

   9,844     7,615  
  

 

 

   

 

 

 

Total debt (average life of 6.9 years, rates averaging 6.3%)

   27,052     28,225  

Less amounts due within one year

   1,407     592  
  

 

 

   

 

 

 
  $25,645    $27,633  
  

 

 

   

 

 

 

2011 Activity

During May 2011, we completed amendments to our senior secured credit agreement and senior secured asset-based revolving credit agreement, as well as extensions of certain of our term loans. The amendments extended $594 million ($572 million outstanding at December 31, 2011) of our term loan A facility with a final maturity of November 2012 to a final maturity of May 2016 and $2.373 billion of our term loan A and term loan B-1 facilities with final maturities of November 2012 and November 2013, respectively, to a final maturity of May 2018.

During June 2011, we redeemed all $1.000 billion aggregate principal amount of our 9 1/8% senior secured notes due 2014, at a redemption price of 104.563% of the principal amount, and $108 million aggregate principal amount of our 9 7/8% senior secured notes due 2017, at a redemption price of 109.875% of the principal amount. The pretax loss on retirement of debt related to these redemptions was $75 million.

During August 2011, we issued $5.000 billion aggregate principal amount of notes, comprised of $3.000 billion of 6.50% senior secured first lien notes due 2020 and $2.000 billion of 7.50% senior unsecured notes due 2022. We used the net proceeds from these debt issuances to redeem all of our outstanding $1.578 billion 9 5/8%/10 3/8% second lien toggle notes due 2016, at a redemption price of 106.783% of the principal amount, and all of our outstanding $3.200 billion 9 1/4% second lien notes due 2016, at a redemption price of 106.513% of the principal amount. The pretax loss on retirement of debt related to these redemptions was $406 million.

During September 2011, we refinanced our $2.000 billion asset-based revolving credit facility maturing on November 16, 2012 to increase the total capacity to $2.500 billion and extend the maturity to 2016.

During October 2011, we issued $500 million aggregate principal amount of 8.00% senior unsecured notes due 2018. We used the net proceed for general corporate purposes, which included funding a portion of the acquisition of the remaining interest in HealthONE.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 10 — LONG-TERM DEBT (Continued)

Senior Secured Credit Facilities And Other First Lien Debt

In connection with the Recapitalization, we

We have entered into the following senior secured credit facilities: (i) a $2.000$2.500 billion senior secured asset-based revolving credit facility maturing on September 30, 2016 with a borrowing base of 85% of eligible accounts receivable, subject to customary reserves and eligibility criteria ($125 million available2.155 billion outstanding at December 31, 2010)2011) (the “ABL credit facility”) and; (ii) a $2.000 billion senior secured revolving credit agreement (thefacility maturing on November 17, 2015 (none outstanding at December 31, 2011 without giving effect to certain outstanding letters of credit); (iii) a $414 million senior secured term loan A-1 facility maturing on November 17, 2012; (iv) a $572 million senior secured term loan A-2 facility maturing on May 2, 2016; (v) a $1.689 billion senior secured term loan B-1 facility maturing on November 17, 2013; (vi) a $2.000 billion senior secured term loan B-2 facility maturing on March 31, 2017; (vii) a $2.373 billion senior secured term loan B-3 facility maturing on May 1, 2018; and (viii) a €291 million, or $377 million-equivalent, senior secured European term loan facility maturing on November 17, 2013. We refer to the facilities described under (ii) through (viii) above, collectively, as the “cash flow credit facility” and, together with the ABL credit facility, the “senior secured credit facilities”), consisting of a $2.000 billion revolving credit facility ($1.189 billion available at December 31, 2010 after giving effect to certain outstanding letters of credit), a $2.750 billion term loan A ($1.618 billion outstanding at December 31, 2010), a $8.800 billion term loan B consisting of a $6.800 billion senior secured term loan B-1 and a $2.000 billion senior secured term loan B-2 ($3.525 billion outstanding under term loan B-1 at December 31, 2010 and $2.000 billion outstanding under term loan B-2 at December 31, 2010) and a €1.000 billion European term loan (€291 million, or $387 million, outstanding at December 31, 2010) under which one of our European subsidiaries is the borrower.

facilities.”

Borrowings under the senior secured credit facilities bear interest at a rate equal to, at our option, either (a) a base rate determined by reference to the higher of (1) the federal funds rate plus 0.50% or (2) the prime rate of Bank of America or (b) a LIBOR rate for the currency of such borrowing for the relevant interest period, plus, in each case, an applicable margin. The applicable margin for borrowings under the senior secured credit facilities may be reduced subject to attaining certain leverage ratios.

The ABL credit facility and the $2.000 billion revolving credit facility portion of the cash flow credit facility expire November 2012. The term loan facilities require quarterly installment payments. The final payment under term loan A is in November 2012. The final payments under term loan B-1 and the European term loan are in November 2013. During April 2010, we entered into an amendment of our senior secured term loan B facility extending the maturity of $2.000 billion of loans outstanding thereunder from November 2013 to March 2017. On November 8, 2010, an amended and restated joinder agreement was entered into with respect to the cash flow credit facility to establish a new replacement revolving credit series, which will mature on November 17, 2015. Under the


F-26


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 10 —LONG-TERM DEBT (Continued)

Senior Secured Credit Facilities And Other First Lien Debt (Continued)
amended and restated joinder agreement, these replacement revolving credit commitments will become effective, subject to certain conditions, upon the earlier of (i) the initial public offering of our common stock and (ii) May 17, 2012. The senior secured credit facilities contain a number of covenants that restrict, subject to certain exceptions, our (and some or all of our subsidiaries’) ability to incur additional indebtedness, repay subordinated indebtedness, create liens on assets, sell assets, make investments, loans or advances, engage in certain transactions with affiliates, pay dividends and distributions, and enter into sale and leaseback transactions. In addition, we are required to satisfy and maintain a maximum total leverage ratio covenant under the cash flow credit facility and, in certain situations under the ABL credit facility, a minimum interest coverage ratio covenant.
During April 2009, we issued

Senior secured first lien notes consist of (i) $1.500 billion aggregate principal amount of 81/2% senior secured first lien notes due 2019 at a price of 96.755% of their face value, resulting in $1.451 billion of gross proceeds. During August 2009, we issued2019; (ii) $1.250 billion aggregate principal amount of 77/8% senior secured first lien notes due 2020 at a price of 98.254% of their face value, resulting in $1.228 billion of gross proceeds. During March 2010, we issued2020; (iii) $1.400 billion aggregate principal amount of 71/4% senior secured first lien notes due 2020 at a price2020; (iv) $3.000 billion aggregate principal amount of 99.095% of their face value, resulting in $1.387 billion of gross proceeds. After the payment of related fees and expenses, we used the proceeds from these debt issuances to repay outstanding indebtedness under our6.50% senior secured term loan facilities.

first lien notes due 2020; and (v) $69 million of unamortized debt discounts that reduces the senior secured first lien indebtedness. Capital leases and other secured debt totaled $350 million at December 31, 2011.

We use interest rate swap agreements to manage the variable rate exposure of our debt portfolio. At December 31, 2010,2011, we had entered into effective interest rate swap agreements, in a total notional amount of $7.100$4.500 billion, in order to hedge a portion of our exposure to variable rate interest payments associated with the senior secured credit facility. The effect of the interest rate swaps is reflected in the effective interest rates for the senior secured credit facilities.

Senior Secured Notes And Other Second Lien DebtNotes

During November 2006, we issued $4.200 billion

Senior secured second lien notes is comprised of senior secured notes (comprised of $1.000 billion of 91/8% notes due 2014 and $3.200 billion of 91/4% notes due 2016), and $1.500 billion of 95/8% cash/103/8%  in-kind senior secured toggle notes (which allow us, at our option, to pay interest in-kind during the first five years) due 2016, which are subject to certain standard covenants. We made the interest payment for the interest period ended in May 2009 by paying in-kind ($78 million) instead of paying interest in cash.

During February 2009, we issued $310$202 million aggregate principal amount of 97/8% senior secured second lien notes due 2017 at a price of 96.673% of their face value, resulting in $300and $5 million of gross proceeds. Afterunamortized debt discounts that reduces the payment of related fees and expenses, we used the proceeds to repay outstanding indebtedness under our senior secured term loan facilities.
second lien indebtedness.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 10 — LONG-TERM DEBT (Continued)

Senior Unsecured Notes

During November 2010, we issued $1.525

Senior unsecured notes consist of (i) $7.194 billion aggregate principal amount of 73/4senior unsecurednotes with maturities ranging from 2012 to 2033; (ii) an aggregate principal amount of $246 million medium-term notes with maturities ranging from 2014 to 2025; (iii) an aggregate principal amount of $886 million debentures with maturities ranging from 2015 to 2095; (iv) an aggregate principal amount of $1.525 billion senior notes due 2021 issued by HCA Holdings, Inc. (the “2021 Notes”) at a price; and (v) $7 million of 100% of their face value, resulting in $1.525 billion of gross proceeds. Afterunamortized debt discounts that reduce the payment of related fees and expenses, we used the proceeds to make a distribution to our stockholders and optionholders.

indebtedness.

General Debt Information

The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture (the “1993 Indenture”) dated December 16, 1993 (except for


F-27


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 10 —LONG-TERM DEBT (Continued)

General Debt Information (Continued)
certain special purpose subsidiaries that only guarantee and pledge their assets under our ABL credit facility). In addition, borrowings under the European term loan are guaranteed by all material, wholly-owned European subsidiaries.

All obligations under the ABL credit facility, and the guarantees of those obligations, are secured, subject to permitted liens and other exceptions, by a first-priority lien on substantially all of the receivables of the borrowers and each guarantor under such ABL credit facility (the “Receivables Collateral”).

All obligations under the cash flow credit facility and the guarantees of such obligations are secured, subject to permitted liens and other exceptions, by:

a first-priority lien on the capital stock owned by HCA Inc., or by any U.S. guarantor, in each of their respective first-tier subsidiaries;

a first-priority lien on substantially all present and future assets of HCA Inc. and of each U.S. guarantor other than (i) “Principal Properties” (as defined in the 1993 Indenture), (ii) certain other real properties and (iii) deposit accounts, other bank or securities accounts, cash, leaseholds, motor-vehicles and certain other exceptions; and

• a first-priority lien on the capital stock owned by HCA Inc., or by any U.S. guarantor, in each of their respective first-tier subsidiaries;
• a first-priority lien on substantially all present and future assets of HCA Inc. and of each U.S. guarantor other than (i) “Principal Properties” (as defined in the 1993 Indenture), (ii) certain other real properties and (iii) deposit accounts, other bank or securities accounts, cash, leaseholds, motor-vehicles and certain other exceptions; and
• a second-priority lien on certain of the Receivables Collateral.

a second-priority lien on certain of the Receivables Collateral.

Our senior secured first lien notes and the related guarantees are secured by first-priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets, subject to certain exceptions, that secure our cash flow credit facility on a first-priority basis and are secured by second priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets that secure our ABL credit facility on a first priority basis and our other cash flow credit facility on a second-priority basis.

Our second lien debt and the related guarantees are secured by second-priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets, subject to certain exceptions, that secure our cash flow credit facility on a first-priority basis and are secured by third-priority liens, subject to permitted liens, on our and our subsidiary guarantors’ assets that secure our asset-based revolving credit facility on a first priority basis and our other cash flow credit facility on a second-priority basis.

Maturities of long-term debt in years 20122013 through 20152016, excluding amounts under the ABL credit facility, are $4.195$3.167 billion, $4.952 billion, $1.681$751 million, $1.020 billion and $1.676$1.537 billion, respectively.

NOTE 11 —CONTINGENCIES

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 11 — CONTINGENCIES

We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.

Health care companies are subject to numerous investigations by various governmental agencies. Under the federal false claims act (“FCA”) private parties have the right to bringqui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received government inquiries from federal and state agencies and our facilities may receive such inquiries in future periods. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our results of operations or financial position.


F-28


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 11 —CONTINGENCIES (Continued)
We are subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. It is management’s opinion that the ultimate resolution of these pending claims and legal proceedings will not have a material, adverse effect on our results of operations or financial position.

The Civil Division of the Department of Justice (“DOJ”) has contacted usthe Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the Centers for Medicare & Medicaid Services’Services criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. The review could potentially give rise to claims against usthe Company under the federal FCAFalse Claims Act or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on us.

NOTE 12 —CAPITAL STOCK
the Company.

On October 28, 2011, a shareholder action was filed in the United States District Court for the Middle District of Tennessee. The case seeks to include as a class all persons who acquired the Company’s certificatestock pursuant or traceable to the Company’s Registration Statement and Prospectus issued in connection with the March 9, 2011 initial public offering. The lawsuit asserts a claim under Section 11 of incorporation was amendedthe Securities Act of 1933 against the Company, certain members of the board of directors, and restated,certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleges deficiencies in the Company’s disclosures in the Registration Statement relating to: (1) accounting for its 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective November 19, 2010. internal controls relating to its accounting for such transactions; and (3) the Company’s revenue growth rate. Subsequently, two additional class action complaints setting forth substantially similar claims were filed in the same federal court. All three of the cases have been consolidated.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 12 — LEASES

We lease medical office buildings and certain equipment under operating lease agreements. Commitments relating to noncancellable operating leases for each of the next five years and thereafter are as follows (dollars in millions):

For the Year Ended December 31,

    

2012

  $280  

2013

   264  

2014

   218  

2015

   171  

2016

   131  

Thereafter

   870  
  

 

 

 
   1,934  

Less sublease income

   (51
  

 

 

 
  $1,883�� 
  

 

 

 

NOTE 13 — CAPITAL STOCK

The amended and restated certificate of incorporation authorizes the Company to issue up to 125,000,0001,800,000,000 shares of common stock, and our amended and restated by-laws set the number of directors constituting the board of directors of the Company at not less than one nor more than 15.

During February 2011, our Board of Directors approved a 4.505-to-one split of our issued and outstanding common shares. All common share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements reflect the 4.505-to-one stock split. During March 2011, we completed the initial public offering of 87,719,300 shares of our common stock at a price of $30.00 per share and realized net proceeds (after costs of the offering) of $2.506 billion.

On September 21, 2011, we repurchased 80,771,143 shares of our common stock beneficially owned by affiliates of Bank of America Corporation at a purchase price of $18.61 per share, the closing price of the Company’s common stock on the New York Stock Exchange on September 14, 2011. The repurchase was financed using a combination of cash on hand and borrowings under available credit facilities. The shares repurchased represented approximately 15.6% of our total shares outstanding at the time of the repurchase.

Distributions

During 2010, our Board of Directors declared three distributions to itsthe Company’s stockholders and holders of stock options. The distributions totaled $42.50$9.43 per share and vested stock option, or $4.332 billion in the aggregate. The distributions were funded using funds available under our senior secured credit facilities, proceeds from the 2021 Notes offering and cash on hand. Pursuant to the terms of our stock option plans, the holders of nonvested stock options received $42.50$9.43 per share reductions (subject to certain tax related limitations for certain stock options that resulted in deferred distributions for a portion of the declared distribution, which will be paid upon the vesting of the applicable stock options) to the exercise price of theirthe share-based awards.

There were no distributions declared during 2011.

Registration Statement Filings

On May 5, 2010, HCA Inc.’s Board of Directors granted approval for HCA Inc. to file with the Securities and Exchange Commission (“SEC”) a registration statement onHOLDINGS, INC.

Form S-1NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) relating to a proposed initial public offering of its common stock. The

Form S-1NOTE 13 — CAPITAL STOCK (Continued) was filed on May 7, 2010.

In connection with the Corporate Reorganization, on December 15, 2010, HCA Holdings, Inc.’s Board of Directors granted approval for the Company to file with the SEC a registration statement on

Form S-1 relating to a proposed initial public offering of its common stock. TheForm S-1 was filed on December 22, 2010, and HCA Inc. filed a request to withdraw its registration statement onForm S-1 at the same time.

Stockholder Agreements and Equity Securities with Contingent Redemption Rights
The stockholder agreements, among other things, contain agreements among the parties with respect to restrictions on the transfer of shares, including tag along rights and drag along rights, registration rights (including customary indemnification provisions) and other rights. Pursuant

Prior to the management stockholder agreements,consummation of the applicableinitial public offering of our common stock, certain employees cancould elect to have the Company redeem their common stock and vested stock options in the eventsevent of death or permanent disability, priorpursuant to the terms of their management stockholder agreements. The consummation of the initial public offering of our common stock byeffectively terminated the Company. At December 31, 2010, there were 2,216,500 common shares and 5,291,700 vested stock options that were subject to these contingent redemption terms.


F-29

rights and the applicable amounts have been reclassified back to stockholders’ equity.


NOTE 14 — EMPLOYEE BENEFIT PLANS

HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 13 —EMPLOYEE BENEFIT PLANS
We maintain contributory, defined contribution benefit plans that are available to employees who meet certain minimum requirements. Certain of the plans require that we match specified percentages of participant contributions up to certain maximum levels (generally, 100% of the first 3% to 9%, depending upon years of vesting service, of compensation deferred by participants for periods subsequent to March 31, 2008, and 50% of the first 3% of compensation deferred by participants for periods prior to April 1, 2008)participants). The cost of these plans totaled $321 million for 2011, $307 million for 2010 and $283 million for 2009 and $233 million for 2008.2009. Our contributions are funded periodically during each year.
We maintained a noncontributory, defined contribution retirement plan which covered substantially all employees. Benefits were determined as a percentage of a participant’s salary and vest over specified periods of employee service. Benefits expense was $46 million for 2008. There was no expense for 2010 and 2009 as the noncontributory plan and the related participant account balances were merged into the contributory HCA 401(k) Plan effective April 1, 2008.

We maintain the noncontributory, nonqualified Restoration Plan to provide certain retirement benefits for eligible employees. Eligibility for the Restoration Plan is based upon earning eligible compensation in excess of the Social Security Wage Base and attaining 1,000 or more hours of service during the plan year. Company credits to participants’ account balances (the Restoration Plan is not funded) depend upon participants’ compensation, years of vesting service and certain IRS limitations related to the HCA 401(k) plan. Benefits expense under this plan was $25 million for 2011, $19 million for 2010 and $26 million for 2009 and $2 million for 2008.2009. Accrued benefits liabilities under this plan totaled $105 million at December 31, 2011 and $84 million at December 31, 2010 and $73 million at December 31, 2009.

2010.

We maintain a Supplemental Executive Retirement Plan (“SERP”) for certain executives. The plan is designed to ensure that upon retirement the participant receives the value of a prescribed life annuity from the combination of the SERP and our other benefit plans. Benefits expense under the plan was $33 million for 2011, $27 million for 2010 and $24 million for 2009 and $20 million for 2008.2009. Accrued benefits liabilities under this plan totaled $237 million at December 31, 2011 and $197 million at December 31, 2010 and $152 million at December 31, 2009.

2010.

We maintain defined benefit pension plans which resulted from certain hospital acquisitions in prior years. Benefits expense under these plans was $37 million for 2011, $30 million for 2010, and $39 million for 2009, and $24 million for 2008.2009. Accrued benefits liabilities under these plans totaled $147 million at December 31, 2011 and $131 million at December 31, 2010 and $115 million at December 31, 2009.

NOTE 14 —SEGMENT AND GEOGRAPHIC INFORMATION
2010.

NOTE 15 — SEGMENT AND GEOGRAPHIC INFORMATION

We operate in one line of business, which is operating hospitals and related health care entities. During the years ended December 31, 2010, 2009 and 2008, approximately 23.5%, 22.8% and 23.1%, respectively, of our revenues related to patients participating in thefee-for-service Medicare program.

Our operations are structured into three geographically organized groups: the EasternNational, Southwest and Central Groups. During February 2011, we reorganized our operational groups and have restated the prior period amounts to reflect this reorganization. At December 31, 2011, the National Group includes 48 consolidating64 hospitals located in Florida, South Carolina, southern Georgia, Alaska, California, Nevada, Utah and Idaho, the Eastern United States,Southwest Group includes 46 hospitals located in Colorado, Texas, Oklahoma and the Wichita, Kansas market, and the Central Group includes 46 consolidating47 hospitals located in the Central United StatesLouisiana, Indiana, Kentucky, Tennessee, Virginia, New Hampshire, northern Georgia and the Western Group includes 56 consolidating hospitals located in the Western United States.Kansas City market. We also operate six consolidating hospitals in England, and these facilities are included in the Corporate and other group.

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 15 — SEGMENT AND GEOGRAPHIC INFORMATION (Continued)

Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, gain on acquisition of controlling interest in equity investment, impairments of long-lived assets, losses on retirement of debt, termination of management agreement, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under


F-30


HCA HOLDINGS, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
NOTE 14 —SEGMENT AND GEOGRAPHIC INFORMATION (Continued)
generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.
The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA, depreciation and amortization, assets and goodwill and other intangible assets are summarized in the following table (dollars in millions):
             
  For the Years Ended December 31, 
  2010  2009  2008 
 
Revenues:            
Eastern Group $9,006  $8,807  $8,570 
Central Group  7,222   7,225   6,740 
Western Group  13,467   13,140   12,118 
Corporate and other  988   880   946 
             
  $30,683  $30,052  $28,374 
             
Equity in earnings of affiliates:            
Eastern Group $(3) $(3) $(2)
Central Group  (1)  (2)  (2)
Western Group  (278)  (241)  (219)
Corporate and other         
             
  $(282) $(246) $(223)
             
Adjusted segment EBITDA:            
Eastern Group $1,580  $1,469  $1,288 
Central Group  1,272   1,325   1,061 
Western Group  3,107   2,867   2,270 
Corporate and other  (91)  (189)  (45)
             
  $5,868  $5,472  $4,574 
             
Depreciation and amortization:            
Eastern Group $354  $364  $358 
Central Group  352   352   359 
Western Group  581   578   552 
Corporate and other  134   131   147 
             
  $1,421  $1,425  $1,416 
             
Adjusted segment EBITDA $5,868  $5,472  $4,574 
Depreciation and amortization  1,421   1,425   1,416 
Interest expense  2,097   1,987   2,021 
Losses (gains) on sales of facilities  (4)  15   (97)
Impairments of long-lived assets  123   43   64 
             
Income before income taxes $2,231  $2,002  $1,170 
             


F-31


   For the Years Ended December 31, 
   2011  2010  2009 

Revenues:

    

National Group

  $12,224   $11,624   $11,047  

Southwest Group

   9,311    8,700    8,282  

Central Group

   6,982    6,727    6,570  

Corporate and other

   1,165    984    877  
  

 

 

  

 

 

  

 

 

 
  $29,682   $28,035   $26,776  
  

 

 

  

 

 

  

 

 

 

Equity in earnings of affiliates:

    

National Group

  $(7 $(4 $(4

Southwest Group

   (251  (277  (240

Central Group

       (1  (2

Corporate and other

             
  

 

 

  

 

 

  

 

 

 
  $(258 $(282 $(246
  

 

 

  

 

 

  

 

 

 

Adjusted segment EBITDA:

    

National Group

  $2,531   $2,431   $2,250  

Southwest Group

   2,370    2,254    2,089  

Central Group

   1,285    1,272    1,325  

Corporate and other

   (125  (89  (192
  

 

 

  

 

 

  

 

 

 
  $6,061   $5,868   $5,472  
  

 

 

  

 

 

  

 

 

 

Depreciation and amortization:

    

National Group

  $512   $508   $516  

Southwest Group

   464    427    426  

Central Group

   347    352    352  

Corporate and other

   142    134    131  
  

 

 

  

 

 

  

 

 

 
  $1,465   $1,421   $1,425  
  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 14 —SEGMENT AND GEOGRAPHIC INFORMATION (Continued)
         
  As of December 31, 
  2010  2009 
 
Assets:        
Eastern Group $4,922  $5,018 
Central Group  5,271   5,173 
Western Group  9,169   8,847 
Corporate and other  4,490   5,093 
         
  $23,852  $24,131 
         
                     
  Eastern
  Central
  Western
  Corporate
    
  Group  Group  Group  and Other  Total 
 
Goodwill:                    
Balance at December 31, 2009 $596  $1,018  $742  $221  $2,577 
Acquisitions  14      65   46   125 
Impairments           (14)  (14)
Foreign currency translation and other  (2)  1   8   (2)  5 
                     
Balance at December 31, 2010 $608  $1,019  $815  $251  $2,693 
                     


F-32


NOTE 15 — SEGMENT AND GEOGRAPHIC INFORMATION (Continued)

   For the Years Ended December 31, 
   2011  2010  2009 

Adjusted segment EBITDA

  $6,061   $5,868   $5,472  

Depreciation and amortization

   1,465    1,421    1,425  

Interest expense

   2,037    2,097    1,987  

Losses (gains) on sales of facilities

   (142  (4  15  

Gain on acquisition of controlling interest in equity investment

   (1,522        

Impairments of long-lived assets

       123    43  

Losses on retirement of debt

   481          

Termination of management agreement

   181          
  

 

 

  

 

 

  

 

 

 

Income before income taxes

  $  3,561   $  2,231   $  2,002  
  

 

 

  

 

 

  

 

 

 

   As of December 31, 
   2011   2010 

Assets:

    

National Group

  $7,827    $7,345  

Southwest Group

   9,908     6,747  

Central Group

   5,187     5,271  

Corporate and other

   3,976     4,489  
  

 

 

   

 

 

 
  $26,898    $23,852  
  

 

 

   

 

 

 

   National
Group
  Southwest
Group
  Central
Group
   Corporate
and Other
  Total 

Goodwill and other intangible assets:

       

Balance at December 31, 2010

  $787   $636   $1,019    $251   $2,693  

Acquisitions

   32    2,533         33    2,598  

Dispositions

   (19  (5           (24

Foreign currency translation and other

       (4       (12  (16
  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

Balance at December 31, 2011

  $800   $3,160   $1,019    $272   $5,251  
  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 14 —SEGMENT AND GEOGRAPHIC INFORMATION (Continued)
NOTE 15 —OTHER COMPREHENSIVE LOSS

NOTE 16 — OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive loss are as follows (dollars in millions):

                     
           Change
    
  Unrealized
  Foreign
     in Fair
    
  Gains (Losses) on
  Currency
  Defined
  Value of
    
  Available-for-Sale
  Translation
  Benefit
  Derivative
    
  Securities  Adjustments  Plans  Instruments  Total 
 
Balances at December 31, 2007 $14  $34  $(44) $(176) $(172)
Unrealized losses onavailable-for-sale securities, net of $25 income tax benefit
  (44)           (44)
Foreign currency translation adjustments, net of $33 income tax benefit     (62)        (62)
Defined benefit plans, net of $40 income tax benefit        (68)     (68)
Change in fair value of derivative instruments, net of $194 income tax benefit           (334)  (334)
Expense reclassified into operations from other comprehensive income, net of $4 and $42, respectively, income tax benefits        6   70   76 
                     
Balances at December 31, 2008  (30)  (28)  (106)  (440)  (604)
Unrealized gains onavailable-for-sale securities, net of $25 of income taxes
  44            44 
Foreign currency translation adjustments, net of $14 of income taxes     25         25 
Defined benefit plans, net of $8 income tax benefit        (10)     (10)
Change in fair value of derivative instruments, net of $76 income tax benefit           (133)  (133)
Expense reclassified into operations from other comprehensive income, net of $6 and $127, respectively, income tax benefits        10   218   228 
                     
Balances at December 31, 2009  14   (3)  (106)  (355)  (450)
Unrealized gains onavailable-for-sale securities, net of $1 of income taxes
  1            1 
Foreign currency translation adjustments, net of $9 of income tax benefit     (16)        (16)
Defined benefit plans, net of $28 income tax benefit        (48)     (48)
Change in fair value of derivative instruments, net of $94 income tax benefit           (161)  (161)
(Income) expense reclassified into operations from other comprehensive income, net of $(4), $7 and $140, respectively, income (taxes) benefits  (9)     11   244   246 
                     
Balances at December 31, 2010 $6  $(19) $(143) $(272) $(428)
                     


F-33


   Unrealized
Gains (Losses) on
Available-for-Sale
Securities
  Foreign
Currency
Translation
Adjustments
  Defined
Benefit
Plans
  Change
in Fair
Value of
Derivative
Instruments
  Total 

Balances at December 31, 2008

  $(30 $(28 $(106 $(440 $(604

Unrealized gains on available-for-sale securities, net of $25 of income taxes

   44                44  

Foreign currency translation adjustments, net of $14 of income taxes

       25            25  

Defined benefit plans, net of $8 income tax benefit

           (10      (10

Change in fair value of derivative instruments, net of $76 income tax benefit

               (133  (133

Expense reclassified into operations from other comprehensive income, net of $6 and $127, respectively, income tax benefits

           10    218    228  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances at December 31, 2009

   14    (3  (106  (355  (450

Unrealized gains on available-for-sale securities, net of $1 of income taxes

   1                1  

Foreign currency translation adjustments, net of $9 income tax benefit

       (16          (16

Defined benefit plans, net of $28 income tax benefit

           (48      (48

Change in fair value of derivative instruments, net of $94 income tax benefit

               (161  (161

(Income) expense reclassified into operations from other comprehensive income, net of $(4), $7 and $140, respectively, income (taxes) benefits

   (9      11    244    246  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances at December 31, 2010

   6    (19  (143  (272  (428

Unrealized gains on available-for-sale securities, net of $1 of income taxes

   1                1  

Foreign currency translation adjustments, net of $3 income tax benefit

       (6          (6

Defined benefit plans, net of $25 income tax benefit

           (42      (42

Change in fair value of derivative instruments, net of $114 income tax benefit

               (197  (197

Expense reclassified into operations from other comprehensive income, net of $9 and $125, respectively, income tax benefits

           16    216    232  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Balances at December 31, 2011

  $7   $(25 $(169 $(253 $(440
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 16 —ACCRUED EXPENSES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

NOTE 17 — ACCRUED EXPENSES AND ALLOWANCE FOR DOUBTFUL ACCOUNTS

A summary of other accrued expenses at December 31 follows (dollars in millions):

         
  2010  2009 
 
Professional liability risks $268  $265 
Interest  309   283 
Taxes other than income  197   190 
Other  471   420 
         
  $1,245  $1,158 
         

   2011   2010 

Professional liability risks

  $298    $268  

Interest

   383     309  

Taxes other than income

   232     197  

Other

   672     471  
  

 

 

   

 

 

 
  $1,585    $1,245  
  

 

 

   

 

 

 

A summary of activity for the allowance of doubtful accounts follows (dollars in millions):

                 
    Provision
 Accounts
  
  Balance at
 for
 Written off,
 Balance
  Beginning
 Doubtful
 Net of
 at End
  of Year Accounts Recoveries of Year
 
Allowance for doubtful accounts:                
Year ended December 31, 2008 $3,711  $3,409  $(2,379) $4,741 
Year ended December 31, 2009  4,741   3,276   (3,157)  4,860 
Year ended December 31, 2010  4,860   2,648   (3,569)  3,939 

   Balance
at

Beginning
of Year
   Provision
for
Doubtful
Accounts
   Accounts
Written
off,

Net of
Recoveries
  Balance
at End
of Year
 

Allowance for doubtful accounts:

       

Year ended December 31, 2009

  $4,741    $3,276    $(3,157 $4,860  

Year ended December 31, 2010

   4,860     2,648     (3,569  3,939  

Year ended December 31, 2011

   3,939     2,824     (2,657  4,106  

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION

On November 22, 2010, HCA Inc. reorganized by creating a new holding company structure. HCA Holdings, Inc. became the new parent company, and HCA Inc. is now HCA Holdings, Inc.’s wholly-owned direct subsidiary. On November 23, 2010, HCA Holdings, Inc. issued the 2021 Notes. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.

The senior secured credit facilities and senior secured notes described in Note 10 are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, wholly-owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our ABL credit facility).

Our condensed consolidating balance sheets at December 31, 20102011 and 20092010 and condensed consolidating statements of income and cash flows for each of the three years in the period ended December 31, 2010,2011, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow.


F-34


HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING INCOME STATEMENT

For The Year Ended December 31, 2010
2011

(Dollars in millions)

                         
  HCA
        Subsidiary
       
  Holdings, Inc.
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Revenues $  $  $17,647  $13,036  $  $30,683 
                         
Salaries and benefits        7,315   5,169      12,484 
Supplies        2,825   2,136      4,961 
Other operating expenses     5   2,634   2,365      5,004 
Provision for doubtful accounts        1,632   1,016      2,648 
Equity in earnings of affiliates  (1,215)     (107)  (175)  1,215   (282)
Depreciation and amortization        782   639      1,421 
Interest expense  12   2,700   (761)  146      2,097 
Gains on sales of facilities           (4)     (4)
Impairments of long-lived assets        58   65      123 
Management fees        (454)  454       
                         
   (1,203)  2,705   13,924   11,811   1,215   28,452 
                         
Income (loss) before income taxes  1,203   (2,705)  3,723   1,225   (1,215)  2,231 
Provision for income taxes  (4)  (955)  1,299   318      658 
                         
Net income  1,207   (1,750)  2,424   907   (1,215)  1,573 
Net income attributable to noncontrolling interests        44   322      366 
                         
Net income attributable to HCA Holdings, Inc.  $1,207  $(1,750) $2,380  $585  $(1,215) $1,207 
                         


F-35


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Revenues before provision for doubtful accounts

  $   $   $18,126   $14,380   $   $32,506  

Provision for doubtful accounts

           1,644    1,180        2,824  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

           16,482    13,200        29,682  

Salaries and benefits

           7,584    5,856        13,440  

Supplies

           2,851    2,328        5,179  

Other operating expenses

       4    2,741    2,725        5,470  

Electronic health record incentive income

           (126  (84      (210

Equity in earnings of affiliates

   (2,543      (86  (172  2,543    (258

Depreciation and amortization

           777    688        1,465  

Interest expense

   120    2,390    (342  (131      2,037  

Gains on sales of facilities

           (127  (15      (142

Gain on acquisition of controlling interest in equity investment

               (1,522      (1,522

Losses on retirement of debt

       481                481  

Termination of management agreement

       181                181  

Management fees

           (491  491          
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   (2,423  3,056    12,781    10,164    2,543    26,121  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Income (loss) before income taxes

   2,423    (3,056  3,701    3,036    (2,543  3,561  

Provision (benefit) for income taxes

   (42  (1,068  1,271    558        719  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income (loss)

   2,465    (1,988  2,430    2,478    (2,543  2,842  

Net income attributable to noncontrolling interests

           63    314        377  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income (loss) attributable to HCA Holdings, Inc.

  $2,465   $(1,988 $2,367   $2,164   $(2,543 $2,465  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING INCOME STATEMENT

For The Year Ended December 31, 2009
2010

(Dollars in millions)

                     
        Subsidiary
       
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Revenues $  $17,584  $12,468  $  $30,052 
                     
Salaries and benefits     7,149   4,809      11,958 
Supplies     2,846   2,022      4,868 
Other operating expenses  14   2,497   2,213      4,724 
Provision for doubtful accounts     2,043   1,233      3,276 
Equity in earnings of affiliates  (2,540)  (95)  (151)  2,540   (246)
Depreciation and amortization     787   638      1,425 
Interest expense  2,356   (500)  131      1,987 
Losses (gains) on sales of facilities     17   (2)     15 
Impairments of long-lived assets     34   9      43 
Management fees     (443)  443       
                     
   (170)  14,335   11,345   2,540   28,050 
                     
Income before income taxes  170   3,249   1,123   (2,540)  2,002 
Provision for income taxes  (884)  1,189   322      627 
                     
Net income  1,054   2,060   801   (2,540)  1,375 
Net income attributable to noncontrolling interests     61   260      321 
                     
Net income attributable to HCA Holdings, Inc.  $1,054  $1,999  $541  $(2,540) $1,054 
                     


F-36


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Revenues before provision for doubtful accounts

  $   $   $17,647   $13,036   $   $30,683  

Provision for doubtful accounts

           1,632    1,016        2,648  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

           16,015    12,020        28,035  

Salaries and benefits

           7,315    5,169        12,484  

Supplies

           2,825    2,136        4,961  

Other operating expenses

       5    2,634    2,365        5,004  

Equity in earnings of affiliates

   (1,215      (107  (175  1,215    (282

Depreciation and amortization

           782    639        1,421  

Interest expense

   12    2,700    (761  146        2,097  

Gains on sales of facilities

               (4      (4

Impairments of long-lived assets

           58    65        123  

Management fees

           (454  454          
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   (1,203  2,705    12,292    10,795    1,215    25,804  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Income (loss) before income taxes

   1,203    (2,705  3,723    1,225    (1,215  2,231  

Provision (benefit) for income taxes

   (4  (955  1,299    318        658  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income (loss)

   1,207    (1,750  2,424    907    (1,215  1,573  

Net income attributable to noncontrolling interests

           44    322        366  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income (loss) attributable to HCA Holdings, Inc.

  $1,207   $(1,750 $2,380   $585   $(1,215 $1,207  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING INCOME STATEMENT

For The Year Ended December 31, 2008
2009

(Dollars in millions)

                     
        Subsidiary
       
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Revenues $  $16,507  $11,867  $  $28,374 
                     
Salaries and benefits     6,846   4,594      11,440 
Supplies     2,671   1,949      4,620 
Other operating expenses  (6)  2,445   2,115      4,554 
Provision for doubtful accounts     2,073   1,336      3,409 
Equity in earnings of affiliates  (2,100)  (82)  (141)  2,100   (223)
Depreciation and amortization     776   640      1,416 
Interest expense  2,190   (328)  159      2,021 
Gains on sales of facilities     (5)  (92)     (97)
Impairments of long-lived assets        64      64 
Management fees     (426)  426       
                     
   84   13,970   11,050   2,100   27,204 
                     
Income (loss) before income taxes  (84)  2,537   817   (2,100)  1,170 
Provision for income taxes  (757)  803   222      268 
                     
Net income  673   1,734   595   (2,100)  902 
Net income attributable to noncontrolling interests     53   176      229 
                     
Net income attributable to HCA Holdings, Inc.  $673  $1,681  $419  $(2,100) $673 
                     


F-37


   HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Revenues before provision for doubtful accounts

  $   $17,584   $12,468   $   $30,052  

Provision for doubtful accounts

       2,043    1,233        3,276  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Revenues

       15,541    11,235        26,776  

Salaries and benefits

       7,149    4,809        11,958  

Supplies

       2,846    2,022        4,868  

Other operating expenses

   14    2,497    2,213        4,724  

Equity in earnings of affiliates

   (2,540  (95  (151  2,540    (246

Depreciation and amortization

       787    638        1,425  

Interest expense

   2,356    (500  131        1,987  

Losses (gains) on sales of facilities

       17    (2      15  

Impairments of long-lived assets

       34    9        43  

Management fees

       (443  443          
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 
   (170  12,292    10,112    2,540    24,774  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Income before income taxes

   170    3,249    1,123    (2,540  2,002  

Provision (benefit) for income taxes

   (884  1,189    322        627  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income

   1,054    2,060    801    (2,540  1,375  

Net income attributable to noncontrolling interests

       61    260        321  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net income attributable to HCA Holdings, Inc.

  $1,054   $1,999   $541   $(2,540 $1,054  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2010
2011

(Dollars in millions)

                         
  HCA
        Subsidiary
       
  Holdings, Inc.
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
ASSETS
                        
Current assets:                        
Cash and cash equivalents $6  $  $156  $249  $  $411 
Accounts receivable, net        2,214   1,618      3,832 
Inventories        547   350      897 
Deferred income taxes  931               931 
Other  202      223   423      848 
                         
   1,139      3,140   2,640      6,919 
                         
Property and equipment, net        6,817   4,535      11,352 
Investments of insurance subsidiary           642      642 
Investments in and advances to affiliates        248   621      869 
Goodwill        1,635   1,058      2,693 
Deferred loan costs  23   351            374 
Investments in and advances to subsidiaries  14,282            (14,282)   
Other  776   39   21   167      1,003 
                         
  $16,220  $390  $11,861  $9,663  $(14,282) $23,852 
                         
                         
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY                        
Current liabilities:                        
Accounts payable $  $  $919  $618  $  $1,537 
Accrued salaries        556   339      895 
Other accrued expenses  12   296   328   609      1,245 
Long-term debt due within one year     554   12   26      592 
                         
   12   850   1,815   1,592      4,269 
                         
Long-term debt  1,525   25,758   95   255      27,633 
Intercompany balances  25,985   (16,130)  (12,833)  2,978       
Professional liability risks           995      995 
Income taxes and other liabilities  483   425   505   195      1,608 
                         
   28,005   10,903   (10,418)  6,015      34,505 
                         
Equity securities with contingent redemption rights  141               141 
                         
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.   (11,926)  (10,513)  22,167   2,628   (14,282)  (11,926)
Noncontrolling interests        112   1,020      1,132 
                         
   (11,926)  (10,513)  22,279   3,648   (14,282)  (10,794)
                         
  $16,220  $390  $11,861  $9,663  $(14,282) $23,852 
                         


F-38


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
   Eliminations  Condensed
Consolidated
 

ASSETS

        

Current assets:

        

Cash and cash equivalents

  $   $   $115   $258    $   $373  

Accounts receivable, net

           2,429    2,104         4,533  

Inventories

           602    452         1,054  

Deferred income taxes

   594                     594  

Other

   50        184    445         679  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   644        3,330    3,259         7,233  

Property and equipment, net

           7,088    5,746         12,834  

Investments of insurance subsidiaries

               548         548  

Investments in and advances to affiliates

           15    86         101  

Goodwill and other intangible assets

           1,605    3,646         5,251  

Deferred loan costs

   22    268                 290  

Investments in and advances to subsidiaries

   16,825                 (16,825    

Other

   450        21    170         641  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
  $17,941   $268   $12,059   $13,455    $(16,825 $26,898  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY

        

Current liabilities:

        

Accounts payable

  $   $   $899   $698    $   $1,597  

Accrued salaries

           568    397         965  

Other accrued expenses

   15    367    449    754         1,585  

Long-term debt due within one year

       1,347    28    32         1,407  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   15    1,714    1,944    1,881         5,554  

Long-term debt

   1,525    23,454    110    556         25,645  

Intercompany balances

   24,121    (12,814  (15,183  3,876           

Professional liability risks

               993         993  

Income taxes and other liabilities

   538    415    556    211         1,720  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   26,199    12,769    (12,573  7,517         33,912  

Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.

   (8,258  (12,501  24,534    4,792     (16,825  (8,258

Noncontrolling interests

           98    1,146         1,244  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   (8,258  (12,501  24,632    5,938     (16,825  (7,014
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
  $17,941   $268   $12,059   $13,455    $(16,825 $26,898  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING BALANCE SHEET

DECEMBER 31, 2009
2010

(Dollars in millions)

                     
        Subsidiary
       
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
ASSETS
                    
Current assets:                    
Cash and cash equivalents $  $95  $217  $  $312 
Accounts receivable, net     2,135   1,557      3,692 
Inventories     489   313      802 
Deferred income taxes  1,192            1,192 
Other  81   148   350      579 
                     
   1,273   2,867   2,437      6,577 
                     
Property and equipment, net     7,034   4,393      11,427 
Investments of insurance subsidiary        1,166      1,166 
Investments in and advances to affiliates     244   609      853 
Goodwill     1,641   936      2,577 
Deferred loan costs  418            418 
Investments in and advances to subsidiaries  21,830         (21,830)   
Other  963   19   131      1,113 
                     
  $24,484  $11,805  $9,672  $(21,830) $24,131 
                     
                     
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY                    
Current liabilities:                    
Accounts payable $  $908  $552  $  $1,460 
Accrued salaries     542   307      849 
Other accrued expenses  282   293   583      1,158 
Long-term debt due within one year  802   9   35      846 
                     
   1,084   1,752   1,477      4,313 
                     
Long-term debt  24,427   103   294      24,824 
Intercompany balances  6,636   (10,387)  3,751       
Professional liability risks        1,057      1,057 
Income taxes and other liabilities  1,176   421   171      1,768 
                     
   33,323   (8,111)  6,750      31,962 
                     
Equity securities with contingent redemption rights  147            147 
                     
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.   (8,986)  19,787   2,043   (21,830)  (8,986)
Noncontrolling interests     129   879      1,008 
                     
   (8,986)  19,916   2,922   (21,830)  (7,978)
                     
  $24,484  $11,805  $9,672  $(21,830) $24,131 
                     


F-39


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
   Eliminations  Condensed
Consolidated
 

ASSETS

        

Current assets:

        

Cash and cash equivalents

  $6   $   $156   $249    $   $411  

Accounts receivable, net

           2,214    1,618         3,832  

Inventories

           547    350         897  

Deferred income taxes

   931                     931  

Other

   202        223    423         848  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   1,139        3,140    2,640         6,919  

Property and equipment, net

           6,817    4,535         11,352  

Investments of insurance subsidiaries

               642         642  

Investments in and advances to affiliates

           248    621         869  

Goodwill and other intangible assets

           1,635    1,058         2,693  

Deferred loan costs

   23    351                 374  

Investments in and advances to subsidiaries

   14,282                 (14,282    

Other

   776    39    21    167         1,003  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
  $16,220   $390   $11,861   $9,663    $(14,282 $23,852  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY

        

Current liabilities:

        

Accounts payable

  $   $   $919   $618    $   $1,537  

Accrued salaries

           556    339         895  

Other accrued expenses

   12    296    328    609         1,245  

Long-term debt due within one year

       554    12    26         592  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   12    850    1,815    1,592         4,269  

Long-term debt

   1,525    25,758    95    255         27,633  

Intercompany balances

   25,985    (16,130  (12,833  2,978           

Professional liability risks

               995         995  

Income taxes and other liabilities

   483    425    505    195         1,608  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   28,005    10,903    (10,418  6,015         34,505  

Equity securities with contingent redemption rights

   141                     141  

Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.

   (11,926  (10,513  22,167    2,628     (14,282  (11,926

Noncontrolling interests

           112    1,020         1,132  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
   (11,926  (10,513  22,279    3,648     (14,282  (10,794
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 
  $16,220   $390   $11,861   $9,663    $(14,282 $23,852  
  

 

 

  

 

 

  

 

 

  

 

 

   

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For The Year Ended December 31, 2010
2011

(Dollars in millions)

                         
  HCA
        Subsidiary
       
  Holdings, Inc.
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Cash flows from operating activities:
                        
Net income $1,207  $(1,750) $2,424  $907  $(1,215) $1,573 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:                        
Change in operating assets and liabilities  12   13   (1,759)  (1,113)     (2,847)
Provision for doubtful accounts        1,632   1,016      2,648 
Depreciation and amortization        782   639      1,421 
Income taxes  27               27 
Gains on sales of facilities           (4)     (4)
Impairments of long-lived assets        58   65      123 
Amortization of deferred loan costs     81            81 
Share-based compensation  32               32 
Equity in earnings of affiliates  (1,215)           1,215    
Other     31            31 
                         
Net cash provided by (used in) operating activities  63   (1,625)  3,137   1,510      3,085 
                         
Cash flows from investing activities:
                        
Purchase of property and equipment        (602)  (723)     (1,325)
Acquisition of hospitals and health care entities        (21)  (212)     (233)
Disposal of hospitals and health care entities        29   8      37 
Change in investments        1   471      472 
Other        (3)  13      10 
                         
Net cash used in investing activities        (596)  (443)     (1,039)
                         
Cash flows from financing activities:
                        
Issuances of long-term debt  1,525   1,387            2,912 
Net change in revolving bank credit facilities     1,889            1,889 
Repayment of long-term debt     (2,164)  (32)  (72)     (2,268)
Distributions to noncontrolling interests        (61)  (281)     (342)
Contributions from noncontrolling interests           57      57 
Payment of debt issuance costs  (23)  (27)           (50)
Distributions to stockholders  (4,257)              (4,257)
Income tax benefits  114               114 
Changes in intercompany balances with affiliates, net  2,590   556   (2,387)  (759)      
Other  (6)  (16)     20      (2)
                         
Net cash provided by (used in) financing activities  (57)  1,625   (2,480)  (1,035)     (1,947)
                         
Change in cash and cash equivalents  6      61   32      99 
Cash and cash equivalents at beginning of period        95   217      312 
                         
Cash and cash equivalents at end of period $6  $  $156  $249  $  $411 
                         


F-40


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Cash flows from operating activities:

       

Net income (loss)

  $2,465   $(1,988 $2,430   $2,478   $(2,543 $2,842  

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

       

Change in operating assets and liabilities

   6    71    (1,755  (1,275      (2,953

Provision for doubtful accounts

           1,644    1,180        2,824  

Depreciation and amortization

           777    688        1,465  

Income taxes

   912                    912  

Gains on sales of facilities

           (127  (15      (142

Gain on acquisition of controlling interest in equity investment

               (1,522      (1,522

Losses on retirement of debt

       481                481  

Amortization of deferred loan costs

       70                70  

Share-based compensation

   26                    26  

Pay-in-kind interest

       (78              (78

Equity in earnings of affiliates

   (2,543              2,543      

Other

       9        (1      8  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) operating activities

   866    (1,435  2,969    1,533        3,933  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from investing activities:

       

Purchase of property and equipment

           (910  (769      (1,679

Acquisition of hospitals and health care entities

           (142  (1,540      (1,682

Disposal of hospitals and health care entities

           200    81        281  

Change in investments

           34    46        80  

Other

               5        5  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash used in investing activities

           (818  (2,177      (2,995
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from financing activities:

       

Issuances of long-term debt

       5,500                5,500  

Net change in revolving bank credit facilities

       (449              (449

Repayment of long-term debt

       (6,577  (17  (46      (6,640

Distributions to noncontrolling interests

           (77  (301      (378

Payment of debt issuance costs

       (92              (92

Issuance of common stock

   2,506                    2,506  

Repurchase of common stock

   (1,503                  (1,503

Distributions to stockholders

   (31                  (31

Income tax benefits

   63                    63  

Changes in intercompany balances with affiliates, net

   (1,918  3,053    (2,098  963          

Other

   11            37        48  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) financing activities

   (872  1,435    (2,192  653        (976
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Change in cash and cash equivalents

   (6      (41  9        (38

Cash and cash equivalents at beginning of period

   6        156    249        411  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash and cash equivalents at end of period

  $   $   $115   $258   $   $373  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For The Year Ended December 31, 2009
2010

(Dollars in millions)

                     
        Subsidiary
       
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Cash flows from operating activities:
                    
Net income $1,054  $2,060  $801  $(2,540) $1,375 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:                    
Change in operating assets and liabilities  90   (1,882)  (1,299)     (3,091)
Provision for doubtful accounts     2,043   1,233      3,276 
Depreciation and amortization     787   638      1,425 
Income taxes  (520)           (520)
Losses (gains) on sales of facilities     17   (2)     15 
Impairments of long-lived assets     34   9      43 
Amortization of deferred loan costs  80            80 
Share-based compensation  40            40 
Pay-in-kind interest
  58            58 
Equity in earnings of affiliates  (2,540)        2,540    
Other  50   (2)  (2)     46 
                     
Net cash provided by (used in) operating activities  (1,688)  3,057   1,378      2,747 
                     
Cash flows from investing activities:
                    
Purchase of property and equipment     (720)  (597)     (1,317)
Acquisition of hospitals and health care entities     (38)  (23)     (61)
Disposal of hospitals and health care entities     21   20      41 
Change in investments     (7)  310      303 
Other        (1)     (1)
                     
Net cash used in investing activities     (744)  (291)     (1,035)
                     
Cash flows from financing activities:
                    
Issuances of long-term debt  2,979            2,979 
Net change in revolving bank credit facilities  (1,335)           (1,335)
Repayment of long-term debt  (2,972)  (7)  (124)     (3,103)
Distributions to noncontrolling interests     (70)  (260)     (330)
Payment of debt issuance costs  (70)           (70)
Changes in intercompany balances with affiliates, net  3,107   (2,275)  (832)      
Other  (21)     15      (6)
                     
Net cash provided by (used in) financing activities  1,688   (2,352)  (1,201)     (1,865)
                     
Change in cash and cash equivalents     (39)  (114)     (153)
Cash and cash equivalents at beginning of period     134   331      465 
                     
Cash and cash equivalents at end of period $  $95  $217  $  $312 
                     


F-41


   HCA
Holdings, Inc.
Issuer
  HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Cash flows from operating activities:

       

Net income (loss)

  $1,207   $(1,750 $2,424   $907   $(1,215 $1,573  

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

       

Change in operating assets and liabilities

   12    13    (1,759  (1,113      (2,847

Provision for doubtful accounts

           1,632    1,016        2,648  

Depreciation and amortization

           782    639        1,421  

Income taxes

   27                    27  

Gains on sales of facilities

               (4      (4

Impairments of long-lived assets

           58    65        123  

Amortization of deferred loan costs

       81                81  

Share-based compensation

   32                    32  

Equity in earnings of affiliates

   (1,215              1,215      

Other

       31                31  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) operating activities

   63    (1,625  3,137    1,510        3,085  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from investing activities:

       

Purchase of property and equipment

           (602  (723      (1,325

Acquisition of hospitals and health care entities

           (21  (212      (233

Disposal of hospitals and health care entities

           29    8        37  

Change in investments

           1    471        472  

Other

           (3  13        10  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash used in investing activities

           (596  (443      (1,039
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from financing activities:

       

Issuances of long-term debt

   1,525    1,387                2,912  

Net change in revolving bank credit facilities

       1,889                1,889  

Repayment of long-term debt

       (2,164  (32  (72      (2,268

Distributions to noncontrolling interests

           (61  (281      (342

Contributions from noncontrolling interests

               57        57  

Payment of debt issuance costs

   (23  (27              (50

Distributions to stockholders

   (4,257                  (4,257

Income tax benefits

   114                    114  

Changes in intercompany balances with affiliates, net

   2,590    556    (2,387  (759        

Other

   (6  (16      20        (2
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) financing activities

   (57  1,625    (2,480  (1,035      (1,947
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Change in cash and cash equivalents

   6        61    32        99  

Cash and cash equivalents at beginning of period

           95    217        312  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash and cash equivalents at end of period

  $6   $   $156   $249   $   $411  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

HCA HOLDINGS, INC.

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

For The Year Ended December 31, 2008
2009

(Dollars in millions)

                     
        Subsidiary
       
  HCA Inc.
  Subsidiary
  Non-
     Condensed
 
  Issuer  Guarantors  Guarantors  Eliminations  Consolidated 
 
Cash flows from operating activities:
                    
Net income $673  $1,734  $595  $(2,100) $902 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:                    
Change in operating assets and liabilities  (11)  (2,085)  (1,271)     (3,367)
Provision for doubtful accounts     2,073   1,336      3,409 
Depreciation and amortization     776   640      1,416 
Income taxes  (448)           (448)
Gains on sales of facilities     (5)  (92)     (97)
Impairments of long-lived assets        64      64 
Amortization of deferred loan costs  79            79 
Share-based compensation  32            32 
Equity in earnings of affiliates  (2,100)        2,100    
Other     (19)  19       
                     
Net cash provided by (used in) operating activities  (1,775)  2,474   1,291      1,990 
                     
Cash flows from investing activities:
                    
Purchase of property and equipment     (927)  (673)     (1,600)
Acquisition of hospitals and health care entities     (34)  (51)     (85)
Disposal of hospitals and health care entities     27   166      193 
Change in investments     (26)  47      21 
Other     (4)  8      4 
                     
Net cash used in investing activities     (964)  (503)     (1,467)
                     
Cash flows from financing activities:
                    
Net change in revolving bank credit facilities  700            700 
Repayment of long-term debt  (851)  (4)  (105)     (960)
Distributions to noncontrolling interests     (32)  (146)     (178)
Changes in intercompany balances with affiliates, net  1,935   (1,505)  (430)      
Other  (9)     (4)     (13)
                     
Net cash provided by (used in) financing activities  1,775   (1,541)  (685)     (451)
                     
Change in cash and cash equivalents     (31)  103      72 
Cash and cash equivalents at beginning of period     165   228      393 
                     
Cash and cash equivalents at end of period $  $134  $331  $  $465 
                     


F-42


   HCA Inc.
Issuer
  Subsidiary
Guarantors
  Subsidiary
Non-
Guarantors
  Eliminations  Condensed
Consolidated
 

Cash flows from operating activities:

      

Net income

  $1,054   $2,060   $801   $(2,540 $1,375  

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

      

Change in operating assets and liabilities

   90    (1,882  (1,299      (3,091

Provision for doubtful accounts

       2,043    1,233        3,276  

Depreciation and amortization

       787    638        1,425  

Income taxes

   (520              (520

Losses (gains) on sales of facilities

       17    (2      15  

Impairments of long-lived assets

       34    9        43  

Amortization of deferred loan costs

   80                80  

Share-based compensation

   40                40  

Pay-in-kind interest

   58                58  

Equity in earnings of affiliates

   (2,540          2,540      

Other

   50    (2  (2      46  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) operating activities

   (1,688  3,057    1,378        2,747  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from investing activities:

      

Purchase of property and equipment

       (720  (597      (1,317

Acquisition of hospitals and health care entities

       (38  (23      (61

Disposal of hospitals and health care entities

       21    20        41  

Change in investments

       (7  310        303  

Other

           (1      (1
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash used in investing activities

       (744  (291      (1,035
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash flows from financing activities:

      

Issuances of long-term debt

   2,979                2,979  

Net change in revolving bank credit facilities

   (1,335              (1,335

Repayment of long-term debt

   (2,972  (7  (124      (3,103

Distributions to noncontrolling interests

       (70  (260      (330

Payment of debt issuance costs

   (70              (70

Changes in intercompany balances with affiliates, net

   3,107    (2,275  (832        

Other

   (21      15        (6
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Net cash provided by (used in) financing activities

   1,688    (2,352  (1,201      (1,865
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Change in cash and cash equivalents

       (39  (114      (153

Cash and cash equivalents at beginning of period

       134    331        465  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

Cash and cash equivalents at end of period

  $   $95   $217   $   $312  
  

 

 

  

 

 

  

 

 

  

 

 

  

 

 

 

HCA HOLDINGS, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

NOTE 1718 —SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION AND OTHER COLLATERAL-RELATED INFORMATION (Continued)

Healthtrust, Inc. — The Hospital Company (“Healthtrust”) is the first-tier subsidiary of HCA Inc. The common stock of Healthtrust has been pledged as collateral for the senior secured credit facilities and senior secured notes described in Note 9.10. Rule 3-16 ofRegulation S-X under the Securities Act requires the filing of separate financial statements for any affiliate of the registrant whose securities constitute a substantial portion of the collateral for any class of securities registered or being registered. We believe the separate financial statements requirement applies to Healthtrust due to the pledge of its common stock as collateral for the senior secured notes. Due to the corporate structure relationship of HCA and Healthtrust, HCA’s operating subsidiaries are also the operating subsidiaries of Healthtrust. The corporate structure relationship, combined with the application of push-down accounting in Healthtrust’s consolidated financial statements related to HCA’s debt and financial instruments, results in the consolidated financial statements of Healthtrust being substantially identical to the consolidated financial statements of HCA. The consolidated financial statements of HCA and Healthtrust present the identical amounts for revenues, expenses, net income, assets, liabilities, total stockholders’ deficit, net cash provided by operating activities, net cash used in investing activities and net cash used in financing activities. Certain individual line items in the HCA consolidated statements of stockholders’ deficit and cash flows are combined into one line item in the Healthtrust consolidated statements of stockholder’s deficit and cash flows.

deficit.

Reconciliations of the HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit and Consolidated Statements of Cash Flows presentationspresentation to the Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit and Consolidated Statements of Cash Flows presentationspresentation for the years ended December 31, 2011, 2010 2009 and 20082009 are as follows (dollars in millions):

             
  2010  2009  2008 
 
Presentation in HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit:            
Share-based benefit plans $43  $47  $40 
Other  120   14   2 
             
Presentation in Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit:            
Distributions from HCA Holdings, Inc., net of contributions to HCA Holdings, Inc.  $163  $61  $42 
             
Presentation in HCA Holdings, Inc. Consolidated Statements of Cash Flows (cash flows from financing activities):            
Other $  $  $(9)
             
Presentation in Healthtrust Inc. — The Hospital Company Consolidated Statements of Cash Flows (cash flows from financing activities):            
Net cash distributions to HCA Holdings, Inc.  $  $  $(9)
             

   2011   2010   2009 

Presentation in HCA Holdings, Inc. Consolidated Statements of Stockholders’ Deficit:

      

Share-based benefit plans

  $35    $43    $47  

Reclassification of certain equity securities with contingent redemption rights

   141            

Other

   36     120     14  
  

 

 

   

 

 

   

 

 

 

Presentation in Healthtrust, Inc. — The Hospital Company Consolidated Statements of Stockholder’s Deficit:

      

Distributions from HCA Holdings, Inc., net of contributions to HCA Holdings, Inc.

  $212    $163    $61  
  

 

 

   

 

 

   

 

 

 

Due to the consolidated financial statements of Healthtrust being substantially identical to the consolidated financial statements of HCA, except for the items presented in the tables above, the separate consolidated financial statements of Healthtrust are not presented.

NOTE 18 —SUBSEQUENT EVENT
February 16, 2011 Increase in Authorized Shares and Stock Split

NOTE 19 — SUBSEQUENT EVENT

On February 16, 2011,3, 2012, our Board of Directors approved an increasedeclared a distribution to the Company’s stockholders and holders of vested stock awards. The distribution will be $2.00 per share and vested stock award, or approximately $975 million in the numberaggregate. The distribution is expected to be paid on February 29, 2012 to holders of authorized sharesrecord on February 16, 2012. The distribution is expected to 1,800,000,000 sharesbe funded using funds available under our existing senior secured credit facilities. Pursuant to the terms of commonour stock award plans, the holders of nonvested stock options and stock appreciation rights will receive a 4.505 -to-one split$2.00 per share reduction (subject to certain tax related limitations for certain stock awards that resulted in deferred distributions for a portion of the Company’s issued and outstanding common stock. The increase indeclared distribution, which will be paid upon the authorized shares andvesting of the applicable stock split are expected to become effective immediately prioraward) to the effectivenessexercise price of their share-based awards. The holders of any nonvested restricted share units will be paid $2.00 per unit upon the vesting of the initial public offering of our common stock. Since the increase in the authorized shares and the stock split are not yet effective, the commonapplicable restricted share and per common share amounts in these consolidated financial statements and notes to consolidated financial statements have not been restated.


F-43

units.


HCA HOLDINGS, INC.

QUARTERLY CONSOLIDATED FINANCIAL INFORMATION

(UNAUDITED)

(Dollars in millions)

                 
  2010 
  First  Second  Third  Fourth 
 
Revenues $7,544  $7,756  $7,647  $7,736 
Net income $476(a) $378(b) $325(c) $394(d)
Net income attributable to HCA Holdings, Inc.  $388(a) $293(b) $243(c) $283(d)
Basic earnings per share $4.11(a) $3.09(b) $2.57(c) $2.99(d)
Diluted earnings per share $4.02(a) $3.01(b) $2.49(c) $2.91(d)
                 
  2009 
  First  Second  Third  Fourth 
 
Revenues $7,431  $7,483  $7,533  $7,605 
Net income $432(e) $365(f) $274(g) $304(h)
Net income attributable to HCA Holdings, Inc.  $360(e) $282(f) $196(g) $216(h)
Basic earnings per share $3.81(e) $3.00(f) $2.07(g) $2.29(h)
Diluted earnings per share $3.76(e) $2.96(f) $2.04(g) $2.24(h)

   2011 
   First  Second  Third  Fourth 

Revenues(i)

  $7,406   $7,249   $7,258   $7,769  

Net income

  $334(a)  $320(b)  $146(c)  $2,042(d) 

Net income attributable to HCA Holdings, Inc.

  $240(a)  $229(b)  $61(c)  $1,935(d) 

Basic earnings per share

  $0.54   $0.44   $0.12   $4.43  

Diluted earnings per share

  $0.52   $0.43   $0.11   $4.25  

   2010 
   First  Second  Third  Fourth 

Revenues(i)

  $6,980   $6,968   $6,926   $7,161  

Net income

  $476(e)  $378(f)  $325(g)  $394(h) 

Net income attributable to HCA Holdings, Inc.

  $388(e)  $293(f)  $243(g)  $283(h) 

Basic earnings per share

  $0.91   $0.69   $0.57   $0.66  

Diluted earnings per share

  $0.89   $0.67   $0.55   $0.65  

(a)First quarter results include $2 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $149 million of costs related to the termination of management agreement (See NOTE 1 of the notes to consolidated financial statements).

(b)Second quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $47 million of losses on retirement of debt (See NOTE 10 of the notes to consolidated financial statements).

(c)Third quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $256 million of losses on retirement of debt (See NOTE 10 of the notes to consolidated financial statements).

(d)Fourth quarter results include $84 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $1.424 billion of gain on acquisition of controlling interest in equity investment (See NOTE 3 of the notes to consolidated financial statements).

(e)First quarter results include $12 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).

(b)(f)Second quarter results include $57 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).

(c)(g)Third quarter results include $1 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $6 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).

(d)(h)Fourth quarter results include $3 million of gains on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $2 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).

(e)(i)FirstThe “Revenues” presented for each quarter results include $3 million of losses on sales2010 and the first and second quarters of facilities2011 have been reduced by the provision for doubtful accounts for each quarter in accordance with our adoption of ASU 2011-07 in the third quarter of 2011. The “Revenues” presented for the second and third quarters of 2011 have been reduced for the reclassification of “Electronic health record incentive income” as a separate line item in our consolidated income statements (See NOTE 3 of the notes to consolidated financial statements) and $6 million of costs related to the impairments of long-lived assets (See NOTE 41 of the notes to consolidated financial statements).
(f)Second quarter results include $2 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $2 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).
(g)Third quarter results include $2 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).
(h)Fourth quarter results include $4 million of losses on sales of facilities (See NOTE 3 of the notes to consolidated financial statements) and $24 million of costs related to the impairments of long-lived assets (See NOTE 4 of the notes to consolidated financial statements).


F-44

F-49